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ABBREVIATIONS
ACAB anticanalicular autoantibodies
AI apoptotic index
APAAP alkaline phosphatase anti-alkaline phosphatase method
BCIP 5-bromo-4-chloro-3-indol-phosphate
BSA bovine serum albumin
cag A cytotoxin-associated gene A
CagA cytotoxin-associated CagA protein, coded by cagA
CCUG Culture Collection of University of Gothenburg, Sweden
Cl confidence interval
D-cells somatostatin cells
DNA deoxyribonucleic acid
dUTP deoxyuridine triphosphate
ELISA enzyme-linked immunosorbent assay
FC foveolar cells
G-cells gastrin cells
GP glandular part
H+, K+ ATP-ase H+, K+ adenosine triphosphatase
H. pylori Helicobacter pylori
HSP60 heat shock protein 60
HMFG human milk fat globule membranes
IgA,G, M Immunoglobulin class A, G, M
IF immunofluorescence
IL interleukin
kb kilobase
kD kiloDalton
LI labelling index
MALT mucosa-associated lymphoid tissue
NAP neutrophil activating protein
NBT nitro blue tetrazolium
NCTC National Collection of Type Cultures, London
OD optical density
OR odds ratio
PAI pathogenesity island
PAP peroxidase-antiperoxidase method
PCA parietal cell antibodies
PCNA Proliferating Cell Nuclear Antigen
PCR polymerase chain reaction
PBS phosphate buffered saline
PZ proliferating zone
RAA relative antibody activity
SD standard deviation
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SDS-PAGE Sodium-dodecyl-sulphate polyacryl-amide-gel- 
electrophoresis 
TdT terminal deoxynucleotidyl transferase
TFSS type IV secretion system
TRIS Tris (hydroxymethyl) aminomethane
TUNEL terminal deoxynucleotidyl transferase-mediated dUTP nick
end-labelling 
vac A gene for vacuolating toxin
Vac A vacuolating toxin
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BACKGROUND
The long tradition o f research into chronic gastritis in Estonia, initiated by Lauri 
Walk in the late 1930s and expanded further by a group of gastroenterologists 
from the University of Tartu under Prof. Kaljo Villako’s guidance forms the 
background of present study. The long-term follow-up research of gastritis in a 
randomly selected population from Saaremaa Island undertaken by Prof. K. Vil­
lako in 1979, and conducted in close collaboration with a Finnish team under 
the aegis o f Prof. Max Siurala since 1971, revealed that chronic gastritis is a 
very common disease among Estonians, with peculiarities of behaviour in the 
antrum and corpus mucosa.
Since the discovery of H. pylori in 1982, it become evident that enhanced 
gastric inflammatory response, development of gastric mucosa atrophy and 
increased risk for peptic ulcer and gastric cancer are associated with this gastric 
pathogen. Infection with H. pylori strains expressing cytotoxin-associated CagA 
protein constitutes factors particularly associated with the aforementioned 
diseases.
Based on the above mention considerations as well as on retrospective 
studies on the frequency o f H. pylori in gastric biopsies from random samples 
of Estonian populations, peptic ulcer patients as well as hospitalized children 
(Maaroos et al. 1990, 1991a, 1991b), the present study was at first undertaken, 
as a cross-sectional investigation of seropositivity for H. pylori in two Estonian 
adult populations and in a population of schoolchildren, since serology is the 
most suitable indicator o f infection rate in epidemiological studies. A large- 
scale epidemiological study of several immunologically mediated diseases orga­
nized by the Tartu University Department o f Immunology, which started in 
1990 in two Southern Estonian small towns, offered a good opportunity to fulfil 
the primary aim of the present study. A cross-sectional study of schoolchildren, 
carried out in 1993-1996 by the staff members of the Tartu University Depart­
ment o f Paediatrics, made it possible to determine the seroprevalence of 
H. pylori in nonhospitalized children.
The background of our seroepidemiological investigations includes also our 
meeting with Prof. Torkel Wadström during the Congress of Interlec 11 (Tartu- 
Tallinn, 1989). He and his colleagues from the University of Lund, particularly 
Ingrid Nilsson, introduced to us serological methods for determination of 
H. pylori and supplied us with H  pylori antigens.
The invaluable opportunity to use the samples o f the 18-years follow-up 
study of chronic gastritis in Saaremaa, prompted us to investigate whether 
seropositivity for H. pylori antigens, such as acid glycine extracted cell surface 
proteins, CagA and heat shock protein 60 (HSP 60), which are highly 
immunogenic, is associated with increased recruitment o f inflammatory cells as 
local immune response of the host to this pathogen and, specifically, with 
progression of atrophic gastritis in a direct long-term follow-up.
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A considerable proportion of H. pylori infected patients develop auto­
immune reactions against gastric epithelial cells. In particular, anticanalicular 
autoantibodies (ACAB), reacting against canalicular structures within human 
parietal cells, can be demonstrated in 30% of infected patients. Gastric H+, 
K + —  adenosine triphosphatase (H+, K+ ATP-ase) represents the major auto­
antigen o f these autoantibodies. This particular type o f antigastric autoimmunity 
can be associated with atrophic corpus gastritis (Negrini et al. 1996, Faller et al. 
1996, Claeys et al. 1998). Hence it was our aim to evaluate the significance of 
ACAB in development of gastric corpus mucosa atrophy, which represented an 
extension o f an earlier research of parietal cell antibodies (PCA) in chronic 
gastritis patients and in a population sample during follow up in Estonia 
(Salupere 1968, Uibo et al. 1984a, 1989, 1991). This part of the study was 
performed under the kind supervision of Dr. Gerhard Faller and Prof. Thomas 
Kirchner from the University of Erlangen-Ntirnberg, pioneers of the elaboration 
of the method for detection of anticanalicular autoantibodies.
There is evidence that H. pylori is associated with changes of epithelial cell 
turnover and increased apoptosis (programmed cell death) in the gastric 
epithelium, which can lead to development of atrophy of the gastric mucosa 
(Moss et al. 1996, Peek et al. 1997, Correa and Miller 1998, Steininger et al. 
1998, von Herbay and Rudi 2000). However, in previous studies apoptosis was 
investigated only in one gastric area, without taking account of the fact that H. 
pylori colonization, as well as activity of gastritis and chronic inflammation can 
exert a different effect on apoptosis o f epithelial cells in the antrum and corpus. 
Moreover, also some follow-up studies evaluated apoptosis only at the initial 
time point (Moss et al. 1999). Therefore, in the present study we attempted to 
examine gastric epithelial cell apoptosis both in the antrum and in corpus at the 
initial and end points of a long-term follow-up study. Also we tested the hypo­
thesis that increased apoptosis may be responsible for progression of atrophy 
and is associated with higher degree of chronic inflammation, activity of 
gastritis and H. pylori colonization. Moreover, upregulation of apoptosis 
protectors, like bcl-2 oncoprotein, by presence of H. pylori, as well as 
enhancement of epithelial cell proliferation may supply cells with a survival 
advantage and hence play a role in carcinogenic pathway (Hockenberry et al.
1990, Lauwers et al. 1994). For a better understanding of the role of H. pylori 
and grade of gastritis in this aspect of cell turnover, as well as on the density of 
antral and corpus specific cells, an investigation of consecutive patients, under­
going gastroduodenoscopy in the University Hospital of Bern was undertaken 
under the kind supervision of Prof. Fred Halter and Prof. Arthur Zimmermann.
Taking into consideration the peculiarities of the behaviour of gastritis in the 
antrum and corpus (Stolte et al. 1990), we aimed also to analyse whether there 
exist dissimilarities between the antrum and corpus mucosa in immune response 
to different H. pylori antigens, in association with development of atrophy and 
in the effect of H. pylori on cellular turnover.
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REVIEW OF LITERATURE
H. pylori is a gastric pathogen, which penetrates the gastric mucus layer, 
facilitated by its spiral shape and multiple flagella, and colonizes the lower part 
o f the mucus layer of the stomach mucosa (Warren and Marshall 1983). 
Adhesion of H. pylori to gastric epithelial cells, involving the interactions 
between sialic acid-binding proteins of H. pylori with gastrointestinal mucins 
(Boren et al. 1993, Hirmo 2000) and Lewis blood group antigens (Klaamas et 
al. 1997, Kurtenkov et al. 1999, Guruge et al. 1998, liver et al. 1998), as well as 
the production of specific virulence factors, like urease and cytotoxins, allow 
for H. pylori to adapt excellently to the gastric environment and to contribute to 
mucosal damage, either directly or indirectly by mediating inflammatory 
response to H. pylori.
H. pylori infection is common world-wide and it is estimated that over one 
half of the world is infected with this organism (Megraud et al. 1989, Taylor 
and Blaser 1991, Pounder 1995), whereas prevalence is much more common in 
developing countries, where most children are infected by 10 years of age 
(Taylor and Parsonnet 1995). Acquisition of H. pylori is a birth cohort-depen­
dent phenomenon (Parsonnet et al. 1992, Banatvala et al. 1993, Cullen et al.
1993, Sipponen 1995, Sonnenberg 1995). It is established that most infections 
with H. pylori occur in childhood (Banatvala et al. 1993, Sipponen 1995) and 
that early acquisition of H. pylori results in more intense inflammation and early 
development of atrophic gastritis with higher risk of gastric cancer and gastric 
ulcer (Blaser et al. 1995, Sipponen et al. 1998).
There is evidence that H. pylori causes acute and chronic inflammation in 
the stomach, the degree of inflammation varies from host to host and is depen­
dent on pathogen strains (Covacci et al. 1999). H. pylori is recognized as a 
causative pathogen for gastritis and is strongly associated with peptic ulcers and 
gastric cancer (Maaroos et al. 1991a, 1994, Vorobjova et al. 1991, Parsonnet et 
al. 1991, Correa 1992, Cover and Blaser 1992a, Halter et al. 1992, Forman 
1996, Kawaguchi et al. 1996, Sipponen et al. 1998, Danesh 1999, Sipponen and 
Marshall 2000). The disease associations are largely dependent on the pheno­
typic appearance of gastritis in the stomach (Sipponen 2001), on the H. pylori 
genotypes and also is determined by a complex interaction between host and 
bacterial factors (Ernst et al. 2000a, Jenks and Kusters 2000, Blaser and Berg 
2001, Israel et al. 2001, Tham et al. 2001).
Virulence factors of H. pylori and pathogenesis of infection
The virulence factors as flagella and urease, required for colonization and 
survival in the human stomach, are produced by all H. pylori strains (Covacci et 
al. 1999). Also, neutrophil activating protein (NAP) and vacuolating cytotoxin 
A (VacA), which act directly on the surrounding gastric mucosa, are expressed 
by all strains o f H. pylori. NAP is involved in the recruitment of neutrophils to
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the gastric mucosa and may contribute to inflammatory response (Evans et al.
1995).
Vacuolating cytotoxin A (VacA)
VacA is known as the major exotoxin, produced by H. pylori, which induces 
cytoplasmic vacuolation in eukaryotic cells (Leunk et al. 1988, Cover et al.
1990, Cover and Blaser, 1992b). VacA consists of 95 kDa monomers proteoly- 
tically cleaved into 37 kDa and 58 kDa fragments. One subunit is endowed with 
biological activity, while the other recognises the receptor on target cells and 
mediates adhesion (Telford et al. 1994). An important property o f VacA is 
alteration o f intracellular vesicular trafficking in eukaryotic cells leading to the 
formation o f large vacuoles. Additionally, VacA causes changes in transepithe- 
lial electrical resistance in polarised monolayers and forms ion channels in lipid 
bilayers o f cell membrane (Reyrat et al. 1999). The vac A  gene is a mosaic that 
varies between strains, particularly in the region encoding its signal sequence 
(s) and its mid-region (m) (Atherton et al. 1995). The toxicity of H. pylori 
strains depends largely on presence of the cell binding domain which exists in 
two allele forms, m l and m2, of the mid-region of the vac A  gene, whereas only 
the m2 cytotoxin is able to induce vacuolisation in primary gastric cells and is 
found in populations that have a high prevalence of peptic ulcer and gastric 
cancer (Pagliaccia et al. 1998). Also, presence of antibodies to VacA is more 
frequently observed in patients with gastric adenocarcinoma (De Figueiredo et 
al. 1998, Grimley et al. 1999). A recent study of Sillakivi et al. (2001) in 
Estonia revealed that there are differences in the distribution of vacA  s and m 
subtypes o f H. pylori between Estonian and Russian patients with the above 
mentioned disease: namely, the si a/ml subtype was found predominantly in 
Estonian patients and the sla/m2 subtype in Russian patients, which indicate the 
diversity o f H. pylori genotypes among different nationalities in Estonia.
Pathogenesity island (PAI) and cytotoxin-associated gene A protein (CagA)
H. pylori strains are grouped into two families, type I and type II, based on the 
fact whether they express or do not express the vacuolating cytotoxin (VacA) 
and the CagA antigen (cytotoxin-associated gene A protein) (Xiang et al. 1993). 
CagA is an immunodominant antigen of H. pylori with molecular weight 
ranging from 128 kDa to 140 kDa (Covacci et al. 1993). There is evidence that 
patients with duodenal ulcers and gastric cancer are most often infected by type
I strains (Covacci et al. 1993, Xiang et al. 1993). The CagA gene is present only 
in type I strains, while the vacA  gene is present in both types and an active toxin 
is produced only by type I strains (Xiang et al. 1993).
Censini et al. (1996) have shown that the difference between type I and type
II is restricted not only to the cagA  and vacA  genes but is due to presence in 
type I strains o f a 40-kb pathogenesity island (PAI) that contains the cagA  gene 
(Censini et al. 1996). Cag PAI induces epithelial cells to secrete IL-8, a media­
tor o f inflammation, by activating nuclear factor kappa B (NFkB) complexes,
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and induces remodelling o f cell surface as well as pedestal formation (Censini 
et al. 1996, Segal et al. 1996). Cag-PAI encodes an ancient, contact-dependent 
secretion system, the so called type IV secretion system (TFSS) that serves to 
transfer a variety o f multimolecular complexes across the bacterial membrane to 
the extracellular space or into other cells (Covacci et al. 1999, Christie et al.
2000). It has been demonstrated recently that via TFSS H. pylori translocates 
CagA protein directly into gastric epithelial cells where it is tyrosine- 
phosphorylated by host cell kinases (Segal et al. 1999, Asahi et al. 2000, 
Backert et al. 2000, Odenbreit et al. 2000, Stein et al. 2000), followed by a 
modification of host cell signal transduction pathways, resulting in actin reorga­
nization and host cell morphological changes, such as elongation and spreading 
of host cells (Segal et al. 1999). CagA is necessary to induce a growth-factor­
like phenotype (hummingbird) in host gastric cells and may play an important 
role in carcinogenesis associated with type I infection. Additionally, a second 
cellular phenotype, induced after attachment by H. pylori (stress fiber 
associated, SFA), is CagA independent and is produced by type I and type I I H. 
pylori and may play a role in the pathogenesis of gastritis (Segal et al. 1999). 
Thus, the importance o f CagA in the pathogenesis of peptic ulcer, gastritis and 
gastric cancer is associated with the fact that CagA is the first H. pylori protein 
shown to be translocated into the host and the one targeted to the host cell signal 
transduction pathway (Backert et al. 2000, Censini et al. 2001). Israel et al. 
(2001) showed that the ability of H. pylori strains to induce epithelial cell 
response related to inflammation depends on the presence of an intact cag PAI.
Heat shock protein (HSP) o f  H. pylori
In 1992, Dunn et al. identified a homologue of the chaperonin 60 family o f heat 
shock proteins (HSP) in H. pylori and showed that this protein is immunogenic 
in individuals infected with H. pylori. HSPs are a highly conserved group of 
proteins found in all (prokaryotes as well eukaryotic) organisms (Craig et al. 
1993). H. pylori synthesizes two HSPs: HSP A (GroES or HSP 10 homologue) 
and HSP B (GroEL or HSP 60 homologue) (Dunn et al. 1992, Macchia et al.
1993, Suerbaum et al. 1994). To protect itself against the host, the pathogen 
activates various evasion mechanisms including HSP synthesis (Zügel and 
Kaufmann 1999). On the other hand, several reports have shown that H. pylori 
HSP60 plays a role in induction of chronic mucosal inflammation, suggesting 
also the triggering role o f HSP60 by an autoimmune response, which results in 
gastric atrophy (Engstrand et al. 1991, 1993, Kamiya et al. 1998). It has been 
shown that purified HSP60 of H. pylori is able to stimulate secretion of IL-8 
from gastric epithelial cells and can be considered one o f the virulence factors 
which plays an important role in mucosal inflammation (Kamiya et al. 1998).
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Immunogenic cell surface associated proteins of H. pylori are summarised in 
Table 1. (according to Nilsson, 1998 with modifications):
MW (kDa) Protein References
120-140 (CagA) Cytotoxin-associated gene A protein Covacci et al. 1993
37,58, 95 (Vac A) Vacuolating cytotoxin A Telford et al. 1994
74 (BabA) Adhesin (receptor) for the Lewis'3 
antigen
liver etal. 1998
26.5-30, 61.5 Urease subunits (A, B, E, F, G, H, I) Hu and Mobley 1990
58 (HspB) 
13 (HspA)
Heat shock-proteins, GroEL and 
GroES homologues
T>\xxmetal. 1992, 
Suerbaum et al. 1994
53 (FlaA)
54 (FlaB) 
29 (HpaA)
Flagellin
Flagellar sheath, outer membrane 
lipoprotein
Kostrzynska et al. 
1991
O ’Toole et al. 1995
31,48-50 , 67 Porins Hancock and Exner 
1997
29-31,33 Immunogenic cell surface proteins with 
high specifity
Nilsson etal. 1997
26 Cell surface exposed protein, H. pylori 
specific
O ’Toole et al. 1991
25 Lectin-like immunogenic adhesin Oderda etal. 1997
19 Outer membrane protein, species 
specific
Drouet et al. 1991
Host response to H. pylori
In most bacterial infections, the host’s immune defence is able to clear in­
fection. This is not the case with H. pylori infection, which continues to persist 
despite strong mucosal and systemic antibody responses and local inflammatory 
responses to the pathogen (Figura 1996, Sommer et al. 1998).
Non-specific host response
Host defence against microbial infection is a complex of non-specific barriers 
and non-specific and specific immune responses. The first factors which 
respond to invasion of H. pylori include digestive enzymes, lysozyme, lacto- 
ferrin, pepsin and gastric acid. The mucus layer of the stomach is the final non­
specific barrier against the bacteria. The glycoproteins of the mucus layer build 
a net containing lectin-like adhesins, which is necessary for prevention of 
bacterial penetration. However, the spiral shape of H. pylori and flagella allows 
H. pylori to penetrate through this glycoprotein gel and reach gastric epithelial 
cells (Andersen and Hoick 1996).
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Non-specific immune response
Initial non-specific immune response to H  pylori suggests a strong neutrophilic 
component (Sobala et al. 1991). Severity of mucosal injury appears to be 
directly correlated with the extent of neutrophilic infiltration (Mai et al. 1992, 
Blaser 1992, Davies et al. 1994, Fiocca et al. 1994). H. pylori antigenic compo­
nents, including the water-soluble H. pylori neutrophils activating protein 
(NAP) and the N-terminal end of the large subunit of H. pylori urease are 
chemotactic for neutrophils (Mai et al. 1992, Evans et al. 1995). Water extracts 
of H. pylori contains NAP which increase the surface expression of 
CD1 lb/CD18 on neutrophils, and facilitate and increase adhesion of neutrophils 
to endothelial cells via the intercellular adhesion molecule-1 (ICAM-1) 
(Yoshida et al. 1993). Attraction of inflammatory cells to the site of infection 
results in generation of reactive oxygen metabolites released by phagocytes, 
activated by H. pylori, which cause local mucosal damage, more expressed in 
case of cytotoxin-producing strains (Davies et al. 1994, Rautelin et al. 1996). 
When destruction of the gastric epithelium is progressing, the bacteria might be 
confronted with numerous phagocytes, which however, appears to be in-effec­
tive from the phagocytotic point of view. Recent observations suggests that cag- 
encoded factors through TFSS are translocated into host cells inducing anti­
phagocytic response that may play an essential role in the immune escape of 
this persistent pathogen (Allen et al. 2000, Ramarao et al. 2000, Odenbreit et al. 
2001).
Adherence of H. pylori to epithelial cells induces increased gene expression 
and secretion o f neutrophil-activating and chemotactic chemokines such as IL-8 
(Crabtree et al. 1994, Sharma et al. 1995, Crowe et al. 1995, Rieder et al.
2001). Expression o f IL-8 in gastric epithelial cells is upregulated by the inflam­
matory cytokines TN Fa and IL-1 following activation of the transcription 
nuclear factor kB (NF-kB) (Sharma et al. 1998), as well as by direct bacterial 
stimulation (Grabtree 1996a).
The ability of H. pylori to control IL-8 induction is associated with cagA  
genes in PAI, through tyrosine phosphorilation in host cell (Yakabi et al. 2000), 
with the picB  gene (Tummuru et al. 1995) as well as with the ice A  1 (induced 
by contact with epithelium) gene (Peek et al. 1998) and is dependent on 
activation o f protein kinase C (Kassai et al. 1999).
Cytokines, derived from inflammatory, stromal or epithelial cells, as well as 
expression of growth factors may modulate the growth and differentiation of the 
epithelial cells and contribute to gastric carcinogenesis (Sipponen et al. 1998). 
Cytotoxic H. pylori strains are stronger inducers of IL-8 expression and are 
associated with an increased antral infiltration of polymorphonuclear leukocytes 
(Cover et al. 1993, Crabtree et al. 1994, Sharma et al. 1995, Blaser 1996).
There are data providing some peculiarities of local immune response in 
H. pylori-infected children. Thus children demonstrate a chronic, macrophagic 
and monocytic inflammatory cell infiltrate and a lack of neutrophils as 
compared with the response observed in adults (Ashorn et al. 1995, Torres et al.
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2000). In infancy and early childhood the stomach lacks a significant number of 
immunocompetent lymphocytes and plasma cells (Torres et al. 2000). Immatu­
rity of immune system in early childhood may explain the dissimilarities 
between childhood and adult gastritis (Sipponen et al. 1996a, Meining et al. 
1996).
H. pylori-specific immune response
H. pylori, a bacterium, harbouring highly immunogenic proteins like CagA, 
ITSP60, flagella associated proteins as well as urease, releasing toxins and living 
close to epithelial surface, induces specific host immune response (Crabtree 
1996a). Immunohistochemical studies have shown that in presence o f H. pylori, 
T-cells (both CD4+ and CD8+ lymphocytes) increase in amount and can be 
located very close to the epithelium (Hatz et al. 1996, Bamford et al. 1998). 
During effector-specific immune response, different patterns of cytokine release 
are characteristic of certain functional T-helper (Th) cell subsets, Thl and Th2 
(Romagnani 1991, Del Prete 1998). There is evidence that during infection with 
H. pylori, the Thl phenotype is dominating (Karttunen et al. 1995, D ’Elios et 
al. 1997, Bamford et al. 1998, Sommer et al. 1998). Upon stimulation Thl type 
cells produce proinflammatory cytokines (IFN-y, TNF-a, IL-1, IL-2, IL-6, IL- 
8), whereas Th2 type cells produce predominantly anti-inflammatory cytokines 
(EL-4, IL-5, IL-10, IL-13, TNFp, PGE) (Del Prete 1998, Bamford et al. 1998, 
Lindholm et al. 1998, Ernst 1999). In inflammatory response, associated with 
H  pylori infection, pro-inflammatory cytokines are predominantly induced and 
the balance o f pro- and anti-inflammatory cytokines is inclined towards 
inflammation (Ernst 1999). It was suggested that during evolutionary adaptation 
to the stomach mucosa, H. pylori might have gained the ability to evoke 
“wrong” Thl immune response, which may block the development of protective 
Th2 immune response and therefore induce chronic inflammation by production 
of IFN-y (Sommer et al 1998).
Polarized Thl type response to H. pylori may contribute to the pathogenesis 
of gastric disease (D’Elios et al. 1997). H. pylori is associated with a strong 
expression of class II transplantation antigens on the epithelial cells (Engstrand 
et al. 1989). The IFN-y produced by stimulated Thl cells increases the expres­
sion of class II MHC molecules, possible receptors for H. pylori. The IFN-y 
increases attachment of H. pylori to gastric epithelial cells and induces 
apoptosis in infected cells expressing class II MHC molecules (Fan et al. 1998). 
It is suggested that VacA toxin interferes with protective immunity by a partial 
inhibion of MHC class 11-dependent antigen presentation (Molinari et al. 1998).
Antibody response to H. pylori
Humoral response to H. pylori antigens results from antibody synthesis by the 
gastric B-cells supported by H. pylori antigen activated Th cells (D’Elios et al. 
199f8). Although secretory type IgA predominate in the gastric juice of
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H. pylori-infected patients, majority of H. pylori-specific IgA are non-secretory 
(Birkholz et al. 1998). It was shown that the gastric mucosa of H. pylori- 
infected individuals contains large numbers of H. pylori-specific IgA-secreting 
cells (Ahlstedt et al. 1999). IgA plasmocytosis is associated with expression of 
the secretory component in the foveolar epithelial cells, which enables 
transepithelial IgA transport and a fine coating of H. pylori with IgA immuno­
globulins (Kirchner et al. 1990). In spite of local IgA response, immunological 
elimination of H. pylori from the stomach is inefficient (Borody et al. 1992, 
Blaser and Parsonnet 1994). For reaching the antigenic target, H. pylori, which 
remains on the luminal side of the epithelial barrier, IgA and IgM antibodies, 
produced by immunocytes, must be translocated through the epithelium. 
External transport of polymeric immunoglobulins into secretion to provide 
secretory IgA and IgM depends on the production of J (joining) chain by the 
mucosal immunocytes (Brandtzaeg and Korsrud 1984). In the study o f Berstad 
et al. (1999) it was found that mucosal immunocytes show reduced J chain 
expression in case o f chronic inflammation. Only J chain-positive IgA and IgM 
immunocytes can contribute to secretory immunity (Brandtzaeg 1995, 
Brandtzaeg et al. 1999). Thus, reduced J chain expression in gastritis may 
contribute to production of IgA as monomers instead of polymers (Berstad et al. 
1999). Secretory immune system appears to be unable to eradicate H. pylori 
probably because of little or no secretory IgA antibodies elicited against this 
bacterium (Birkholz et al. 1998). On the other hand, the protective role of 
secretory IgA received with breast milk, against H. pylori colonization in early 
childhood (Thomas et al. 1993) or the result of active or passive IgA local vac­
cines in experimental animals are well known facts (Czin et al. 1993, Lee et al.
1995, Goto et al. 1999). Mucosal IgA response is important in blocking of 
bacterial adherence, in inhibition of the motility of H. pylori and in neutrali­
zation of toxins (Figura and Crabtree 1994, Crabtree 1996a). Crabtree et al. 
(1991) have shown that mucosal IgA recognition of the H  pylori CagA protein 
was associated with increased mucosal polymorph infiltration and epithelial 
surface degeneration. A recent study of Oksanen (2001) showed that presence 
of serum IgA antibodies to H. pylori indicates higher risk for CagA-positive 
H. pylori infection and possibly more severe late sequelae of gastric diseases.
Serum antibodies to H. pylori antigens of classes IgG, IgA and less 
frequently IgM are detected in infected individuals (Kosunen et al. 1992) and 
the diagnostic significance of serum immune response, especially o f the IgG 
class, is evident (Feldmann et al. 1995, Marchildon et al. 1996). Titres o f serum 
antibodies to H. pylori fall with eradication of bacteria (Kosunen et al, 1992; 
Kato et al. 1999). In a study of Kosunen et al. (1992) it was shown that the high 
sensitivity (97%) of IgG antibody tests and the 50% decrease in IgG within 
6 months after eradication of H. pylori infection have made IgG the most useful 
immunoglobulin class for follow-up of antimicrobial therapy in individual 
patients. IgA and IgM titres, initially elevated in 64% and 4% of patients, 
showed similar trends as IgG antibodies after eradication. In the study o f Wang
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et al. (1994), half patients became IgG negative at 6 months after treatment, and 
nearly all patients became IgG negative at 12 months. A long-term follow-up 
study of IgG and IgA in children after H. pylori eradication showed that 
approximately half patients with successful eradication remained IgG-sero- 
positive and IgA-seropositive at 12 months’ after treatment, whereas the 
decrease in the titre of the IgA class was significantly larger (Kato et al. 1999).
Systemic immune response to the highly immunogenic CagA protein (Cover 
et al. 1990, Sobala et al. 1991, Crabtree et al. 1991, Covacci et al. 1993) has 
revealed an association between the IgG antibodies to CagA and peptic ulcer, 
gastric epithelial degeneration, increased activity of gastritis, atrophy, intestinal 
metaplasia and gastric cancer (Figura et al. 1990, Cover et al. 1990, 1995, 
Crabtree et al. 1991, 1993, Kuipers et al. 1995, Beales et al. 1996, Ando et al. 
2000, Oksanen et al. 2000, Vaucher et al. 2000). Systemic immune response to 
CagA in children was also found to be associated with duodenal ulcer, high 
score of chronic inflammation, increased activity of gastritis and high level of 
serum pepsinogen (Oderda et al. 1993, Korzon et al. 1999, Plebani et al. 1999, 
Lerro et al. 2000).
The high immunogenicity of HSP60 (HspB) of H. pylori was shown first by 
Dunn et al. in 1992. Several studies have supported the idea that H. pylori 
HSP60 is an immunodominant protein (Engstrand 1992, Yokota et al. 1994). 
HSP60 is located on the surface of the bacteria, which allows the host immune 
system to better recognize it (Dunn et al. 1992, 1997, Yamaguchi et al. 1996, 
Yunoki et al. 2000). Humoral immune response against H. pylori HSP60 is 
strongly induced in patients with H. pylori infection, and there exists a 
correlation between serological and mucosal inflammatory response to H. pylori 
(Macchia et al. 1993, Perez-Perez et al. 1994). Perez-Perez et al. (1994) suggest 
that specific serum IgG response to H. pylori HSP may be a marker of 
inflammation, or these antibodies can play a direct role in the pathogenesis of 
H. pylori-induced inflammation. Moreover, according to the study of Yunoki et 
al. (2000), decrease in inflammation in the gastric mucosa of successfully 
treated patients correlates with a decrease in the level of antibodies to HSP60. 
Serum IgA antibodies to HSP60 were found to be associated with H. pylori 
induced gastric atrophy (Barton et al. 1998). Macchia et al. (1993) discussed the 
issue why host immune system responds with high levels of antibodies against 
such a conserved protein like HSP, which should be very well tolerated by the 
host. Macchia et al. (1993) proposed two possibilities: 1). immune response is 
directed only against epitopes specific for H. pylori HSP60, and 2). immune 
response is directed against epitopes common of H. pylori HSP60 and its human 
homologue, which would mean a failure in host tolerance. It is also suggested 
that antibodies to H. pylori HSP60 could cross-react with their human counter­
part playing a role in tissue damage that occurs in H. pylori-induced gastritis.
Summarizing this part of the review, concerning immune response to 
H. pylori cell surface proteins including highly immunogenic CagA and HSP60, 
it is evident that persons infected by H. pylori show strong local and systemic
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immune response against the bacterial antigens, which is, however, insufficient 
for clearance of the bacterium and may in turn cause intensive active and 
chronic inflammation in the gastric mucosa. Cell-mediated response to H. pylori 
is Thl response, which is normally induced against intracellular pathogens. In 
H. pylori infection, this type of cell-mediated immunity is not only ineffective 
but may be highly damaging owing to the induction of harmful cytokines, like 
IL-2, IFN-y and TNF-a, which enhance inflammation.
Chronic H. pylori gastritis
H  pylori is the main cause of chronic gastritis. This gastric pathogen leads to 
acute and chronic inflammation of the gastric mucosa (Marchall and Warren
1984, Goodwin et al. 1986, Sipponen and Hyvärinen 1993). Initially non- 
atrophic gastritis develops into atrophic gastritis (Villako and Siurala 1981, Vil­
lako et al. 1982, 1995, Kekki et al. 1983, Siurala et al. 1985, Maaroos et al. 
1990a, Sipponen et al. 1991). Without treatment H. pylori gastritis remains a 
chronic disease. Spontaneous improvement may occur in the antrum (in elderly 
persons) with progression of corpus atrophy (Sipponen and Hyvärinen 1993). 
The course and end-stage of gastritis may be influenced by peculiarities of 
H. pylori strains colonizing gastric mucosa and host response, as well as by 
presence or absence of autoimmunity or additional environmental factors 
(Sipponen et al. 1991, Blaser and Berg 2000, Jenks and Kusters 2000).
Classification o f  gastritis
In 1947, Schindler recognized acute and chronic gastritis on the basis of gastro­
scopy and intraoperative biopsy and introduced the terms “chronic superficial” 
and “chronic atrophic gastritis”. This classification was modified in 1968 by 
Siurala. According to Siurala et al. (1968) normal mucosa (N): no inflam­
mation, normal glands; chronic (superficial) gastritis without atrophy (S): 
chronic mononuclear inflammation in the lamina propria without loss o f normal 
mucosal glands; chronic (atrophic) gastritis with slight, moderate or severe 
atrophy (A l, A2, A3 respectively): slight, moderate or severe (total) loss of 
normal glands, and of chronic mononuclear inflammation and growth of 
metaplastic glands of various extent (Sipponen et al. 1990a).
The classification o f chronic gastritis introduced in 1972 by Whitehead et al. 
was morphological, describing mucosal type (antrum or corpus), grade of 
gastritis, and activity and presence of metaplasia. In 1973, Strickland and 
Mackay defined two topographical groups of advanced atrophic gastritis: Type 
A and Type B. Type A is chronic atrophic gastritis of the corpus with parietal 
cell antibodies (PCA) and elevated basal serum gastrin level, which leads to 
pernicious anaemia. Type B is antral atrophic gastritis without PCA, and serum 
gastrin level is within or below normal value. In 1975, Glass and Pitchumoni 
suggested the term “AB” gastritis to describe distribution of gastritis both in the 
antrum and corpus. The classification of A, B or AB types was proposed to 
indicate severe forms o f atrophic gastritis, and it corresponds to atrophy-
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induced changes in gastric function, like output of acid, pepsinogen and the 
intrinsic factor (in case of type A or AB), or secretion of gastrin (in case of type 
B) (Sipponen et al. 1996a). In 1987, Kekki et al. combined both topography and 
morphology in their classification of gastritis. According to this classification 
the antrum and corpus mucosa are documented separately and scored as 
follows: normal (grade 0) —  no loss of glands and no round cell infiltration; 
chronic gastritis with no loss of glands, irrespective of the depth of inflam­
mation, is termed “superficial gastritis” —  slight, moderate or severe accumu­
lation of round cells in the lamina propria (grades 0.5, 1.0, 1.5). Atrophy is 
graded as mild, moderate or severe loss of glands (grades 2, 3, 4). This grading 
shows an excellent correlation with different functional parameters (Kekki et al. 
1987). The classifications of gastritis, described by Siurala, 1968, and Kekki,
1987, were used in longitudinal studies of chronic gastritis by Finnish and 
Estonian investigators (Siurala et al. 1968, Varis 1981, 1982, Sipponen et al.
1989, 1990a, 1994a, Villako et al. 1976, 1982, 1984, 1990, 1991, 1995, Maa­
roos etal. 1985, 1986, 1990a,b, 1991a,b, 1994).
In 1988, Correa and in 1990 Yardley classified chronic gastritis into three 
categories: diffuse antral gastritis (DAG), multifocal (metaplastic) atrophic 
gastritis (MAG) and corpus-limited atrophic gastritis of autoimmune origin. The 
disadvantage of this classification was that it does not take into account the fact 
that gastritis is a progressive disease, assuming that different forms reflect 
multiple aetiologic and pathogenic pathways (Prise 1991, Sipponen et al. 
1996a). The classification of gastritis by Wyatt and Dixon (1988) maintains type 
A for autoimmune type of gastritis, while H. pylori-associated gastritis (bacte­
rial) with its predominantly antral distribution is termed type B. Type C 
(chemical injury) is reflux gastritis or gastritis due to drugs or chemicals. The 
classification o f Stolte and Heilmann (1989) is similar, but, in addition the 
authors regard type AB gastritis as combined autoimmune gastritis and gastritis 
caused by H. pylori. The disadvantage of this classification is non-recognition 
o f the progressive nature of chronic gastritis, developing from superficial to 
atrophic.
The Sydney System
In 1990, the Working Party at the Scientific Committee of the 9th World 
Congress in Gastroenterology in Sydney proposed a new gastritis classification 
which emphasises the importance of combining topographical, morphological 
and etiological information (Price 1991), and which corresponds to the earlier 
classifications of gastritis, reflects impairments in function of the gastric 
mucosa and delineates the gastritis dissimilarly associated with different gastric 
disorders (Sipponen 1994b).
The Sydney System is divided into two parts, histological and endoscopic. 
This review focuses on the histological division.
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The classification relies on a separate assessment of the antrum and corpus, 
while a minimum of two biopsies per site are recommended.
The Sydney System recognizes three morphological patterns o f gastritis: 
acute gastritis, chronic gastritis and special forms. Acute gastritis is rare, usually 
a transient condition, in which acute granulocytic inflammation occurs without 
significant round cell inflammation. Chronic gastritis is defined as a disease in 
which lymphocytic and plasma cell inflammation is a predominant microscopic 
feature. Special form s  contain a range of entities of lesions with established 
histopathological and clinical impacts, such as eosinophilic or lymphocytic 
gastritis.
Five items o f gastritis-related histopathological features have been selected 
as the most important regarding the grading: chronic inflammation (lympho­
cytic/plasma cell inflammation in lamina propria); activity (acute granulocytic 
inflammation in lamina propria, gastric pits and surface epithelium); atrophy 
(loss of normal glands); intestinal metaplasia and density of H. pylori. These 
variables are to be graded as none, mild, moderate or severe.
No graded variables include lymphoid aggregates or follicles, degenerative and 
hyperplastic alterations of the epithelium, eosinophilic infiltration, etc. (Price 
1991, Sipponen 1994b).
There exist three patterns of topographical distribution: antral gastritis, 
corpus gastritis and pangastritis. Marked dissimilarities in the grade o f mucosal 
changes between the antrum and corpus are expressed with the terms “antral 
predominant” or “corpus predominant”.
To indicate the aetiology of gastritis, such as H. pylori, autoimmune origin 
or certain gastric irritants, the Sydney System provided an aetiological classi­
fication limb (Price 1991; Sipponen 1994b).
Up dated Sydney System
In 1994, at the Houston gastritis workshop, the Sydney System was revised and 
updated. In general, the principles and grading of the Sydney System were only 
slightly modified, the grading being provided with a visual analogue scale. For 
optimal assessment, five biopsy specimens were recommended. Further, the 
terminology of the final classification was improved to emphasize the 
distinction between the atrophic and the nonatrophic stomach (Dixon et al 
1996).
Chronic H. pylori gastritis — a cohort phenomenon
It is estimated that H. pylori is a birth cohort-dependent phenomenon (Parsonnet 
et al. 1992, Banatvala et al. 1993, Sipponen et al. 1994a, Sipponen 1995, 1997, 
Sipponen et al. 1996b, Roosendaal et al. 1997). M ost//, pylori infections occur 
during childhood (under the age of 20) in every cohort (generation) (Banatvala 
et al. 1993, Sipponen et al. 1994a). Incidence of new cases of H. pylori 
infection in childhood has been high in cohorts, born at the beginning o f the last
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(Sipponen 1997). It is spectacular that after being high in childhood acquision 
rate slows down exponentially with age in all cohorts, and new infections occur 
quite rarely in adulthood (annual incidence 0.15-0.4%) (Cullen et al. 1993, 
Kuipers et al. 1993, Parsonnet 1995, Valle et al. 1996, Sipponen et al. 1996b, 
Sipponen 1997, Roosendaal et al. 1997). Prevalence of H. pylori infection 
varies between countries, being usually high in developing countries and low in 
developed countries (Megraud et al. 1989, Pounder 1995, Mitchell 1999). 
Across child populations, H. pylori prevalence ranges from less than 10% to 
over 80%) (Torres et al. 2000). This variation in the prevalence of H. pylori 
infection and H. pylori gastritis between different populations and countries can 
be. explained by differences in the rate of H. pylori acquision in childhood, 
which is largely dependent on socio-economic conditions in childhood (Jones et 
al. 1987, Drumm et al. 1990, Mendall et al. 1992, Webb et al. 1994, Patel et al.
1994, Parsonnet 1995, Veldhuyzen 1995, Sipponen 1997, Miyaji et al. 2000). 
Low prevalence occurs in the USA, Canada and in Northern and Western 
Europe; high prevalence is noted in India, Africa, Latin America and Eastern 
Europe (Torres et al. 2000).
Epidemiological studies of chronic gastritis and H. pylori infection among 
Estonian populations (Kambja, Saaremaa, Karksi-Nuia) of different birth 
cohorts showed, however, that H. pylori prevalence in Estonia is high among 
persons born at the beginning and in the middle of the last century. In Estonia, 
the cohort specific prevalence of H. pylori infection is 70-90% for generations 
bom at the beginning of 20th century and it remains high (60-80%) for those 
born after 1945 (Maaroos 1995). Studies of chronic gastritis in an Estonian 
population from Saaremaa in 1979 (Maaroos et al. 1990a) and in a Finnish 
outpatient series (Sipponen et al. 1994a) shows that the prevalence rates of 
H. pylori infection and gastritis in Estonia were similar to those in Finland (70- 
80%>) for groups born at the beginning of the last century, while a difference 
was revealed for later birth cohorts born after 1945. H. pylori infection and 
gastritis frequency was higher in Estonia than in Finland, which means that 
acquisition rate of H. pylori in the childhood in the youngest birth cohort has 
remained high in Estonia. This is supported by studies of H. pylori prevalence 
in Estonian children with abdominal complaints, which established that 58%> of 
children aged 4-15 years were H. pylori positive and 61%> had H. pylori 
gastritis (Maaroos et a l 1991b, 1993), indicating that the rate of acquisition of
H. pylori is still high in Estonian children.
Also, a three-year follow-up study of Estonian children from Saaremaa since 
birth (start in 1993), carried out by R.Tammur and published by Lindkvist 
(1999), demonstrated very high seroconversion rates during the first years of 
life: 27%) in the first year, 25%> in the second year and 12% in the third year. 
Cumulative incidence in the cohort (born 1993) for the three-year period was 
59%. An important finding in the study of Tammur and Lindkvist (Lindkvist 
1999) was that the peak age for infection in Estonia was under of 3 years, which 
is still very high in recent cohorts. Regarding the role of poor environmental
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59%. An important finding in the study of Tammur and Lindkvist (Lindkvist
1999) was that the peak age for infection in Estonia was under of 3 years, which 
is still very high in recent cohorts. Regarding the role of poor environmental 
hygiene in acquision of H. pylori in childhood, it is noteworthy that a specific 
independent risk factor for infection other than age in Estonia was non-use of a 
toothbrush among small children. These results are consistent with the 
suggestion o f an oral-oral transmission route for H. pylori (Lindkvist 1999).
Natural course o f  chronic gastritis
Chronic gastritis is local immune response to H. pylori infection (Sipponen et 
al. 1998). Chronic H. pylori gastritis results from an infection acquired in 
childhood and tends to persist at a quite constant prevalence level in the cohort 
for decades (Sipponen 1995). In the early stage, chronic gastritis appears as an 
immune response of the gastric mucosa against H. pylori in the form of mono­
nuclear, round cell inflammation (immunocompetent lymphocytes and immuno­
globulin secreting plasma cells) both in the antrum and corpus mucosa (Wyatt
1991, Price 1991, Sipponen 1997), with a predominance of inflammation in the 
antrum (Maaroos et al. 1990a, Stolte et al. 1990, Karttunen et al. 1991, 
Bayerdörffer et al. 1992, Sipponen et al. 1996a, Ahlstedt et al. 1999). A special 
feature o f H. pylori gastritis is that it is practically always associated with acute 
inflammation (Sipponen et al. 1998). Polymorphonuclear neutrophil infiltration 
(indicating activity o f gastritis) is associated with inflammatory process and its 
intensity depends upon differences in H. pylori strains (more pronounced in 
cytotoxic strains) (Crabtree 1996a) and upon dissimilarities in the host’s 
reactions (Sipponen et al. 1996).
There exists a correlation between grade of mononuclear and acute 
infiltration and grade of H. pylori colonization of the gastric mucosa (Kekki et 
al. 1987, Kartunnen et al. 1991, Stolte et al. 1995), which in turn indicates that 
the pathogenesis of inflammation is the host’s reaction to H. pylori itself or to 
specific bacterial mediators of mucosal inflammation (Blaser 1992, Crabtree 
1996a, Sipponen et al. 1996a).
Activity of gastritis (acute polymorphonuclear inflammation) may contribute 
to the damage o f the epithelium and mucosal glands due to neutrophil-related 
toxic free radicals and reactive oxygen metabolites from inflammatory cells 
(Davies et al. 1994, Fiocca et al. 1994, Rautelin et al. 1996), or due to trans- 
epithelial migration (Parkos et al. 1992). Neutrophil adherence to the endo-the- 
lium may cause a leakage of protein as a result of microvascular damage 
(Kurose et al. 1994). Because neutrophilic inflammation is typically localized in 
neck areas of the mucosal glands, which is responsible for cell replication and 
renewal, the damaging properties of neutrophils may constitute a risk for loss of 
the glands (Fiocca et al. 1994).
Inflammatory, non-atrophic stage of chronic gastritis (non-atrophic gastritis) 
is known as “superficial gastritis” in the literature (Siurala et al. 1968, White­
head et al. 1972, Kekki et al. 1987, Sipponen 1997). Gastritis progresses from
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1985, Sipponen et al. 1991, Kawaguchi et al. 1996). In patients with advanced 
atrophic gastritis, chronic inflammation is milder with respect to degree 
(Sipponen et al. 1996a). An important observation based on a 6-year follow-up 
of a Saaremaa random sample and on a 32-year follow-up of a Finnish popula­
tion was that atrophic gastritis developed only in persons who had a preceding
H. pylori non-atrophic gastritis (Villako et al. 1991, Sipponen et al. 1996b, 
Valle etal. 1996).
Atrophy means loss of normal mucosal glands, and consequently, loss of 
normal physiological function of the gastric mucosa (in the corpus: reduction of 
acid output; in the antrum: a poor serum gastrin response to various stimuli) 
(Sipponen and Marchall 2000). In chronic H. pylori gastritis, atrophic changes 
appear first in the antrum, showing a gradual pylorocardial extension with time 
and increasing age (Kimura 1972, Maaroos et al. 1985). In some cases H. pylori 
gastritis may end in severe corpus-predominant atrophic gastritis or corpus- 
limited atrophy with healing of the antrum (Annibale et al. 1997, Sipponen and 
Marshall 2000). In parallel with progression of atrophic gastritis, the extent and 
severity o f intestinal metaplasia increase with age (Siurala et al. 1985, Ihamäki 
et al. 1985). Intestinal metaplasia represents a transformation of the gastric 
epithelium and glands from secretoiy to absorptive (Sipponen et al. 1998). With 
the increasing grade and extent of atrophic gastritis, H. pylori infection tends to 
burn out and the colonization of the mucosa may be minimal (Sipponen 2001).
Atrophic gastritis can be limited to the antrum or corpus, or can be 
multifocal, affecting both to a varying extent and grade (Villako et al. 1976, 
Correa 1980, Siurala et al. 1985, Sipponen 2001). The common topographic 
phenotypes of H. pylori gastritis and atrophic gastritis are the following:
I. “Ulcer phenotype” of gastritis: predominance or restriction of H. pylori- 
related inflammation in the antrum, in association with the nonatrophic 
corpus mucosa. It is the most common phenotype, with an increased risk of 
peptic ulcer disease, particularly, duodenal ulcer.
2. “Corpus predominant gastritis” : presence of atrophic gastritis in the corpus of 
the stomach, which indicates a low risk of peptic ulcer and reduction in the 
capacity of the patient to secrete acid.
3. Advanced “multifocal atrophic gastritis”: the occurrence of advanced 
atrophic gastritis and intestinal metaplasia multifocally in the stomach, 
which indicates low acid secretion capacity and an increased risk of gastric 
neoplasias (“gastric cancer phenotype of gastritis”).
Presence of normal and healthy gastric mucosa, which indicates an extremely 
low risk of both peptic ulcer disease or gastric cancer is a finding of high clini­
cal relevance (Sipponen 2001).
The topographic phenotypes of H. pylori gastritis are similar risk conditions 
for gastric diseases all over the word. The existing geographical heterogeneity 
in the prevalence of the sequelae of H. pylori infection might be based on large 
differences in acquisition rate between populations but not only reflecting the 
differences in bacterial strains or host responses (Sipponen 2001).
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Progression of atrophic gastritis from mild to severe is a time related 
phenomenon (Kekki et al. 1983, 1984, 1987, Sipponen et al. 1996a); several 
factors can influence progression of H. pylori gastritis into atrophic gastritis, 
such as differences in the cytotoxicity of H. pylori, genetic liability o f the host 
to acquire atrophic gastritis, and in some cases also dietary habits and presence 
or absence of vitamins (Correa 1992, Kuipers et al. 1995, Sipponen and 
Marshall 2000). Long-term follow-up studies in Finland show that although 
more than half infected patients acquire atrophic gastritis during their lifetime, 
20—30% of H. pylori infected subjects do not acquire atrophic gastritis (Ihamäki 
et al. 1985, Valle et al. 1996). Atrophic gastritis develops approximately 20 
years after H. pylori acquisition and, thereafter, increases in prevalence rate 
with age. The age-specific prevalence of atrophic gastritis in general population 
is positively related to the incidence and prevalence rate of H. pylori infection 
in the population (Sipponen 2001).
Overview of the epidemiological studies of H. pylori gastritis 
in Estonian populations
The study of chronic gastritis has a long tradition in Estonia. Already in the 
1930s roentgenological and endoscopic methods were introduced by L. Walk 
for defining atrophic gastritis, followed by endoscopic and roentgenological 
investigations of the stomach by K. Villako in the 1950s. V. Salupere intro­
duced suction biopsy in Estonia in 1960 and a fiberoscopy in the 1970s, which 
opened wide possibilities for the morphological and immunological research of 
gastritis in different gastroduodenal diseases, conducted by V. Salupere as well 
as by H.-I. Maaroos and R. Uibo (Salupere 1965, 1966, 1978, 1991, Salupere et 
al. 1974, 1975, Maaroos et al. 1981, 1985, 1989, 1990a,b, 1991a,b, Uibo 1979, 
Uibo etal. 1984a,b, 1989, 1991).
Epidemiological studies of chronic gastritis among Estonians were carried 
out in two randomly selected adult populations, Kambja (1972, rural, age 15-65 
years) and Kuressaare, Saaremaa (urban, initially 227 persons, age 15-69 years) 
with follow-up in 1979, 1985, 1991 and 1997 (Villako e ta l. 1976, 1982, 1990,
1991, 1995).
The study of chronic gastritis in Kambja showed that gastritis, either in the 
antrum or in the corpus, or simultaneously in both, occurred in 78%>, while 
antral gastritis was more frequent than corpus gastritis (68%> versus 45%). In 
case o f pangastritis, changes in the antrum and corpus often reflected different 
stages o f gastritis. It was established that prevalence of corpus and antrum 
gastritis increases with age (Villako et al. 1976).
An epidemiological study of a representative sample of urban population in 
Saaremaa, conducted in 1979, revealed the occurrence o f chronic gastritis in the 
antrum in 64% and in the corpus in 62% of cases. The prevalence o f atrophic 
antral and corpus gastritis was high: 38%> and 37%, respectively (Villako et al. 
1982). A follow-up study of behaviour of chronic gastritis in Saaremaa showed 
that the main trend of chronic gastritis was slow “one-step progression” in
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severity of chronic inflammation and appearance of atrophy and intestinal meta­
plasia. Inflammation progressed particularly in the antrum in young age groups. 
Retrospective morphological studies on H. pylori showed that grade of chronic 
inflammation is well correlated with extent of H. pylori colonization in the 
antrum but not in the corpus (Villako et al. 1991, Maaroos et al. 1990a). 
Besides, there was revealed an evident intraindividual tendency for maintaining 
the grade o f H. pylori colonization at a constant level during a 6-year follow-up. 
H. pylori colonization occurred concomitantly with the development of gastritis. 
The development of antrum atrophy was accompanied with a decreasing in and 
the eventual disappearance of H. pylori in the antrum. Normalization o f the 
antral mucosa occurred with persistent corpus atrophy and the concomitant 
disappearance of H. pylori in both compartments of stomach mucosa. The grade 
of H. pylori increased with increase in severity of superficial gastritis and 
decreased with progression of atrophic changes. In the antrum, a life-long 
correlation was found between H. pylori colonization and inflammatory 
reaction. The host response ratio (ratio of chronic inflammation score to grade 
of H. pylori colonization) was significantly higher in the youngest age group 
(15-19 years) as compared with the other age groups as well as in subjects in 
whom the antral gastritis regressed during follow-up. Parietal cell antibodies 
developed in two subjects who were H. pylori positive at the first examination. 
These findings suggest that autoimmune mechanisms can be started in subjects 
who were previously exposed to H. pylori-related gastritis. A difference was 
established between the antral and corpus mucosa in their tendency to be 
associated with H  pylori: the severity of inflammation response and atrophy in 
the antrum are more specifically and strongly linked to changes in H. pylori 
colonization in the antrum compared with respective changes in the corpus 
(Kekki et al. 1991).
The re-examination of the same persons in 1991 (12 years later) showed that 
H. pylori gastritis is a rather stable, slowly changing disease. The prevalence of 
atrophic gastritis was three times higher in the corpus than in the antrum. Both 
progression as well as a significant improvement and complete healing of 
gastritis are possible but rare (healing rate 0.3% per year). In the antrum, low H. 
pylori colonization seems to predict improvement in chronic inflammation in 
the long term, suggesting that the antrum is immunologically more active than 
the corpus (Villako et al. 1995).
The data of the last observation (1997) will be presented further in this study 
(Papers VI-IX).
H. pylori and gastric autoimmunity
The initial division of chronic gastritis into Type A and Type B (Strickland and 
Mackay, 1973 and Wyatt and Dixon, 1988) indicated that Type A gastritis is 
characterized by autoimmune genesis and accompanies pernicious anaemia, 
whereas Type B is nonauto immune (Strickland and Mackay 1973, Salupere 
1978), predominantly H. /jy/orz-associated gastritis (Whyat and Dixon 1988,
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Strickland 1990). At present there is ample evidence that H. pylori too is 
responsible for induction of autoimmune processes in the gastric mucosa 
(Engstrand et al. 1991,Negrini et al. 1989, 1991, 1993, 1996, Varis et al. 1993, 
Ma etal. 1994, Faller et al. 1996, 1997, 1998, Appelmelk etal. 1996).
The main target of autoimmune reactions described in the stomach is parietal 
cells and its secretory product intrinsic factor (Taylor 1959, Irvine et al. 1962, 
Markson and Moor 1962). Among pernicious anaemia patients, parietal cell 
antibodies (PCA) have been found in 90% of patients with atrophic corpus 
gastritis (Irvine et al. 1962, Taylor et al. 1962, Strickland and Mackay 1973, 
Glass and Pitchumoni 1975). PCA have been found also in other gastritis forms, 
not associated with pernicious anaemia, which involve mainly the antrum 
(Schraier et al. 1983, Wyatt et al. 1992). Furthermore, there have been de­
monstrated immune reactions to antral mucosa (Salupere et al. 1972, Vandelli et 
al. 1979, Uibo et al. 1984b). Studies of Vandelli et al. (1979) and Uibo et al. 
(1984b) showed that in several antrum gastritis cases (6% of cases in a study of 
Vandelli and 16%> of cases in a study of Uibo) there occur antibodies to gastrin 
cells; both researchers suggested that antral gastritis too can be associated with 
immunological abnormalities, in which the role of H. pylori has now been 
established (Jaskiewicz et al. 1993, Seifarth et al. 1996, Sommer et al. 1998).
Gastric H+, K+ ATPase as a major parietal cell autoantigen 
The parietal cell autoantigen is located of cell surface membrane, covering 
microvilli on its free surface and lining the secretory canaliculi of the gastric 
parietal cells (Hoedemaeker and Ito 1970). Studies of biochemical and mole­
cular cloning identified this autoantigen as the a-and P-subunits of gastric H+, 
K+ ATPase (Karlsson et al. 1988, Goldkorn et al. 1989, Toll et al. 1990). 
Membrane-bound gastric H+, K+ ATPase represents a proton pump responsible 
for acidification of the stomach lumen (Ganser and Forte 1973, Reuben et al. 
1990). Gastric H+, K+ ATPase consists of two subunits, the transmembrane 100 
kDa catalytic a-subunit and the 60-90 kDa glycoprotein p-subunit and it is 
localized in the intracellular membranes of gastric parietal cells (Karlsson et al. 
1988, Toh et al. 1990, Ma et al. 1994). It has also been established that gastric 
H+, K+ ATPase serves as the causative autoantigen in the pathogenesis of 
experimental autoimmune gastritis (Scarff et al. 1997, Toh et al. 2000). Toh et 
al. (2000) proposed the following scenario for the genesis of the gastric lesion 
initiated by the p subunit o f gastric H+, K+ ATPase: dendritic cells in the 
gastric mucosa become activated, capture and process gastric H+, K+ ATPase, 
released during the turnover of parietal cells, and migrate then to draining 
lymphnode. In T-cell areas of the lymphnode, dendritic cells present gastric H+, 
K+ ATPase peptide to naive CD4+ CD25- T-cells. In the presence of nai've 
regulatory CD4+CD25+ T-cells, activation of naive pathogenic CD4+ T-cells 
and IL-2 secretion is suppressed. In absence of regulatory T-cells, naive 
pathogenic CD4+ T-cells become activated. Activated pathogenic CD4+ T-cells
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acquire adhesion molecules that allow their migration to the stomach via 
efferent lymphatic and blood vessels of the gastric mucosa, where they infiltrate 
the mucosa in response to appropriate chemotactic stimuli. Antigen-specific 
CD4+ T-cells recruit other CD4+ T-cells, monocytes, CD8+ cells and B-cells 
through release of cytokines (Steinman 1996). Supported by activated CD4+ T 
cells, B-cells produce autoantibodies to gastric H+, K+ ATPase (Toh et al.
2000). Recent data o f d’Elios et al. (2001) showed that H+ K+ ATPase is the 
target autoantigen of Thl type cytotoxic T-cells in autoimmune gastritis. Acti­
vation of proton pump-specific Thl cytotoxic/proapoptotic T-cells in the gastric 
mucosa can represent an effector mechanism for the target cell destruction in 
autoimmune gastritis.
It was shown in many studies that infection with H. pylori induces auto­
antibodies reactive with gastric parietal cell canaliculi and that autoantibodies to 
H+, K+ ATPase indicate a link between bacterial and classical autoimmune 
gastritis (Negrini et al. 1991, 1996, Ma et al. 1994, Faller et al. 1996, 1997, 
Appelmelk et al. 1996, 1998). Faller et al. (1997) showed a good correlation 
between H. pylori infection, antiluminar antibodies binding to the foveolar 
epithelium as well as anticanalicular autoantibodies and corpus mucosa atrophy 
with increased fasting gastrin levels (Faller et al. 1997). This relationship was 
supported by a significant reduction of anticanalicular autoantibodies after H. 
pylori eradication (Faller et al. 1997). Recently, it was shown that antigastric 
autoantibodies, reacting against canaliculi of human parietal cells, are not only 
detectable in the serum but are produced locally in the gastric mucosa of H. 
pylori infected patients (predominantly IgA type) (Faller et al. 2000).
Antigastric autoimmunity and molecular mimicry
Because most H. pylori strains contain human blood group antigens Lewis X 
and Lewis Y, which are expressed also on epithelial cells in the gastric mucosa 
(Sherburne and Taylor 1995, Aspinall et al. 1996, Simoons-Smit, 1996 et al.), it 
has been proposed that such molecular mimicry is responsible for formation of 
antigastric autoantibodies, particularly in animal models (Negrini et al. 1996, 
Aspinall et al. 1996, Appelmelk et al. 1996, 1997). In a study of Guruge et al. 
(1998) it was shown that if the host is colonized by a H. pylori strain that ex­
presses adhesins, promoting attachment to epithelial receptors, and if that strain 
expresses also Lewis X surface antigens, mimicking host parietal cell structure 
then the course o f infection leads to development of autoantibodies to parietal 
cells and, as a consequence, a tendency for atrophic gastritis with loss of 
parietal cells.
However, Faller et al. (1998) showed that human autoantibodies against the 
canaliculi of parietal cells could not be absorbed by Lewis X or Lewis Y posi­
tive H. pylori strains. Additionally, Clayes et al. (1998) demonstrated that 50% 
of anticanalicular autoantibodies react with the peptide part of the a  or p 
subunit of gastric H+, K+, ATPase but not with a carbohydrate structure such as
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the blood group antigen. These authors suggest that there exist some other 
pathogenic mechanisms leading to formation of antigastric autoantibodies.
Furthermore, heat shock proteins have been considered as the cause of anti­
genic mimicry between H  pylori and host structures, which gives evidence of a 
high degree of homology (Macchia et al. 1993). Engstrand et al. (1991) 
demonstrated that monoclonal antibodies, raised against HSP60 (GroEL) of 
Mycobacterium, cross-reacted exclusively with the HSP60 protein of H. pylori 
as well as with gastric epithelial cells in all H. pylori positive specimens. 
Engstrand et al. (1991) suggested that intraepithelial y/5 T-cells may play a role 
in host defence against H. pylori, and that H. pylori may trigger autoimmune 
response to stress proteins expressed by gastric epithelial cells.
Negrini et al. (1996) reported an additional autoimmune target —  the 
mucosal neck and chief cells of the gastric mucosa. The cross reaction between 
H. pylori and epithelial cells, observed by Negrini, was directed to the glandular 
epithelium of the stomach, in particular, to the regenerative mucosal neck cells. 
Also, a significant correlation of anticanalicular autoantibodies was found with 
presence of intraepithelial lymphocytes within the glandular epithelium, with 
periglandular lymphocytes and with corpus atrophy. In the concept o f molecular 
mimicry introduced by Negrini, H. pylori presents common epitopes to the host 
which react with antibody response, recognizing the gastric mucosal epithelium 
and, together with other host and environmental factors, influences the tendency 
of chronic gastritis to progress into atrophic gastritis and gastric cancer (Negrini 
etal. 1996).
Invasion of human gastric mucosa by H. pylori
Considering the interaction between H. pylori and host immune response and 
gastric tissue damage, there arises the question about the possible entry o f H. 
pylori to the human gastric epithelium. H. pylori has been considered to 
colonize the gastric mucosa exclusively extracellularly (Blaser 1997). However, 
there are data confirming an intracellular location of H. pylori (Bode et al.
1988, Andersen and Hoick 1990, Evans and Graham 1992, Noach et al. 1994, 
Engstrand et al. 1997, Ko et al. 1999, Su et al. 1999, Björkholm et al. 2000, 
Petersen et al. 2000). Björkholm et al. (2000) show that H. pylori can invade 
epithelial cells actively in culture, while production of vacuolating cytotoxin 
increases the ability to invade Hep-2 cells. The authors suppose that invasion of 
the gastric epithelium contributes to the bacterium’s ability to establish persis­
tent infection that evades mucosal defence and sometimes also antimicrobial 
therapy in case antibiotics with extracellular activity are used. Su et al. (1999) 
found that invasion o f cultured cells by H. pylori occurs via an integrin- 
mediated pathway and entry is higher for type I (cytotoxin) strains.
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H. pylori and induction of apoptosis and proliferation 
of gastric epithelial cells
Cell proliferation and apoptosis (programmed cell death) are essential events 
involved in the cellular turnover of the gastric tissue (Hall et al. 1994). Normal 
mucosa integrity is maintained when the rate of cell loss by apoptosis is well 
balanced by the rate of production of new cells by epithelial proliferation (Kerr 
et al. 1972, Suzuki and Ishii 2000). Abnormalities of cell turnover may 
contribute to atrophy when cell loss is excessive compared with proliferation, 
and to neoplasia in an opposite case (Thompson 1995, Que and Gores 1996, 
Moss et al. 1996, Jones et al. 1997, Suzuki and Ishii 2000).
Programmed cell death (apoptosis)
The term apoptosis (a7ro7rucoaiq- falling off) and its description were 
introduced by Kerr in 1972 to denote controlled cell deletion, which appears to 
play a complementary role but opposite to that of mitosis in the regulation of 
animal cell populations. Cell death can occur by necrosis or by apoptosis.
Distinction between apoptosis and necrosis
The key morphological features of apoptosis, originally described by Kerr et al. 
(1972), included shrinkage and blebbibg of the cytoplasm; preservation of the 
structure of cellular organelles, including the mitochondria; condensation and 
margination of chromatin. In contrast, necrotic cells first increase their cellular 
water content and thus their volume; nuclei lose the typical chromatin structure 
which is seen as irregular clumping; cell membrane ruptures, discharging 
cellular contents into the environment (Studzinski 1999). Apoptosis affects cells 
one at a time. At tissue level, apoptosis produces little or no inflammation, since 
shrunken portions of the cell are engulfed by the neighbouring cells, especially 
macrophages, rather than being released into the extracellular fluid. In contrast, 
in necrosis, cellular contents are released into the extracellular fluid and have an 
irritant effect on the nearby cells, causing inflammation. The apoptotic mecha­
nism of cell death is fundamental to the normal development of tissues and 
organisms, whereas cell death by necrosis is usually accidental and therefore 
does not have such significance (Studzinski 1999).
One of the most extensively studied biochemical events in apoptosis is 
chromatin fragmentation by endonuclease activation. DNA double-strand 
cleavage occurs in the linker regions between nucleosomes, producing DNA 
fragments. In contrast, necrosis is accompanied by random DNA breakdown. 
Presence of 5 '-phosphate (5’-P) and 3 '-hydroxyl (3’-OH) DNA termini in 
apoptotic cells is an important biochemical feature of apoptotic DNA fragments. 
Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end- 
labelling (TUNEL) method, which is commonly used to detect apoptotic cells, 
is based on presence of 3'-OH termini (Gavrieli et al. 1992).
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Factors involved in induction and regulation o f  apoptosis 
Initiating signals for apoptotic cascades can be either extracellular or intra­
cellular. Apoptosis is dependent upon a balance between a series of inducer and 
inhibitory factors (Majno and Joris 1995). Activation of cysteine proteases that 
are present in the cytoplasm as zymogens and that cleave protein chains after 
aspartic acid residues (caspases) is the most important event characterizing the 
process of apoptosis (Blajeski and Kaufmann 1999). Caspase-3 is regarded as 
one o f central executioner molecules that is activated in many cell types after 
exposure to apoptotic stimuli and that is responsible for cleaving various 
proteins and thereby disabling important cellular processes (Nicholson and 
Thornberry, 1997). Release of three apoptotic protease-activating factors (in­
cluding cytochrome C) from mitochondria may play a key role in the activation 
of caspase-3 (Zhou and Savesen 1997). Mitochondrial caspase-3 can be 
activated by numerous proapoptotic stimuli, including H. pylori (Mancini et al. 
1998, Slomiani et al. 1999, Pothoff et al. 2000). The cellular target for 
caspases-6 and -7 is actin, which can induce cytoskeletal changes and, as a 
consequence, cell condensation (Studzinski 1999).
Apoptosis can be regulated by several mechanisms. Bcl-2 family proteins 
play critical roles in the regulation o f apoptosis (Reed 1996). Bcl-2 was initially 
discovered as an overexpressed protein in human B-cell lymphomas (Pegoraro 
et al. 1984). Bcl-2 protein is membrane-associated and is localized in a nuclear 
envelope, in the endoplasmic reticulum and on the inner aspect of mitochondrial 
membrane (Hockenbery et al. 1990). Overexpression of bcl-2 protects many 
cell types against apoptosis in response to viral infection, hypoxia, and 
chemotherapeutic agents (Reed 1996). A number o f bcl-2 family members such 
as Bcl-2, Bcl-Xi, Bcl-w, Mcl-1, Al/bfl-1 serve to inhibit apoptosis, whereas 
Bax, Bik, Bak Bad, Bid, Bcl-Xs Mrk promote apoptosis (Reed 1996, Granville 
et al. 1998). Changes in the levels or bioactivities of these proteins are as­
sociated with a variety of physiological processes where cell death occurs, 
including fetal development, haematopoietic and immune cell differentiation. 
However, pathological alterations in expression of bcl-2 family proteins have 
been documented in cancer, autoimmunity, immunodeficiency and other 
diseases (Thomson 1995, Krajewska et al. 1996, Reed 1999).
Apoptosis can be induced by the interaction of the receptor molecule Fas 
with Fas ligand (Fas-L). Fas (CD95) is a glycosylated transmembrane receptor 
belonging to the tumor necrosis factor (TNF)/nerve growth factor (NGF) 
receptor family which, by binding to Fas ligand, induces apoptosis through 
activation o f the caspase cascade (Nagata and Goldstein 1995).
Induction o f  apoptosis by H. pylori
There is ample evidence of induction of apoptosis of gastric epithelial cells as 
well as gastric T-cells by H. pylori (Moss et al. 1996, Chen et al. 1997, Wagner 
et al. 1997, Anti et al. 1998, Konturek et al. 1999, Jones et al. 1999, von Her- 
bay and Rudi 2000, Jang and Kim 2000, Yoshimura et al. 2000).
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Several mechanisms have been proposed regarding how H. pylori can in­
fluence apoptosis o f epithelial cells. Adherence of H. pylori to epithelial cells 
seems to be important by induction of apoptosis, because the latter can be 
prevented by a physical barrier separating H. pylori from epithelial cells (Chen 
e ta l  1997).
Fas-mediated signalling
The role of Fas-mediated signalling in apoptosis of gastric epithelial cells in 
response to H. pylori infection is also indicated (Wagner et al. 1997, Rudi et a l
1998, Jones et a l 1999, von Herbay and Rudi 2000, Koyama et al. 2000). Jones 
et al. (1999) suggested that during infection with H. pylori, gastric epithelial 
cells, exhibiting enhanced Fas receptor expression, could be eliminated by 
infiltrating lymphocytes that express the Fas ligand. In a study of Rudi et al.
(1998), a markedly elevated number of apoptotic cells were identified in the 
surface epithelium, antral pyloric glands, and lamina propria in 83% of biopsies 
from patients with H. pylori gastritis. These authors suggest that H. pylori-as- 
sociated chronic gastritis involves apoptosis of gastric epithelial cells by upre- 
gulation of CD95 (Fas) expression and increase in CD95L (FasL) expression in 
both lymphocytes o f the lamina propria and gastric epithelial cells, and there­
fore apoptosis might occur also by suicide mediated by FasL-Fas interaction 
among epithelial cells. Moreover, these authors found that upregulation of 
CD95 receptor expression and induction of apoptosis was achieved with 
cytotoxic H. pylori strains. Koyama et al. (2000) suggested a possible apoptotic 
depletion of invading mucosal lymphocytes, which expressed the Fas receptor 
and its ligand. The role of Fas signalling in gastric injury was shown in animal 
models o f autoimmune gastritis, where enhanced Fas expression was detected 
on gastric parietal cells, which correlates topographically with induction of 
apoptosis of these cells (Nishio et al. 1996). This indicates that one mechanism 
by which autoimmune-mediated target cell destruction may be affected is Fas- 
FasL interactions. It is noteworthy that autoantibodies, directed against gastric 
parietal H+, K+ ATPase detected in sera from H. pylori infected patients, corre­
lates with presence o f gastric atrophy and, moreover, with apoptotic cell loss 
(Clayeas et al. 1998, Steininger et al. 1998). In a recent study of Randlkofer et 
al. (2000) it was shown that H. pylori and inflammatory cytokine TNF-a induce 
apoptosis in isolated parietal cells, presumably stimulating the effector caspase-
3, which might contribute to development of atrophic gastritis. Also other 
cytokines, produced by Thl cells (IFN-y, IL-2, IL-1), can potentiate H. pylori- 
induced apoptosis in gastric epithelial cells (Wagner et al. 1997, Fan et al. 1998, 
Rudi et al. 1998). These cytokines may induce sensitisation of epithelial cells to 
Fas-mediated apoptosis (Houghton et al. 1999).
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H. pylori and the bcl-2 fam ily
Regulation of apoptosis is a complex process that includes also apoptosis- 
related proteins such as the bcl-2 family. Konturek et al. (1999) demonstrated 
that H. pylori induces apoptosis in the gastric epithelium due to an upregulation 
of proapoptotic Bax and a down regulation of antiapoptotic bcl-2 proteins. Bax 
mRNA and protein expression was higher in the antrum than in the corpus, 
which was associated with greater inflammatory changes observed in the 
antrum. Konturek et al. (1999) suggested a possible role of proinflammatory 
cytokines in induction of apoptosis.
There is also evidence that H. pylori induces apoptosis of T-cells. Ernst et al. 
(2000b) showed that H. pylori induced apoptosis in Fas-bearing T-cells through 
induction of FasL expression. Since this effect was linked to products encoded 
by cag PAI, the authors proposed that this mechanism can lead to persistent 
infection with cytotoxic strains favoured by a negative selection of T-cells 
encountering specific H. pylori antigens.
Apoptosis at different states o f  gastric mucosa
As a consequence of H. pylori infection, apoptotic cells, are localized mainly in 
epithelial cells in the upper foveolae. Increase in apoptosis may be accompanied 
by epithelial proliferation in the middle portions of gastric pits (proliferating 
zone) (Suzuki and Ishii 2000).
Apoptotic cells are rare in the generative cell zone of the normal mucosa. 
With progression of atrophic gastritis, the generative cell zone shifts downward 
and there occur a relatively large number of apoptotic cells. In the intestinalized 
glands, both apoptotic and proliferative cells are present in deeper gland 
portions corresponding to the generative zone. The frequency of apoptotic cells 
per crypt is higher in incomplete than in complete metaplasia, implying greater 
underlying DNA damage in the former and are presumably more frequently 
eliminated by apoptosis to avoid cell transformation (Ishida et al. 1996).
Only a few studies have dealt with association of atrophic alterations, 
developing in the course of time, with apoptosis in epithelial cells. Moss et al.
(1999), who evaluated the apoptosis to cell proliferation ratio for the antrum 
epithelial cells in a 31-year follow-up study of a cohort of Finnish patients, 
found that patients who developed atrophy later, had initially mildly increased 
gastric epithelial cell proliferation and apoptosis, and assumed increased 
cellular turnover in the atrophy group. However, the ratio o f apoptosis to 
proliferation was not a determinant risk for development of atrophy decades 
later. At the same time, some authors have proposed that atrophic gastritis is the 
result of sustained large-scale apoptosis of the gastric mucosa (Mannick et al. 
1996, Correa and Miller 1998). Apoptosis of the neck region mucosal glands is 
critical, as this region is the site of epithelial replication and regeneration of 
mucosal glands and surface epithelia. Depletion of mucosal glands may be 
caused by the failure to replace gland cells steadily over time via apoptosis —  a 
consequence of persistent inflammation (Correa and Miller 1998).
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Another aspect, upregulation of apoptosis protectors, such as bcl-2 on­
coprotein, and consequent decrease in apoptosis with enhanced cell prolife­
ration, raises the problem of malignant transformation. The bcl-2 confers survi­
val advantage on cells harbouring this oncogene (Hockenberry et al. 1990). The 
bcl-2 plays an important role in many continuously proliferative epithelia 
preventing apoptosis in regenerative compartments (Xia and Talley 2001). An 
aberrant expression of bcl-2 was demonstrated in patients with chronic atrophic 
gastritis with intestinal metaplasia as well as with gastric epithelial dysplasia 
(Lauwers et al. 1994, Krajewska et al. 1996, Mao-Kendler et al. 1999). The bcl-
2 is often topographically restricted to the long-lived or proliferating cell zone 
(Hockenberry et al. 1991), evidently to protect the renewal potential o f the 
mucosa (Lauwers et al. 1994). According to Lauwers et al. (1994), the cellular 
components o f premalignant lesions of the stomach, like intestinal metaplasia 
and gastric epithelial dysplasia, might have a prolonged life span through an 
aberrant expression of bcl-2 protein. These authors also suggested that bcl-2 is 
associated with cellular immaturity, which is in concordance with the finding 
that gastric preneoplastic lesions are composed of immature cells (Eastwood 
1977, Lipkin et al. 1985). Thus, highly proliferative immature neoplastic cells 
would have a growth advantage because of their prolonged life span resulting 
from an alteration of apoptosis.
H. pylori and epithelial cell proliferation in the gastric mucosa 
The gastric mucosal proliferative zone is located at the base of the gastric pits. 
The major flow of cells proceeds upward, towards the foveolar zone and the 
lumen. This migration takes approximately one week and ends in apoptosis. 
There occurs also a downward migration, from the proliferative zone towards 
the base o f the gastric glands, which appears over 2-3 months (Moss 1998),
For examination of the numbers of proliferating cells in tissues, a variety of 
different techniques have been used, such as measurement of the number of 
cells incorporating tritiated thymidine or bromodeoxyuridine (BrdU) in their 
nucleic acids, or detection by immunohistochemical methods with antibodies 
against endogenous cell cycle-associated antigens such as the proliferating cell 
nuclear antigen (PCNA) and Ki-67 (Hart-Hansen et al. 1979, Lipkin et al. 1985, 
Hall et al. 1990, Brenes et al. 1993, Filipe et al. 1993, Cahill et al. 1994, Lynch 
et al. 1994, Pich et al. 1994, Fraser et al. 1994, Chow et al. 1995, Havard et al.
1996, Yamaguchi et al. 2000). The proliferating cell nuclear antigen (PCNA) is 
a 36 kDa nuclear protein involved in DNA synthesis and related to the S-phase 
and expressed also during the late G1 and early G2 cell cycle phases (Takasaki 
et al. 1981). The Ki-67 is a nuclear antigen expressed in all phases of the 
proliferating cell cycle except for GO (Gerdes et al. 1984).
Many investigators have demonstrated increased cell proliferation in gastric 
glands, associated with H. pylori infection (Brenes et al. 1993, Fraser et al.
1994, Cahill et al. 1994, Lynch et al. 1995, Bechi et al. 1996, Baldini et al.
1999, Hishi et al. 1999, Nardone et al. 1999, Szaleczky et al. 2000). H. pylori-
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infected patients display an overall increase in epithelial cell proliferation 
within the gastric foveolae, with an upward shift of proliferating cells towards 
the surface (Anti et al. 1998), which is thought to be caused by an increase in 
the mucosal content of ammonia, known to be a strong stimulus of cell 
proliferation (Tsujii et al. 1993).
Increase in gastric epithelial cell proliferation has been observed mostly in 
vivo in response to increase in cell injury and death (Fan et al. 1996, Wagner et 
al. 1997, Shirin et al. 1999). However, in vitro studies have shown inhibition of 
cell growth by direct exposure of H. pylori (Knipp et al. 1996, Shirin et al. 
1999). Shirin et al. (1999) and Ahmed et al. (2000) showed that H. pylori can 
arrest gastric cells in the G0/G1 phase of the cell cycle. It was suggested that 
cyclin-dependent kinase inhibitors play a role in the G1 cell cycle arrest caused 
by H. pylori and its involvement in changing regulatory proteins p53, p21 and 
cyclin E in the cell cycle (Ahmed et al. 2000). It was surmised that one possible 
explanation for the discrepancy between in vivo and in vitro studies may be that 
while in vivo studies on patients, infected by H. pylori, reveal of the effect of 
persistent H. pylori infection, then in vitro studies as well as in vivo 
experimental studies reveal a short-term H. pylori mediated effect (Ricci et al.
1996). Elevated cell proliferation rate in patients with H. pylori infection might 
be related to H. pylori induced inflammation rather than to the direct effect of 
the pathogen (Tracz et al. 1995).
A study o f Fan et al. (1996) indicated that proliferation o f the gastric 
epithelial cell line can be stimulated directly by H. pylori and indirectly by H. 
pylori induced cytokine. Also, a study of Anti et al. (1998) found a correlation 
between cell proliferation indices and polymorphonuclear and mononuclear cell 
densities in the antrum mucosa. In a study of cell kinetics at different stages of 
progression from normal mucosa through chronic active gastritis, gastric 
atrophy and intestinal metaplasia to gastric cancer, Cahill et al. (1996) es­
tablished increased epithelial cell proliferation in all stages, with the highest 
index in gastric cancer. This study showed also increased epithelial cell pro­
liferation associated with H. pylori.
The literature has been inconsistent regarding the fact whether CagA 
positive strains can stimulate more gastric cell proliferation compared with 
CagA negative strains. There are data that unlike CagA-negative strains, CagA- 
positive strains induce higher rates of epithelial cell proliferation without 
increased apoptosis, which indicates the disbalance between cell growth and 
death and accounts for the association of cytotoxic H. pylori strains with gastric 
cancer (Peek et al. 1997, Sipponen et al. 1998). In some studies CagA-positive 
and CagA-negative strains did not display any significant differences in 
stimulating cell cycle arrest in vitro studies (Ahmed et al. 2000). In a recent 
study o f Moss et al. (2001) increased proliferation in both the antrum and 
corpus in H  pylori positive patients was not related to H  pylori CagA status. 
According to a study of Ricci et al. (1996), VacA specifically inhibited cell 
proliferation, whereas CagA exerted no effect on cell proliferation.
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H. pylori and antral gastrin- and somatostatin-cell density
Gastrin is a hormone regulating gastric acid secretion and growth of the 
gastrointestinal epithelium, which is also implicated in the genesis of peptic 
ulcer in conjunction with H. pylori infection. The secretion and expression of 
gastrin are under the paracrine control of somatostatin, which is produced by 
somatostatin (D-cells) having in close contact with gastrin-producing G-cells. 
D-cells contain also neuronal nitric oxide synthetase and appear to regulate 
apoptosis o f G-cells by paracrine release of nitric oxide. Both G- and D-cells 
are derived from a common multihormonal precursor cell present in the regene­
rative (isthmus) region of the gastric units (Larsson 2000).
In 1967, E. Solcia (University of Pavia) described a cell (G-cell) in the antral 
mucosa, which he identified as the probable site of gastrin secretion (Solcia et 
al. 1967). In 1968, McGuigan demonstrated, using direct immunofluorescence 
method (McGuigan 1968), that these cells contained gastrin (Modlin 1995).
H. pylori infection is associated with increased serum gastrin concentration 
which normalizes after eradication of the bacteria (Chittajallu et al. 1991, 
Katelaris et al. 1993, Queiroz et al. 1993, Annibale et al. 2000). Several studies 
established that H. pylori gastritis is associated with selective reduction and 
suppression of D-cells, which results in reduced inhibition of G-cell secretion 
by somatostatin and, as a consequence, enhanced level of gastrin (Moss et al.
1992, 0dum  et al. 1994, Kaneko et al. 1992, Calam 1998, Tham et al. 1998, 
Kamada et al. 1998, Park et al. 1999). G-cell density does not seem to be 
affected by presence of H. pylori (Moss et al. 1992, Kamada et al. 1998). In 
contrast, there has been described a reduction in antral G-cells and gastrin 
secretion with increasing atrophic gastritis (Asnaes and Johansen 1975, 
Creutzfeld et al. 1976, Crivelli et al. 1977, Stave et al. 1978, Marotta et al.
1990, Sipponen et al. 1990b). Several data point also to the role of proinflam- 
matory cytokines as well as the influence of lymphocyte infiltration on gastrin 
biosynthesis in G-cells (Konturek et al. 1999b) and a correlation of hyper- 
gastrinemia with antrum chronic inflammation (Kaneko et al. 1992).
Graham et al. (1993) proposed that increased gastrin response in H. pylori 
infection is dependent more on the functional activity of G- and D-cells rather 
than on G- or D-cell mass, which is in consistent with the data o f Tahara and Ito 
(1983) that serum gastrin level does not reflect directly the number o f G-cells in 
the antrum.
In summary, the outcome of colonization of the gastric mucosa with H. pylori 
depends on many interactions between host factors, bacterial factors and various 
environmental influences that modulate host response, including immune 
response to this pathogen. Chronic H. pylori gastritis resulting from acquision 
of the gastric pathogen in childhood, appears to be local immune response to
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this pathogen and, on the other hand as consequence of direct damaging 
properties o f H. pylori or indirect, mediating by inflammatory response.
The purpose of our study was to evaluate some associations between host 
immune response to different H. pylori antigens and development o f atrophic 
gastritis, to analyse its peculiarities for the antrum and corpus mucosa and to 
determine the influence o f H. pylori on epithelial cell turnover in the stomach 
mucosa.
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AIMS OF THE STUDY
1. To determine the seroprevalence of H. pylori infection and seropositivity for 
different H. pylori antigens in Estonian adult populations, in a non-selected 
group of schoolchildren of different age and residence and in a consecutive 
group of gastric cancer patients.
2. To assess the prevalence of H. pylori in gastric biopsies of children with 
abdominal complaints in case of different morphological and topographical 
types of gastritis, and to compare the efficacy of H. pylori detection by Giemsa 
staining and by immunohistochemical method, as well as to examine the 
reactivity of antibodies to H  pylori towards epithelial cells in the antrum and 
corpus mucosa.
3. To establish the association of immune response to different H. pylori 
antigens, like CagA, H. pylori HSP 60 and acid glycine extracted cell surface 
proteins of H. pylori as well as presence of anticanalicular autoantibodies 
(ACAB) and parietal cell autoantibodies (PCA) as a sign of autoimmune 
reaction o f H. pylori infected persons to host gastric epithelial cells, with the 
course of H. pylori gastritis, particularly development of atrophy in the antrum 
and corpus mucosa in adult population during 18 years of follow-up.
4. To examine the apoptosis of gastric epithelial cells both in the antrum and 
corpus mucosa at the initial and end time points of a 18-year follow-up study 
and to test the hypothesis that increased apoptosis may be associated with 
development of atrophy.
5. To evaluate the extent of apoptosis of gastric epithelial cells as well as 
immune response to different H. pylori antigens as depending on grade of 
chronic inflammation, activity of gastritis, intestinal metaplasia and grade o f H. 
pylori colonization.
6. To assess the effect of H. pylori on epithelial cell proliferation, on expression 
of the apoptosis protector oncoprotein bcl-2 in the epithelial cells and in 
interstitial lymphocytes and on the density of specific antral (gastrin and 
somatostatin cells) and corpus ({3 H+, K+ ATP-ase immunoreactive) mucosa 
cells.
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STUDY POPULATIONS
1. Population study from Karksi-Nuia and Abja-Paluoja,
Southern Estonia (Papers I and II)
This study was part of a large epidemiological investigation of several im- 
munologically mediated diseases, begun in 1990 in two small towns in Southern 
Estonia. All inhabitants from Karksi-Nuia, aged 15-95 years, and the in­
habitants from Abja-Paluoja, aged 50-91 years, were invited to participate in 
the study. Response rate was 84% in Karksi-Nuia and 11% in Abja-Paluoja. 
Altogether 1461 persons (637 men, median age 41 years; 824 women, median 
age 42 years) from Karksi-Nuia and 497 persons (189 men, median age 
60 years; 308 women, median age 62 years) from Abja-Paluoja were studied.
Sixty-four persons (28 male, 36 female) from Karksi-Nuia were invited 
6 months later for further studies and gastroduodenoscopy due to elevated 
serum IgA or IgG anti-gliadin antibody levels to find out cases of coeliac 
disease (Uibo et al 1993). In all of them also two biopsy specimens were taken 
from the gastric corpus and antral mucosa.
The results obtained from the two towns were analysed separately since the 
persons participating in the study in Abja-Paluoja were older.
Serum samples were taken from all participants and were analysed for IgG 
antibodies to acid glycine-extracted cell surface proteins o f H. pylori and for 
parietal cell antibodies (PCA).
2. Representative sample of the Karksi-Nuia adult population (Paper III)
A total o f 199 subjects (86 male, 113 female, median age 42.4 years) formed a 
representative sample of adult population from the South Estonian town of 
Karksi-Nuia. The subjects were selected from the 1461 persons (637 male, 824 
female, median age 42.3 years) who had participated in the large seroepi- 
demiological study in 1990 and donated blood. The relative proportion of 
males/females of different age was calculated on the original material of 1461 
samples, and this proportion was extrapolated to a set o f 200 samples. 
According to these proportions, serum samples from each age/sex group of the 
whole material were randomly selected by the computer. In the present study, 
199 sera out of the 200 samples were available for the determination of 
H. pylori and CagA status.
3. Group of patients with gastric carcinoma (Paper III)
Forty-five consecutive patients (22 male, 23 female, median age 64.5 years) 
with gastric adenocarcinoma, operated on and diagnosed pathohistologically in 
the Clinic o f Oncology, University of Tartu, and recruited during two periods, 
in 1986-1987 and in 1995-1996, were studied. Gastric cancer patients came 
from Tartu and from South Estonian counties including Karksi-Nuia. Adeno­
carcinoma was localised in the antrum in 14 cases, in the corpus in 17 cases,
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and both in the antrum and corpus in 14 cases. Gastric carcinomas were 
classified histologically according to Lauren (Lauren, 1965). The intestinal type 
adenocarcinoma was diagnosed in 18 cases, the diffuse type in 9 cases and the 
indeterminate type in 14 cases; 4 cases were inoperable (histological type not 
known).
The sera o f these persons were collected before gastric surgery and were 
stored at -20°C until assayed and analysed for IgG antibodies to acid glycine 
extracted cell surface proteins of H. pylori and anti-CagA IgG.
In order to compare the presence of IgG antibodies to CagA, using ELISA 
and immunoblot, 141 sera which included all 45 sera from gastric cancer 
patients, 52 sera from a representative population sample with borderline 
absorbance values in CagA ELISA, 9 sera from gastric and duodenal ulcer 
patients (all H. pylori positive in ELISA with the use of the glycine extracted 
cell surface antigen) and 35 sera from children with abdominal complaints, 
treated in Tartu Children’s Hospital (10 H. pylori positive cases and 25 
H. pylori negative cases both in ELISA and morphologically) were con­
sequently analysed by immunoblot. Additionally, a group of age and sex 
matched controls (45 sera from the serum bank of the Department of 
Immunology, University of Tartu) were studied in immunoblot assay, using a 
commercial Helico Blot 2.0 kit, for comparison with gastric cancer patients.
4. Group of schoolchildren of different age living in urban and 
rural areas in Southern Estonia (Paper IV)
A cross-sectional study of schoolchildren was carried out from autumn 1993 to 
spring 1996 in five Southern Estonian counties. Secondary schools were 
selected proceeding from the consideration that they should be of similar size in 
each county, which yielded a total of 20 schools. Within a particular school, 
children were selected randomly from the school roll, and every third 9-, 12- 
and 15- year-old child was afforded an opportunity to participate. The overall 
response rate o f 78% yielded a total of 1074 children who agreed to participate 
in the study. However, 56 of these children were excluded for the following 
reasons: absence from school on the day of the study (16 children), chronic 
disease (diabetes, asthma, etc.: 7 children), reluctance to undergo blood 
sampling despite a prior agreement (13 children), inadequately completed 
questionnaires (20 children). The investigated children were ethnic Estonians.
Serum samples were tested and analysed from a total of 421 children (190 
boys, 231 girls). The distribution of the studied 421 schoolchildren according to 
age, gender and place of residence is presented in Paper IV, Table I.
Serum samples were collected and stored at -20°C until assayed for IgG 
antibodies to acid glycine extracted cell surface proteins of H. pylori and to 
CagA protein.
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5. Group of children with abdominal complaints (Paper V)
One hundred and twelve children (41 boys and 71 girls; age range 1-16 years, 
median age 12 years) with abdominal complaints, defined according to Apley’s 
criteria (Apley and Naish 1958) and endoscoped in Tartu Children’s Hospital in 
the period 1990-1991, were studied.
In this group the prevalence of H. pylori in gastric antrum and corpus biopsy 
specimens with different grades of gastritis was evaluated using Giemsa 
staining and immunohistochemistry. In order to compare the results of the study 
based on the children’s mucosa respective data for adults, 38 biopsies (20 from 
the antrum and 18 from the corpus mucosa) taken from 23 consecutive patients 
with peptic ulcer (16 with gastric and 7 with duodenal ulcer; mean age 
52.7±9.0), endoscoped in the Department of Gastroenterology in Tartu Uni­
versity Hospital, were studied.
6. Adult sample from the island of Saaremaa in a 18 year follow-up 
study of chronic gastritis (Papers VI-IX)
Seventy persons (31 male, 39 female, median age 57.5 years) of an adult sample 
of 304 from Saaremaa Island, most of whom had previously been investigated 
by endoscopy and biopsy in 1979, 1985 and 1991, were re-investigated by 
endoscopy and biopsy in 1997. Of the initial 304 subjects, 227 were randomly 
selected and 77 wished to be investigated due to an abdominal complaint 
(Villako et al. 1982).
During the 18-year follow-up, of the original 304 subjects, 39 had died by 1997 
(gastric carcinoma —  2, coronary heart disease and heart failure —  17, 
malignancies other than gastric causes or leukaemia —  11, cerebral insult —  6, 
other causes —  3). The other subjects were lost because of high age, severe illness, 
change of residence, failure of communication or refusal. Gastroduodenal 
endoscopy was performed at the beginning of the study and subsequently at 6, 12 
and 18 years. The results of the 6- and 12-year follow-up studies of the course of 
gastritis are described elsewhere (Villako etal. 1991,1995). The course of gastritis 
is evaluated as the difference between the first and the last follow-up examinations 
over 18 years.
In paper VI, the state of gastric mucosa and the presence of H. pylori in 
histological sections were assessed in 66 subjects, and a serologic evaluation of 
IgG antibodies to H. pylori and to the CagA protein of H. pylori was performed 
on 70 sera.
In paper VII, anticanalicular autoantibodies (ACAB) were evaluated in the 
sera o f 62 persons (30 men, 32 women, mean age 57.6±11.4). The inclusion 
criteria for 62 out of 68 persons for assessment of ACAB were: seropositivity 
for H. pylori in ELISA, presence of H. pylori in antrum and/or corpus biopsy 
specimens, assessment of antrum and corpus biopsy specimens by two patho­
logists.
Additionally, antrum and corpus biopsies and serum samples for 37 out of 
the 62 persons (mean age 43.7 ± 10.6, 21 males, 16 females) were available
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from 1985, i.e. from the time 12 years earlier. Serum samples from both points 
of time were stored at -20°C and were then screened for ACAB and classical 
PCA.
In paper VIII, apoptotic index (Al) was evaluated in 68 persons (31 men, 37 
women, median age 39 in 1979), whose antrum and corpus biopsy specimens 
were available for both time points, 1979 and 1997. Apoptotic index (Al) was 
evaluated in the samples of 1979 for 52 antrum and 64 corpus biopsy specimens 
and in the samples of 1997 for 58 antrum and 66 corpus biopsy specimens. The 
dynamics of Al between the two time points, 1979 and 1997, was evaluated in 
the antrum biopsies of 49 persons and in the corpus biopsies of 64 persons.
In paper IX, a serological evaluation of IgG antibodies to H. pylori HSP60 
was performed on 68 sera collected in 1997. In these persons the state of gastric 
antrum and corpus mucosa was evaluated in 1979 and 1997. Additionally, IgG 
antibodies to H. pylori HSP60 were tested in a 12-year follow-up in 52 persons 
whose serum and histological data were available for 1985 and 1997.
7. Group of 59 patients investigated by routine endoscopy
in the Department of Gastroenterology of the University Hospital,
Bern (Paper X)
A total of 59 patients (34 men, median age 47), endoscoped in the Department 
of Gastroenterology of University Hospital, Bern, in 1993 (retrospective 
study—  39 persons) and in January-February 1994 (prospective study —  20 
persons), were studied. The group of patients included 20 persons with peptic 
ulcer (gastric ulcer —  4 cases; duodenal ulcer —  16 cases), 18 with erosion in 
the antrum or/and corpus mucosa and duodenitis, 5 with hiatus hernia, one with 
reflux oesophagitis, one with gastric corpus adenocarcinoma, one with a tumour 
of the liver and pancreas, one with colon carcinoma, and one with liver 
cirrhosis. In 11 patients no pathological gastroduodenoscopic findings were 
established.
In 40 patients, biopsies were sampled both from the antrum and corpus, in 16 
patients only from the antrum, and in 3 patients only from the corpus.
In this group of patients gastric epithelial cell proliferation was studied, and 
staining for bcl-2, and for gastrin and somatostatin cells as well as for p H+, K+ 
ATPase reactive parietal cells was performed.
48
METHODS
Serologic: evaluation of IgG antibodies to H. pylori
Enzyme-linked immunosorbent assay (ELISA) fo r  evaluation o f  IgG antibodies 
to the acid glycine-extracted cell surface proteins o f  H  pylori 
Seropositivity to H. pylori cell surface proteins (strains NCTC 11637 or CCUG 
1784) was evaluated using ELISA. Acid glycine (pH 2.2)-extracted cell surface 
proteins (0.5 jug per well) were used for the coating of microtitre plates (NUNC, 
Roskilde, Denmark). The studied sera were diluted to 1:800; the second anti­
body was alkaline phosphatase-labelled anti-human IgG (DAKO, Glostrup, 
Denmark) which was diluted to 1:500. The results were expressed by corrected 
mean absorbance values as a percentage of reference standards (human gamma­
globulin, Pharmacia & Upjohn, Stockholm, Sweden). The cut-off value for 
seropositivity was set to a relative antibody activity (RAA) (Lelwala-Guruge et 
al. 1992) of 25. The sensitivity of the test was 98%, specificity 82%>.
ELISA fo r  evaluation o f  IgG antibodies to the 128-kDa cytotoxin-associated 
(CagA) protein
Anti-CagA IgG were detected by ELISA using the recombinant fragment of the 
CagA antigen His-17/12 of HP CCUG 17874 strain following the methodology, 
described by Xiang et al. (1993), with modifications. In our study the recom­
binant antigen was diluted in 0.1 M carbonate buffer of pH 9.6 to a final 
concentration of 1.25 |j,g/ml. Maxisorp Immunoplates (NUNC, Roskilde, Den­
mark) were coated with 100 |ul/well in duplicate and incubated for 16h at 4°C, 
washed three times with PBS (pH 7.4) containing 0.05%> Tween 20. The wells 
were saturated with 200 |ul/well of 1% bovine serum albumin (BSA) in PBS —  
Tween at 37°C for 2h. After washing the plates three times, 100 jlxI of each 
serum sample diluted to 1:300 in 1% BSA —  PBS, were added to the wells in 
triplicate (two wells with the antigen and one without the antigen) and in­
cubated at 37°C for 2h. The plates were then washed three times, and 
100 jul/well o f alkaline phosphatase-conjugated anti-human IgG (DAKO, 
Glostrup, Denmark), diluted to 1:1000 in 1% BSA-PBS, were added and in­
cubated at 37°C for 1.5h. After three washes, 100 |ul/well of a substrate 
solution, containing p-nitrophenyl phosphate (Sigma Chemical Co, St. Louis, 
MO, USA) in diethanolamine-MgCl2 buffer, were added to each well and 
incubated at 37°C for 30 min. Each plate contained a positive and a negative 
control serum. Absorption was read at 405 nm. The absorption value derived 
from the mean value o f absorption in two wells with the antigen minus the 
absorption value in well without antigen was taken as the absorbance value of 
the studied sera. Instead of the cut-off of 0.250 OD used by Xiang et al. 1993, 
the absorbance value o f 0.300 (A 405 nm) was set as the cut-off point in our 
study, based on the calculation o f ELISA results, derived from the mean 
absorbance value of 25 H. pylori negative persons (histologically and serologi-
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cally) plus two standard deviations, by using square root transformation (Brown 
et al. 1989). Interassay variation was 11.5%.
ELISA fo r  evaluation o f  IgG antibodies to the H  pylori heat shock protein 60 
For determination o f antibodies to H.pylori HSP 60, LabSyst (Labsystems, 
Finland) 96 well plates were coated with H. pylori HSP 60 at a concentration of 
1 |ug/ml (0,1 |ug/well) for 16 h at 4°C. The HSP 60 used was purified from the 
supernatant o f sonicated H. pylori cells by gel filtration on Superose 12® and by 
ion exchange chromatography on MonoQ® at pH 6.7. The purity o f the antigen 
was tested by immunoblot using the serum of H. pylori infected patients and 
was found to be approximately 91% homogeneous. After 1.5 h o f blocking with 
2% bovine serum albumin in PBS, the plates were washed four times with PBS-
0.05%) Tween 20 (Sigma, St. Louis, USA). Serum samples were diluted to 
1:800 in PBS-0.02%> Tween and incubated for 1.5 h at 37°C. Alkaline 
phosphatase conjugated rabbit anti-human IgG (DAKO, Glostrup, Denmark) 
was used as the secondary antibody (dilution 1:500, incubation for lh  at 37°C). 
Bound antibodies were visualized by addition of a substrate solution containing 
1 mg/ml /?-nitrophenylphosphatase (Sigma Chemical Co, St. Louis, MO USA) 
in diethanolamine buffer, pH 9.8. Optical density was read at 405 and 492 nm 
after 50 min of incubation.
The results were expressed as corrected mean absorbance values as a 
percentage o f the value for a reference standard (human gammaglobulin, 
Pharmacia & Upjohn, Stockholm, Sweden) as relative antibody activity (RAA). 
The cut-off value for seropositivity to H. pylori HSP 60 (RAA=24) was based 
on the results obtained from the testing of 28 sera previously known to be 
negative for antibodies against the H. pylori glycine extracted cell surface 
protein (mean absorbance value o f 28 H. pylori negative persons plus two 
standard deviations). The sensitivity of the test was 69% and specificity 83%.
Immunoblot fo r  evaluation o f  IgG antibodies to H. pylori 
Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed using a Protean II Cell Vertical Electrophoresis equipment (Biorad, 
Richmond, CA). Glycine extracted proteins from seven pooled antigen batches 
of HP strain NCTC 11637 were separated in a gradient gel (5-20%) with a 5%> 
stacking gel (acrylamide/bis 29:1, Biorad, Richmond, CA) and were used for 
protein separation. The antigen (140 fxg/gel) was diluted four times in a sample 
buffer (0.5M TRIS-HCL pH 6.8, 0.5% bromphenol blue, 8% glycerol, 4% SDS, 
4% 2-mercaptoethanol) and heated at 95°C for 3 min. After cooling, the 
proteins were loaded on the gel and separated for 16h at 80 V. Molecular weight 
standards (Promega, Scandinavian Diagnostic Service, Falkenberg, Sweden), 
including proteins ranging from 14.3 to 97.4 kD in size, were treated similarly.
The proteins were transferred electrophoretically to the Immobilon PVDF 
membrane (0.45 |iim, Millipore Intertech, Bedford, MA, USA) using a semi-dry
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electro-blotter equipment (Ancos, Vig, Denmark) during 1.5h at a constant 
current of 0.8 mA/cm2.
The membrane was saturated by incubation for 2x15 min. in blocking 
buffers I and II (from M. Rucheton, Orstom Laboratories, Montpellier, France) 
(Rucheton et al. 1992). Saturated membranes were rinsed once for 10 min. in a 
washing buffer and cut into strips. The strips were overlaid with sera diluted to 
1:100 in a washing buffer under gentle agitation for 16 h at 4°C. The strips were 
then rinsed 3x5 min. and incubated for 2h at 4°C with horseradish-peroxidase 
labelled anti-human IgG antibodies (DAKO, Glostrup, Denmark) diluted to 
1:600. After repeated rinsing, bound antibodies were detected by reaction in a 
50 mM sodium acetate buffer (pH 5.0) containing 0.04% 3-amino-9- 
ethylcarbazole (Sigma Chemical Co, St. Louis, MO, USA) and 0.015% H2O2 . 
The intensity o f the bands obtained with patient sera was compared to that of 
the strip incubated with human gammaglobulin (KABI/ Pharmacia, Stockholm, 
Sweden) included as a calibrator in each analysis.
In analysis, special attention was paid to presence of antibodies to the 
cytotoxin-associated high molecular protein band of 128 kD.
Immunoblot using a Helico Blot 2.0 kit
IgG response to different H  pylori proteins in the gastric cancer group and in age- 
sex matched non-cancer controls was analysed using a commercial kit Helico Blot 
2.0 (courtesy of Genelabs Diagnostics, Singapore), following the manufacturers’ 
recommendations. Patients’ sera (dilution 1:100) were incubated on commercial 
strips for 1 h at room temperature, followed by incubation with goat anti-human 
IgG conjugated with alkaline phosphatase, dilution 1:1000, for 1 h at room 
temperature. Finally, the strips were incubated with a substrate solution (5-bromo- 
4-chloro-3-indoy 1-phosphate (BCIP) and nitro blue tetrazolium (NBT) for 15 min. 
The intensity of the bands obtained with patients’ and control sera was compared 
with that of the commercial control. The sample was considered positive in case it 
was found reactive with any one band of 116 kD, 89 kD, 35 kD, or with any two 
bands of 30 kD, 26.5 kD, 19.5 kD.
Histopathological evaluation of state of gastric mucosa and 
H. pylori colonization
In 68 persons from a group of adult persons from Saaremaa, formalin-fixed, 
paraffin-embedded gastric biopsy specimens from the antrum (3 specimens) and 
corpus mucosa (6 specimens), taken in 1979 and 1997 and in 52 persons taken 
also in 1985, were stained with haematoxylin and eosin as well as with a 
modified Giemsa stain. The state of the gastric mucosa and presence of
H. pylori in histological sections were assessed in accordance with the updated 
Sydney system (Dixon et al. 1996) and scored from 0 (no changes) through 1 
(mild) and 2 (moderate) to 3 (severe changes). The course o f gastritis was 
evaluated as the difference between the first (1979) and the last (1997) follow- 
up examination over 18 years.
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In 120 children with abdominal complaints, endoscoped in Tartu Children’s 
Hospital, and in 59 patients, endoscoped at the Department of Gastroenterology 
o f the University Hospital, Bern, presence of H. pylori and the state o f the 
gastric mucosa were examined in haematoxylin and eosin-stained sections and 
were graded as follows: normal, i.e. no loss of glands and no chronic inflam­
mation (score 0); superficial gastritis, i.e. non-atrophic gastritis in three stages: 
mild, moderate or severe (score numbers 0.5, 1.0 and 1.5 correspondingly); 
atrophic gastritis in three stages: mild, moderate, severe (score numbers 2.0, 3.0 
and 4.0 correspondingly).
Immunohistochemical methods
Evaluation o f  H. pylori on histological sections
Formalin-fixed, paraffin-embedded biopsy specimens were studied using 
peroxidase-antiperoxidase (PAP) method. After deparaffinisation, 5 |Lim tissue 
sections were pre-treated with 0.1% trypsin (Spofa, Prague, Chech Republic) 
15 min. at 37° C and with hydrogen peroxide in methanol for 30 min. at 20°C to 
prevent non-specific reactions. As primary antibodies, rabbit anti-H. pylori 
polyclonal antibodies (anti-H. pylori IgG; DAKO, Glostrup, Denmark) were 
used (dilution 1:50; incubation overnight at 4°C). Sections from the same 
biopsy specimens, incubated without the primary antibody, served as negative 
controls. As the secondary antibody, swine-anti- rabbit IgG (DAKO, Glostrup, 
Denmark) was used (dilution 1:100; incubation 1 h at 20°C), followed by incu­
bation with the peroxidase antiperoxidase rabbit complex (DAKO, Glostrup, 
Denmark; dilution 1:500; incubation 1 h at 20°C). Binding of specific anti­
bodies was visualized using 3,3-diaminobenzidine tetrahydrochloride (DAB; 
Sigma Chemical Co, St. Louis, MO, USA). The sections were counterstained 
with haematoxylin and examined by one investigator (T.V.) blinded to the 
results o f gastritis grading and the results of H. pylori positivity based on 
Giemsa preparations. The entire surface of all sections present on the slide was 
examined. Staining was considered positive if brown-stained organisms o f a 
typical shape were seen on the luminal surface of the corpus or antrum glands 
(Fig. 1). Additionally, we assessed the immunostaining of antral or corpus 
epithelial cells with anti-H. pylori IgG (Fig. 2).
Evaluation o f  anticanalicular autoantibodies (ACAB) 
in serum against canalicular structures within human parietal cells 
ACAB, reacting against canalicular structures within human parietal cells, were 
detected using immunohistochemical method. Heterologous formalin-fixed and 
paraffin-embedded gastric corpus mucosa, without pathological alterations and 
not expressing blood groups A and B, was incubated overnight at 20°C with 
sera diluted to 1:100 in the RPMI 1640 medium (Biochrom, Berlin, Germany). 
As the secondary antibody, alkaline phosphatase conjugated rabbit anti-human 
IgG (DAKO, Hamburg, Germany), diluted to 1:10 in the RPMI 1640 medium,
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Figure 1. Positive staining for H. pylori on the surface of the foveolar epithelium cells of 
the corpus mucosa (arrow). Peroxidase-antiperoxidase method, using anti-H. pylori 
polyclonal antibodies (DAKO); x 40 objective, x 10 eyepiece.
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Figure 2. Positive staining with anti-H. pylori polyclonal antibodies (DAKO) localized in 
the cytoplasma of corpus mucosa cells in the neck part o f the glands (arrow). Peroxidase- 
antiperoxidase method; x 20 objective, x 10 eyepiece.
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was used (incubation at 20°C for 90 min.). After washing, positive reaction was 
induced with fast red. The sections were counterstained with haematoxylin, 
mounted with Aquatex and examined by light microscopy, without the know­
ledge o f respective patient data or histological alterations. One positive control 
serum was included in each immunohistochemical staining session, and nega­
tive controls were performed omitting the human serum. Intensive red immuno­
histochemical staining, visible at the canaliculi of parietal cells in the corpus 
mucosa, was taken as positive reaction (Fig. 3, Fig. 4 and Paper VII, Fig 2.).
Indirect immunofluorescence methodfor evaluation o f  PCA 
Classical IgG-type PCA was examined using indirect immunofluorescence 
method (Fig. 5). Unfixed cryostat sections from the mouse stomach fundal 
region was used as the antigen. Rat kidney and liver sections were studied as 
controls. The dilution of the studied sera was 1:10 and 1:100. FITC-conjugated 
sheep anti-human IgG was used as the secondary antibody. Every set of tests 
contained a known PCA positive and a PCA negative serum.
Evaluation o f  apoptosis using terminal deoxynucleotidyl transferase-mediated 
dUTP-biotin nick end labelling (TUNEL) method
Apoptosis was evaluated with the use of TUNEL (terminal deoxynucleotidyl- 
transferase mediated dUTP-biotin nick end labelling) histochemistry method 
(Gavrieli et al. 1992). After deparaffmisation and rehydration, the sections were 
digested with proteinase K (Sigma, St Lois, MO) for 30 min. at 20°C (20 |ug/ml 
in TRIS-HCL). After washing with PBS (pH 7.4) a TUNEL reaction was 
performed using the In Situ Death Detection Fluorescein Kit (Boehringer 
Mannheim, Germany). The principle of the test is the following: DNA strand 
breaks, generated during apoptosis, were identified by labelling with fluorescein 
dUTP (digoxigenin-11-deoxyuridine triphosphate) using terminal deoxynucleo­
tidyl transferase (TdT). By an enzymatic reaction (incubation for 40 min. at 
37°C) with TdT, fluorescein labelled dUTP was specifically transferred to the 
3 ’-OH ends o f DNA. After washing, with PBS (pH 7.4) and treatment with 
BSA (bovine serum albumin, 1 mg/ml in PBS) for 10 min., the sections were 
subsequently incubated with monoclonal mouse antifluorescein antibodies 
(DAKO, Glostrup, Denmark, diluted 1:10, incubation for 30 min. at 20°C). 
After washing the sections were incubated with rabbit anti mouse biotinylated 
monoclonal antibodies (DAKO, Glostrup, Denmark, diluted 1:50, for 30 min. at 
20°C), followed by incubation with the Strept AB Complex (streptavidin 
complexed with biotinylated alkaline phosphatase; DAKO, Glostrup, Denmark) 
and fast red as a substrate. Counterstaining was done with haematoxylin. 
Apoptotic cells with incorporated dUTP showed a distinct bright red signal in 
the nucleus (Fig. 6 and in Paper VII, Fig. 1). For negative controls TdT was 
omitted. The corpus gastric mucosa with lymphofollicules, containing apoptotic 
lymphocytes, was used as positive control.
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Figure 3. In situ binding pattern of anticanalicular autoantibodies reacting against the 
canalicular membranes within the human parietal cells o f the gastric corpus mucosa; x 40 
objective, x 10 eyepiece.
Figure 4. Intensive staining for anticanalicular autoantibodies throughout the cytoplasma 
of parietal cells in PCA positive cases (x 100 objective, x 10 eyepiece).
Figure 5. Parietal cell autoantibodies reacting by indirect immunofluorescence test 
(x 100 objective, x 10 eyepiece).
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Figure 6. Apoptotic cells in the foveolar cell compartment o f the antrum mucosa (arrow, * 
40 objective, x 10 eyepiece). TUNEL histochemistry.
Morphometry. The rate of apoptotic cells in the antrum and corpus mucosa was 
quantified by counting, in triplicate, 200 cells of the foveolar cells (FC) 
compartment, 200 cells in the proliferating zone (PZ) (neck part) (only for well 
oriented glands) and 200 cells of the glandular part (GP) of the section, using a 
light microscope with magnification x400. The mean value of positively 
labelled nuclei per 200 cells, calculated in three different section areas separa­
tely for FC, PZ and GP, were expressed as apoptotic index (AI). Intra-assay 
variation for AI was 11%. Counting was done by one observer (T.V.) who was 
not aware of morphological data or the year of sampling (done in mixed 
manner).
Evaluation o f  gastric epithelial cell proliferation, apoptosis protector bcl-2 
protein and immunostainingfor gastrin and, somatostatin cells and J3-H+, K+ 
ATP-ase in the canaliculi o f  parietal cells using Alkaline Phosphatase Anti- 
Alkaline Phosphatase (APAAP) method and Avidin-Biotin method 
Gastric epithelial cell proliferation was assessed by employing the Proliferating 
Cell Nuclear Antigen (PCNA) and Ki-67 (MIB 1) labelling. PCNA immu­
nostaining was performed using alkaline phosphatase anti-alkaline phosphatase 
(APAAP) procedure. After deparaffmisation and pre-treatment with 20% acetic 
acid (15 sec, 4°C) and 3% BSA (Merck) in TRIS-NaCl buffer (20 min., 20°C), 
tissue sections were incubated overnight (4°C) with a primary mouse 
monoclonal antibody against PCNA (PCNA PC 10, DAKO, Glostrup, Denmark, 
dilution 1:50). Rabbit anti-mouse immunoglobulin (DAKO, Glostrup, Denmark, 
dilution 1:30) was used as the secondary antibody (incubation 30 min, at 20°C). 
The APAAP mouse monoclonal antibody complex (DAKO, Glostrup, 
Denmark, dilution 1:50) was then applied for 60 min. To enhance the intensity 
of final staining, these two steps were repeated. New fuchsine (Merck)- 
naphthol AS-Bi phosphate (Sigma, St. Louis, USA), in a TRIS-HC1 buffer, pH 
8.7, containing 2.1 mg/ml levamisole (Sigma, St. Louis, USA), was used as the 
alkaline phosphatase substrate for 20 min. at room temperature. The reaction 
was stopped by rinsing the sections in cold water. The sections were co­
unterstained with haematoxylin (Merck) and mounted with Aquatex (Merck).
Immunostaining for Ki-67, bcl-2 oncoprotein as well as for gastrin, soma­
tostatin, and P- H+, K+ ATPase immunoreactive cells was performed using 
avidin-biotin procedure. After deparaffmisation and rehydration, the sections 
were treated in a microwave oven in a 10 mM citrate buffer, pH 6.0, once at 190 
W for 5 min. and twice at 140 W for 5 min. before staining for Ki-67, bcl-2 and 
gastrin cells. Further, the plastic jar was allowed to cool for 15 min. at room 
temperature and was then washed for 10 min. in a TRIS-NaCl buffer, pH 7.5.
As primary antibodies, monoclonal anti Ki-67 (MIB-1, Dianova, Hamburg, 
dilution 1:50), the anti-human bcl-2 oncoprotein (clone 124, DAKO, Glostrup, 
Denmark, dilution 1:50), the anti- |3 subunit of H+, K+ ATP-ase (AB 2611 
kindly donated by Dr. J.G. Forte, Berkeley, USA; dilution 1:200), polyclonal
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anti-gastrin (DAKO, Glostrup, Denmark; dilution 1:300) and anti-somatostatin 
(DAKO, Clostrup, Denmark; dilution 1:1000) were used. Anti- (3-H+, K+ 
ATPase and anti-somatostatin antibodies were applied on tissue sections 
without microwave pre-treatment. All primary antibodies were diluted in a 
TRIS-NaCl buffer with 0.1% casein and 0.1% NaN3 (pH 7.5). The preparations 
were incubated with primary antibodies for 60 min. at 20°C. Subsequently, the 
sections were incubated with rabbit anti-mouse biotinylated immunoglobulins 
(DAKO, Glostrup, Denmark) for monoclonal primary antibodies, or with swine 
anti-rabbit immunoglobulins biotinylated immunoglobulins (DAKO, Glostrup, 
Denmark) for polyclonal primary antibodies at dilution 1:200 for 45 min. The 
Avidin-Biotin Complex (DAKO, Glostrup, Denmark) was applied for 45 min. 
at room temperature. Alkaline phosphatase reaction was developed for 30 min. 
in the New Fuchsine substrate solution. The specimens were then washed in tap 
water, counterstained with haematoxylin and mounted with Aquatex (Merck). 
Negative controls were performed by replacing the primary antibodies by the 
TRIS-NaCl buffer.
A typical Ki-67 labelling pattern in the PZ and FC compartments of the 
corpus mucosa is shown in Fig. 7. Bcl-2 positive staining o f interstitial 
lymphocytes in the antrum mucosa is shown in Fig. 8. Staining of G-cells and 
D-cells is presented in Figs. 9 and 10.
Staining with the monoclonal antibodies directed against P- H+, K+ ATPase 
in parietal cell canaliculi is presented in Fig. 11.
In our earlier study (Vorobjova et al. 1989), which was undertaken to 
evaluate the expression o f the epithelial membrane antigen in the antrum and 
corpus mucosa of patients with different states of gastric mucosa (normal, 
chronic gastritis, gastric ulcer and gastric cancer), using monoclonal antibodies 
to human milk fat globule membranes (HMFG) by peroxidase-antiperoxidase 
(PAP) method, we revealed a dark brown staining in the cytoplasm of the 
parietal cells. Positive staining, evaluated using HMFG monoclonal antibodies, 
corresponded to the staining of parietal cell canaliculi (cf. Fig. 11, use of 
monoclonal antibodies to p H+, K+ATPase and Fig. 12a, for 1989, use of 
monoclonal antibodies to HMFG). Regrettably, in 1989 when we published our 
paper we failed to interpret these results properly, nor did we pay attention to 
this fact. As early as 1979, Heyderman et al. indicated that monoclonal anti­
bodies directed against HMFG membrane proteins cross-reacted with gastric 
mucosal cells. Later, in 1995, Walker et al. published in J Clin Pathol the study 
“Identification o f parietal cells in gastric body mucosa with HMFG-2 mono­
clonal antibody”. The authors used the mentioned antibodies and, additionally, 
double staining with monoclonal antibodies, directed against an epitope on the 
a  subunit of H+, K+ ATPase, and recommended to use HMFG monoclonal 
antibodies as highly specific markers of human gastric parietal cells.
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Figure 7. Ki-67 labelling pattern in the proliferating zone and in the foveolar cell compart­
ment o f the corpus mucosa (intensive red staining, arrow; x 20 objective, x 10 eyepiece). 
Avidin-Biotin method.
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Figure 8. Bcl-2 positive staining for interstitial lymphocytes in the antrum mucosa (inten­
sive red staining, arrow; x 40 objective, x 10 eyepiece). Avidin-Biotin method.
Figure 9. Positive staining for gastrin cells in the glandular part o f the antrum mucosa 
(intensive red staining; x 40 objective, x 10 eyepiece). Avidin-Biotin method.
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Figure 10. Positive staining for somatostatin cells in the glandular part o f the antrum mu­
cosa (x 40 objective, x 10 eyepiece). Avidin-Biotin method.
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Figure 11. Positive staining for p-H+, K+ ATP-ase in the canaliculi o f parietal cells (in­
tensive red staining, x 100 objective, x 10 eyepiece). Avidin-Biotin method.
Figure 12a. Positive staining for parietal cell canaliculi using monoclonal antibodies to 
HMFG (reproduced by a permission from Arch Pathol (Vorobjova et al. 1989)).
Figure 12b. Negative staining for parietal cell canaliculi (reproduced by a permission 
from Arch Pathol (Vorobjova et al. 1989)).
Evaluation o f  immunostained sections.
The sections were examined using an objective x40 and an eyepiece xlO. Antral 
and corpus mucosa glands were divided into the foveolar cells, the proliferating 
zone (neck-isthmus) and the glandular part. In each of them five fields were 
examined.
Only bright red stained nuclei were considered positive either for PCNA or 
for Ki-67. PCNA and Ki-67 labelling index (LI) were defined as the proportion 
of bright red stained nuclei in relation to 100 nuclei counted per field. Bcl-2 
positive staining for interstitial lymphocytes was scored as 0-5. Bcl-2 staining 
of epithelial cells in the antrum and corpus mucosa was considered positive (red 
staining o f the cytoplasm) or negative.
The densities o f G, D and p- H+, K+ ATP-ase positive cells were expressed 
as the mean values o f cells counted in five fields of each gland part. The slides 
were analysed by one investigator (T.V.) who was not aware of the data of 
histological alterations. Intraobserver variability was 12.6+7.0%.
The persons studied and the methods employed are summarised in Table 2.
Statistical methods
Differences in H.pylori status and in the prevalence of antibodies to the acid 
glycine extracted cell surface proteins of H. pylori and to CagA between 
different groups were tested by the chi-square test. Odds ratios (OR) with 95% 
confidence intervals (Cl) were estimated using the Mantel-Haenzel statistics 
with the Exact software. Effects were considered to be statistically significant if 
the 95% Cl did not include the value 1.0. Differences in the mean values of OD 
as the expression of the level of anti-CagA IgG were calculated by Student’s t- 
test.
Association of grade of activity of gastritis, chronic inflammation, atrophy, 
intestinal metaplasia and damage of surface epithelial cells with CagA positivity 
was evaluated using multiple logistic linear regression analysis by the SAS 
package; p value <0.05 was considered statistically significant.
Statistical differences between the ACAB-positive group and ACAB- 
negative group were evaluated by chi-square and the McNemar tests using 
Statgraphics and SPSS statistical software. Odds ratios (OR) with 95% 
confidence intervals (Cl) were estimated using the Mantel-Haenzel statistics 
with the Exact software. Differences were considered statistically significant if 
95% Cl did not include the value 1.0. Differences in the mean values of age 
were calculated by the Mann-Whitney test (Statgraphics software). The K-value 
for measuring agreement between histological assessments was calculated using 
the SPSS statistical software. P values < 0.05 were considered significant.
The Wilcoxon signed rank test served for evaluation of the differences 
between the apoptotic index (Al) of the same persons in the samples of 1979 
and 1997, and the Mann-Whitney unpaired nonparametric test served for 
analysis o f Al for two groups according to different grades of atrophy, chronic 
infiltration, activity of gastritis and H. pylori colonization. Differences
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Table 2. Persons studied and methods employed.
Studied Groups
Number
of
persons
Age
(median)
Male/
Female
Study performed Method
1. Population study 
Karksi-Nuia
Abja-P aluoja
1461
497
42
61
637/824
189/308
H. pylori status, PCA 
H. pylori status
ELISA (IgG to surface proteins of H. pylori), 
Indirect immunofluorescence method 
ELISA (IgG to surface proteins of H. pylori)
2. Representative sample 
of Karksi-Nuia
199 42 86/113 H. pylori status, 
CagA status
ELISA, Imunoblot (IgG to surface proteins of H. pylori) 
ELISA (IgG to recombinant fragment of CagA)
3. Patients with gastric 
adenocarcinoma
45 64.5 22/23 H. pylori status 
CagA status
ELISA, Imunoblot (IgG to surface proteins of H. pylori) 
ELISA (IgG to recombinant fragment of CagA)
4. Schoolchildren 421 9, 12, 15 190/231 H. pylori status 
CagA status
ELISA (IgG to surface proteins of H. pylori) 
ELISA (IgG to recombinant fragment of CagA)
5. Children with abdominal 
complaints
112 12 41/71 H. pylori status Morphological (Giemsa staining), 
Immunohistochemical (anti-H. pylori antibodies)
6. Adult sample from Saaremaa 
Island
Sample of 1997 70 57.5 31/39 H. pylori status (n=70), 
CagA status (n=70),
H. pylori HSP60 (n=68) 
ACAB (n=62),
PCA (n=62),
Apoptotic index (n=68)
ELISA (IgG to surface proteins of H. pylori)
ELISA (IgG to recombinant fragment of CagA)
ELISA (IgG to H. pylori HSP60)
Immunohistochemical
Indirect immunofluorescence method
TUNEL
Samples of 1979 and 1997 68 39 in 1979 31/37 H.pylori status, 
Apoptotic index
Morphological (Giemsa staining) 
TUNEL
Samples of 1985 and 1997 52
37
45 in 1985 
44 in 1985
26/26
21/16
H. pylori status,
H. pylori HSP60 
H. pylori status, HSP 60 
ACAB
Morphological (Giemsa staining), ELISA (IgG to surface 
proteins of H. pylori), ELISA (IgG to H. pylori HSP60) 
TUNEL
7. Patients investigated by routine 
endoscopy
(University Hospital, Bern)
59 47 34/25 H. pylori status,
Staining for PCNA, Ki- 
67, bcl-2, G-, D- cells, p 
H+K+ATPase
Morphological
APAAP, Avidin-Biotin immunohistochemistry
in the number of persons with different grades of H. pylori colonization at two 
time points of observation were checked by the chi-square test. The effect of 
different variables on the expected values of Al and on the difference between 
the mean values of Al for different compartments of antrum and corpus mucosa 
sections in the samples of 1979 and 1997 was evaluated by multifactorial 
dispersion analysis by SAS/LAB with the SAS package. P values < 0.05 were 
considered significant.
Differences in the number of cases positive to H. pylori HSP 60 between the 
groups were tested using chi-square test. Differences in the mean values of 
RAA as the expression o f the anti-Ä pylori HSP 60 IgG level were calculated 
with the Student t test. Odds ratios (OR) with 95% confidence intervals (Cl) 
were estimated using the Mantel-Haenzel statistics with the Exact software. The 
differences were considered statistically significant when 95% Cl did not 
include the value 1.0. Correlation between the RAA values of the cell surface 
proteins o f H. pylori as well as the RAA values of H. pylori HSP 60 antibodies 
and grade o f H. pylori colonization, chronic inflammation, atrophy and activity 
of gastritis, as well as their interrelationships were evaluated, using the 
Spearman rank and Pearson correlation tests (Statistika, Statsoft 99) and 
multifactorial dispersion analysis with the SAS package. P-values < 0.05 were 
considered significant.
The values of the labelling index of PCNA, Ki-67, bcl-2, gastrin, 
somatostatin and (3-H+, K+ ATP-ase positive cells were indicated as mean ± 
SD. Statistical analysis was done with Student’s t-test, chi-square test, 
Spearman rank correlation analysis (Statgraphics software) as well as with the 
use of multiple regression analysis (Statistika, Statsoft 99). P-values < 0.05 
were considered significant.
Ethics
This study was approved by the Committees of Ethics of the University of Tartu 
and of the University of Bern, Switzerland.
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RESULTS
1. Seroprevalence of H. pylori in a population from Southern Estonia 
(Papers I and II)
IgG antibodies to acid glycine extracted cell surface proteins of the H.pylori 
strain NCTC 11637 were detected in 1271 out of 1461 (87%) persons studied in 
Karksi-Nuia. The prevalence rate of antibodies increased significantly from 
69% in the age group of 15-19 years to 83% in the age group of 20-29 years 
(p=0.002), and to 89% in the age group of 30-39 years (p=0.04). There was no 
significant difference between any of the older age groups (p>0.05) (Paper I, 
Table 1) and Fig 13.
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Figure 13. Seroprevalence of antibodies to the acid glycine extracted cell surface 
proteins o f H. pylori in different age groups in the Karksi-Nuia population.
In Abja-Paluoja, 444 out of 497 (89%) persons had IgG antibodies to H. pylori 
acid glycine extracted cell surface proteins. There was no significant difference in 
the prevalence of H pylori antibodies in different age groups (Paper I, Table 2).
A comparison of the results of serological and histological H. pylori deter­
minations, and the state of the gastric mucosa in 64 persons of Karksi-Nuia, 
subjected to endoscopy, is presented in Table 3 (Paper I). There was good 
agreement between the histological and serological findings for H. pylori. The 
sensitivity of the ELISA test for the NCTC 11637 strain antigen of H. pylori 
was 98% (51/52), specificity was 82% (9/11). The positive predictive value was 
96%. The false positive rate for the NCTC 11637 antigen was 18%, the false 
negative rate 2%.
15-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 90-99 
n=159 n=184 n=327 n=275 n=289 n=146 n=63 n=16 n=2
65
We found statistically significant correlations between RAA values in 
ELISA and grade of H. pylori colonization evaluated histologically as the sum 
of grades for the antrum and corpus (r=0.389; p=0.002). H. pylori grade in the 
antrum correlated significantly with the scores of mucosa changes in the antrum 
(r^O.482; p=0.0001). H. pylori grades for the corpus correlated with the scores 
of mucosa changes in the corpus (r=0.310; p=0.015). No significant correlation 
was found between RAA values in ELISA and severity of gastritis (total score 
of antral and corpus gastritis) (r=0.220; p=0.08).
PCA were detected in 36 (2.5%) of the 1461 persons studied. PCA were 
found in 26 out of 1271 (2%) H  pylori positive, and in 10 out of 190 (5.2%) 
H. pylori negative persons (p=0.007). OR for association between PCA and 
H  pylori positivity was 0.37 (95% Cl 0.18-0.78). However, there was a signi­
ficant age-dependent increase in PCA positivity among the H. pylori infected 
persons but not among the H. pylori negative persons (Paper II, Table 1). Thus, 
in the age group of 30-49 years, 1.1% of H. pylori positive persons had PCA in 
comparison with 3.8% and 5.5% in the following age groups (p=0.008). In 
H. pylori negative persons, the prevalence of PCA among three subsequent age 
groups was not significantly different (9.4%, 8.3% and 1.5% for the age groups 
of 30-49, 50-69 and >70 years, respectively; p=0.03).
2. CagA protein seropositivity in a random sample of adult population and 
gastric cancer patients in Estonia (Paper III)
The prevalence of IgG antibodies to acid glycine extracted cell-surface H  pylori 
proteins was 85% (169/199) in a random adult population sample and 91% 
(41/45) in gastric cancer patients (Paper III, Table 1), which was not signi­
ficantly different (p=0.39). Anti-CagA IgG were present in 63% (126/199) of 
the population sample, while the highest prevalence of CagA antibodies was 
found in the 20-29 age group: 19/25 (76%) in all studied persons and 18/22 
(82%) in persons defined as H. pylori positive.
In gastric cancer patients prevalence of anti-CagA IgG was significantly 
higher, 87% (39/45; p=0.004). H. pylori positive gastric cancer patients showed 
anti-CagA IgG reactivity in 90% (37/41) of cases versus 71% for CagA positive 
persons in the H. pylori positive population sample (120/169; p=0.01). The 
significant association between CagA positivity and gastric cancer was con­
firmed (OR=3.76; 95% Cl 1.59-8.91).
IgG response to different H. pylori proteins, evaluated using a Helico Blot 2. 
0 kit in 45 gastric cancer patients and in 45 age and sex matched controls, is 
presented in Table 3:
Group No 116 kD 89 kD 35 kD 30 kD 26.5 kD 19.5 kD
Gastric cancer 
patients
45 43/45 25/45 8/45 17/45 30/45 9/45
Controls 45 25/45 12/45 21/45 31/45 31/45 12/45
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Seropositivity to 116 kDa and 89 kDa proteins, associated with pathogenic 
CagA and Vac A proteins of H. pylori, was significantly more frequent in the 
group of gastric cancer patients than in age and sex matched non-gastric cancer 
controls (p=0.00003, p=0.005 correspondingly). Simultaneous seropositivity to 
CagA (116 kDa) and VacA proteins (89 kDa) in the gastric cancer group 
(25/45) was also significantly more frequent than for controls (9/45) 
(p=0.0005). IgG response to any protein of 116, 89, 35, 30, 26.5 and 19.5 kDa 
or their combinations in case of different localisation, type, differentiation or 
stage of gastric cancer was not significant. Nor did we observe a significant 
difference between the histological type or localisation of cancer and anti-CagA 
positivity in ELISA.
The difference in the prevalence of anti-CagA IgG between the cor­
responding age groups in the population sample and in gastric cancer patients 
(Paper III, Table 1) was not significant (p>0.05 for groups 30-39 to 70 and >70 
years). However, when only the subjects aged 50 years and older from the 
population and from among gastric cancer patients were taken into account, a 
significant difference was revealed in the prevalence of anti-CagA IgG between 
the cancer group and the population sample defined as H. pylori positive (31/35 
and 41/62, correspondingly; p=0.02; OR=3.96; 95% Cl 1.24-12.5).
A comparison of the occurrence of IgG antibodies to a recombinant fragment 
of CagA antigen, evaluated by using ELISA, and to CagA protein of acid 
glycine extracted cell-surface proteins of H. pylori, evaluated by using 
immunoblot, both of which were performed on 141 sera, is presented in Table 2 
(Paper III). ELISA and immunoblot showed an agreement of results in 113/141 
(80%) of cases.
3. Seropositivity for H. pylori and for the CagA protein in schoolchildren of 
different age from urban and rural areas in Southern Estonia (Paper IV)
The prevalence of IgG antibodies to acid glycine extracted cell-surface H.pylori 
proteins in schoolchildren was 56% (235/421), to CagA, 28% (118/421). Out of 
235 H.pylori positive schoolchildren, 109 were CagA positive (46%). Nine 
children negative to the cell surface protein in H.pylori-ELISA were positive in 
CagA-ELISA. H.pylori and CagA seropositivity in ELISA in schoolchildren of 
various age from different places of residence in Southern Estonia is presented 
in Table 2 (Paper IV). There was no significant difference in H.pylori and CagA 
positivity between girls and boys. Schoolchildren aged 9, 12 and 15 years 
revealed no significant difference either in H.pylori status or CagA positivity.
Schoolchildren living in a rural area (including both villages and farms) had 
a significantly higher H.pylori prevalence rate (118/181; 65%) as well as CagA 
positivity (64/181; 35%) compared with those living in towns, 117/240 (49%) 
and 54/240 (22%), respectively (p=0.001 for H.pylori prevalence rate and 
p=0.005 for CagA prevalence rate). The odds ratio (OR) for the association 
between H.pylori infection and place of residence in rural areas was 1.96 (95%
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CI 1.32-2.92). We found also a significant association between CagA positivity 
and place of residence in rural areas: OR=1.88 (95% Cl 1.22-2.88).
4. H. pylori in gastric mucosa of children with abdominal complaints: 
superiority of H. pylori detection by Giemsa staining over specific antibody 
staining. Detection of antigen-reactive corpus mucosa cells by immuno- 
histochemistry (Paper V)
Gastritis of any degree and localisation was found in 84/112 (75%) children 
with abdominal complaints. The most frequent topographical and morpho­
logical type of gastritis was gastritis without atrophy localised simultaneously in 
the antrum and corpus mucosa (47/103 or 45.6% cases studied). Gastritis 
without atrophy restricted to the antrum was seen in 30/103 (29%) cases and 
gastritis without atrophy restricted to the corpus, in 3/103 (3%) cases. The 
prevalence of different states of gastric mucosa and of H. pylori positivity, 
detected using two different methods, is presented in Table 1 (Paper V).
H. pylori was detected by Giemsa staining in 83/112 (74%) of children. 
Immunohistochemical assessment of H. pylori, using anti-H. pylori IgG, re­
sulted in a significantly lower H  pylori yield (55/112 or 49%; p=0.001). A 
comparison of positive staining for H. pylori, using the Giemsa method, and 
anti-H. pylori IgG in antrum and corpus biopsy specimens for different morpho­
logical types of gastric mucosa change is presented in Table 2 (Paper V).
In 12 out of 108 (11%) corpus mucosa specimens a positive staining with 
anti-H. pylori IgG was localised in the cytoplasma of corpus epithelial cells in 
the neck part of the glands (Fig. 2). This staining was diffuse and affected 
mainly the apical part of the cells. No H. pylori bacilli were identified in the 
cytoplasma of the mucus neck cells. All control sections (incubated without 
primary antibodies) were negative for such staining (Fig. 1 and 2, Paper V). In 8 
out of these 12 cases, the corpus mucosa was normal, and gastritis without 
atrophy was found in 4 out of 12 cases. H pylori were detected in Giemsa- 
stained sections in 2 out of these 12 cases.
The state of the gastric mucosa of adult controls was the following: gastritis 
without atrophy in the antrum was established in 9/20 and atrophic antrum 
gastritis was established in 11/20 cases. In corpus mucosa specimens normal 
mucosa was identified in 2/16, non-atrophic gastritis in 7/18 and atrophic 
gastritis in 9/18 cases. Antrum biopsy specimens were Giemsa-positive in 14/20 
cases and immunostain-positive in 10/20 cases. Corpus biopsy specimens were 
Giemsa-positive in 12/18 cases and immunostain-positive in 9/18 cases. In adult 
biopsy specimens, Giemsa staining revealed H. pylori in 26/38 (68%) cases and 
immunohistochemical method revealed it in 19/38 (50%) cases (p=0.08). In 
adult mucosa sections, immunostaining in the mucus neck cells was established 
neither in the corpus nor in the antrum.
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5. Association of CagA positivity with development of atrophy and activity 
of gastritis (Paper VI)
Histological observation
Histological data and H. pylori status in the antrum and corpus mucosa for 66 
samples studied for histology and CagA status in 1997 are presented in Table 1 
(Paper VI). The course of atrophy in the antrum and corpus mucosa over 18 
years is presented in Table 2 (Paper VI). Between two observations, in 1979 and 
1997, 7/64 (11%) subjects developed atrophy in the antrum, while 22/64 (35%) 
developed atrophy in the corpus (p=0.001). Development of atrophy in the 
corpus but not in the antrum was significantly associated with high activity of 
gastritis both in the initial and late period of observation (p=0.0003) (Paper VI, 
Table 3).
Serological data
The prevalence of IgG antibodies to acid glycine extracted cell surface proteins 
of H. pylori in 1997 was 94% (66/70). Of H. pylori positive persons, 71% 
(47/66) were CagA positive.
The odds ratios (OR) for the association of grade of activity of gastritis, 
inflammation, atrophy, intestinal metaplasia or epithelial cell damage with 
CagA positivity in 1997 are presented in Table 4 (Paper VI). Logistic linear 
regression analysis showed that the strongest effect on CagA positivity was 
exerted by activity of gastritis in the corpus (p=0.0001) followed by activity of 
gastritis in the antrum mucosa (p=0.04). However, CagA positivity was 
significantly associated both with presence of atrophy in the antrum and corpus 
(p=0.04, p=0.002, respectively). In the corpus mucosa, the effect of atrophy on 
level of anti-CagA antibodies was also significant (p=0.0007). CagA positivity 
was associated with presence of intestinal metaplasia in the antrum but not in 
the corpus.
Course o f gastritis during follow-up and CagA status
There was an association between CagA positivity in 1997 and progression of 
atrophy in the antrum and corpus mucosa during follow-up from 1979 to 1997. 
Among 42 persons who had no atrophy in the antrum mucosa in 1979 and in 1997, 
24 (57%) were CagA positive, whereas among 9 in whom atrophy developed 
during follow-up, 8 (89%) were CagA positive. In the corpus mucosa, persons 
who did not develop atrophy during follow-up were CagA positive in 13 out of 25 
(52%) cases. On the other hand, among 26 persons who developed atrophy, or in 
whom it progressed 23 (88%) were CagA positive (p=0.01; OR=7.07 (1.80-27.7). 
The intensity of immune response to CagA (mean value of optical density (OD) of 
IgG antibodies to CagA) was significantly higher among persons who developed 
atrophy in the corpus (OD=0.982+0.508) compared with those who did not deve­
lop it (OD=0.476±0.438; p=0.003). Also, development of atrophy in the antrum 
was associated with higher response to the CagA protein (OD=0.985±0.577 versus 
0.601±0.532 in those who did not developed atrophy; p=0.05).
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Persons with high grades of chronic inflammation in the corpus during 18 years 
of observation had significantly higher immune response to CagA (1.352+0.433) 
compared with those in whom chronic inflammation remained mild during the 
follow-up period (0.201±0.026; p=0.0005).
6. Significant increase in antigastric autoantibodies (ACAB) in a long-term 
follow-up study of H. pylori gastritis (Paper VII)
Prevalence o f ACAB
The prevalence of ACAB in the follow-up group (samples of 1985 and 1997) as 
well in 62 persons investigated in 1997 are presented in Tables 1 and 3 (Paper 
VII).
ACAB were found in 29 of the 62 (47%) subjects investigated in 1997. In 
the follow-up group, ACAB were detected in 8/37 (22%) in 1985 and in 17/37 
(46%>) in 1997. All eight patients, positive for ACAB in 1985, remained positive 
for these autoantibodies, whereas nine of the 29 patients who were negative in 
1985 developed ACAB during the follow-up period. The increase in ACAB 
during this period was statistically significant (p=0.004; McNemar test).
Prevalence o f PCA
Among the 62 serum samples examined in 1997, 3/62 were positive for classical 
PCA (Fig. 5). All three persons were positive for ACAB also in 1997. In the 
follow-up sample, all 37 persons who had been followed up from 1985 to 1997, 
were negative for classical PCA in 1985, while 2/37 became PCA positive in
1997. The latter were ACAB+ also in 1985 and 1997. All PCA+ persons revealed 
highly intensive staining for ACAB throughout the cytoplasma (Fig. 4.).
Course o f gastritis and ACAB
In samples for 62 persons examined in 1997 a significant association was found 
between ACAB and corpus mucosa atrophy (grades 1-3). Of 30 persons with 
atrophy of the corpus mucosa (grades 1-3), 19 (63%) had ACAB, while 
autoantibodies were found in only ten of 32 (31%) subjects without atrophy 
(p=0.01; OR=3.8; 95% Cl 1.4-10.6).
The relationship between ACAB and development of corpus atrophy of 
different grades is shown in Table 4 (Paper VII) separately for 37 persons who 
were followed up for 12 years. In summary, although the prevalence of atrophy 
was higher in the subset of infected persons with ACAB than in the subset 
without these autoantibodies, no statistically significant association between 
ACAB and corpus mucosa atrophy could be established either at the beginning 
of the study or at the end of the follow-up period.
Intestinal metaplasia, chronic inflammation, activity o f gastritis, H. pylori 
colonization and ACAB
In the sample of 1997 (n=62) a significant association was noted between 
presence of intestinal metaplasia in the corpus (grades 1—2) and ACAB (8
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ACAB+ out of 8 cases with intestinal metaplasia grades 1-2 versus 21 ACAB+ 
out of 54 cases without intestinal metaplasia; p=0.004).
There was no significant association between grade of activity of gastritis 
and presence or absence of ACAB at any time of observation. A tendency of the 
prevalence of ACAB to increase during 12 years follow-up was observed 
among persons with a moderate grade of chronic inflammation.
In the sample of 1997 the number of persons with H. pylori colonisation 
grade 3 increased significantly: from 7/37 specimens in the antrum in 1985 to 
20/37 in 1997 (p=0.003); from 5/37 specimens in corpus in 1985 to 17/37 in 
1997 (p=0.005). However, development of ACAB in these persons was not 
statistically significant (p=0.11 for antrum specimens with H. pylori coloni­
zation grade 3; p=0.42 for corpus mucosa specimens with H. pylori colonization 
grade 3).
7. Apoptosis in different compartments of the antrum and corpus mucosa 
in chronic H. pylori gastritis. An 18-year follow-up study (Paper VIII)
Gastric mucosa alterations
Grading of chronic inflammation, activity of gastritis, atrophy, intestinal 
metaplasia and H. pylori colonization in the antrum and corpus mucosa samples 
from 68 persons studied in 1979 and 1997 are presented in Table 1 (Paper VIII). 
Additionally, the grading of the parameters of the Sydney classification for 
chronic gastritis, affecting the antrum and the corpus separately or 
simultaneously, are presented in Table 4. Our finding was that activity of 
gastritis, chronic inflammation, presence of intestinal metaplasia and H. pylori 
colonization affected in most cases both parts of the stomach simultaneously, 
whereas atrophic alterations in 1997 were localised predominantly in the corpus 
mucosa (20/68 versus 5/68 for the antrum, and 12/68 for both). Moreover, the 
prevalence of isolated atrophic corpus gastritis increased significantly during 18 
years of follow-up (20/68 versus 9/68; p=0.02).
Gastric mucosa alterations and age
The results of the comparison of the mean age of the studied persons regarding 
absence or presence of atrophy, chronic inflammation, activity of gastritis, 
intestinal metaplasia and H. pylori colonization in the antrum and corpus 
mucosa are presented in Table 5. In 1997, persons who had atrophic alterations 
in the antrum mucosa (grades 1-3) were older (64.0+9.7) than those without 
atrophy (55.2+11.0; p=0.004). The age difference was not observed for corpus 
atrophy in 1997, whereas at the beginning of the study persons who had atrophy 
in the corpus already in 1979 were older (46.6+10.2) than those without atrophy 
(36.7+10.5; p=0.002; r=0.45; p=0.0001). This was not valid for the antrum in 
1979. However, persons who developed atrophy in the antrum 18 years later 
were older in 1979 than those who did not develop atrophy (45.4+7.5 versus 
36.9±10.8;p=0.03).
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Table 4. Grading of activity of gastritis, chronic inflammation, atrophy,intestinal metaplasia and H. pylori colonization by different 
topographical localisations in the antrum and corpus mucosa in 1979 and 1997.
Grade
1979 1997
Activity of 
gastritis
Chronic
inflamm Atrophy
Intestinal
meta­
plasia
H. pylori Activity of gastritis
Chronic
inflamm. Atrophy
Intestinal
meta­
plasia
H. pylori
Isolated ANTRUM
1 4 2 6 7 4 12 0 5 6 0
2 4 7 1 1 3 1 0 0 1 0
3 2 0 0 0 0 0 0 0 0 0
Total 10 9 7 8 7 13 0 5 7 0
Isolated CORPUS
1 5 1 6 3 1 3 1 12 3 2
2 2 3 2 0 2 1 0 6 1 0
3 1 1 1 0 3 0 1 2 0 1
Total 8 5 9* 3 6 4 2 20** 4 3
Simultaneously 
present (grades 1-3) 
in ANTRUM and 
CORPUS 27 35 8 2 46 39 61 12 6 59
Simultaneously absent 
from ANTRUM and 
CORPUS 23 19 44 55 9 12 5 31 51 6
Total 68 68 68 68 68 68 68 68 68 68
Significant difference: ** > * p=0.02.
Table 5. Comparison of the mean age of the studied persons from Saaremaa by absence or presense of atrophy, chronic 
inflammation, activity of gastritis, intestinal metaplasia and H. pylori colonization in the antrum and corpus mucosa as well by 
development or non-development of atrophy.
Status of gastric mucosa Year of  
study
ANTKUM CORPUS
n Mean age p value n Mean age p value
No atrophy 1997 51 55.2±11.0 36 55.6+11.9
Atrophy (1-3) 1997 17 64.0±9.7 0.004 32 59.6+10.4 0.18
No atrophy 1979 53 38.4±10.8 51 36.7+10.5
Atrophy (1-3) 1979 15 42.9+12.7 0.17 17 46.6+10.2 0.002
No development o f atrophy 1997 44 36.9±10.8 28 35.1+10.2
Development of atrophy 1997 9 45.4+7.50 0.03 23 38.8+10.6 0.21
No chronic inflammation 1997 7 60.0+11.6 5 60.6+6.9
Chronic inflammation (1-3) 1997 61 57.1+11.3 0.52 63 57.1+11.6 0.51
No activity of gastritis in 1997 16 59.2+10.6 25 56.8+12.0
Activity of gastritis (1-3) 1997 52 56.8+11.5 0.47 43 57.5+11.2 0.82
No intestinal metaplasia 1997 55 55.6+11.2 58 56.1+11.1
Intestinal metaplasia (1-2) 1997 13 64.7+8.7 0.008 10 64.7+9.6 0.02
No H. pylori colonization 1997 9 59.5+12.0 6 54.8+11.1
H. pylori colonization (1-3) 1997 59 57.0+11.2 0.55 62 57.6+11.4 0.56
Course o f gastritis and dynamics o f A l
The course of atrophy in the antrum and corpus mucosa during 18 years of 
observation is presented in Table 2 (Paper VIII). During the follow-up period, 
development of atrophy in the antrum mucosa was established in 9/68 persons 
and in the corpus in 23/68 persons.
The dynamics of Al in three compartments of the studied sections of 
samples from persons without and with development of atrophy in the antrum 
mucosa are presented in Fig. 2; the dynamics of Al in the corpus is shown in 
Fig. 3 (Paper VIII).
The value of Al for FC of the antrum or corpus mucosa showed no 
significant changes at two time points of observation either in persons without 
atrophy (p=0.74 for the antrum and p=0.62 for the corpus) or in persons who 
developed atrophy (p=0.10 for the antrum and p=0.18 for the corpus). Al for PZ 
and GP in the corpus mucosa specimens of 1997 decreased significantly, 
compared with the specimens of 1979, irrespective of the dynamics of atrophic 
alterations, i.e. persons who developed atrophy (p=0.005 for PZ and p=0.00008 
for GP) or did not develop atrophy (p=0.02 and p=0.00007 for PZ and GP, 
respectively). In the antrum mucosa there occurred a significant decrease in Al 
for GP in persons without development of atrophy (p=0.0000005), and an 
obvious decrease in Al also in persons who developed atrophy (p=0.05). No 
significant difference was observed between the mean values of Al for FC, PZ 
and GP in the antrum or corpus in persons either with or without development 
of atrophy.
According to multifactorial dispersion analysis (Paper VIII, Table III), the 
strongest independent effector of Al in the antrum mucosa in 1979 were the 
grade of activity of gastritis (in FC; p=0.01) and degree of chronic inflammation 
(in GP; p=0.03), in 1997, grade of H. pylori colonization (in FC; p=0.02 and in 
GP; p=0.03). In the corpus mucosa, the strongest independent effect on Al in 
1979 was exerted by activity of gastritis (in FC; p=0.02) and by chronic 
inflammation (in PZ; p=0.04).
Age had no effect on AL Correlation analysis did not reveal any correlation 
between age and the values of Al for FC, PZ and GP. Multifactorial dispersion 
analysis showed that only grade of H. pylori colonization had a significant 
effect on the difference between Al values for FC in the antrum during follow- 
up.
Apoptotic index and CagA status in the samples o f 1997 
Seropositivity for CagA did not influence the mean value of Al in the studied 
compartments either in antrum or in corpus mucosa in samples from 1997 
(Table 6; p>0.05). Nor did multiple regression analysis reveal any significant 
association between CagA status and the value of AL
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Table 6. Apoptotic index (AI) for different compartments of antrum and corpus mucosa specimens by different CagA status in the 
samples of 1997.
CagA status 
(OD>0.300 
positive)
No. of  
persons 
studied
ANTRUM CORPUS
Apoptotic index 
mean ±SD (No. of sections studied)
Apoptotic index 
mean±SD (No. of sections studied)
FC PZ GP FC PZ GP
CagA+ 47 8.7+6.6 (37) 2.1±2.7 (11) 1.3+1.5 (38) 7.8±7.2 (46) 2.3+3.0 (24) 1.2±1.8 (46)
CagA- 21 7.5+6.3 (20)pl 1.7±1.6 (6)p2 1.4±2.6 (20)p3 7.4+7.1 (20)p4 1.5+2.0 (14)p5 1.4±2.4 (20)p6
p values for the difference between the values of AI in CagA+ and CagA- groups according to Mann-Whithney test: p l-0 .55; p2—1.0; 
p3=0.59; p4=0.86; p5:=0.89; p6=0.66. FC -  foveolar cells; PZ -  proliferating zone; GP -  glandular part.
Apoptotic index for the corpus mucosa and the status o f anticanalicular 
autoantibodies (ACAB)
Presence of ACAB did not influence the value of Al in the studied compart­
ments of corpus mucosa (Table 7; p>0.05):
ACAB
status
1997
No. of persons 
studied for ACAB 
and apoptosis
Apoptotic index (1997) for corpus mucosa 
Mean+SD
Foveolar cells Proliferating zone Glandular part
ACAB + 6 7.1±6.5 2.3+3.1 1.1+1.9
A C A B - 14 8.1±7.6 1.8+2.5 1.7+3.5
8. Seropositivity for H. pylori HSP 60 and its correlation with gastritis 
parameters (Paper IX)
Forty-four out of 68 (65%) persons from Saaremaa were positive for H. pylori 
HSP 60 antibodies compared to 63 out of 68 (92%) positive sera in ELISA 
using H. pylori glycine extracted cell surface proteins as the antigen. Seventy 
per cent (44 out of 63) of sera, positive for the glycine extracted cell surface 
proteins of H. pylori possessed IgG antibodies to H. pylori HSP 60.
Grading of H. pylori colonization, activity of gastritis, chronic inflammation 
and atrophy, as well as odds ratios (OR) for the association between H. pylori 
HSP 60 and gastritis in the antrum and corpus mucosa are presented in Table 1 
(Paper IX). A significant difference was found in the seroprevalence of 
H. pylori HSP 60 between persons with histological presence and absence of 
H. pylori in gastric biopsies (41/59 versus 3/9 in the antrum, p=0.03; 43/62 
versus 1/6 in the corpus, p=0.01). Among six persons whose antrum as well as 
corpus was morphologically H. pylori negative (4/6 also without chronic 
inflammation both in the antrum and corpus), only one was seropositive for 
H. pylori HSP 60. The mean RAA value of anti-Hpylori HSP 60 IgG in persons 
without histologically observable H. pylori colonization in the antrum or corpus 
mucosa was significantly (p=0.01) lower than the respective value in persons 
with H. pylori. However, grade of histological H. pylori colonization did not 
correlate significantly with seropositivity for H. pylori HSP 60 (r=0.12; p=0.29 
for the antrum and r=0.07; p=0.52 for the corpus).
The correlation between anti-H. pylori HSP 60 IgG antibodies and grade of 
chronic inflammation was significant (r=0.35, p=0.003 for the antrum mucosa 
and r=0.24; p=0.04 for the corpus mucosa; Paper IX, Figs. 1 and 2). Persons 
with a severe grade of chronic inflammation expressed simultaneously in the 
antrum and corpus displayed significantly higher values of RAA of anti- 
H. pylori HSP 60 (73.8+20.8) compared with those without of chronic inflam­
mation (15.5+21.2; p=0.004) (Paper IX, Table 2).
There was found no correlation between seropositivity to H  pylori HSP 60 
and grade of atrophy (r=0.013; p=0.91 for the antrum and r=0.04; p=0.70 for the
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corpus), or activity of gastritis (r= 0.20; p=0.08 for the antrum; r=0.12; p=0.29 
for the corpus).
In multiple regression analysis, H. pylori HSP 60 was significantly associated 
with grade of chronic inflammation (for the antrum: (3=0.635; p=0.003; for the 
corpus: [3=0.474; p=0.01). Grade of chronic inflammation in the antrum was the 
strongest independent predictor of seropositivity to H. pylori HSP 60 (P=0.626; 
p=0.01). Moreover, a strong correlation between grade of chronic inflammation 
and grade of H. pylori was found for the antrum mucosa(r=0.45; p=0.00008) 
while the correlation for the corpus mucosa was weaker (r=0.19 p=0.11, 
Spearman correlations analysis; r=0.29; p=0.01, Pearson correlations analysis).
Analogously, immune response to the acid glycine extracted cell surface 
proteins of H. pylori showed a significant correlation of RAA values with grade 
of chronic inflammation (r=0.36; p=0.002 for the antrum and r=0.50; 
p=0.000014 for the corpus) as well as with grade of activity of gastritis (r=0.30; 
p=0.01 for the antrum mucosa and 1-0.29; p=0.01 for the corpus mucosa). 
According to multiple regression analysis the strongest independent effect on 
RAA values, reflecting immune response to the acid glycine extracted cell 
surface proteins of H  pylori, was exerted by grade of chronic inflammation in 
the corpus mucosa ((3=0.673; p=0.0002).
Mean values of RAA to the acid glycine extracted cell surface proteins of 
H. pylori at different grades of H. pylori colonization separately and simulta­
neously for the antrum and corpus mucosa according to the samples of 1997 are 
presented in Table 8.
H. pylori colonization 
Grading
N RAA value 
Mean+SD (median)
ANTRUM
0 9 51.8+43.7 (32)*
1 mild 18 102.0+33.3 (112)**
2 moderate 9 114.8+19.1 (107)a
3 severe 32 95.8+22.1 (96.5)nn
CORPUS
0 6 29.1+17.7 (23)#
1 mild 21 100.9+31.5 (112)##
2 moderate 10 104.5+19.7 (105.5)
3 severe 31 99.2+26.6(100)
Simultaneously in ANTRUM and CORPUS
0 6 29.1 + 17.7 (23)0
1 mild 13 107.1+30.0 (115)00
2 moderate 4 117+20.7 (114)
3 severe 21 97.1+22.5 (94) 000
Significant difference (Mann —  Whithney method): ** > * p=0.008; a > aa p=0.03; 
## > # p=0.0005; 00 > 0 p=0.0009; 000 > 0 p=0.0004.
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Immune response to the acid glycine extracted cell surface proteins of H. pylori 
was not significantly influenced by grade of H. pylori colonization.
Progression o f chronic inflammation and seropositivity to H. pylori HSP 60 
Increase in the grade of chronic inflammation in the antrum and corpus mucosa, 
as well as the positivity and mean values of RAA to H. pylori HSP 60 in serum 
samples from 1997 are presented in Table 3 (Paper IX). Persons who had no 
chronic inflammation during 18 years of observation, were negative also for 
H. pylori HSP60 in 1997 (17.4+18.8), while those whose degree of chronic 
inflammation in the antrum increased from grade 0 in 1979 to grade 3 in 1997 
showed significantly higher values of RAA to H. pylori HSP 60 (65.7+21.2; 
p=0.008)
The corpus mucosa of persons whose chronic inflammation increased from 
mild to severe displayed significantly higher mean values of RAA to H. pylori 
HSP 60 (72.5±34.8) compared with persons in whom chronic inflammation 
remained mild during the follow-up period (24.6±25.8; p=0.04). Also, persons 
with severe chronic inflammation in the corpus at both time points showed 
more pronounced immune response to H. pylori HSP 60 (62.7+30.6) than those 
who had moderate chronic inflammation in 1979 and 1997 (29.0+16.5; p=0.02).
Dynamics o f atrophy and seropositivity for H. pylori HSP 60 
Seropositivity for H. pylori HSP 60 did not differ in persons who developed 
atrophy in the antrum or corpus during 18 years of observation (4/5 versus 
24/37 cases for the antrum; OR=2.16; 95% Cl 0.29-15.9 and 17/23 versus 
16/27 for the corpus; OR=1.94; 95% Cl 0.60-6.2).
Seropositivity for H. pylori HSP 60 in the samples o f 1985 and 1997 and 
12-year follow-up o f antigastric autoantibodies
Among 52 sera positive for the cell surface proteins of H. pylori, studied for 
H. pylori HSP 60 in 1985 and in 1997, 40 (77%) were positive in 1985 and 36 
(69%) were positive in 1997. Five out of 52 persons who were negative in 1985 
developed IgG antibodies to H  pylori HSP60 in 1997, and 9 out of 52 persons 
who were positive in 1985 became negative for H. pylori HSP 60 in 1997. 
According to multifactorial dispersion analysis the highest association occurred 
between RAA to H. pylori HSP60 and grade of chronic inflammation in the 
antrum mucosa (F=3.58; p=0.03 for 1985 and F=4.06; p=0.01 in 1997).
In the group of 37 H. pylori infected persons who were studied for presence 
of ACAB in the 12-year follow-up, no significant association was found 
between seropositivity for H. pylori HSP 60 and ACAB (p=0.98; Table 9).
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Table 9. Presence of ACAB and seropositivity for H. pylori HSP 60 in persons 
followed up in 1985 and 1997.
Person no. ACAB in 1985
ACAB 
in 1997
H. pylori HSP 60 
in 1985 
(RAA value)
H. pylori HSP 60 
in 1997 
(RAA value)
1 - - 46 45
2 - - 22 29
3 - - 41 80
4 - - 19 35
5 - - 59 35
6 - - 66 102
7 - - 60 81
8 - - 30 13
9 - - 59 46
10 - - 14 5
11 - - 59 34
12 - - 71 22
13 - - 24 8
14 - - 66 72
15 - - 106 72
16 - - 51 17
17 - - 66 44
18 - - 34 19
19 - - 21 5
20 - - 67 91
Mean value 48.6±23.1* 42.7±30.2#
21 - + 42 35
22 - + 25 37
23 - + 64 87
24 - + 35 16
25 - + 44 38
26 - + 68 43
27 - + 13 99
28 - + 58 30
29 - + 61 45
Mean value 45.5±18.8** 47.7±27.1##
30 + + 43 30
31 + + 17 18
32 + + 26 11
33 + + 70 65
34 + + 27 42
35 + + 51 62
36 + + 9 19
37 + + 61 70
Mean value 38.0±21.6*** 39.6±23.5###
Between * and ** p= 0.83; between * and *** p= 0.35; between ** and *** p= 0.56; 
Between # and ## p= 0.50; between # and ### p= 0.79; between ## and ### p= 0.77.
79
In 68 samples investigated in 1997 both for IgG to H. pylori HSP60 and ACAB, 
no association was found between these two parameters either: ACAB were 
found in H. pylori HSP60 positive persons in 22/44 (50%) cases and in HPS60 
negative persons in 10/24 (42%) cases (OR=1.4 (95% Cl 0.5-3.72; p=0.51).
9. Immune response to different antigens of H. pylori and age
The mean RAA values of IgG antibodies to cell surface proteins of H. pylori, 
H. pylori HSP 60 and the mean values of OD, reflecting IgG antibody response 
to the CagA protein for different age groups of 68 persons from Saaremaa, are 
presented in Table 10.
Table 10. Value of immune response to different H. pylori antigens in different age 
groups of an adult sample from Saaremaa in 1997.
Age groups No Acid glycine extracted 
cell surface proteins 
of H. pylori 
Mean RAA value+SD
CagA protein 
Mean OD+SD
H. pylori HSP 60 
Mean RAA 
value+SD
30-40 6 106.8+31.3 0.703+0.493 52.1+40.2
41-50 11 96.6+30.5 0.738+0.634 35.4+28.0
51-60 22 88.2+36.1* 0.738+0.551 31.9±24.9#
61-70 20 87.5+34.2** 0.615+0.549 52.0+32.3##
71-80 9 112.3+21.7*** 0.911+0.523 43.4+26.7
Total 68 94.2+33.1 0.720+0.547 41.7+29.9
*** > * p=o.07; 
## > # p=0.02.
The only significant difference in immune response to H. pylori HSP 60 was 
observed between the age group 61-70 and the age group 51-60 years (p=0.02). 
According to correlation analysis there occurred no significant correlation 
between age and immune response to H  pylori cell surface proteins (r=0.01; 
p=0.9), H. pylori HSP 60 (r=0.1; p=0.37) or the CagA protein (r=0.01; p=0.89).
10. Glandular proliferation and density of specific cells in the antrum and 
corpus in H. pylori associated gastritis (Paper X)
The state of the antrum and corpus mucosa and the presence of H. pylori in the 
studied biopsy specimens are presented in Table 1 (Paper X). There was a 
significant positive correlation between density of H. pylori and severity of 
gastritis in the antrum (r=0.37, p=0.006) but not in the corpus mucosa (r=0.13, 
p=0.37).
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Gastric epithelial cell proliferation in association with severity o f gastritis and 
H. pylori colonization
Mean PCNA and Ki-67 LI in different parts of antral and corpus glands, and 
their relation to gastritis and H  pylori status are presented in Table 2 (Paper X). 
Overall mean PCNA LI was significantly higher in the antrum than in the 
corpus mucosa (p=0.02 for PZ; p=0.01 for GP). PCNA LI in FC and GP of 
corpus glands in presence of atrophic alterations was significantly higher com­
pared with non-atrophic and normal mucosa (p=0.007 and p=0.03 respectively). 
Correlation analysis showed also a significant correlation of PCNA LI in corpus 
glands with severity of chronic inflammation and atrophy (r=0.34; p=0.03 for 
FC and r=0.46; p=0.001 for GP). However, there was no correlation of PCNA 
LI with severity of gastritis in the antrum (p=0.40, p=0.81; p=0.29 for FC, PZ 
and GP respectively). PCNA LI and Ki-67 LI in FC, PZ and GP of the corpus 
mucosa did not correlate with H. pylori colonization (p=0.47, p=0.53; p=0.09 
for PCNA LI and p=0.99; p=0.51; p=0,14 for Ki-67). GP of antral glands, 
however, revealed a tendency for a negative correlation between mean PCNA 
LI and H. pylori density score (r— 0.23; p=0.09). The mean values of PCNA 
and Ki-67 LI in the antrum and corpus were significantly correlated (p=0.01 to 
0.004 depending on the gland part). A significant positive correlation was found 
between Ki-67 LI and severity of chronic inflammation and atrophy in FC and 
GP of the corpus mucosa (r=0.32; p=0.04; r=0.46; p=0.01) but not with H. 
pylori density score (p=0.12; p=0.70; p=0.51 in FC, PZ and GP).
Multiple regression analysis showed that proliferation activity in the corpus 
mucosa depended significantly on severity of chronic inflammation and atrophy 
but not on H. pylori density (for PCNA LI in FC (3=0.51; p=0.0007; in GP (3=
0.46; p=0.002; for Ki-67 LI in FC p=0.33; p=0.03; for GP p=0.36; p=0.01). In 
the antrum mucosa, proliferation activity showed a tendency for a negative 
association with antrum gastritis only for Ki-67 in PZ ((3= -0.23; p=0.09).
Immunoreactivity o f gastric epithelial cells and interstitial lymphocytes 
for the bcl-2 protein
Bcl-2 positive staining was found in epithelial cells, i.e. in parietal cells of the 
corpus mucosa and in neck cells of the antral mucosa (16 cases: 8 in the antrum 
mucosa and 8 in the corpus mucosa; (Paper X Table 3). In the antrum, positive 
staining for bcl-2 positive epithelial cells was observed predominantly in the 
atrophic PZ of the mucosa (4/8 cases). In the corpus, bcl-2-positive staining of 
epithelial cells occurred in the normal and in the non-atrophic GP of the glands 
(3/8 and 2/8 cases, respectively), in 2 out of 8 cases in the non-atrophic PZ and 
only in one case in the atrophic PZ of corpus mucosa.
The density of bcl-2 positive interstitial lymphocytes in the corpus mucosa 
was positively correlated with severity of chronic inflammation and atrophy in 
PZ and GP (r=0.37, p=0.01; 1-0.29, p=0.04). The mean value of the score for 
bcl-2 positive staining of interstitial lymphocytes (Paper X, Table 3) was
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significantly higher in atrophic corpus gastritis than in non-atrophic gastritis 
(for FC, PZ and GP, p=0.01, p=0.02 and p=0.002 respectively). The score for 
overall mean bcl-2 positive staining of interstitial lymphocytes for PZ of the 
antrum mucosa was significantly higher compared with the respective score for 
PZ of the corpus mucosa (p=0.02).
Multiple regression analysis demonstrated that bcl-2 positive staining of 
interstitial lymphocytes in the corpus mucosa depended significantly on severity 
of gastritis but not on H. pylori density score (for FC 0=0.45; p=0.002; for PZ 
P=0.47; p=0.001; for GP p=0.58; p=0.00003). In the antral mucosa, positive 
staining of interstitial lymphocytes for bcl-2 was associated more with H. pylori 
score (in PZ (3=0.24; p=0.08).
Gastrin, somatostatin and(3- H+, K+ ATP-asepositive cell densities and 
association with gastritis and H  pylori score
The densities of G- and D- cells in PZ of antral glands revealed a significant 
negative correlation with score for severity of atrophic alterations (r— 0.34, 
p=0.009, r— 0.52, p=0.0004, respectively). Mean G- and D-cell density (Paper 
X, Table 4) was significantly lower in non-atrophic and in atrophic gastritis 
compared with the normal mucosa (p=0.04; p=0.02 for G-cells and p=0.02 and 
p=0.0005 for D-cells). Mean G- cell number in the H. pylori positive atrophic 
mucosa tended to be lower (16.2±14.7) compared with the H. pylori negative 
atrophic mucosa (26.2+25.2, p=0.22), and D- cell density in the antrum tended 
to be a negatively correlated with H. pylori score in the antrum (r— 0.24, 
p=0.06, respectively).
The density of (3- H+, K+ ATP-ase positive parietal cells in the atrophic 
corpus mucosa was significantly lower compared with the normal mucosa 
(p=0.0004) and non-atrophic gastritis (p=0.0001). There were no significant 
differences between the mean densities of |3-H+, K+ ATP-ase positive parietal 
cells in the H. pylori positive and H  pylori negative mucosa (p=0.29). Also, 
multiple regression analysis showed that the density of p- H+, K+ ATP-ase 
positive cells was significantly dependent on grade of atrophy in the corpus 
(P=-0.65; p=0.000007) but not on H. pylori score (P=0.053; p=0.66).
A comparison of the antrum and corpus with regard to proliferation activity, 
expression of bcl-2 and density of specific cells in association with severity of 
gastritis and H. pylori colonization is presented in Table 5 (Paper X).
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DISCUSSION
Seropositivity to H. pylori and CagA protein in adult populations from 
Southern Estonia and Saaremaa Island
The present study showed an extremely high frequency (87%—94%) of IgG 
antibodies to H  pylori in two Estonian adult populations aged 15 years and 
older, as determined by ELISA using a H.pylori acid glycine extracted cell 
surface proteins as the antigen. Serum IgG antibodies to H.pylori are used most 
frequently for locating persons with H.pylori infection (Perez-Perez et al. 1988, 
Mendall et al. 1992, Megraud 1993, Rosenstock et al. 2000). Our results are in 
concordance with the data of previous studies performed in Estonia with the use 
of morphological method for assessment of H. pylori (Maaroos et al. 1990a,b, 
Villako et al. 1990). Thus, it can be concluded that Estonia is among the 
countries with high H.pylori prevalence, like some other East European 
countries where socio-economic conditions were not comparable with those of 
developed countries during long period. There is evidence that socio-economic 
factors play an important role in acquisition of this bacterium (Jones et al. 1987, 
Fiedorek et al. 1991, Mendall et al. 1992, Miyajj et al. 2000, Opekun et al. 
2000). At the same time, it has been established that acquisition of H. pylori is a 
birth cohort-dependent phenomenon (Banatvala et al. 1993, Sipponen 1995; 
Maaroos 1995). According to the analysis, performed by Maaroos (1995), on 
Estonian populations from Kambja and Saaremaa, the cohort specific 
prevalence of H. pylori has remained high (60-80%) in cohorts born after 1945. 
However, on the basis of our results, the youngest birth cohort (born in 1975— 
1984) in the Karksi-Nuia population displays the lowest seroprevalence of 
H. pylori (69%) compared with 83% to 94% for the studied older cohorts.
This study and previous studies on occurrence of H. pylori in Estonian 
children (Maaroos et al. 1991b, 1993) showed that 41% to 59% of the children 
aged 5 to 15 years possessed H.pylori infection, i.e. its frequency was nearly the 
same as that found for youngest age group of our adult population, which 
indicates that most Estonian people are infected early in their life. According to a 
three-year follow-up study of Estonian children from Saaremaa Island from birth, 
59% of children under the age of 3 years are H. pylori infected, while H. pylori 
seroprevalence among their mothers (mean age 24) was 83% (Lindkvist 1999). 
Taking into account the opinion of Mitchel (1999) that the relative risk of a child 
to acquire H.pylori is proportional to the prevalence of H.pylori in the adult 
population of childbearing age, as well as recent study of Miyaji et al. (2000), 
who showed that acquisition of H. pylori infection occurs in early childhood, 
especially via contact with infected mothers, it can be supposed that Estonian 
children acquire H.pylori often from their parents. In the present study the 
occurrence of H.pylori in the age groups 20-29 years and 30-39 years was 83% 
and 89%, respectively, which is in concordance with the data of Lindkvist (1999).
Among adult persons in the older age group a certain number of subjects 
were seronegative for H.pylori. There are several ways to explain this, but two
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seem to be the most likely: either the gastric mucosa of these persons is not 
suitable for H.pylori colonization, or their immune system (possibly local IgA 
response) eliminates the infection in its early stages. Progression of gastritis to 
atrophic gastritis and the unsuitability of the atrophic gastric mucosa for 
maintaining H.pylori in the stomach, shown in several studies (Siurala et al. 
1988, Tytgat 1992, Wyatt et al. 1992, Solnick and Tompkins 1993, Varis et al. 
1993), may be the reason for H.pylori clearance and elimination of infection in 
some cases (Sipponen 2001).
The fact that already young Estonian people (aged 15 to 29) display high 
prevalence of H.pylori infection is of great importance, because it is related to 
possible early development of chronic gastritis and, subsequently, to high 
gastric cancer risk (Parsonnet et al. 1991, Forman et al. 1991, Graham et al.
1992, Sipponen and Marshall 2000). Gastric cancer is a common form of 
carcinoma in Estonia with a mean age-standardised incidence rate of 31.9 for 
males and 15.0 for females per 100.000 inhabitants in the period of 1993-1997 
(Aarelaid and Mägi, 2000).
The prevalence of anti-CagA antibodies in a random adult population in 
Estonia was 63%, and anti-CagA positivity among H. pylori infected persons 
was 71%, which is significantly higher than average CagA seropositivity (49%) 
for 17 populations evaluated by the Eurogast Study Group (Crabtree et al. 
1996b, Webb et al. 1999). Besides, anti-CagA and anti-VacA positivity in our 
gastric cancer group was significantly higher than in the non-cancer control. 
This result confirms the data of the higher percentage of serological recognition 
of cytotoxin associated H. pylori proteins in gastric cancer patients compared 
with control subjects (Crabtree et al. 1993, Blaser et al. 1995, de Figueiredo et 
al. 1998, Grimley et al. 1999). Our data on seropositivity for the acid glycine 
extracted cell surface proteins of H. pylori showed no significant difference 
between gastric cancer patients and the random population sample. This finding 
is in accordance with a study of Klaamas et al. 1996, which shows that overall 
H. pylori seropositivity for blood donors and for gastric cancer patients was not 
significantly different in Estonia.
Basing on the data of Crabtree et al. (1993), that recognition of 120 kD 
protein did not vary with age in gastric cancer patients, as well as on the data of 
the Eurogast Study Group concerning similar CagA positivity for the age 
groups 25-34 and 55-64 in 17 studied populations (Crabtree et al. 1996b), we 
supposed that the higher prevalence of CagA antibodies in gastric cancer 
patients was not influenced by the age difference between the gastric cancer 
group and population as a whole. This supposition is supported also by a 
significant association between CagA positivity and gastric cancer in H  pylori 
positive persons aged 50 and older.
It is notable that 20-29-year-old persons in the Estonian population appeared 
to have the highest prevalence of CagA antibodies. Taking into account the 
evidence that CagA positive strains nearly doubled the risk for developing 
gastric cancer over the ensuing 21 years (Blaser et al. 1995), we suggest that
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young people (aged 20-29) with a high prevalence of CagA antibodies may be 
at high risk for developing gastric cancer.
A comparison of the evaluation of the antibodies to CagA protein in sera 
using both ELISA and immunoblot showed that the results of these tests agreed 
in 80% of cases. This is comparable with the results of the study by Xiang et al. 
1993, where the agreement between the results in ELISA (using a recombinant 
fragment of CagA) and immunoblot (using total H. pylori extract as the antigen) 
was 85%. The cause of the 20% disagreement between the results in ELISA and 
immunoblot in our study may be due to the fact that in our CagA ELISA we 
used a recombinant CagA fragment (37.5 kD fused protein) as the antigen, 
whereas in immunoblot we employed acid glycine extracted cell surface 
protein. The overall good agreement between the results in the anti-CagA- 
ELISA and immunoblot in our study indicates that the use of a recombinant 
fragment of CagA protein in ELISA might prove a useful tool for evaluation of 
CagA status, especially in epidemiological studies.
Seropositivity for H. pylori and CagA protein in a non-selected group 
of schoolchildren
The seroprevalence of H.pylori in a nonselected group of schoolchildren was 
56%, which did not differ significantly from the histological finding of H.pylori 
(58%) among Estonian children with abdominal complaints, obtained in a pre­
vious study (Maaroos et al. 1991b). According to literature data, the percentage 
of H.pylori infection in children, aged 9-15 years, without abdominal com­
plaints varies from 3% in Sweden (Granstrom et al. 1997), 8.3-16.7% in 
Germany (Hornemann et al. 1997), 12% in children of Texas (Opekun et al. 
2000), 11-23% in Holland (Roosendaal et al. 1997) and 16.7% in the UK 
(O’Donohoe et al. 1996) to 26% in Japan (Okuda et al. 1996), 36.8-68.4%) in 
Turkey (Gurakan et al. 1996) and 34%-52% in China (Li et al. 1995). Thus the 
seroprevalence of H.pylori in schoolchildren in our study is higher than it is in 
most European countries.
The specific finding of the present study was that half of H.pylori positive 
schoolchildren, living in Southern Estonia, possess anti-CagA antibodies. These 
children should be given further attention with respect to development of 
gastritis, peptic ulcer or gastric cancer later in life, taking into account the 
association between infection with a cytotoxic strain and development of the 
above-mentioned diseases (Crabtree et al. 1991, Kuipers et al. 1995, Figura
1996, Parsonnet et al. 1997).
Literature data regarding CagA positivity in H. pylori infected children 
(mostly children with recurrent abdominal pain or peptic ulcer) reveal the 
presence of infection with cytotoxic strains in 28.5 to 80.6% of cases when using 
different methods for the investigation of CagA positivity, such as ELISA, PCR 
and Western Blot (Oderda et al. 1993, Czkwianianc et al. 1997, Gzyl et al. 1997, 
Alarcon et al. 2000). CagA positivity among asymptomatic children was 54%, as 
evaluated by Elitsur et al. (1999), and 83%, as evaluated by (Karczewska et al.
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1997), which is higher than the prevalence rate found in our study. This might be 
explained by the use of other methods for the establishment of CagA positivity in 
their studies, such as Western Blot (Helico blot 2.0, GeneLabs Diag. S. A.), as 
well as by the use of another CagA antigen in ELISA.
We compared H.pylori and CagA prevalence in healthy schoolchildren living 
in urban and rural areas of the same geographical region. It was found that 
children from rural areas (in villages and farms) were more often infected with 
H.pylori and with cytotoxic strains. The fact that children in rural areas had higher 
seroprevalence of H.pylori might hypothetically be explained by socio-economic 
differences as well as by the use of different water sources (here: external) in 
farms compared with urban households. Klein et al. (1991) showed that children 
living in homes with external water sources were three times more likely to be 
infected with H.pylori compared with households with internal water sources. 
However, the study of Lingkvist (1999), performed on a children’s cohort from 
Saaremaa, found no correlation between seroprevalence to H. pylori and the kind 
of water used, while non-use of toothbrush was a strong independent predictor for 
H. pylori infection in Estonian children under 3 years of age.
Literature data point out that a major proportion of H.pylori infection is 
acquired in early childhood (Klein et al. 1991, Graham et al. 1992, Mendall et 
al. 1992, Mitchell et al. 1992, Neale et al. 1995, Ashorn et al. 1996). An 
extensive seroepidemiological study of H.pylori infection, conducted on various 
populations by Megraud et al. (1989) showed that in France 3.5% of children 
were infected in the first decade of life. In the second decade, H.pylori 
prevalence increased to 16.3% and in the third decade, to 24.8%, which is still a 
markedly lower percentage compared with our results. The sharpest rise of 
antibodies to H.pylori in Sweden appears between 9 and 10 years of age (20%) 
(Lindkvist et al. 1996). In a study of Graham et al. (1992) it was shown that the 
prevalence of H.pylori infection was stable during a variable period in late 
childhood but increased in early adulthood. According to Sipponen et al. 
(1996b) H.pylori gastritis is acquired in childhood (age less than 20) in more 
than 50% of cases. On the basis of the present study it can be supposed that half 
Estonian schoolchildren are infected with H.pylori, while half of them possess 
cytotoxin-producing strains in the first decade of life.
H. pylori in the gastric mucosa of children with abdominal complaints
In the retrospective study of children with abdominal complaints, we compared 
the detection rate of H. pylori in the antrum and corpus mucosal biopsies from 
children using two methods, Giemsa staining and immunohistochemical 
investigation. It turned out that H. pylori was more frequently found in Giemsa 
preparations than at immunohistochemical investigation employing a polyclonal 
antibody directed against H. pylori. The concordance of the two methods in the 
detection of H. pylori in antrum biopsies was 70%, and in corpus biopsies 73%.
The fact that the use of polyclonal antibodies for assessment of H. pylori 
resulted in an H. pylori yield inferior to that obtained by Giemsa staining is not in
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line with the data of other authors, who showed that immunohistochemistry is a 
more sensitive and specific staining method for evaluation of H. pylori in biopsies 
compared with conventional staining (Andersen et al. 1988, Barbarosa et al. 
1988, Loffeld et al. 1991, Ashton-Key et al. 1996). One possible reason for this 
disagreement includes the hypothesis that H  pylori strains colonizing the gastric 
mucosa of the analysed children might have contained antigenic components 
different from the strains of H. pylori against which the polyclonal antibodies 
used in this study were produced. This possibility, based on certain disagreement 
between recognition of H. pylori in haematoxylin-eosin and peroxidase-stained 
sections, was pointed out by Andersen et al. (1988). Another reason why some 
Giemsa-positive cases were immunostain-negative could be the fact that in most 
cases of discrepancy a low grade of H. pylori density was observed in the studied 
sections. Giemsa staining detects both intact and damaged H. pylori, while 
immunohistochemical reactivity may depend on presence of fully intact orga­
nisms harbouring a still complete set of respective antigens.
An additional aspect of the differential epitope reactivity of the antibody used 
in the present study was revealed on the staining of gastric epithelial cells subsets. 
Staining of the corpus gland neck cells by anti-H. pylori antibodies was found in 
11% of biopsies, which suggests the cross reactivity of anti-H. pylori antibodies 
with gastric epithelial epitopes, as proposed previously by Negrini et al. (1989, 
1993, 1996). The reaction may be related to the autoimmune mechanisms playing 
a pathogenic role of H. pylori in progression of chronic gastritis (Negrini et al.
1993, 1996). This hypothesis is partly supported by our study of the Karksi-Nuia 
population, showed that long-term H. pylori infection may be a predictor for 
development of gastric autoimmunity (Paper II). It is, however, notable that in 8 
out of 12 cases with intracytoplasmic staining of corpus mucosal cells, the corpus 
mucosa was otherwise normal, i.e. without acute or chronic inflammation which 
might indicate impairment of the immune response of these children to H. pylori 
(Torres et al. 2000). This observation does not preclude that such children with 
the sofar normal mucosa may be predisposed to develop autoimmune gastritis 
later in life. In this light, the finding of neck cell reactivity in the young age group 
is interesting, especially when considering that the use of anti- H. pylori 
antibodies on adult mucosal sections did not reveal immunostaining of epithelial 
cells in the neck part of corpus or antrum mucosa in any case. These facts might 
point out the peculiarities of immune response to H. pylori infection in childhood 
(Meining et al. 1996).
An alternative mechanism involved in staining of gastric gland neck cells by 
anti-H. pylori antibodies may be related to epithelial invasion by H. pylori 
(Andersen and Hoick 1990, Ko et al. 1999, Su et al. 1999, Björkholm et al. 
2000), or to endocytosis of H. pylori by epithelial cells followed by degradation 
of the microorganisms. In fact, internalisation of H. pylori by cells has been 
observed earlier (Bode et al. 1988, Andersen and Hoick 1990, Evans and 
Graham 1992). We can suppose that the children’s mucus layer is more pre­
disposed to H. pylori penetration and invasion, which contributes to acquisition
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of this bacterium predominantly in childhood. In a study of Blom et al. (2000) 
different patterns of H. pylori adherence to gastric mucosa cells were shown in 
children and adults. The authors found that a contact of H. pylori with the 
microvilli of gastric mucosa cells was significantly higher in children compared 
with adults, whereas adhesive pedestals dominated in adults, which can 
contribute to the lifelong infection of humans. The finding that H. pylori was 
not detected within cells by Giemsa staining in our study may indicate intra­
cellular bacterial breakdown.
The association of CagA positivity with development of atrophy, 
activity of gastritis and chronic inflammation
The prospective 18-year follow-up study of an adult sample from Saaremaa Island 
shows that chronic H. pylori gastritis progresses gradually into atrophic gastritis 
and that this progression seems to be related particularly to presence of CagA- 
positive strains. The specific finding of this population study was that progression 
of atrophy as well as activity of gastritis in the antrum and corpus mucosa were 
associated with CagA positivity
Progression of gastritis to atrophic gastritis has been known for a long time 
(Siurala et al. 1980, Villako et al. 1982, Ihamäki et al. 1985, Sipponen et al. 
1994a, Valle et al. 1996). The reason why atrophic gastritis develops in some but 
not in all affected individuals is unknown. Infection with H. pylori, particularly 
presence of CagA and cytotoxicity of the bacterium, are one way to affect the 
state of the gastric mucosa and dynamics of gastritis (Cover et al. 1990, Crabtree 
et al. 1991, Kuipers et al. 1995, Figura 1996, Sozzi et al. 1998). The association 
between systemic IgG response to CagA and gastric atrophy has also been shown 
(Beales et al. 1996, Oksanen et al. 2000). Our data are in accordance with studies 
indicating that the CagA-positive H. pylori status causes more aggressive gastritis 
than the CagA-negative status suggesting that CagA positive gastritis tends to 
progress to atrophic gastritis more frequently than CagA negative gastritis (Kui­
pers et al. 1995, Beales et al. 1996, Yamaoka et al. 1997, Warburton et al. 1998).
According to our study, development of atrophy in the corpus mucosa was 
significantly associated with activity of corpus gastritis. Furthermore, the 
association between activity of gastritis and CagA positivity was particularly 
significant for the corpus. There is evidence that H. pylori CagA protein 
stimulates well-pronounced active and chronic inflammatory response in the 
gastric mucosa (Crabtree et al. 1994, Sharma et al. 1995, Peek et al. 1995, 
Marchetti et al. 1995, Rautelin et al. 1996, Yamaoka et al. 1997, Ando et al. 
2000). Since local immune response to H. pylori reflects antigenicity of the 
infecting organisms and taking into account that CagA induces strong humoral 
response, Figura (1995) proposed to determine indirectly the degree of 
polymorphonuclear cell infiltration in the stomach by the levels of systemic IgG 
to this protein. In our study the mean values of OD of anti-CagA IgG (which 
reflect the level of antibodies in sera) was associated with higher grade of 
activity of gastritis and atrophy, as well as with higher grade of chronic
inflammation, particularly in the corpus mucosa. This is in concordance with 
the results of Ando et al. (2000), which showed a good correlation of anti- 
CagA response with neutrophil infiltration, intestinal metaplasia, H. pylori 
density and IL-8 levels, suggesting that the absolute levels of these antibodies 
may be markers for gastric inflammation.
There is evidence that patients infected by cytotoxic strains and/or patients with 
anti-CagA antibodies are more likely to have active gastritis and to develop peptic 
ulcer or gastric cancer (Cover et al. 1990, Crabtree et al. 1991, Blaser et al. 1995, 
Figura et al. 1996, Orsini et al. 1998, Parsonnet et al. 1997). Both direct bacterial 
cytotoxicity with direct delivery of CagA into gastric epithelial cells and 
inflammatory cell aggression against the gastric epithelium may predispose the 
patient to peptic ulcer disease (Fiocca et al. 1994, Segal et al. 1999, Stein et al. 
2000, Asahi et al. 2000, Odenbreit et al. 2000). The association between CagA, 
peptic ulcer and gastric cancer is most logical assuming that CagA is related to 
aggressiveness of gastritis. Occurrence of CagA infection results in more active 
gastritis which is more likely to ends up in atrophic gastritis. This sequence of 
events is supported by the present results.
The 18-year follow-up study of gastritis revealed a difference in the course of 
atrophy between the antrum and corpus mucosa, and established its relation to 
activity of gastritis. Thus 11% of the subjects developed atrophy in the antrum, 
while 35% developed it in the corpus. CagA positivity was also more closely 
associated with activity of gastritis and development of atrophy in the corpus than 
in the antrum mucosa.
The fact that the relationship between CagA and atrophic antral gastritis was 
not as strong as the relationship between CagA and atrophic corpus gastritis is 
somewhat unlogical but is obviously based on the natural course of gastritis in the 
present study population. There may occur healing of antral gastritis, while 
atrophic gastritis is progressing in the corpus (Kekki et al. 1984, Siurala et al. 
1985, Maaroos et al. 1986, Valle et al. 1996). Such healing of antral gastritis may 
hence take place particularly in presence of a CagA positive strain. In other words, 
a significant worsening of atrophic gastritis in the corpus, as is the case in presence 
of CagA strains, is associated with opposite events in the antrum. If analysis were 
restricted to cases with atrophic antral gastritis only, presence of CagA strains 
would reveal the association with atrophic antral gastritis as well. Although the 
present material did not allow such analysis, there occurred a significant 
association between CagA and intestinal metaplasia in the antral mucosa even in 
the our series.
Prevalence of anticanalicular autoantibodies and their significance 
for development of gastric mucosa atrophy
An important finding of the present study was that the prevalence of ACAB 
increased significantly during the follow-up period of 12 years. One can 
suppose that ACAB are formed in the course of time, and their appearance may 
be related to the duration of H. pylori infection. However, as the exact time of
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the onset of H. pylori infection in persons enrolled in this study is unknown, the 
duration of infection cannot be established either. It should be pointed out that 
the mean age of persons who were positive for ACAB at the beginning of the 
study, or turned positive for ACAB during 12 years, was not significantly 
different from the mean age of those who remained negative for ACAB during 
the whole period. This is in agreement with earlier data published by Faller et 
al. 1997, indicating that the age profile of H. pylori infected patients with 
antigastric autoantibodies was not significantly different from the age profile of 
patients without these autoantibodies. As most H. pylori infections occur in 
childhood (Sipponen 1995) and can persist throughout life, the age of an 
infected adult person and the duration of H. pylori infection can be regarded as 
roughly equivalent. The evidence of the role of the person’s age or the duration 
of H. pylori gastritis in formation of ACAB is based on studies of infected 
children, reporting a lower prevalence of ACAB (Faller et al. 1999, Ierardi et al.
1998). Furthermore, a significant age-dependent increase in PCA positivity was 
shown in H. pylori infected persons but not in H. pylori negative persons in the 
studied Karksi-Nuia population, which suggests that long-lasting H. pylori 
gastritis might represent an important factor for formation of PCA (Paper II). 
Other studies in which formation of classical PCA was followed up over time 
have revealed similar results (Hawkins et al. 1979, Uibo et al. 1989).
The association of ACAB with H. pylori gastritis, particularly with atrophic 
gastritis, in the corpus mucosa has been established in several previous studies 
(Faller et al. 1996, 1997, Negrini et al. 1996, Clayeas et al. 1998, Steininger et 
al. 1998) and was proved again on a group of 62 persons in this investigation.
Progression of superficial gastritis to atrophic gastritis has been shown in 
several previous follow-up studies (Villako et al. 1982, 1991, 1995, Ihamäki et 
al. 1985, Kuipers et al. 1995, Valle et al. 1996). In the present study we 
attempted to find an answer to the question why gastritis remains non-atrophic 
and confined to superficial mucosa layers in one patient, while gastric atrophy 
develops in another. Since ACAB are correlated with atrophic corpus gastritis, 
and since autoimmune reaction can lead to loss of parietal cells and evolution of 
gastric atrophy, then ACAB can serve as relevant markers for defining patients 
who are at higher risk for development of gastric atrophy (Faller et al. 1997). 
However, in this follow-up study we could not establish a significant 
association between presence of ACAB and development of atrophy over 
twelve study years. The lack of such a correlation is obviously due to the low 
number of enrolled persons, since such correlation was observed when the 
number of patients with the same epidemiological background increased from 
37 to 62 at the end of the study. Also, the study period might have been too 
short. Uibo et al (1989) reported that in a six-year follow-up period, changes in 
the gastric mucosa in autoimmune gastritis and in autoantibody negative 
gastritis revealed no significant differences. The antrum and corpus mucosa of 
two persons who developed PCA did not reveal any alterations over six years. 
In contrast, in a much longer, 32-year follow-up study, the appearance of PCA
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occurred in parallel with progression of corpus atrophy, disappearance of H. 
pylori and improvement of the antral mucosa (Valle et al. 1996).
Like in previous investigations, all PCA positive persons in our study were 
also positive for ACAB (Faller et al. 1997) On the other hand, only three out of 
all 29 ACAB positive persons were positive for PCA. This can be explained by 
the different binding sites of ACAB and classical PCA within parietal cells 
(Claeys et al. 1998). Interestingly, three persons who had classical PCA in 1997 
showed very intensive staining for ACAB throughout the cytoplasma (Fig. 4). 
Two of them had moderate or severe corpus atrophy. In the follow-up group 
only two persons turned out to be positive for PCA in 1997. However, although 
both had displayed intensive staining for ACAB already in 1985 and 1997, one 
developed corpus atrophy, but the other did not. It could be hypothesized that 
ACAB precede classical PCA, and that epitope switching takes place in the 
process of H. pylori associated antigastric autoimmunity. This hypothesis could 
also explain why not all ACAB+ persons were PCA+ in our study and in 
previous research (Faller et al. 1997, Claeyes et al. 1998).
In our study we were able to confirm previous reports on a significant 
correlation between ACAB and gastric mucosa atrophy (Faller et al. 1997, 1998, 
Steininger et al. 1998). However, the data of this study do not allow to clearly 
define whether ACAB are the cause or the consequence of gastric atrophy. There 
are some patients who are ACAB positive but do not yet have atrophy. In these 
patients antigastric autoimmunity precedes atrophy. On the other hand, there are 
also patients who have atrophy but are still negative for ACAB. We can surmise 
that in this subgroup of persons ACAB can develop during further progression of 
atrophy and appear at the time when gastric cells are sufficiently degraded and 
autoantigens are presented to immunocompetent cells.
The association of apoptosis in different compartments of the antrum and 
corpus mucosa with development of atrophy, grade of activity of gastritis, 
chronic inflammation and H. pylori colonization
This study represents the first prospective long-term investigation of apoptosis 
in three different compartments of both antrum and corpus mucosa specimens, 
taken from a random adult cohort at the initial and end points of an 18-year 
follow-up of chronic H. pylori gastritis. Although the results of a 31-year 
follow-up study of gastric cellular turnover and development of atrophy were 
published by Moss et al. 1999, these authors examined apoptosis at one (initial) 
time point and only in corpus biopsies.
The specific finding of the present study was that Al for PZ and GP of the 
corpus mucosa and for GP of the antrum mucosa decreased significantly during 
18 years of follow-up, irrespective of the dynamics of atrophic alterations (in per­
sons without development of atrophy versus in persons with development of 
atrophy).
There is evidence that cell turnover in the gastric mucosa is related to a 
delicate balance between cell proliferation and apoptosis. More intensive cell
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proliferation may induce increase in apoptosis, i.e. programmed cell death, in 
order to maintain tissue homeostasis (Kerr et al. 1972, Thompson 1995, Moss et 
al. 1996). It can be also supposed that cell turnover is more intensive in younger 
persons. Consequently, to keep cell turnover in balance, apoptosis must be more 
intensive. There exists evidence that in some cell types the ability to undergo 
apoptosis declines and upregulation of the bcl-2 gene due to chromosome trans­
location becomes more frequent with age (Warner 1997). It could be hypothe­
sized that there may occur also reduction of the intensity of cell turnover in PZ 
and GP of the mucosa, because gradual cell turnover through the lifespan of a 
mammal eventually exhausts the finite capacity of somatic cells to replicate 
(Ostler et al. 2000). The subjects of our study were 18 years younger in 1979 
than in 1997. Therefore one explanation of the significantly higher Al for PZ 
and GP of antrum and corpus mucosa specimens, sampled in 1979, compared 
with those sampled in 1997, could be the age difference. One can suppose that 
cell turnover in the FC compartment, which is continuously more exposed to 
several damaging factors, has to maintain its intensity also in old age. Also, it 
can be hypothesized that sustainment of intensive cell turnover in the FC 
compartment might be important for a better survival of bacteria on the non­
damaged epithelium of the host (Parente et al. 2001). From methodological 
point of view, comparison of paraffin-embedded biopsy specimens, obtained 
with a 18-year interval, should not affect the results, because according to the 
data of Bardales et al. (1997), the use of formalin-fixed and paraffin-embedded 
archival material as old as 25 years yielded a staining pattern by the TUNEL 
method similar to that of freshly prepared tissues.
Al was not significantly different in the group without atrophy and in the 
group who developed atrophy 18 years later, which refutes our hypothesis that 
increased apoptosis might induce progression of atrophic gastritis. An ana­
logous result was demonstrated in a follow-up study of Moss et al. (1999), in 
which the ratio of apoptosis to proliferation was not a determinant of risk for 
development of atrophy 31 years later.
It seems that development of atrophy cannot be explained only by violation 
of the balance between apoptosis and proliferation. As far as the association of 
apoptosis with gastritis is concerned, the results of several studies are quite 
different. For example, the findings of a study of Steininger et al. (1998) 
suggests that gastric atrophy might be the result of apoptosis in the gastric 
epithelium. Also, according to the opinion of Genta (1997), increased apoptosis 
in the gastric mucosa can lead to development of atrophy. However, Moss et al. 
(1996) found that apoptotic cell number does not correlate with degree of 
histological gastritis and that compensatory decrease in apoptotic activity takes 
place during progression of atrophic gastritis and intestinal metaplasia. A recent 
study of Scotiniotis et al. (2000) showed that in H. pylori antral gastritis, 
apoptosis was significantly reduced within the foci of intestinal metaplasia due 
to increased cell proliferation, which could contribute to H. pylori associated 
gastric carcinogenesis. Neither a study of Moss et al. (1996) nor a study of Anti
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et al. (1998) established the correlation of Al with acute or chronic inflam­
mation, whereas Jang et al. (2000) found an association between increased 
apoptosis in antral epithelial cells with degree of acute inflammation and 
density of H. pylori colonization.
Most authors have found a significant association between apoptosis and 
presence of H. pylori in the gastric mucosa (Moss et al. 1996, Chen et al. 1997, 
Konturek et al. 1999a, Scotiniotis et al. 2000, Von Herbay and Rudi 2000), 
suggesting a direct effect (Mannick et al. 1996, Moss et al. 1996, Smoot et al.
1997, Kohda et al. 1999) of H. pylori on mucosal cell apoptosis, or on further 
modulation of gastric epithelial cell apoptosis by immune mediators produced 
by neutrophils in response to H. pylori (Kim et al. 2000). The finding of 
Konturek et al. (1999a) suggests that H. pylori induces apoptosis in the gastric 
epithelium due to upregulation of proapoptotic Bax protein, while Bax 
overexpression is stronger in the antrum than in the corpus. The authors also 
found that activity of gastritis was higher in the antrum than in the corpus. 
These results are in accordance with our results concerning the association of 
Al in the FC compartment with grade of H. pylori colonization and activity of 
gastritis, which was more pronounced in the antrum than in the corpus mucosa.
A significant finding of our study was that the association of apoptosis with 
H. pylori colonization was expressed differently in the antrum and corpus 
mucosa, and that the effect of grade of activity of gastritis and chronic 
inflammation on Al was more expressed in the antrum than in the corpus, which 
may support the evidence of a different environment in the antrum and in the 
corpus (Stolte et al. 1990, Bayerdörffer et al. 1992).
Literature offers data about the role of CagA status in inducing or changing 
apoptosis in gastric epithelial or infiltrating T-cells (Peek et al. 1997, Anti et al.
1998, Figura et al. 1998, Rokkas et al. 1999; Ernst et al. 2000b, Kim et al. 
2000). A recent study of Moss et al. (2001) found increased apoptosis in the 
antrum and corpus only in patients with c^g^-positive H. pylori strains. The 
results of our study did not reveal a significant effect of CagA status on the 
value of Al either in the antrum, or in the corpus. According to the data of Peek 
et al. (1997) and Rokkas et al. (1999), CagA positive strains induce gastric cell 
proliferation which, however, is not accompanied by a simultaneous increase in 
apoptosis. On the basis of the data of Peek et al. (1999), the association of 
apoptosis with cagA positive strains is dependent upon the expression of vacA 
and genes within cagA PAI. Therefore these authors found heterogeneity of the 
levels of gastric epithelial cell proliferation and apoptosis within the H. pylori 
colonized mucosa, as well as a different effect of H. pylori on apoptosis at 
different time points since co-culturing of epithelial cells with H. pylori 
reference strains. One can surmise that the relationship between the CagA status 
and apoptosis of epithelial cells cannot be unambiquously characterized by a 
simple comparison of both of these statuses. Our results about the association of 
apoptosis with activity of gastritis are in better agreement with a study of Kim 
et al. (2000), who found that extent of apoptosis was similar in case of CagA
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positive and CagA negative H. pylori infected cells, while apoptosis of gastric 
epithelial cells and caspase-3 activation can be modulated by the immune 
response of neutrophils.
Literature data suggest that autoimmune corpus gastritis develops in the 
course of time, as a result of antigastric autoimmune reaction against parietal 
cells (Strickland and Mackay 1973). Anticanalicular autoantibodies too are 
associated with atrophic corpus gastritis, as was shown in the present study. In a 
study of Steininger et al. (1998) apoptotic cell loss in the glandular zone of the 
corpus mucosa correlated with anticanalicular autoantibodies. However, in our 
study AI in the corpus mucosa revealed no association with presence or absence 
of ACAB in the studied persons; nor was there found any correlation between 
AI and atrophic alterations in the corpus.
Seropositivity for H. pylori HSP 60 and its correlation 
with gastritis parameters
The specific finding of our study was that immunological response to H. pylori 
HSP 60 was associated with H. pylori, which is strongly correlated with grade 
of chronic inflammation, particularly in the antrum mucosa.
Our results concerning seropositivity for H. pylori HSP 60 among H. pylori 
infected persons are in accordance with the data of Macchia et al. (1993), who 
found that 50% of H. pylori infected patients with gastroduodenal diseases 
displayed immune response to H. pylori HSP 60. The authors noted that 
presence of H. pylori HSP 60 positivity varied greatly among different indi­
viduals. Suerbaum et al. (1994) demonstrated that 76.3% of H. pylori infected 
patients were positive for MBP-HspB recombinant proteins. Why only some 
infected persons develop immunological response to HSP 60 is not known. 
Kansau and Labigne (1996) explained this by host specific factors.
We established a significant difference in seropositivity for H. pylori HSP 60 
between persons in whom H. pylori was morphologically present in the gastric 
mucosa and those in whom it was absent, but it was not affected by grade of H. 
pylori colonization. Our finding that immunological response to H. pylori HSP 
60 is related to chronic inflammation, particularly in the antrum mucosa, 
confirms the view that H. pylori HSP 60 is able to evoke inflammatory response 
in the gastric mucosa (Engstrand et al. 1991, 1993, Dunn et al. 1992, Perez- 
Perez et al. 1994, Leri et al. 1996, Hayashi et al. 1998, Kamiya et al. 1998, 
Kawahara et al. 1999, Yamaguchi et al. 1999), as well as supports previous 
studies where immunologic response of the gastric mucosa to luminal antigens 
and inflammatory reactions involved was more pronounced in the antrum than 
in the corpus (Valnes et al. 1984, Bayerdörffer et al. 1992). Analogously, im­
mune response to the cell surface proteins of H. pylori was strongly associated 
with chronic inflammation in the antrum and corpus, but was not significantly 
influenced by grade of H. pylori colonization, particularly in the corpus. This 
fact may reflect the circumstance that immune response to H. pylori is 
influenced rather by host response than by grade of H. pylori colonization.
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A good correlation between serological response to H  pylori Hp54K 
(analogue to HSP 60) and mucosal inflammation (both acute and chronic) was 
found in a study of Perez-Perez et al. (1994). In our study, however, we could 
not establish a correlation between serological response to H. pylori HSP 60 and 
grade of activity of gastritis in the antrum or corpus mucosa. Nor did we detect 
any association with atrophy or with dynamics of atrophic alterations during 
18 years of follow-up, whereas in a study of Barton et al. (1998), IgA antibodies 
to mycobacterial and human HSP 60 (sharing 75% of sequence homology with 
H. pylori HSP 60) were associated with the presence of gastric atrophy.
The particular association of serological response to H. pylori HSP 60 with 
chronic gastric inflammation can be explained by the fact that H. pylori HSP 60 
induces IL-8 secretion by human gastric cells (Yamaguchi et al. 1999). The IL- 
8 is known as an pro-inflammatory cytokine (Crabtree et al. 1994). The 
important finding of our study was that presence of antibodies to H. pylori HSP 
60 was associated also with increase in chronic inflammation during 18 years of 
follow-up. Persons who developed higher grade inflammation during 18 years 
displayed also a higher level of IgG antibodies to H. pylori HSP 60 at the end 
point of observation. These follow-up data support the view that H. pylori HSP 
60 plays an important role in triggering of gastric mucosal inflammation (Perez- 
Perez et al. 1994, Kamiya et al. 1998).
An additional point for discussion is the possible involvement of H. pylori 
HSP60 in induction of autoimmunity-mediated gastritis (Engstrand et al. 1991, 
Macchia et al. 1993, Kansau and Labigne, 1996). Engstrand et al. (1991) 
showed that intraepithelial gamma/delta T-cells play a role in host defence 
against H. pylori, and that H  pylori itself may trigger an autoimmune response 
to heat shock proteins as stress proteins expressed by gastric epithelial cells. 
However, the studies of Taylor et al. (1999) as well as of Dunn et al. (1997) 
showed that the antibody, raised to H. pylori HSP60, reacted only with H. pylori 
cells but not with gastric mucosal tissue. A study of Kamoshida et al. (1999) did 
not find any significant difference in HSP60-like immunoreactivity in the 
gastric epithelium between H. pylori positive and H. pylori negative biopsies 
either. We tested the hypothesis whether there exists an association between 
presence of anticanalicular autoantibodies and seroprevalence of antibodies to 
H. pylori HSP60. The results of our study did not support this hypothesis. Since 
we did not examine local response to the H. pylori HSP60 derived antigen on 
the level of the gastric mucosa, our results point only indirectly to absence of 
this association. Studies of Faller et al. (1998) and Claeys et al. (1998) did not 
confirm the cross-reaction of ACAB with H. pylori antigens either.
Differences in glandular proliferation and homeostasis of specific cells 
between the gastric antrum and corpus in H. pylori associated gastritis
Based on the study of gastric epithelial cell proliferation and expression of bcl-2 
protein in the antrum and corpus mucosa in patients undergoing gastroscopy, 
we found that severity of gastritis and presence of H. pylori influenced gastric
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epithelial cell proliferation and expression of the bcl-2 protein in epithelial cells 
as well as in interstitial lymphocytes differently in the antrum and corpus 
mucosa. In the corpus, a significant positive correlation was found between 
proliferation activity and grade of chronic inflammation and atrophy (atrophic 
mucosa exhibited higher PCNA and Ki-67 LPs), whereas in the antrum mucosa, 
proliferation indices tended to correlate negatively with grade of gastritis 
(atrophic mucosa displayed lower Ki-67 LI). These findings are in accordance 
with the data of Bechi et al. (1996), which suggest differences in the proli­
ferative activity of epithelial cells between the gastric antrum mucosa and 
corpus mucosa, but show discordance with the data of other authors, which 
show enhancement of LI with increasing degrees of gastritis both in the antrum 
and corpus mucosa (Hart-Hansen et al. 1979, Lipkin et al. 1985).
Proliferation rates for the corpus glandular epithelium were not related to H. 
pylori status in our study. In the antrum glands, Ki-67 LI tended to be inversely 
related to higher H. pylori score as well as to gastritis score. A study of Chow et 
al. (1995) showed too that H. pylori does not increase antrum cell proliferation. 
Reduced proliferative activity of antrum gland cells with increasing grade of 
gastritis is not an unexpected finding because it represent gastritis harbouring a 
significant proportion of involutes glands in probable proliferative quiescence, 
since severe cell loss does not permit normal cell maturation and differentiation 
(Bechi et al. 1996). The contrastive findings for the gastric corpus, namely 
increased proliferative activity, especially in FC and GP, suggest that corpus 
gland cell populations maintain active cell turnover despite reduction in cellular 
mass as established through grading criteria. Extension of the proliferative com­
partment with consequent displacement of proliferating cells to the epithelial 
surface has indeed been reported in advanced gastritis (Hart-Hansen et al. 1979, 
Deschner et al. 1972). Moreover, corpus gastritis may be in an earlier phase of 
inflammatory evolution compared with antrum gastritis, retaining still its 
proliferative repertoire: there is evidence that lesions in the antrum can be 
considered older than lesions in the corpus (Lipkin et al. 1985). Indeed, in our 
group of patients, cases with atrophic antrum alterations prevailed over atrophic 
corpus alterations.
It was our aim to test whether cell protection from apoptosis is related to 
gastritis and H. pylori colonization. Immunoreactivity for the apoptosis 
protector, bcl-2 protein, was detected in a subset of gastric epithelial cells, 
mainly in the glandular neck region. The noteworthy finding of our study was 
that both glandular proliferation and bcl-2 protein reactivity were differently 
expressed already in the normal (i.e. without chronic inflammation or atrophy of 
the glands) corpus and antrum mucosa. In normal corpus glands, the balance 
between cell proliferation and programmed cell death was manifested as lower 
PCNA and Ki-67 LFs and higher bcl-2 protein staining of epithelial cells in GP 
compared with the atrophic mucosa. However, compared with atrophic glands, 
the balance between cell proliferation and apoptosis in the normal antrum 
mucosa was attained in a different way: there was a tendency for increased cell
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proliferation and reduced bcl-2 protein staining of epithelial cells. In our study, 
overall mean PCNA LI too was significantly higher in the antrum than in the 
corpus. This finding may support the evidence of presence of a different 
environment in the antrum mucosa and in the corpus mucosa (Stolte et al. 
1990), as well as of dissimilarities in the antrum and corpus regarding the 
interaction between the bacterium and the host (Sipponen et al. 1996a).
For the atrophic corpus mucosa, we established higher proliferation index 
compared with respective index for normal corpus glands, and simultaneous 
increase in bcl-2 positivity of interstitial lymphocytes. While upregulation of the 
bcl-2 as the apoptosis protector factor suggests reduced apoptosis, its asso­
ciation with prolonged higher proliferation activity can be regarded as a factor 
contributing to development of MALT lymphoma and carcinogenesis (Lauwers 
et al. 1994, Banerjee et al. 2000). A positive correlation of positive staining for 
bcl-2 in interstitial lymphocytes of the corpus with grade of gastritis may also 
indicate that these lymphocytes are protected from programmed cell death and 
may hence be responsible for increase in chronic inflammation.
Lower Ki-67 proliferation index for the atrophic antral mucosa was 
associated with more frequent bcl-2 protein staining of epithelial cells in the 
neck part of glands (PZ) than in the normal mucosa, which indicates possible 
protection from cell loss and may thus reflect an important mechanism for 
retaining the renewal potential of antrum glands (Lauwers et al. 1994).
Our investigation showed that antral G- and D-cell densities decrease 
significantly already at the stage of non-atrophic gastritis and reach a minimum 
in atrophic gastritis. This finding confirms previous data demonstrating 
decrease in G-cells, particularly in atrophic gastritis (Crivelli et al. 1977, Stave 
et al. 1978, Marotta et al. 1990, Graham et al. 1993). We detected only a few 
G- and D-cells in the corpus, predominantly in atrophic areas, probably in the 
transition area between the antrum and the corpus. In our study the presence of 
H. pylori tended to be associated with decrease in G- and D- cell densities in the 
antrum, however, this decrease was significantly affected by advanced grade of 
atrophic gastritis. Our results are consistent with the observation of Wyatt et al. 
(1989), who found also significantly fewer gastrin cells in H. pylori positive 
patients, while this decrease was positively correlated with degree of antral 
atrophic gastritis. The lower density of D-cells in the H. pylori positive antrum 
mucosa, found in our study, is in agreement with the evidence that H. pylori 
induces reduction of somatostatin cells (Moss et al. 1992, 0dum et al. 1994, 
Park et al. 1999, Tham et al. 1998).
Concerning the third type of specific gastric cells, i.e. P- H+, K+ ATP-ase- 
reactive parietal cells, we found that their density was dependent rather on grade 
of atrophic gastritis than on H. pylori density. Atrophy in the corpus mucosa 
may represent a more powerful factor for inducing decrease in specific cells, 
and advanced stages of mucosal atrophy exhibit depletion of specific cells 
irrespective of H. pylori status.
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SUMMARY
This investigation was undertaken to determine the seroprevalence of H. pylori 
infection among Estonian population, both in adults and in children. The aim 
was to establish, whether present H. pylori infection is aggressive or not by 
detecting the antibodies to cytotoxin associated protein, to heat shock protein 60 
and to the acid glycine extracted cell surface proteins of H. pylori. Also, we 
attempted to establish possible factors which play a role in progression of 
gastritis into atrophic gastritis (presence of autoantibodies, apoptosis), as well as 
to assess the association of host immune response to different#, pylori antigens 
with histological parameters of gastritis, and to find out whether there exist 
some immunological factors differing for various topographic types of gastritis. 
In addition, the influence of H. pylori on cell turnover in the antrum and corpus 
mucosa was studied.
Altogether, we studied 1461 persons from Karksi-Nuia and 497 persons 
from Abja-Paluoja (from an unselected population of two small towns in 
Southern Estonia), 70 adult Estonians from Saaremaa Island (from a primary 
sample of 227 subjects endoscoped in 1979 and reinvestigated by endoscopy 
and biopsy in 1997), 421 schoolchildren selected randomly from a population of 
urban or rural areas in Southern Estonia, 112 children with abdominal 
complaints, endoscoped in Tartu Children’s Hospital, and 45 consecutive 
gastric cancer patients from the Tartu University Clinic of Oncology, as well as 
45 age and sex matched non-gastric controls (from the serum bank of the 
Department of Immunology, University of Tartu). Also, 59 patients investigated 
by routine endoscopy in the Department of Gastroenterology of the University 
Hospital, Bern, were included in the study.
The state of the gastric mucosa and presence of H. pylori in histological 
sections were assessed in accordance with the updated Sydney system. 
Seroprevalence of IgG antibodies to H. pylori acid glycine extracted cell surface 
proteins and IgG antibodies to the recombinant fragment of 128 kD cytotoxin- 
associated (CagA) protein were detected by ELISA and immunoblot. Immu­
nological response to H. pylori HSP 60 was evaluated using purifed H. pylori 
HSP 60 in ELISA.
H. pylori on histological sections was evaluated using peroxidase-anti- 
peroxidase method and polyclonal anti- H. pylori antibodies. Anticanalicular 
autoantibodies (ACAB) in the serum were evaluated immunohistochemically on 
the gastric corpus mucosa paraffin sections from patient cases without 
pathological alterations. Classical IgG-type parietal cell antibodies (PCA) were 
examined by indirect immunofluorescence method. Apoptosis was evaluated 
using TUNEL method. Gastric epithelial cell proliferation (with PCNA and Ki- 
67 labelling), bcl-2 protein staining and immunostaining for G, D cells and P- 
H+, K+ ATP-ase in parietal cell canaliculi were evaluated immunohisto­
chemically.
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The results showed that the seroprevalence of H. pylori infection in Estonian 
adult population is extremely high. IgG antibodies to the acid glycine extracted 
cell surface proteins of H. pylori were detected in 87% of inhabitants from 
Karksi-Nuia, in 89% of inhabitants from Abja-Paluoja and in 94% of an adult 
sample from Saaremaa. A significant increase was established in the sero­
prevalence of H. pylori from 69% in the youngest age group of 15-19 years to 
83%) in 20-29 year-olds, while persons aged 20-29 years are characterised by 
the highest prevalence (76%) of anti-CagA IgG in the population, which may 
indicate high risk for developing gastric cancer among them. Seroprevalence to 
H. pylori in gastric cancer patients was 91%, which was similar to seropre­
valence in a random adult population, while the prevalence of anti-CagA 
antibodies was significantly higher in gastric cancer patients (87%) compared 
with adult population from Karksi-Nuia (63%) and from Saaremaa (70%). 
Additionally, seropositivity for cytotoxin associated CagA and VacA proteins 
was significantly more frequent among gastric cancer patients than among age 
and sex matched non-gastric controls. This support the view that cytotoxic 
strains of H. pylori constitutes factors particularly associated with increased risk 
of the development of gastric cancer.
Of schoolchildren, aged 9-15 years, living in Southern Estonia, 56% were 
seropositive for H. pylori, while 46% of them were anti-CagA positive. Neither 
H. pylori nor CagA positivity was significantly different in girls and boys, or in 
children aged 9, 12 or 15 years. Schoolchildren from rural areas were infected 
significantly more often with CagA seropositive strains compared with those 
living in towns.
Gastritis of any degree and localization was found in 75% of children with 
abdominal complaints (median age 12), while the most frequent morphological 
and topographical type of gastritis was nonatrophic gastritis localized 
simultaneously in the antrum and corpus mucosa (46% of the cases studied). 
The prevalence of H. pylori among Estonian children with abdominal com­
plaints, determined by Giemsa staining, was higher (74%) than the prevalence 
obtained by the use of immunohistochemical method (49%). In 11% of cases 
the staining of epithelial cells in the neck part of corpus glands was established 
by anti-i/ pylori IgG, which may indicate the possible immunological cross­
reactivity of anti-// pylori IgG with gastric epithelial cell antigen epitopes or 
internalization of H. pylori by epithelial cells in the children’s gastric mucosa. 
These facts might point to peculiarities of interactions between H. pylori and 
host in childhood, considering that the use of anti-iZ pylori antibodies on adult 
mucosa sections did not reveal immunostaining of epithelial cells in any one 
case.
Immune response to the CagA protein of H. pylori was strongly associated 
with activity of gastritis, presence of atrophy and damage of surface epithelial 
cells in the antrum and corpus mucosa, as well as with presence of intestinal 
metaplasia in the antrum. In the antrum mucosa, the strongest association was 
established between CagA positivity and presence of atrophy, whereas in the
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corpus the strongest association occurred between CagA positivity and grade of 
activity of gastritis. Moreover, progression of atrophy in the antrum mucosa and 
particularly in the corpus mucosa was associated with CagA positivity. This 
supports the view about the role of the cytotoxin-associated CagA protein in 
enhanced gastric inflammatory response and atrophic alterations of the stomach 
mucosa.
The prevalence of anticanalicular autoantibodies (ACAB) increased signifi­
cantly with duration of H. pylori gastritis from 22% in 1985 to 46% in 1997. A 
significant association was found between ACAB and corpus mucosa atrophy 
as well as presence of intestinal metaplasia in the corpus. A significant age- 
dependent increase in PCA positivity was also shown in H. /ry/on-infected 
persons but not in H. pylori negative persons in the study of the Karksi-Nuia 
population. This fact implies that long-lasting H. pylori gastritis may represent 
an important factor for formation of PCA and possibly also ACAB. Comparison 
of presence of ACAB and classical IgG type PCA antibodies in the follow-up 
group allowed to hypothesize that ACAB preceded classical PCA and that 
epitope switching takes place in the process of H. pylori-associated antigastric 
autoimmunity.
The analysis of apoptotic index (Al) for the foveolar cells, the proliferating 
zone and the glandular part of the antral and corpus mucosa in 18-year follow- 
up did not reveal any difference between persons with and without development 
of atrophy. The Al in the antrum was higher in persons with high activity of 
gastritis, chronic inflammation and grade of H. pylori colonization. The highest 
independent effect on apoptosis in the corpus was exerted also by activity of 
gastritis and chronic inflammation. Neither CagA status nor the presence of 
ACAB influenced the value of Al for all studied compartments in the antrum 
and in corpus mucosa.
Seropositivity for H. pylori HSP 60 in the studied persons was 65%. 
Serological response to H. pylori HSP 60 was seen only in subjects with H. 
pylori in the antrum or corpus and it was strongly correlated with grade of 
chronic inflammation, but not with activity of gastritis or development of 
atrophy. Grade of chronic inflammation in the antrum was the highest indepen­
dent predictor of seropositivity for H. pylori HSP 60. No significant association 
was found between seropositivity to HSP 60 and presence of ACAB in the 12- 
year follow-up study. According to our study, H. pylori HSP 60 does not appear 
to be involved in molecular mimicry with antigens in the canalicular structure 
of the parietal cells in the corpus mucosa.
The intensity of serological immune response to H. pylori HSP 60 and to the 
acid glycine extracted cell surface protein antigens of H. pylori was associated 
not so much with grade of H. pylori colonization as with grade of chronic 
inflammation. This allowed to suppose that in serological response to both of 
these H. pylori antigens the intensity of host response plays a more important 
role than grade of H. pylori colonization.
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Severity of gastritis and density of H. pylori colonization influence gastric 
epithelial cell proliferation and expression of bcl-2 differently in the antrum and 
corpus mucosa. In the corpus mucosa, proliferation activity and expression of 
bcl-2 in interstitial lymphocytes was significantly higher in atrophic than in 
non-atrophic gastritis but did not depend on H. pylori density, while bcl-2 
positive epithelial cells predominated in the non-atrophic corpus glands. In 
contrast, the proliferative activity of the antral mucosa showed a tendency 
toward a negative association with severity of gastritis, and expression of bcl-2 
positive interstitial lymphocytes was more associated with H. pylori density. 
Homeostasis of antral G- and D- cells as well as loss of p- H+, K+ ATP-ase — 
reactive cells in the corpus was shown to be a function of the degree of atrophic 
alterations rather than a function of H. pylori.
Summarizing the present results about the association between immune 
response to different H. pylori antigens and its histological appearance in the 
antrum and corpus mucosa the following can be concluded:
The state of corpus mucosa was particularly strongly associated with 
immune response to CagA protein, while the state of the antrum mucosa was 
associated with immune response to H. pylori HSP60;
Atrophy in the antrum as well as in the corpus mucosa was strongly 
associated with CagA positivity, while the atrophy in the corpus was associated 
also with presence of ACAB. The other factors, influencing development of 
atrophy in addition to CagA positivity were activity of gastritis for the corpus 
mucosa, and age for the antrum mucosa. The association of ACAB with 
progression of corpus atrophy was not significant. Nor did apoptotic index 
appear to be associated with atrophy, or to predict atrophy. Immunological 
response to H. pylori HSP 60 did not correlate with development of atrophy.
The results of our research showed that different histological signs (as 
evaluated by the Sydney classification system of gastritis) are associated with 
immune response to H. pylori antigens in different ways. Activity of gastritis, 
(particularly in the corpus), atrophy (in the antrum and corpus) and intestinal 
metaplasia (in the antrum mucosa) are associated with immune response to CagA 
protein. Grade of chronic inflammation, particularly in the antrum mucosa, is 
associated with serological response to HSP 60 of H. pylori, while chronic 
inflammation in the corpus mucosa is associated predominantly with immune 
response to the acid glycine extracted cell surface proteins of H. pylori (Fig. 14).
Thus, H. pylori harbouring highly immunogenic proteins, like CagA and 
HSP60, induce local immune response in the stomach mucosa, appearing as 
acute and chronic inflammation, as well as systemic serological response. 
Seropositivity for CagA protein may serve as a sign of activity of gastritis and 
atrophy and might even predict development of atrophy, particularly in the 
corpus. Positivity of patients’ sera for anticanalicular antibodies may suggest 
also presence of corpus atrophy, while positivity for H. pylori HSP60 indicates 
chronic inflammation in the antrum mucosa. Seropositivity for different
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Figure 14. Scheme of associations between the histological parameters of gastritis in 
the antrum and corpus and serological response to different H. pylori antigens.
H. pylori antigens serves as a marker of histological appearance in the antrum 
and corpus mucosa in H. pylori infection. However, apoptotic index is not 
associated with development of atrophy but is largely dependent on grade of 
activity of gastritis and, particularly in the antrum, on grade of H. pylori 
colonization.
The antrum and the corpus mucosa displayed some differences in progres­
sion of atrophy. According to the 18-year follow-up of an adult population from 
Saaremaa, atrophy developed in the antrum mucosa in 11% of cases and in the 
corpus mucosa in 35% of cases. Persons who developed atrophy in antrum 
mucosa during follow-up were older at the beginning of observation, than those 
whose did not develop atrophy. In contrast, for the corpus mucosa there was 
revealed no age difference between persons who developed atrophy or did not 
develop it, but the subjects who had corpus atrophy already in 1979 were older 
than those without atrophy at the beginning of observation. It was noteworthy
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that immune response to different H. pylori antigens revealed no association 
with age. Activity of gastritis exerted an effect on development of atrophy only 
in the corpus mucosa.
The association of apoptosis in gastric epithelial cells with grade of H. pylori 
colonization was also expressed differently in the antrum and corpus mucosa. 
The peculiarity of the antrum was a strong association of apoptotic index with
H. pylori colonization. Also, the effect of activity of gastritis and chronic 
inflammation on apoptotic index was more expressed in the antrum than in the 
corpus. Moreover, epithelial cell proliferation and expression of the apoptosis 
protector oncoprotein bcl-2 in interstitial lymphocytes in the antrum was 
correlated predominantly with H. pylori, while in the corpus they were 
correlated with gastritis score.
The findings of our investigation point to several peculiarities of the antrum 
versus corpus in immune response to different H. pylori antigens and the 
association of this response with mucosal alterations, especially with cellular 
turnover and development of atrophy in the two parts of the stomach mucosa, 
which may support the evidence of presence of a different environment in the 
antrum and corpus.
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CONCLUSIONS
1. The seroprevalence of H. pylori infection in Estonian adult population is 
extremely high, 87% to 94%, from which 63% to 71% account for CagA 
positive cases. The lowest seroprevalence of H. pylori (69%) was established 
for the youngest studied birth cohort (15-19 years). Most Estonian people are 
infected early in their life. Of schoolchildren aged 9-15 years and living in 
Southern Estonia 56% are seropositive for H  pylori and 46% of them have 
antibodies to CagA protein. Schoolchildren from rural areas possess signifi­
cantly more often CagA seropositive strains compared with those from towns.
2. The prevalence of H. pylori among Estonian children with abdominal 
complaints (median age 12 years) was higher (74%) when it was assessed from 
gastric mucosa samples using Giemsa staining, than when it was assessed with 
immunohistochemical method employing anti-H. pylori polyclonal antibodies 
(49%). The staining of epithelial cells in the neck part of corpus glands with the 
use of anti-H. pylori IgG indicates the possible immunological cross-reactivity 
of anti-Ä pylori IgG with epithelial cell epitopes, or internalization of H. pylori 
by these cells and may point to the peculiarities of interactions between H. 
pylori and host in childhood.
3. A significant association occurs between seropositivity for H. pylori CagA 
protein and activity of gastritis, presence of atrophy and damage of surface 
epithelial cells in the antrum and corpus. Unlike CagA-negative strains, CagA- 
positive strains of H. pylori enhance development of atrophic gastritis of the 
antrum and corpus. This association is more pronounced for the corpus mucosa. 
Development of atrophy in the corpus mucosa is significantly associated also 
with activity of gastritis, and in the antrum mucosa also with age.
4. The occurrence of autoantibodies reacting against canalicular structures 
within the human parietal cells increased significantly with duration of H. pylori 
gastritis. The correlation between these antibodies and presence of gastric 
corpus atrophy was confirmed. A significant age-dependent increase in parietal 
cell antibodies positivity was shown in H. pylori-infected persons.
5. Antibody response to H. pylori HSP 60 was associated with histological 
presence of H. pylori in the antrum and corpus mucosa and was strongly 
correlated with grade of chronic inflammation, particularly in the antrum 
mucosa, as well as with progression of chronic inflammation, but not with the 
development of atrophy during 18 years of follow-up, or with activity of 
gastritis.
6. The apoptotic index of epithelial cells for the proliferating zone as well as for 
the glandular part of the corpus mucosa and for the glandular part of the antrum 
mucosa decreased significantly during 18 years of follow-up irrespective of the 
dynamics of atrophic alterations. H. pylori colonization in the antrum during 18
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years had a significant effect on the difference in apoptotic index between the 
two time points of observation only for the foveolar cells of the antrum mucosa. 
Apoptotic index is related to activity of gastritis in general but does not appear 
to be associated with atrophy or to predict atrophy. The association of apoptosis 
with H  pylori colonization was expressed differently in the antrum and corpus 
mucosa, being more pronounced in the antrum.
7. In the antrum, proliferation activity of epithelial cells revealed a tendency to 
be negatively correlated with gastritis, and the expression of bcl-2 positive 
interstitial lymphocytes was more strongly associated with H  pylori score, 
while in the corpus, proliferation activity of epithelial cells as well as expression 
of bcl-2 in interstitial lymphocytes was strongly dependent on severity of 
gastritis but not on H  pylori density. This indicates that severity of gastritis and 
H. pylori colonization influence cellular turnover differently in the antrum and 
corpus.
8. Seropositivity for different H. pylori antigens may indicate presence of 
certain histological manifestations in the antrum and corpus mucosa.
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SUMMARY IN ESTONIAN
IMMUUNVASTUS HELICOBACTER PYLORI' le, 
SELLE SEOS KROONILISE GASTRIIDI DÜNAAMIKAGA JA 
EPITEELRAKKUDE APOPTOOSINING 
PROLIFERATSIOONIGA ANTRUMIS JA KORPUSES
Käesolev töö on järjeks gastriidi uurimise pikaajalisele traditsioonile Tartu 
Ülikoolis, millele pani 1930 aastatel aluse Lauri Walk ja mida jätkas professor 
Kaljo Villako eestvedamisel ülikooli töögrupp koostöös professor Max Siurala 
juhitud Soome gastroenteroloogide rühmaga. Juhusliku valikuga moodustatud 
eestlaste rühmade uurimisel selgus, et maal (Kambja arstijaoskonnas) elavatest 
isikutest esineb antrumi gastriiti 68%-l ja  korpuse gastriiti 45%-l, Saaremaa 
linnaelanikel vastavalt 64% ja  62% (Villako et al. 1976, 1982).
Tänaseks on teada, et Marshalli ja  Warreni poolt 1982. a. avastatud Helico­
bacter pylori (H. pylori) osaleb gastriidi, peptilise haavandi ja  maovähi patoge- 
neesis. Eestis alustati H. pylori uurimist juba 1986. a. ja  histoloogilist meetodit 
kasutades tehti kindlaks, et H. pyloriga. on täiskasvanud eestlaste juhusliku 
valikuga moodustatud rühmas nakatunud 73%, maohaavandi haigetest 91% ja 
kaksteistsörmikhaavandi all kannatajatest 96%. Samuti leiti, et eestlaste nakatu­
mine lastel on kõrge, mis on üheks gastriidi tekkimise riskifaktoriks juba 
lapseeas (Maaroos et al. 1990a, 1991a, 1991b).
H. pylori infektsioon on kohordifenomen, s.t. nakatumine toimub lapseeas ja  
täiskasvanutel lisandub uusi esmajuhte vähe. Eestis ja  Soomes tehtud gastriidi ja 
H. pylori esinemise histoloogiliste uurimistega tehti kindlaks, et gastriit ja  
H. pylori esines neil, kes olid sündinud eelmise sajandi algusest kuni Teise maa­
ilmasõjale järgnenud perioodini, mõlemal maal ühesuguse sagedusega. Pärast 
seda vähenes gastriidi esinemine Soomes, mitte aga Eestis (Maaroos 1995).
H. pylori on tugevate immunogeensete omadustega, põhjustades antikehade 
produktsiooni ja  paikse rakulise immuunvastuse maolimaskestas. Samuti on 
teada, et just H. pylori tsütotoksilistel tüvedel on oluline osa gastriidi, peptilise 
haavandi ja  maovähi patogeneesis (Cover et al. 1990, Crabtree et al. 1991, 
Sipponen and Hyvärinen 1993, Vaucher et al. 2000). Seetõttu oli vaja määrata 
H. pylori tsütotoksiiniga assotsieeritud proteiini (CagA) antikehade esinemist 
populatsioonis nii täiskasvanutel kui ka lastel. Vereseerumis antikehade määra­
mise kaudu saab suure täpsusega diagnoosida H. pylori infektsiooni (Perez- 
Perez et al. 1988, Megraud 1993). Seni aga puudusid seroepidemioloogilised 
uurimised H. pylori leviku kohta eestlastest täiskasvanute ja  laste hulgas.
H. pylori gastriit on kohalik immuunvastus selle bakteri infektsioonile (Sip­
ponen et al. 1998). H. pylori tüvede antigeensed komponendid on mitmesugu­
sed. Kroonilise gastriidi ja  eriti maolimaskesta atroofia patogeneesi seisukohalt 
on oluline teada, millised H. pylori antigeensed komponendid (nagu CagA,
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kuumašoki-proteiin) on seotud selliste gastriiti iseloomustavate näitajatega nagu 
gastriidi aktiivsus, krooniline infiltratsioon limaskestas, atroofia, intestinaalne 
metaplaasia, ja  seda nii antrumis kui ka korpuses. Mainitud seoste teadmine 
võimaldaks prognoosida erisuguste H. pylori tüvede mõju maolimaskesta 
muutustele.
Artoofia tekke võimalikuks põhjuseks on peetud parietaalrakkude anti- 
geenidevastaseid immuunreaktsioone (Salupere 1968, Uibo et al. 1991), sh. 
antikanalikulaarseid antikehi (Faller et al. 1996, Steininger et al. 1998). Oluliste 
tegurite hulka on arvatud ka H. pylori võimet mõjutada maolimaskesta rakkude 
apoptoosi ja  proliferatsiooni (Moss et al. 1996, Konturek et al. 1999, Lauwers 
et al. 1994). Seni ei ole uuritud H. pylori seost apoptoosi ja  gastriidi dünaami­
kaga longitudinaaluurimise alg-ja lõpp-punktis ning ühel ajal nii antrumis kui 
ka korpuses.
Uurimuse eesmärk
1. Kindlaks teha H. pylori antigeenidele vastavate antikehade levik täis­
kasvanud eestlastel, mitteselekteeritud koolilaste rühmas ja  maovähi- 
haigetel.
2. Määrata H. pylori esinemissagedus ülakõhuvaevustega lastel antrumis ja  
korpuses, kasutades H  pylori immunohistokeemilist uuringut ning Giemsa 
värvimismeetodit, ja  võrrelda nende meetodite tundlikkust ning eripära.
3. Kindlaks teha H  pylori antigeenidega (rakupinnaproteiin, CagA, kuuma- 
šokivalk) seotud immuunvastuse ja  antikanalikulaarsete antikehade seos 
gastriidi dünaamikaga.
4. Hinnata apoptoosi antrumi- ja  korpuselimaskesta epiteelrakkudes, selle 
seost H. pylori kolonisatsiooni, gastriidi aktiivsuse, kroonilise põletiku ning 
atroofiaga täiskasvanute 18-aastasel longitudinaalsel uurimisel.
5. Kindlaks teha H. pylori ja  gastriidi mõju rakkude proliferatsioonile ja  
apoptoosi pärssiva proteiini bcl-2 ekspressioonile antrumis ja  korpuses ning 
antrumi ja  korpuse spetsiifiliste rakkude esinemissagedusele.
Uuritavad ja meetodid
Uuriti 1461 (vanuse mediaan 42 a) Karksi-Nuia ja  497 (vanuse mediaan 61 a) 
Abja-Paluoja elanikku (selekteerimata populatsiooni uurimine), 70 täiskasvanut 
(vanuse mediaan 1979. a 57,5 a) Saaremaalt (longitudinaalne uurimine aastatel 
1979-1997), 421 linnas ja  maal elavat selekteerimata koolilast (vanuses 9, 12 ja 
15 a), 112 ülakõhuvaevuste tõttu TÜ Lastekliinikus gastroskopeeritud last (va­
nuse mediaan 12 a), 45 järjestikku TÜ Onkoloogia Kliinikus hospitaliseeritud 
maovähihaiget (vanuse mediaan 64,5 a) ja  viimastele vanuse ja soo poolest 
vastavat kontroll isikut (TÜ ÜMPI immunoloogia uurimisgrupi seerumipangast)
136
ning 59 haiget (vanuse mediaan 47 a), kes olid endoskopeeritud ülakõhuvae- 
vuste tõttu Berni Ülikooli Kliiniku gastroenteroloogia osakonnas.
H. pylori IgG tüüpi antikehi (pinnaproteiini, CagA ja  kuumašokivalgu 
vastaseid) määrati ELISA meetodil. Osal uuritavatest määrati täiendavalt ka 
H. pylori pinnaproteiini, CagA, vakuoliseeriva tsütotoksiini (VacA) vastaseid 
antikehi immunobloti-meetodil. Antrumi- ja  korpuselimaskesta seisundit ning 
H  pylori hinnati hematoksüliin-eosiiniga ja Giemsa järgi värvitud histoloo- 
gilistel preparaatidel, tuginedes gastriidi Sidney klassifikatsiooni kriteeriumi­
dele. Samuti määrati H. pylori esinemine koelõikudes immunohistokeemiliselt, 
kasutades H. pylori vastaseid antikehi ja  peroksüdaas-antiperoksüdaas-meetodit. 
Antikanalikulaarsed antikehad määrati uuritavate seerumis immunohistokee­
miliselt, kasutades maoresektsioonil saadud normaalsest korpuselimaskestast 
valmistatud parafiinlõike. Parietaalrakkudevastased (nn klassikalised) antikehad 
määrati kaudsel immuunfluorestsentsmeetodil. Apoptoos tehti kindlaks 
TUNEL-meetodil, epiteelrakkude proliferatsioon, bcl-2 ekspressioon epiteel- 
rakkudes ja  interstitsiaalsetes lümfotsüütides määrati immunohistokeemiliselt 
(APAAP- ja  avidiin-biotiin-meetodid), kasutades proliferatsiooni markerit 
PCNA ja  Ki-67 ning bcl-2 proteiini vastaseid antikehi. Immunohistokeemiliselt 
(avidiin-biotiin-meetod) määrati gastriini- ning somatostatiinirakkude ja  H+, K+ 
ATPaasi sisaldavate parietaalrakkude hulk, kasutades vastavaid antikehi.
Uurimuse peamised tulemused
H. pylori pinnaproteiinivastaste IgG tüüpi antikehade esinemissagedus täiskas­
vanud eestlastel on väga suur (84-94%) ja enamik nendest on CagA seroposi- 
tiivsed (63-70%). Madalaim H. pylori seropositiivsus (69%) on uuritavast 
populatsioonist kõige noorematel (15-19-aastastel). Koolilaste hulgas (9-15 a) 
on H. pylori suhtes seropositiivseid 56%, 46% nendest on ka CagA-positiivsed, 
mis tähendab, et enamus eestlastest on saanud H. pylori nakkuse juba lapsena. 
Koolilastel, kes elavad maal, on võrreldes linnalastega suurem CagA antikehade 
levimus.
Maovähihaigetest leiti seropositiivsus H. pylori pinnaproteiini vastu 91 %-l, 
mis ei erinenud täiskasvanute kontrollgrupis leitud tulemusest, kuigi neil haigeil 
oli tunduvalt sagedasem CagA seropositiivsus (87%), võrreldes Karksi-Nuia 
(63%>) ja  Saaremaa elanikega (70%). Samuti oli maovähihaigetel, võrreldes 
kontrollrühma isikutega, sagedamini VacA-vastaseid antikehi. See tulem kinni­
tab tsütotoksiliste tüvede rolli maovähi riskifaktorina.
H. pylori määramine histoloogilistes lõikudes ülakõhuvaevustega lastel 
Giemsa meetodil võimaldas bakterit sagedamini kindlaks teha (74%) kui immu- 
nohistokeemilise meetodiga (49%). See võib olla tingitud sellest, et antigeensed 
komponendid H. pylori nendel tüvedel, mis koloniseerivad uuritud laste mao- 
limaskesta, erinevad nendest, mille vastu meie poolt kasutatud H. pylori vasta­
sed antikehad olid produtseeritud. 11%-1 uuritud juhtudest reageerisid H. pylori
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antikehad korpuselimaskesta proliferatiivse tsooni epiteelrakkudega, mis võib 
olla tingitud immunoloogilisest ristreaktsioonist või peegeldada H. pylori 
tungimist epiteelrakkudesse. See viitab H. pylori ja  peremeesorganismi suhete 
eripärasusele lapseeas.
Gastriidi aktiivsus, maolimaskesta atroofiaja selle areng aastate jooksul ning 
nii antrumi kui ka korpuse epiteelrakkude kahjustus on rohkem väljendunud 
CagA-positiivsetel isikutel. Korpuselimaskesta atroofia arenemine on seotud ka 
gastriidi aktiivsusega, antrumi limaskesta atroofia lisaks veel isikute vanusega. 
Nimetatud tulemus toetab arvamust H. pylori tsütotoksilise proteiiniga seotud 
antigeenide mõju kohta maolimaskestas toimuvatele muudatustele ja  atroofia 
tekkele.
Parietaalrakkude kanaliikulitega reageerivate antikehade levimus suureneb 
tunduvalt H. pylori tekitatud gastriidi pikajalisel kestmisel. Meie uuringud näi­
tasid, et nende antikehade esinemine on sagedasem korpuselimaskesta atroofia 
korral. Seega on kanaliikulitega reageerivate antikehade esinemine maokorpuse 
limaskesta atroofia markeriks. Varasemate uuringutega on tõestatud parietaal- 
raku autoantikehade ja  atroofia seos. Käesoleva uuringu järgi suureneb 
H  pylori positiivsetel isikutel seoses vanusega parietaalraku autoantikehade 
esinemissagedus, mis omakorda võiks olla nendel oleva korpuselimaskesta 
atroofia kaudseks tunnuseks.
Antikehi H. pylori kuumašokivalgu vastu oli täiskasvanutest 65%-l, kus­
juures antikehade leid oli spetsiifiline H. pylori olemasolule limaskestas (anti­
kehi ei leitud H. pylori negatiivsetel isikutel). H  pylori kuumašokivalguvastaste 
antikehade esinemine sõltus H. pyloriga seotud põletiku astmest. Eriti tugevasti 
oli see seis väljendunud antrumilimaskesta põletiku korral. See toetab arvamust, 
et H. pylori antikehade tekkes on oluline peremehe organismi immuunvastuse 
tugevus, mitte H. pylori kolonisatsiooni aste. H. pylori kuumašokivalguvastaste 
antikehade esinemine ei korreleerunud gastriidi aktiivsusega, ega atroofia 
arenguga.
Apoptoosiindeks (korpuselimaskesta rakkude proliferatsiooni piirkonnas 
ning korpuse ja  antrumi näärmete piirkonnas) vähenes tunduvalt uuritavate 18- 
aastase jälgimise jooksul ning see võib olla seotud rakkude asendumisprotsessi 
aeglustumisega patsientide vananemisel. Samas aga apoptoosiindeksi vähene­
mine ei olnud seotud mao antrumi- või korpuselimaskesta atroofia arenguga. 
Aktiivse gastriidiga isikutel ning maolimaskesta H. pylori intensiivsema koloni­
satsiooni korral oli apoptoos rohkem väljendunud, iseäranis antrumis.
Gastriidi väljendusaste ja  H. pylori kolonisatsiooni aste on seotud epiteel­
rakkude proliferatsiooniga ning bcl-2 ekspressiooniga antrumi- ja  korpuse- 
limaskestas erinevalt. Rakuproliferatsiooni aktiivsus antrumis on negatiivses 
korrelatsioonis gastriidi raskusastmega, bcl-2 ekspressioon interstitsiaalkoe 
lümfotsüütides ei ole seotud gastriidi raskusega. Seejuures on korpuses prolife­
ratsiooni aktiivsus ja  bcl-2 ekspressioon seotud tugevasti gastriidi, mitte aga 
H. pylori kolonisatsiooni astmega. Gastriini- ning somatostatiinirakkude ja  H+,
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K+ ATPaasi reaktiivsete parietaalrakkude hulk vastavas maoosas sõltub pigem 
atroofia astmest kui H. pylori kolonisatsiooni tihedusest.
Uuringute tulemuste põhjal võib väita, et antrumis- ja  korpuselimaskesta 
atroofia tekib eri sagedusega (18-aastase longitudinaaluurimise põhjal antrumis 
11%, korpuses 35%). Kuigi nii antrumis kui ka korpuses oli atroofiline gastriit 
enam väljendunud CagA-positiivsetel isikutel, mõjutas CagA positiivsus atroo­
fia arengut korpuses rohkem kui antrumis. Gastriidi aktiivsus korpuses korre­
leerub rohkem kui antrumis CagA olemasoluga. Immuunvastus H  pylori 
kuumašokiproteiinile ja  sellega seotud muutused korreleeruvad rohkem krooni­
lise infiltratsiooniga antrumis kui ka korpuses. Samuti mõjutavad gastriidi 
raskus ja  H  pylori kolonisatsiooni tihedus rakuproliferatsiooni ja  bcl-2 ekspres­
siooni antrumis ja  korpuses erinevalt. Niisugune leid võib tähendada seda, et 
H. pylori infektsiooni tulemusena tekkiv immuunvastus on antrumi-ja korpuse- 
limaskestas erinev.
H  pylori, mis omab tugevalt immunogeenseid proteiine, nagu CagA, 
kuumašokivalk, kutsub esile maolimaskesta paikse immunvastuse, mis ilmneb 
nii akuutse kui ka kroonilise põletikureaktsioonina (gastriidi näol), samuti 
tekitab süsteemse seroloogilise immunvastuse. Seropositiivsus CagA proteiini 
suhtes võib olla gastriidi aktiivsuse ja  atroofia märgiks, võimaldades isegi prog­
noosida atroofia arengut, iseäranis korpuselimaskestas. Parietaalrakkude kana- 
liikulitega reageerivate antikehade korral võib oletada maokorpuse atroofiat, 
seropositiivsus H. pylori kuumašokivalgu suhtes aga võib olla kroonilise 
infiltratsiooni indikaatoriks, iseäranis antrumis. Seega, seropositiivsus erinevate 
H. pylori antigeenide suhtes võib peegeldada erisugused histoloogilisi muutusi 
antrumi ja  korpuse limaskestas. Seevastu apoptootiline indeks ei ole seotud 
atroofia arenguga, olles aga rohkem väljendunud gastriidi suurema aktiivsuse 
korral. Apoptootiline indeks antrumilimaskestas sõltub H. pylori kolonisatsiooni 
astmest.
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Heidi-lngrid Maaroos, Torkel Wadström* and Raivo Uibo
Objectives: Previous retrospective histological studies have revealed a Helico­
bacter pylori infection rate of 73-79%. Cross-sectional studies on H. pylori 
prevalence are still lacking in Estonia.
Design: A total of 1461 inhabitants between the ages of 15 and 95 years from 
the village of Karksi-Nuia and 497 between the ages of 50 and 91 years from 
Abja-Paluoja were examined for IgG antibodies to H. pylori. This study was 
performed on a quasi-global sample of the general adult rural population in two 
villages in southern Estonia.
Method: A cell-surface glycine extract of H. pylori strain NCTC 11637 was used 
as antigen in an enzyme-linked immunosorbent assay.
Results: IgG antibodies to H. pylori strain NCTC 11637 were detected in 
87.0±2.3% of the inhabitants of Karksi-Nuia and in 89.3±3.6% of those from 
Abja-Paluoja. IgG prevalence rates increased from 69.0±9.5% in the 15- to
19-year-old age group to 83.017.1% in the 20- to 29-year-olds (P<0.05).
Conclusion: We found an extremely high prevalence rate of H. pylori infection in 
this Estonian adult rural population. H. pylori infection was very prevalent among 
young people (aged 15-29 years).
European Journal of Gastroenterology & Hepatology 1994, 6:529-533
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Introduction
The strong association between Helicobacter pylori 
infection and chronic gastritis and peptic ulcer has 
been extensively documented [1,2]. Recently, several 
studies [3- 9] have observed a close relationship be­
tween H. pylori infection, chronic gastritis and gas­
tric cancer, thus, indicating a significant new area for 
investigations related to this microorganism.
In Estonia, the frequency of H. pylori has been stud­
ied retrospectively from gastric biopsy specimens in 
random samples, collected from the rural population 
of southern Estonia in 1972 (154 participants, 79% H. 
pylori-positive) and from the adult urban population 
of Kuressaare, the island of Saaremaa (227 partici­
pants, 73% H. pylori-positive) in 1979 [10,11].
The present study is a cross-sectional investigation 
of H. pylori seropositivity in an Estonian adult pop­
ulation. The frequency of histologically verified H. 
pylori infection is high in Estonia and serology is 
the most suitable indicator of the rate of infection 
in epidemiological studies [12-14].
For this purpose, representative populations from 
two southern Estonian villages were studied. This 
study was part of a large epidemiological investiga­
tion of several immunologically mediated diseases 
begun in 1990 in these two villages.
Methods
All inhabitants aged 15-95 years from Karksi-Nuia 
and those aged 50-91 years from Abja-Paluoja were 
invited to participate in this study. The response rate 
was 84% from Karksi-Nuia [1461 participants; 637
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men (median age 41 years), 824 women (median 
age 42 years)] and 77% from Abja-Paluoja [497 partic­
ipants; 189 men (median age 60 years), 308 women 
(median age 62 years)]. Serum samples were taken 
from all participants. Sixty-four subjects (28 men and 
36 women) from Karksi-Nuia were invited for further 
study and underwent gastroscopy because of ele­
vated serum IgA or IgG anti-gliadin antibody levels 
for diagnosis of coeliac disease. Although no cases 
of coeliac disease were diagnosed, four people were 
found to have peptic ulcer disease [15]. Two biopsy 
specimens were taken from the gastric corpus and 
the antral mucosa from all subjects. The results ob­
tained from the two villages were analysed sepa­
rately since the subjects participating in the study in 
Abja-Paluoja were older.
IgG antibodies to H. pylori were determined us­
ing an enzyme-linked immunosorbent assay (ELISA) 
with a cell-surface glycine extract of H. pylori strain 
NCTC 11637 as antigen [16,17]. The protein concen­
tration of both antigens was 5|ig/ml. A commercial 
human IgG (Kabi Pharmacia AB, Stockholm, Swe­
den) was used at a concentration of 100 units as a 
positive control for both antigens. The absorbance 
values were expressed as relative antibody activi­
ties (RAA) [16]. RAA values of 25 and over were re­
garded as positive [18]. The interassay variation in 
the assay using the antigen preparation from strain 
NCTC I I 637 was 13.5%; the intra-assay variation was 
5.0 + 1.73%.
The gastric biopsy specimens were stained using 
standard haematoxylin and eosin and Giemsa meth­
ods. The severity of H. pylori infection was evalu­
ated as follows: 0, absence of bacteria; 1, <20 per 
field; 2, 20-60 per field; 3, >60 per field [19]. Four to 
six fields were examined. An objective of 40x and 
an ocular with lOx magnification were used. If H. 
pylori colonization was patchy, the grade was clas­
sified according to the most pronounced grade of 
colonization. Changes in the mucosa were graded 
as follows: 0, normal mucosa; 0.5, slightly super­
ficial gastritis; 1, moderate; 1.5, severe round cell 
infiltration; 2, slight atrophic gastritis; 3, moderate;
4, severe atrophy of glands. This system for grad­
ing gastritis is comparable with the Sydney system, 
however, in the estimation of the grade of atrophic 
gastritis, the level of infiltration was not taken into 
account. The morphologic criteria used for discrimi­
nating between different grades of superficial and 
atrophic gastritis have been described in more detail 
elsewhere [19].
Each participant was questioned about the past and 
present history of gastric diseases, including peptic 
ulcer disease, as well as other illnesses, surgery and 
medications.
Statistical analyses were performed using the statis­
tical package Statgraphics. Tests included the Chi- 
squared test, the Student’s t-test and Spearman’s 
rank correlation test. This study was approved.by the 
Committee of Ethics at Tartu University.
Results
IgG antibodies to H. pylori strain NCTC 11637 were 
detected in 1271 (87.0±2.3%; median age 43 years) 
out of the 1461 subjects studied in Karksi-Nuia. The 
prevalence rates of antibodies to NCTC 11637 sig­
nificantly increased from 69.0 + 9.5% in those aged 
15-19 years to 83.0 ±7.1% in those aged 20-29 years 
0c2 = 9.26, P= 0.002), and to 89.0 ±7.7% in those 
aged 30-39 years (%2 = 4.1, P= 0.04). There was no 
significant difference between any of the older age 
groups CP>0.05; Table 1).
In Abja-Paluoja, 444 (89.3 ±3-6%) out of 497 (269 
women, 175 men; median age 6l  years) subjects had 
IgG antibodies to H.pylori strain NCTC 11637. There 
was no significant difference in the prevalence of H. 
pylori antibodies in the different age groups studied 
(Table 2).
Table 1. Age-specific prevalence rates of Helicobacter pylori antibodies to the NCTC 11637 strain in the Karksi-Nuia population.
Age distribution (%) No. H. pylori-positive (%)
Age group No. of _______________________  _____________________________________________________  Mean values
(years) subjects Men Women Total Men Women of RAA±SD
15-19 159 12 10 109 (69)* 54/74 (73) 55/85 (65) 51.7 + 35.8
20-29 184 13 12 152 (83)* 72/85 (85) 80/99 (81) 63.5±31.0
30-39 327 24 21 291 (89)* 138/153 (91) 153/174 (87) 71.4 + 58.5
40-49 275 17 20 247 (90) 99/108 (92) 148/167 (89) 71.7± 29.5
50-59 289 20 20 264 (91) 116/126 (92) 148/163 (91) 78.2±40.3
60-69 146 10 10 135 (92) 59/63 (94) 76/83 (91) 76.9 + 31.2
70-79 63 3 5 59 (94) 21/22(95) 38/41 (93) 73.9±31.2
80-89 16 1 1 13 (81) 4/6 (67) 9/10 (90) 56.0±27.0
90-99 2 0 1 1 (50) 0 1/2 (50) 69.5 ±48.5
Total 1461 100 100 1271 563/637 (88) 708/824 (86)
RAA, relative antibody activities. ’Significantly different (between those aged 15-19 and 20-29 years: x 2 = 9.26, P= 0.002; between those aged 
20-29 and 30-39 years: *2 = 4.1, p=0.04).
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Table 2. Age-specific prevalence rates of Helicobacter pylori antibodies to the NCTC 11637 strain in the Abja-Paluoja population.
Age group 
(years)
No. of 
subjects
Age distribution (%) No. H. pylori-positive (%)
Men Women Total Men Women of RAA + SD
50-59 200 48 35 182 (91) 82/90 (91) 100/110 (91) 72.5 + 29.7
60-69 191 33 41 170 (89) 59/63 (94) 111/128 (87) 72.5 ±31.7
70-79 86 15 19 75 (87) 27/29 (93) 48/57 (84) 75.1 ±33.3
80-89 19 4 4 16 (84) 7/7 (100) 9/12 (75) 69.9 ±29.8
90-99 1 0 1 1 (100) 0 1/1 (100) 40.0+0
Total 497 100 100 444 (89) 175/189 (92) 269/308 (87)
There was no statistically significant difference in H. pylori positivity between any of the age groups studied. RAA, relative antibody activities.
Table 3. A comparison of histological and serological results of Helicobacter pylori detection and the state of the gastric mucosa in the 64 
subjects who underwent gastroscopy.
Evalutation of H. pylori State of the gastric mucosa (grade)
Superficial Atrophic
Serology Histologyt Normal gastritis gastritis
IgG to NCTC 11637 (0) (0.5-1.5) (2-4) Total
Antral mucosa
- - 8 0 1 9
_ + 0 1 0 1
+ - 1 0 1 2
+ + 5 45 1 51*
Total 14 46 3 63*
Corpus mucosa
- 6 1 2 9
- - 1 0 0 1
+ + 0 2 0 2
+ - 9 35 6 50*
Total + 16 38 8 62*
‘ Determination of the state of the gastric mucosa was impossible due to inadequate size of biopsy specimens from the antrum in one subject 
and from the corpus mucosa in two others. tHistology for both the antrum and corpus.
There was a tendency towards a higher prevalence 
of H.pylori-positive subjects among men when com­
pared with women in each age group in both vil­
lages (Tables 1 and 2). The median age of men did 
not differ from that of women in either village (41 
and 42 years, respectively, for Karksi-Nuia, 60 and 
62 years, respectively, for Abja-Paluoja). The age dis­
tribution between men and women was not signifi­
cantly different (Tables 1 and 2).
A comparison of the results of serological and his­
tological H. pylori determinations, and the state of 
the gastric mucosa in the 64 participants from Karksi- 
Nuia subjected to endoscopy is presented in Table 3. 
As can be seen, there was a good agreement (95%) 
between the histological and serological findings for 
H. pylori. Disagreement was revealed in three sub­
jects only, two of whom were found to be H. pylori- 
positive on serology and negative on histology, and 
one histologically proven case had no IgG antibod­
ies to H. pylori. The histological absence or presence 
of /-/. pylori was the same in the biopsy specimens 
taken from the antrum and from the corpus mucosa.
The sensitivity of the ELISA test with the NCTC 11637 
strain antigen when compared with the results of
morphology was 98% (52 out of 53); the specificity 
was 82% (nine out of 11); the positive predictive 
value was 96%; the false-positive rate with NCTC 
11637 antigen was 18%, whereas the false-negative 
rate was 2%.
We found statistically significant correlations be­
tween the RAA values for the ELISA and the grade of 
H. pylori colonization when evaluated histologically 
as the sum of the grades in the antrum and corpus 
(r = 0.389; P~ 0.002). The grade of H. pylori colo­
nization in the antrum significantly correlated with 
scores of mucosal changes in the antrum (r = 0.482;
0.0001). H. pylori grades in the corpus corre­
lated with scores of mucosal changes in the corpus 
(r = 0.310; P -  0.015). No significant correlation was 
observed between the RAA values on ELISA and the 
severity of gastritis (a total score of antral and corpus 
gastritis; r = 0.220; P=0.08).
The follow-up studies, where H. pylori antibodies to 
NCTC 11637 strain were investigated twice within 6 
months, showed a concordance of results in 61 out 
of 64 subjects studied. There were also no significant 
differences between the RAA values in both serum 
samples (t= 1.89, P=0.06). In three subjects, the im­
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mune response to H. pylori strain NCTC 11637 was 
changed during the follow-up period. In two sub­
jects with antibodies to NCTC 11637 at the beginning 
of the study, the second blood sample was free of 
antibodies and there was no histological evidence 
of H. pylori colonization. One subject, originally 
antibody-negative, became seropositive for NCTC 
11637. The presence of H. pylori was also confirmed 
histologically.
Discussion
The present study revealed an extremely high fre­
quency (87.0 + 2.3%) of IgG antibodies to H. pylori 
in an Estonian population aged 15 years and over, as 
determined by an ELISA using a H. pylori standard 
strain NCTC 11637 antigen. Serum IgG antibodies to 
H. pylori are most frequently used for the diagnosis 
of H. pylori infection [12-14], These antibodies cor­
relate well with the persistence of H. pylori in the 
gastric mucosa [14,20]. This was confirmed by the 
present study, where only in three out of 64 subjects 
with a histological and serological evaluation of H. 
pylori infection, there was no concordance between 
the two methods.
Thus, 87.0±2.3% of the Estonian population is in­
fected with H.pylori. This is a higher H.pylori preva­
lence rate than that observed in previous studies per­
formed in Estonia [10,11] and is due to the use of 
the more sensitive serological method for the de­
tection of H. pylori in the present study. Hence, 
it can be concluded that Estonia is among those 
countries with a high H.pylori prevalence rate, such 
as Poland, and developing countries with poor so­
cioeconomic conditions [12,21-25]. In similar stud­
ies performed in areas with high H. pylori preva­
lence rates, there are always some individuals with­
out H. pylori infection, especially in the younger age 
groups [20,25].
In studies performed in several developed countries, 
it has been shown that until the third decade of life, 
H. pylori infection is uncommon and increases at 
approximately 1% per year [2,12,13,20,26-29]. So far, 
the prevalence of H. pylori infection in children in 
Estonia has been studied in 5- to 15-year-olds with 
abdominal complaints [30,31]. In 41-56% of the chil­
dren studied, H. pylori infection was detected histo­
logically or serologically, i.e. at almost the same fre­
quency as detected in the youngest age group in our 
study. Taking into account the opinion of Mitchel 
et al. [32] that the relative risk of a child acquiring
H. pylori infection is proportional to the prevalence 
of H. pylori in the adult population of childbearing 
age, we can assume that Estonian children easily 
acquire H. pylori from their parents; in the present 
study in those aged 20-29 years and 30-39 years, the
prevalence of H.pylori is 83.0±7.1 and 89-0±7.7%, 
respectively.
However, there are also a num ber of subjects with­
out H. pylori infection in the higher age groups. 
These subjects deserve special attention because 
presumably they have been in continuous con­
tact with H. pylori without developing an infection. 
There are several ways to explain this, but two pos­
sibilities are most likely: either the gastric mucosa of 
these persons is not suitable for H. pylori coloniza­
tion or their immune system cleans out the infection 
in its early stages. The unsuitability of atrophic gas­
tric mucosa for the persistent colonization of H. p y ­
lori in the stomach has been shown in several stud­
ies [7,33-35] and this may be a reason for H. pylori 
clearance in some of the older individuals. In others, 
genetically determined incompatibility between gas­
tric mucous glycoproteins and H. pylori might be of 
importance, but this is a field which has not been 
extensively studied to date. The lack of colonization 
in some individuals may also be explained by dif­
ferences in cell-surface adhesins of various H. pylori 
strains [36].
The fact that young Estonian people (aged 15-29 
years) already have a high prevalence of H.pylori in­
fection is of great importance because this is related 
to the possible early development of chronic gastritis 
with a high risk of gastric cancer [1-4,7,37,38]. In­
deed, chronic gastritis is very common in Estonia [39] 
and gastric cancer is a common form of carcinoma 
here, with an incidence rate of 37.0 for men and 18.6 
for women per 100 000 inhabitants in 1987 [40].
In conclusion, the serological evaluation of IgG an­
tibodies to II. pylori standard strain NCTC 11637 
among the rural population of southern Estonia 
showed an extremely high (87.0±2.3%) prevalence 
rate of II. pylori infection in the population studied.
That young Estonian people (aged 15-29 years) al­
ready have a high prevalence of H. pylori infection 
(69- 83%) is important for the possible development 
of chronic gastritis and risk of gastric cancer. How­
ever, in spite of a very high infection rate of H. p y ­
lori in this population, some of the subjects are still 
free of infection. To elucidate the reasons for this 
resistance, farther studies should pay more attention 
to the immune mechanisms and genetically deter­
mined differences of H. pylori receptor structures in 
the gastric mucosa.
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Abstract
Based on clinical studies, a negative association between Helicobacter pylori and autoimmune corpus gastritis is 
described. In the present investigation of an unselected population o f 1461 adults we can state, however, that there exists a 
relationship between H. pylori infection and the development of gastric corpus autoimmunity. As confirmation for the 
gastric autoantibody development through molecular mimicry, a high homology (72% in 25 amino acid overlap) between the 
beta subunit of H. pylori urease and that of H +  K +  ATPase, the gastric parietal cell autoantigen, was revealed.
Keywords: Helicobacter pylori; IgG antibody; Parietal cell antibody; Gastric autoimmunity; Chronic gastritis; Amino acid 
sequence
1. Introduction
There is a large amount of experimental and 
clinical data confirming that Helicobacter pylori is 
the major etiological factor in the development of 
both chronic non-immune (type B) gastritis and its 
important associates, duodenal ulcer and gastric can­
cer. On the contrary, few studies have been per­
formed so far to elucidate the role of H. pylori in 
autoimmune (type A) gastritis and, as a rule, only 
patients with pernicious anaemia have been studied
'  Corresponding author. Tel: (372) 7 476564; Fax: (372) 7 
430365; E-mail: raivo@imlab.ut.ee
[1,2], Pernicious anaemia, however, is characterised 
by deep atrophic gastritis which is not convenient for 
the existence of H. pylori [3], Therefore it is evident 
that, in order to get a more realistic picture about the 
role of H. pylori in gastric autoimmune processes, 
autoimmune gastritis should be investigated for H. 
pylori at much earlier stages. In clinical material this 
is not easy to do because uncomplicated autoimmune 
gastritis is an incidental finding [3]. Thus, the way to 
address the issue is to perform a study of a large 
unselected population group. For these reasons, the 
population of a small town, Karksi-Nuia, in Estonia 
was chosen for the present investigation (with the 
permission of the Committee of Ethics for Medical 
Investigations at the University of Tartu, Estonia).
0928-8244/95/$09.50 © 1995 Federation of European Microbiological Societies. All rights reserved 
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2. Materials and methods
All inhabitants of age 15 years or older of 
Karksi-Nuia were asked, by personal invitation let­
ters, to participate in the study. A total of 1461 
(84%) individuals, median age 43 years, 637 males 
and 824 females, responded. All the participants 
were informed about the content of the investiga­
tions, their subjective health status was interviewed 
and analysed in relation to their personal out-patient 
records, samples of a venous blood were taken for 
serological studies (stored at — 20° C), and, if neces­
sary, routine out-patient investigations were pre­
scribed.
As a marker of autoimmune (type A) gastritis 
[3,4], parietal cell antibodies (PCA) were determined 
by the indirect immunofluorescence method using 
unfixed cryostate sections from mouse stomach fun- 
dal region as an antigen. Rat kidney and liver sec­
tions were explored as controls. The dilution of the 
tested sera was 1:10 and fluorescein isothiocyanate- 
conjugated sheep anti-human immunoglobulin was 
used as the secondary antibody. Every set of tests 
contained a known PCA positive as well as a PCA 
negative serum. Other tissue antibodies 
(mitochondrial, smooth muscle antibodies) were ex­
cluded since they gave no reaction with control 
antigens [5],
The H. pylori infection was serologically verified 
by the enzyme-linked immunosorbent assay with a 
cell surface glycine extract of H. pylori strain NCTC 
11637 as an antigen [6]. This assay detects antibodies 
of IgG type and the results are in a high correlation 
(sensitivity 98%) with the presence of H. pylori in 
the gastric mucosa (unpublished). The test results 
were expressed in relative antibody activities (RAA), 
i.e. the ratio of the tested serum result in optical
density (OD) units to the positive control serum 
result in OD units considered equal to 100 units. If 
the RAA value for the tested serum was 25 or over, 
the test result was regarded as indicative of the 
presence of H. pylori.
The statistical analysis of the significance of the 
results was performed by x 2 and Fisher’s exact tests 
as appropriate.
3. Results and discussion
Our studies revealed PCA in 36 (2.5%) from the 
1461 individuals: in 22 females (2.7% from the 824 
females studied) and in 14 males (2.2% from the 637 
males studied), including a pair of close relatives (a 
mother of 42 years and her son of 17 years of age). 
He was the only person with PCA in the youngest 
group of the inhabitants studied (PCA frequency in 
this group was 0.3%). A continuous increase of the 
frequency of PCA was observed in the older age 
groups: at age 30-49 years it was 2.0%, at age 
50-69 years 4.1%, and among persons of 70 years 
and older it was 6.2%. None of the persons with 
PCA had any clinical signs of anaemia which could 
have indicated the possibility of pernicious anaemia. 
According to their case histories, no diagnoses of 
pernicious anaemia had been made before the study, 
but in one female, iron deficiency anaemia had been 
diagnosed and she had been receiving treatment for 
it during the last two years.
IgG antibodies to H. pylori were detected in a 
total of 1271, i.e. in 87% of the persons studied. The 
lowest percentage of H. pylori antibodies (76%) was 
revealed in the age group of 15-29 years, which 
differed significantly ( \ 2 — 28.47, P < 0.001) from 
the occurrence of these antibodies in the next age
Table 1
The distribution of parietal cell antibody (PCA) positivity among persons with and without Helicobacter pylori antibodies
Age groups (years)
15-29 30-49 50-69 >70
Studied PCA + Studied PCA + Studied PCA + Studied PCA.+
H. pylori positive 261 1 (0.4%) 538 6 (1.1% )a 399 15 (3.8%)a 73 4 (5.5%) *
H. pylori negative 82 0 (0%) 64 6 (9.4%) b 36 3 (8.3%) b 8 1 (12.5%) b
All 343 1 (0.3%) 602 12(2.0%) 435 18 (4.1%) 81 5 (6.2%)
a x 2 = 9.577; P =  0.008. b x 1 = 0.138; P  = 0.933.
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group of 30-49 years (89%). No statistically signifi­
cant differences of H. pylori antibody incidence 
were seen between the older age groups where H. 
pylori was detected in at least 90% of the persons 
studied (Table 1). Among the 36 PCA positive per­
sons, antibodies to H. pylori were detected in 26 (10 
males and 16 females, median age 60 years), whereas
10 (5 males and 5 females, median age 44 years) 
were seronegative for H. pylori. In 7 of the 10 
seronegative persons, antibodies to H. pylori were 
revealed in their family members (the family mem­
bers of the remaining three were not studied). A 
comparative analysis of the incidence of PCA among 
the H. pylori positive and H. pylori negative per­
sons showed an age dependency in the H. pylori 
positives above 30 years (Table 1). Thus, in the age 
group of 30-49 years, 1.1% of H. pylori positives 
have PCA in comparison to 3.8% and 5.5% in the 
next age groups (significant difference, x 2 ~  9.577, 
P = 0.008). In H. pylori negatives, the PCA inci­
dence was practically similar in three subsequent age 
groups, respectively 9.4%, 8.3% and 12.5% (non­
significant difference, x 2 — 0.138, P =  0.933).
As far as we are aware, this is the first study 
where the H. pylori and gastric autoimmunity inci­
dence has been analysed in a large population sam­
ple without participant selection. Thanks to the high 
participation rate in all main age groups (mean 84%), 
we were able to obtain material which should well 
describe the natural relationship between these two 
pathogenetically important parameters in chronic 
gastritis. In selected (clinical) material these relation­
ships could not be revealed because such selected 
material includes only a part of the patients with 
autoimmune gastritis due to absence of complica­
tions in its earlier stages.
Consequently, based on our results, we can state 
that there exists a relationship between the H. pylori 
infection and the development of gastric autoimmu­
nity. First, we could demonstrate a high coincidence 
of PCA and H. pylori antibodies which is not seen 
in patients with pernicious anaemia [1,2]. If not 
detected in persons with PCA, H. pylori was re­
vealed in those of their family members who were 
available for serological studies. It shows that the H. 
pylori seronegative persons, too, have also been 
exposed to H. pylori and are likely to have been 
infected with H. pylori at some point of their life. 
The fact that they were free from H. pylori during 
the study can be accounted for the existence of deep
gastric corpus atrophy most characteristic for au­
toimmune gastritis [3,5],
Secondly, starting from the age of 30 years where 
the H. pylori infection was revealed in 89-91% of 
the inhabitants, there was a significant age-dependent 
increase of PCA positivity among the H. pylori 
infected persons but not among the H. pylori nega­
tive ones suggesting that the long-lasting H. pylori 
infection might be an important factor for the devel­
opment of PCA. Accordingly, the longer the duration 
of the infection, the greater the possibility to develop 
PCA. Once developed, PCA will promote the atro­
phy of the gastric corpus mucosa through the im­
mune reaction toward its autoantigenic target [4]. 
During the due course of corpus atrophy, the gastric 
milieu becomes more and more unfavourable for the 
H. pylori colonisation until its total disappearance. 
Thus, we have reached the situation which is opera­
tive in the group of H. pylori negative and PCA 
positive persons. This is probably the group where 
pernicious anaemia appears in the part of persons 
who are under the influence of yet unknown genetic 
and immunological factors.
What could be the mechanism of induction of 
autoimmune reactions against the gastric mucosa by 
H. pylori infection? As in many other similar situa­
tions [7], molecular mimicry between some of the H. 
pylori antigens and the PCA autoantigen, gastric 
H + K +  ATPase [4], could be involved. To evaluate 
this possibility, we compared, by PROSIS micro­
computer software, all the known sequences of H. 
pylori proteins (EMBL release of March 3, 1994) 
with that of gastric H + K + ATPase. The highest 
homology (72% in 25 amino acid overlap) was 
revealed between the beta subunit of H. pylori ure­
ase and the beta subunit of H + K + ATPase includ­
ing 8 identical amino acids and 10 conservative 
replacements ([, identical amino acids; •, conserved 
substitutions):
H. pylori urease beta subunit
30 40 50
L I A E V E H D Y T I Y G E E L K F G G G K T L R
L M Q T I D P Y T P D Y Q D Q L K - S P G V T L R  
70 80
H + K + ATPase beta subunit
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Lower homologies (6-7 identical amino acids 
with some conservative replacements within 25 com­
parable amino acids) were revealed on many occa­
sions, including the already published homology with 
H. pylori vacuolating toxin [8]. Since urease is a 
common surface component of different strains of 
H. pylori as well as a putative virulence factor and 
immune reactions against H. pylori urease are uni­
versally seen in nearly all persons with H. pylori 
infection [9], we propose that immune reactions to 
urease trigger the autoimmune reactivity against H + 
K + ATPase in susceptible persons. To prove this 
hypothesis, concomitant antibody studies with both 
purified enzyme preparations as well as with the 
overlapping region of these enzymes need to be 
further performed in groups of persons with different
H. pylori and PCA states. Moreover, similar experi­
ments with activated T cells should also be per­
formed since cell-mediated immunity might be of 
primary importance in the development of gastric 
autoimmunity [4],
Taken together, our results suggest that PCA and 
autoimmune corpus gastritis development could be 
related to the gastric mucosal pathogen H. pylori. 
Although there have recently been a few other stud­
ies that have pointed to this possibility [10], much 
more molecule-oriented confirmative investigations 
are needed. We hope that the present report might 
provide some useful suggestions for analogous stud­
ies. As one can see from the review by Oldstone [7], 
such suggestions have led to a number of studies of 
different autoimmune diseases, some of which have 
produced valuable results for the understanding of 
disease pathogenesis, the relationship between Kleb­
siella pneumonia and ankylosing spondylitis being 
an example.
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CagA protein seropositivity in a random sample 
of adult population and gastric cancer patients 
in Estonia
Tamara Vorobjova®, Ingrid Nilssond, Karl Kullb, Heidi-lngrid Maaroos0, 
Antonello Covaccie, Torkel Wadströmd and Raivo Uibo3
Objective The prevalence of antibodies to CagA protein, 
associated with the risk of developing gastric cancer 
(GC), was studied in an Estonian adult population with a 
high prevalence of Helicobacter pylori (HP) infection and 
in a group df GC patients.
Design In a representative sample of a random adult 
population from the South Estonian town of Karksi-Nuia, 
containing 199 subjects (86 M, 113 F, mean age 42.4) 
and in 45 (22 M, 23 F, mean age 64.5) consecutive 
patients with gastric adenocarcinoma, recruited during 
the periods 1986-87 and 1995-96 in the Hospital of 
Oncology, University of Tartu, anti-CagA IgG antibodies 
were determined by enzyme-linked immunosorbent assay 
(ELISA) using a recombinant fragment of CagA protein. 
The occurrence of anti-CagA IgG in ELISA was compared 
with immunobkit results for 141 subjects.
Results Seropositivity to acid glycine extracted cell 
surface proteins of HP was 85% in the population and 
91% in GC patients (p =  0.39). Anti-CagA IgG antibodies 
were present in 63% of the population and in 87% of GC 
patients (p =  0.004). The highest prevalence of anti-CagA 
IgG in the population sample occurred in the age group
20-29 (76%). A comparison of anti-CagA positivity 
evaluated by using ELISA and immunoblot showed an 
agreement of results in 80% of cases.
Conclusion HP seropositivity was similarly high in the 
Estonian random adult population sample and in GC 
patients, however, the prevalence of anti-CagA IgG was 
Significantly higher in GC patients. Moreover, persons 
aged 20-29 years in the population possess the highest 
prevalence of anti-CagA IgG and should be given further 
attention with respect to the development of GC later in 
life.
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Introduction
There is much evidence that Helicobacter pylori (HP) is 
involved in the development of gastric cancer (GC) [1-6]. 
Infection with HP strains expressing the 128 kDa cyto- 
toxin-associated (CagA) protein constitutes a factor asso­
ciated with increased risk of the development of peptic 
ulcer disease and GC [7-17]. In a previous study we found 
a very high seroprevalence (87%) of HP in an Estonian 
adult population [18]. It is remarkable that population 
studies in both Kuressaare (1979) [19] and Karksi-Nuia 
(1990) [18] showed that 58-69% of young Estonians aged 
15-19 years are infected with HP and that there is a first 
significant peak (83%) of HP infection in the 20-29 year 
age group. This fact is of great importance as it is related 
to the possible risk of developing GC later in life [20, 
21]. Indeed, the incidence rate of stomach cancer for 
males and females in Estonia is higher than the average 
of the other European countries [22].
Taking into account the above facts, the aim of this 
study was to evaluate the prevalence of antibodies to a 
recombinant fragment of the CagA protein in a random 
sample of the Estonian adult population and to compare 
it with the presence of antibodies to CagA in GC 
patients. As an additional task, the presence of anti­
bodies to the CagA evaluated by using enzyme-linked 
immunosorbent assay (ELISA) was compared with the 
results of immunoblot.
Subj'ects and material
The study included 199 subjects (86 males, 113 females, 
mean age 42.4 years) forming a representative sample of 
adult population from the South Estonian town of Karksi- 
Nuia. We selected these subjects from 1461 persons (637 
males, 824 females, mean age 42.3 years) who had partici­
pated in and donated blood for our large seroepidemiolog-
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ical study the results of which were published elsewhere 
[I8J. In the latter study, 84% of all inhabitants of Karksi- 
Nuia were involved [18J. The relative proportion of 
males/females of different age was calculated on the origi­
nal material of 1461 samples and this proportion was 
extrapolated to a set of200 samples. According to these pro­
portions, serum samples from each age/sex group of the 
whole material were randomly selected by the computer. 
In the present study, 199 sera out of the 200 samples were 
available for the determination of HP and CagA status. 
Additionally, 45 consecutive patients (22 males, 23 
females, mean age 64.5 years) with gastric adenocarcinoma, 
operated on and diagnosed pathohistologically in the 
Hospital of Oncology, University of Tartu, and recruited 
during two periods, in 1986-87 and 1995—%, were studied. 
GC patients came from the town of Tartu and from South 
Estonian counties, including Karksi-Nuia. Serum samples 
from GC patients were collected before gastric surgery and 
were stored at -20 °C until assayed.
Adenocarcinoma was localized in the antrum in 14 cancer 
patients, in the corpus in 17 cases and in the antrum and 
corpus in 14 cases. The gastric carcinomas were classified 
histologically according to the Lauren system [23]. The 
intestinal type of adenocarcinoma was diagnosed in 18 
cases, the diffuse type in nine cases and the indetermi­
nate type in 14 cases; four cases were inoperable.
In order to compare the presence of IgG antibodies to 
CagA, using ELISA and immunoblot, 141 sera which 
included all 45 sera from GC patients, 52 sera from a 
representative population sample with borderline absorb­
ance values (OD 0.245-0.345) in CagA ELISA, nine sera 
from gastric and duodenal ulcer patients (all HP-positive 
in ELISA with glycine-extracted cell surface antigen) and
35 sera from children with abdominal complaints, treated 
in Tartu Children’s Hospital (10 HP-positives and 25 HP- 
negatives both in ELISA and morphologically) were con­
sequently analysed by immunoblot.
This study was approved by the Committee of Ethics ^t 
the University of Tartu.
Methods
ELISA
HP status was determined using a serological evaluation 
of IgG antibodies to HP (strain NCTC 11637) by ELISA 
as reported previously [18, 24]. Briefly, 0.5 |xg of acid 
glycine (pH 2.2)-extracted cell surface proteins per well 
were used for coating microtitre plates (NUNC, Roskilde, 
Denmark). The sera were diluted to 1:800; the second 
antibody was alkaline phosphatase-labelled anti-human 
IgG (DAKO, Glostrup, Denmark) which was diluted to 
1:500. The results were expressed by corrected mean 
absorbance values as a percentage of a reference standard 
(human 7-globulin, KABI/Pharmacia, Stockholm, Sweden).
The cut-off value for seropositivity was set to a relative 
antibody activity (RAA) of 25. Interassay variation was 
13%; intraassay variation was 5% [18].
Anti-CagA IgG were detected by ELISA using a recom­
binant fragment of the CagA antigen His-17/12 of the HP 
CCUG 17874 strain following the methodology, described 
by Xiang et al. [25], with modifications. In our study the 
recombinant CagA antigen was diluted in 0.1 mol/l 
carbonate buffer of pH 9.6 to a final concentration of
1.25{Ag/ml. Maxisorp Immunoplates (NUNC, Roskilde, 
Denmark) were coated with 100 jtl/well in duplicate and 
incubated for 16 h at 4°C, washed three times with PBS 
(pH 7.4) containing 0.5% Tween 20. The wells were sat­
urated with 200 fil/well of 1% bovine serum albumin 
(BSA) in PBS-Twccn at 37 °C for 2 h. After washing the 
plates three times, 100 (jlI of each serum sample diluted 
to 1:300 in 1% BSA-PBS was added to the wells in trip­
licate (two wells with an antigen and one without an anti­
gen) and incubated at 37 °C for 2 h. The plates were then 
washed three times and 100 pil/well of alkaline phos­
phatase-conjugated anti-human IgG (DAKO), diluted 
to 1:1000 in 1% BSA-PBS, was added and the plates 
were incubated at 37 °C for 1.5 h. After three washes, 
100 ^.I/well of a substrate solution containing p-nitro- 
phenyl phosphate (SigmaChemical, St. Louis, MO, USA) 
in dicthanolamine-MgClz buffer was added to each well 
and incubated at 37 °C for 30 min. Each plate contained 
a positive and a negative control scrum. Absorption was 
read at 405 nm. The absorption value derived from the 
mean value of absorption in two wells with antigen minus 
the absorption value in a well without antigen was taken 
as the absorbancc value of the studied sera. Instead of the 
cut-off0.250 OD, used by Xiang etal. [25], the absorbance 
value 0.300 (A 405 nm) was taken as the cut-off point in 
our study, based on the calculation of ELISA results, 
derived from the mean absorbance value of 25 HP- 
negative persons (histologically and serologically) plus 
two standard deviations, by using square root transforma­
tion [26]. Interassay variation was 11.5%.
Immunoblot
Sodium dodecyl sulphate polyacrylamide gel electro­
phoresis (SDS-PAGE) was performed using a Protean II 
Cell Vertical Electrophoresis equipment (Bio-Rad, 
Richmond, CA, USA). Glycine-extracted proteins from 
seven pooled antigen batches of HP strain NCTC 11637 
were separated in a gradient gel (5-20%) with a 5% 
stacking gel (acrylamide-bis 29:1, Bio-Rad) and were used 
for protein separation. The HP strain NCTC 11637 is 
known as a cytotoxic strain expressing CagA protein [27]. 
The antigen (140 fig/gel) was diluted four times in a 
sample buffer (0.5 mol/l Tris-HCI pH 6.8, 0.5% 
bromphenol blue, 8% glycerol, 4% SDS, 4% 2-mercapto- 
ethanol) and heated at 95 °C for 3 min. After cooling, the 
proteins were loaded on the gel and separated for 16 h at 
80 V. Molecular weight standards (Promega, Scandinavian
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Diagnostic Service, Falkenberg, Sweden), including 
proteins ranging from 14.3 to 97.4 kDa in size, were 
treated similarly.
The proteins were transferred electrophoretically to the 
Immobilon PVDF membrane (0.45 p-m, Millipore Inter­
tech, Bedford, MA, USA) using a semi-dry electro-blotrer 
equipment (Ancos, Vig, Denmark) for 1.5 h at a constant 
current of 0.8 mA/cm2.
The membrane was saturated by incubation for 2x15  min 
in blocking buffers I and II (from M. Rucheton, Orstom 
Laboratories, Montpellier, France) [28]. Saturated 
membranes were rinsed once for 10 min in a washing 
buffer and cut into strips. The strips were overlaid wjth 
sera diluted to 1:100 in a washing buffer under gentle 
agitation for 16 h at 4 °C. The strips were then rinsed for 
3 x 5  min. and incubated for 2 h at 4 “C with horseradish 
peroxidase-labelled ami-human IgG antibodies (DAKO) 
diluted to 1:600. After repeated rinsing, bound antibodies 
were detected by adding 50 mmol/1 sodium acetate buffer 
(pH 5.0) containing 0.04% 3-amino-9-ethylcarbazole 
(Sigma Chcmical) and 0.015% H2Oz. T he intensity of the 
stained bands obtained with patient sera was compared 
with that of the strip incubated with human 7-globulin 
(KABI/Pharmacia, Stockholm, Sweden) included as a cali­
brator in each analysis.
At analysing, special attention was paid to the presence 
of antibodies to the cytotoxin-associated high molecular 
protein band of 128 kDa.
Statistical analysis
Differences in HP status and in the prevalence of anti­
bodies to CagA between groups were tested by Yates’s 
corrected x2 test- Odds ratios (OR) with 95% confidence 
intervals (Cl) were estimated using Cochran-Mantel- 
Haenszel statistics with the SAS computer program to
examine the magnitude of the associations. Effects were 
considered to be statistically significant if the 95% Cl did 
not include the value 1.0.
Results
The prevalence of IgG antibodies to acid glycine- 
extracted cell-surface HP proteins was 85% (169/199) in 
a random adult population sample and 91% (41/45) in GC 
patients (Tabic 1), which was not significantly different 
(/> = 0.39).
Anti-CagA IgG were seen in 63% (126/199) of the popu­
lation sample. In GC patients the prevalence of anti-CagA 
JgG was significantly higher, 87% (39/45; p  = 0.004). HP- 
positive GC patients showed anti-CagA IgG reactivity in 
90% (37/41) of cases, whereas in the population sample 
71% of HP-positive persons (120/169) were CagA posi­
tive (p = 0.019) (Table I).
The OR for the association between HP infection and 
GC was 1.82 (95% Cl 0.61—5.39), which was not statisti­
cally significant, but we found significant association 
between CagA positivity and GC, where OR was 3.76 
(95% Cl 1.59-8.91).
In the population sample the highest prevalence of CagA 
antibodies was found in the 20-29 year age group: 19/25 
(76%) in all persons studied, 18/22 (82%) in persons 
defined as HP positive, which was statistically not 
different from the corresponding proportions in the other 
age groups (p *= 0.65, p  = 0.57, p  -  0.52, p  = 0.52, p  = 0.99, 
p  = 0.08 comparing with age groups 15-19, 30-39, 40-49, 
50-59, 60-69 and >70 years, respectively).
The difference in the prevalence of anti-CagA IgG 
between the corresponding age groups in the population 
sample and in GC patients (Table 1) was not statistically 
significant ip > 0.05 for groups 30-39 to 5*70 years).
Table i T h e  p re v a le n c e  o f  IgG  a n tib o d ie s  to  g ly cine-ex trac ted  ce ll- su rfa c e  p ro te in s  o f  H P a n d  to  a  
re c o m b in a n t fra g m e n t o f  C agA  p ro te in  in a  re p re se n ta tiv e  s a m p le  o f a d u lt  E s to n ia n  p o p u la tio n  a n d  
in g a s tr ic  c a n c e r  p a t ie n ts  _________________ _____________________
Subjects, age groups n HP+ CagA+ CagA+/HP+
Population
15-19 22 13/22 (59%) 11/22 (50%) 9/13 (69%)
20-29 25 22/25 (88%) 19/25 (76%) 18/22 (82%)
3IO-39 44 39/44 (89%) 28/44 (64%) 28/39 (72%)
40-49 38 34/38 (89%) 26/38 (68%) 24/34 (71%)
50-59 39 34/39 (87%) 24/39 (62%) 23/34 (68%)
60-69 20 17/20 (85%) 13/20 (65%) 13/17 (68%)
5s70 11 10/11 (91%) 5/11 (45%) 5/10 (50%)
Total 199 169/199 (85%)* 126/199 (63%)' 120/169 (71%)*
Cancer patients
30-39 2 2/2 (100%) 2/2 (100%) 2/2 (100%)
40-49 4 4/4 (100%) 4/4 (100%) 4/4 (100%)
50-59 6 5/6 (83%) 6/6 (100%) 5/5 (100%)
60-69 13 ! t/13  (85%) 10/13 (77%) 10/11 (91%)
70-79 20 19/20 (95%) 17/20 (85%) 16/19 (84%)
Total 45 41/45 (91%)" 39/45 (87%)" 37/41 (90%)“
Statistical comparison: * and *• X3 =  0.71; p  — 0.39; '  and n X’ =  8.1; p  =  0.004; 1 and M X: =  5.49; p —0.019.
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However, if only subjects aged 50 years and older from 
the population and GC patients were taken into account, 
a significant difference in the prevalence of anti-CagA 
IgG was revealed between the cancer group and the popu­
lation sample defined as HP positive (31/35 and 41/62, 
respectively; p  = 0.02; OR = 3.96; 95% Cl 1.24—12.5).
Anti-CagA positivity in GC patients’ sera with adenocar­
cinoma in the antrum region occurred in 11/14 cases 
(OR = 0.39; 95% Cl 0.08-1.87), in the corpus in 14/17 
(OR = 0.56; 95% Cl 0.11-2.67) and in the antrum and 
corpus in 14/14 (OR = 3.36; 95% Cl 0.39-28.5) cases (no 
significant difference; p  > 0.05). We did not observe a 
significant difference between the histological type of 
cancer and anti-CagA positivity. Anti-CagA IgG were 
found in seia from patients with intestinal adenocarci­
noma in 16/18 (OR = 1.39; 95% Cl 0.27-6.%) cases, in 
the diffuse type in 9/9 (OR = 1.80; 95% Cl 0. J9—16.9) 
cases and in the indeterminate type in 10/14 (OR ■= 0.17; 
95% Cl 0.03-0.86) cases {p > 0.05). All four inoperable 
cases with indeterminate rype of carcinoma were anti- 
Cag A positive.
A comparison of the occurrence of IgG antibodies to a 
recombinant fragment of CagA antigen, evaluated by 
ELISA, and to CagA protein in acid glycine extracted 
cell-surfaoe proteins of HP, evaluated by using 
immunoblot, both of which were performed cn 141 sera, 
is presented in Table 2. Anti-CagA positivity in ELISA 
was found in 79/141 (56%) cases and the CagA protein 
band was recognized in immunoblot in 90/141 (64%) 
cases. Disagreement of results occurred in 28/141 cases 
(20%). Nineteen ELISA-negative patients were posi­
tive in immunoblot and nine CagA ELISA-pos'tive 
patients were negative in immunoblot. ELISA and 
immunoblot showed an agreement of results in 113/141 
(80%) cases.
Discussion
In the present study we compared the prevalence of anti- 
CagA antibodies in an adult random population sample 
with a high prevalence of HP antibodies and in GC 
patients using a recombinant fragment of the CagA 
antigen by ELISA.
The prevalence of anti-CagA antibodies in a random adult 
population in Estonia was 63% and anti-CagA positivity 
among HP-infected persons was 71%, which is signifi­
cantly higher (x2 ** 61.3, p  = 0.000) than the average CagA 
seropositivity (49%) of 17 populations evaluated by the 
Eurogast Study Group [29]. Anti-CagA positivity in our 
GC group was significantly higher than in the population. 
This result confirms carliei data regarding the higher 
percentage of serological recognition of the cytotoxin asso­
ciated 128 kDa HP protein in GC patients when 
compared with control subjects [6, 12, 13, 30], Our data 
on seropositivity to glycine-extracted cell surface proteins 
of HP in GC patients and in the random population 
sample showed no significant difference. This finding is 
in accordance with a recent study by Klaamas et al. [31 ] 
which shows that overall HP seropositivity for blood 
donors and for GC patients did not differ significantly in 
Estonia.
Using reported data on the increasing prevalence of HP 
antibodies with age (20], wc discussed the possible influ­
ence of age on anti-CagA prevalence in the group of 
elderly GC patients. A significant difference in the preva­
lence of anti-CagA IgG between the cancer group and 
controls was found when only subjects aged 50 and older 
in the population sample were taken into account. Based 
on the data of Crabtree et al. [12] that 120 kDa protein 
recognition did not vary with age in GC patients and on 
the recent data of the Eurogast Study Group concerning 
similar CagA positivity for age groups 25-34 and 
55-64 years in 17 studied populations [29], we considered 
that the higher prevalence of CagA antibodies in GC 
patients was not influenced by the age difference between 
the GC group and the population as a whole. This is 
supported also by a significant associa jo r  (OR « 3.%; 95% 
Cl 1.24—12.5) between CagA positivity and GC in HP- 
positive persons aged 50 and older.
It is notable that 20-29-year-old persons in the Estonian 
population seem to have the highest prevalence of CagA 
antibodies and that CagA positivity among HP-positive 
persons is the highest also in this age group. In our 
previous random population study [18], the first statisti­
cally significant increase in antibodies to glycine-extracted
Tabte 2 C o m p a riso n  o f  IgG a n tib o d y  re s p o n s e  to  a  re co m b in an t fra g m e n t o f  C agA  p ro te in  (ELISA) a n d  to  
C agA  p ro te in  o f  a d d  g ly d n e -e x tra c te d  cell s u r f a c e  p ro te in o f  H P ( im m u n o b lo t)______________
CagA protein band Agreement of results 
CagA positrvny recognition in (both positive, Disagreement
Sera studied n in ELISA immunoblot or both negative) of results
Karksi-Nuia Population sample 52 17/52 (35%) 25/52 (48%) 35/52 17/52
Gastric cancer 45 39/45 (87%) 44/45 (98%) 40/45 5/45
Peptic ulcer 9 9/9 (100%) 8/9 (89%) 8/9 1/9
Children HP- 25 5/25 (20%) 4/25 (16%) 22/25 3/25
Children HP+ 10 9/10 (90%) 9/10 (90%) 8/10 2/10
Total 141 79/141 (56%) 90/141 (64%) 113/141 (80%) 28/141 (20%)
CagA seropositivity in Estonian population Vorobjova et al. 45
ccll surface proteins of HP (83%) was demonstrated in 
the 20-29 year age group. Also, according to another 
Estonian population study carried out in Kuressaare [19], 
the morphological evaluation of HP infection showed the 
first significant increase in HP posicivicy (83%) in the age 
group 20-29 years. Taking into account the evidence that 
CagA-positive strains nearly doubled the risk of devel­
oping GC over the ensuing 21 years [13], we suggest that 
young people (aged 20-29 years) with a high prevalence 
of CagA antibodies may be infected with a CagA-positive 
strain and therefore may have a higher risk of developing 
GC later in life.
A comparison of the evaluation of antibodies to the CagA 
protein in sera using both ELISA and immunoblot 
fhowed that the results of these tests agreed in 80% of 
cases. This is comparable to the results of the study by 
Xiang etat. [25], where the agreement between the results 
in ELISA (using a recombinant fragment of CagA) and 
immunoblot (using total HP extract as an antigen) was 
85% for positive cases. The cause of the 20% disagree­
ment between the results in ELISA and immunoblot in 
our study may be due to the fact that in our CagA ELISA 
we used a recombinant CagA fragment (37.5 kDa fused 
protein) as an antigen [25], whereas in immunoblot 
glycine-extractcd cell surface protein was employed. 
Therefore, it is not precluded chat some sera containing 
antibodies to the fragment of CagA protein may not 
have reacted with the entire 128 kDa protein owing to 
configuration differences between these two antigenic 
targets and, vice versa, epitopes in the recombinant 
fragment of the CagA protein were not recognized by 
some sera reacting with the entire 128 kDa protein. It is 
possible that in immunoblot sera react with CagA proteins 
through a different spectrum of epitopes compared with 
that in ELISA, which renders immunoblot more sensi­
tive [32],
The overall good agreement between the results in the 
anti-CagA-ELlSA and immunoblot in our study indicates 
that the use of a recombinant fragment of CagA protein 
in ELISA might prove a useful tool for the evaluation of 
CagA status, especially in epidemiological studies.
Conclusion
This study has shown chat HP seropositivity was simi­
larly high in an Estonian adulc random populacion sample 
and in GC patients, whereas the prevalence of anti-CagA 
IgG was significantly higher in GC pacients chan in the 
random population sample studied (87% versus 63%; 
OR = 3.76; 95% Cl 1.59-8.91). Persons aged 20-29 years 
in the population with the highest prevalence of anci- 
CagA IgG should be given further atcention with respect 
to the development of cancer later in life. A comparison 
of the evaluation of IgG antibodies to CagA ELISA and 
immunoblot showed good agreement of results.
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Seropositivity to Helicobacter pylori and CagA protein in 
schoolchildren of different ages living in urban and rural 
areas in southern Estonia
Tamara Vorobjova3, Heli Grünbergb, Marje Oonac, Heidi-lngrid Maaroosc, 
Ingrid Nilssond, Torkel Wadström0, Antonello Covaccie and Raivo Uiboa
Objective To evaluate Helicobacter pylori and CagA 
seropositivity in a non-selected group of schoolchildren in 
southern Estonia, with reference to previous studies where 
high seroprevalence to H. pylori (87%) and anti-CagA 
positivity (63%) in an adult population from the same 
region were found.
Study population A total of 421 schoolchildren selected 
haphazardly from a random population (n =  1018, ages 9, 
12 or 15 years) and living in urban or rural areas.
Methods H. pylori status was determined by evaluation of 
IgG antibodies against cell surface proteins of H. pylori, 
strain CCUG 17874, using standard ELISA. Anti-CagA IgGs 
were determined by ELISA using a recombinant fragment 
of CagA (CCUG 17874) as solid-phase antigen. 
Absorbance values > 0.3 (405 nm) were taken as a CagA- 
positive result based on a study of 25 sera from H. pylori- 
negative children.
Results Of the 421 subjects, 235 (56%) were H. pylori- 
ELISA positive, and 109 out of the 235 (46%) were anti- 
CagA positive. Neither H. pylori nor CagA positivity were 
significantly different in girls and boys, or in children aged 
9,12 or 15 years. The H. pylori prevalence rate (118/181,
65%) as well as CagA positivity (64/181, 35%) in rural 
areas were higher compared with those in towns (117/240, 
49% and 54/240,22%, respectively; P= 0.001 and 
P= 0.005).
Conclusion Of schoolchildren living in southern Estonia, 
56% were seropositive to H. pylori. Half of them had anti- 
CagA antibodies. Schoolchildren living in rural areas were 
infected significantly more often with CagA-seropositive 
strains compared with those living in towns. Eur J 
Gastroenterol Hepatol 12:97-101 ©2000 Lippincott 
Williams & Wilkins
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Introduction
There is ample evidence that Helicobacter pylon is the 
main cause of chronic gastritis and is involved in the 
development of gastric cancer [1—4]. Infection with H. 
pylori strains expressing cytotoxin-associated CagA pro­
tein complex is more virulent and is associated with 
increased risk. of development of atrophic gastritis, 
peptic ulcer disease and gastric cancer [5-8]. Acquisi­
tion of the infection in childhood appears to be a risk 
factor for gastric cancer [9-12].
Considering the high prevalence of H. pylori (87%) and 
of anti-CagA seropositivity (63%) in the adult popula­
tion from a region of southern Estonia in our previous 
studies [13,14], the aim of this study was to evaluate H.
The study was presented in part at the Xlth International Workshop on 
Gastroduodenal Pathology and Helicobacter pylori, Budapest, 2 -5  September 
1998 (Abstract A76) and at the World Congress of Gastroenterology, Vienna, 
Austria, 6 -11  September 1998 (Abstract ExhB3302).
pylori and CagA protein seropositivity in a non-selected 
group of schoolchildren of different ages and places of 
residence in southern Estonia.
Methods
Subjects
A cross-sectional study of schoolchildren was carried 
out from Autumn 1993 to Spring 1996 in five southern 
Estonian counties. Twenty secondary schools were 
selected assuming that they were of similar size in each 
county. Within each school, children were selected 
randomly from the school roll, and every third 9-, 12- 
and 15-year-old child was afforded an opportunity to 
participate. The overall response rate of 78% yielded a 
total of 1074 children who agreed to participate in the 
study. However, 56 of these children were excluded for 
the following reasons: absence from school on the day 
of the study (16 children), chronic disease (diabetes, 
asthma, etc.; seven children), reluctance to undergo
0 954-691X © 2000 Lippincott Williams & Wilkins
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blood sampling despite prior agreement (13 children), 
and inadequately completed questionnaires (20 chil­
dren). The final group of 1018 children made up almost 
10% of the children living in this region: 319 aged 9 
(154 boys and 165 girls, age range 8.5-9.6 years), 343 
aged 12 (160 boys and 183 girls, age range 11.5- 
12.6 years) and 356 aged 15 (155 boys and 201 girls, age 
range 14.5-15.6 years). The investigated children were 
all ethnic Estonians.
A further random selection was performed among the 
1018 children to reduce the study size, resulting in a 
total of 421 children (231 girls, 190 boys) from whom 
serum samples were tested and analysed. The distribu­
tion of the studied 421 schoolchildren according to age, 
gender and place of residence is presented in Table 1.
The Committee of Ethics at the University of Tartu 
approved the study.
Procedures
The serum samples collected from the children were 
stored at —20°C until assayed.
H. pylori status was determined using a serological 
evaluation by ELISA of IgG antibodies to H. pylori 
(strain CCUG 17874) as reported previously [13,14]. 
Briefly, 0.5 fig of acid (pH 2.2) glycine-extracted cell- 
surface proteins per well was used for coating microtitre 
plates (NUNC, Roskilde, Denmark). The studied sera 
were diluted 1:800; the second antibody was alkaline 
phosphatase-labelled anti-human IgG (DAKO, Glos­
trup, Denmark) diluted 1:500. ELISA results were 
expressed as the corrected mean absorbance values as a 
percentage of the reference standard (human 7-globu­
lin, Pharmacia & Upjohn, Stockholm, Sweden). The 
absorbance values were expressed as relative antibody 
activity (RAA) [15]. RAA =  25 was taken as the cut-off 
value for seropositivity, derived from the mean value of 
RAA units plus two standard deviations in 39 histologi­
cally H.pylori-negative children (median age 11) endo­
scoped because of abdominal complaints in Tartu 
Children’s Hospital. Inter-assay variation was 13% and 
intra-assay variation was 5%.
Anti-CagA IgG were detected by ELISA using a
recombinant fragment of the CagA antigen His-17/12 
of H. pylori strain CCUG 17874 following the modified 
methodology of Xiang etal. [16], The recombinant 
CagA antigen was diluted in 0.1 mol/l carbonate buffer 
with pH 9.6 to a final concentration of 1.25 Jig/ml. 
Maxisorp Immunoplates (NUNC, Roskilde, Denmark) 
were coated with 100 pJ/well in duplicate and incubated 
for 16 h at 4°C, then washed three times with phos­
phate-buffered saline (PBS, pH 7.4) containing 0.05% 
Tween-20. The wells were saturated with 200 |xl/well 
of 1% bovine serum albumin (BSA) in PBS-Tween at 
37°C for 2 h. After washing the plates three times, 
100 fil of each serum sample diluted to 1:300 in 1% 
BSA-PBS was added to the wells in triplicate (two 
wells with the antigen and one without the antigen) 
and incubated at 37°C for 2 h. The plates were then 
washed three times, and lOOjil/well of alkaline phos­
phatase-conjugated anti-human IgG (DAKO), diluted 
to 1:1000 in 1% BSA-PBS, was added, and the plates 
incubated at 37°C for 1.5 h. After three washes, 100 (xl/ 
well of a substrate solution containing />-nitrophenyl 
phosphate (Sigma Chemical Co., St Louis, Missouri, 
USA) in a diethanolamine-MgCl2 buffer was added to 
each well and incubated at 37°C for 30 min. Each plate 
contained a positive and a negative control serum. 
Absorption was measured at 405 nm. The absorption 
value derived from the mean value of absorption for 
two wells with the antigen minus the absorption value 
for the well without the antigen was taken as the 
absorbance value of the sample. Rather than the cut-off 
of 0.250 OD used by Xiang etal. [16], the absorbance 
value 0.300 (405 nm), based on the calculation derived 
from the mean absorbance value of the serum samples 
of 25 histologically and serologically H. pylori-negative 
children (median age 12) plus two standard deviations 
was taken as the cut-off point in this study, employing 
square root transformation method [17]. Inter-assay 
variation was 8%.
Statistical analysis
Differences in H. pylori status and in the prevalence of 
antibodies to CagA between various groups were tested 
by the %2 test. Odds ratios (OR) with 95% confidence 
intervals (Cl) were estimated using Mantel-Haenszel 
statistics with the Exact software (Exact v.2.0 ©  David 
D. Martin, 1988-1994) to examine the magnitude of
Table 1 D istribution of th e  s tu d ie d  schoo lch ild ren  (n  =  4 21 ) acco rd in g  to  a g e , g e n d e r  an d  
p lac e  o f re s id e n c e
Gender Place of residence
Age Girls Boys Town Village Farm Total
9 years 47 (50%) 47(50%) 39(42%) 35(37%) 20(21%) 94(22% )
12 years 78(53%) 69(47%) 78(53%) 51(35%) 18(12%) 147(35%)
15 years 106(59%) 74(41%) 123(69%) 33(18%) 24(13%) 180(43%)
Total 231 (55%) 190(45%) 240(57%) 119(28%) 62(15%) 421(100% )
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the association. Effects were considered to be statisti­
cally significant if the 95% Cl did not include the value
1. 0.
Results
The prevalence of IgG antibodies to acid glycine- 
extracted cell-surface H. pylori proteins in the studied 
schoolchildren was 56% (235/421). Anti-CagA IgG were 
found in 28% (118/421). Of the 235 H. /^/on-positive 
schoolchildren, 109 were CagA-positive (46%). Nine 
children negative to the glycine-extracted cell-surface 
protein in the H. pylori ELISA were positive in the 
CagA ELISA. The H. pylori and CagA seropositivity in 
ELISA in schoolchildren of different ages and places of 
residence in southern Estonia is presented in Table 2.
There was no significant difference in H. pylori and 
CagA positivity between girls and boys. Schoolchildren 
aged 9, 12 and 15 years revealed no significant differ­
ence in H. pylori status and CagA positivity either. A 
slight tendency to an increase in H. pylori and CagA 
positivity was observed in 12- and 15-year-old children 
compared with 9-year-old children (P > 0.05).
Schoolchildren living in rural areas (including both 
villages and farms) had a significantly higher H. pylori 
prevalence rate (118/181; 65%) as well as CagA positiv­
ity (64/181; 35%) compared with those living in towns 
(117/240 (49%) and 54/240 (22%), respectively) (P = 
0.001 for H. pylori prevalence rate and P =  0.005 for 
CagA prevalence rate). The odds ratio (OR) for the 
association between H. pylori infection and the place of 
residence in rural areas was 1.96 (95% Cl 1.32-2.92). 
We also found a significant association between CagA 
positivity and the place of residence in rural areas: 
OR =  1.88 (95% Cl 1.22- 2.88).
Discussion
In the present study, we determined H. pylori and 
CagA seropositivity in a non-selected group of school­
children aged 9, 12 and 15 years, who are living in 
neighbouring urban and rural areas in southern Estonia,
using cell-surface proteins of H. pylori and the recombi­
nant fragment of the CagA antigen in ELISAs.
The seroprevalence of H. pylori was 56%, which did 
not differ significantly from the histological finding of 
H. pylori (58%) among Estonian children with abdom­
inal complaints, obtained in a previous study [18]. 
According to literature data, the percentage of H. pylori 
infection in children, aged 9-15 years, without abdom­
inal complaints varies from 3% in Sweden [19], 8.3- 
16.7% in Germany [20], 11-23% in the Netherlands 
[21] and 16.7% in the UK [22] to 26% in Japan [23], 
36.8-68.4% in Turkey [24] and 34-52% in China [11]. 
Thus the seroprevalence of H. pylori in schoolchildren 
according to our study is higher than it is in most 
European countries.
The specific finding of the present study was that half 
of the H. />jf/ö77-positive schoolchildren living in south­
ern Estonia have anti-CagA antibodies. These children 
should be given further attention with respect to the 
development of gastritis, peptic ulcer or gastric cancer 
later in life, taking into account the association between 
infection with a cytotoxic strain of H. pylori and 
development of the above-mentioned diseases [5- 
8,25],
Literature data regarding CagA positivity in H. pylori- 
infected children (most studies being concerned with 
children with recurrent abdominal pain) reveal the 
presence of infection with cytotoxic strains in 28.5- 
80.6% of cases when using different methods for the 
investigation of CagA positivity such as ELISA, PCR 
and Western blot [26-34]. CagA positivity among 
asymptomatic children was 64% as evaluated by Elitsur 
and Neace [32] and 82.6% as evaluated by Karczewska 
et al. [33], which is higher than the prevalence rate 
found in our study. This might be explained by the use 
of other methods for the detection of CagA positivity in 
their studies, such as Western blot or another CagA 
antigen in ELISA.
We compared H. pylori as well as CagA prevalence in
Table 2 H. pylori a n d  C agA  serop o sitiv ity  in sch o o lch ild re n  of d iffe ren t a g e s  an d  in d iffe ren t p la c e s  o f re s id e n c e  in s o u th e rn  E sto n ia  
e v a lu a te d  by ELISA
Gender Age (years) Place of residence
Girls Boys 9 12 15 Town Village Farm Total
Number of persons 
H. pylori- positive 
CagA-positive 
CagA-positive in 
H. py/on-positive sera
231 
127 (55%) 
71 (31%) 
65 (51%)
190 
108 (57%) 
47 (25%) 
44 (41%)
94 
46 (49%) 
20(21%) 
19 (41%)
147 
81 (55%) 
40 (27%) 
39 (48%)
180
108 (60%) 
58 (32%) 
51 (47%)
240 
117* (49%) 
54 ' (23%) 
47 (40%)
119 
79 (66%) 
42 (35%) 
40 (51%)
62 
39 (63%) 
22 (35%) 
22 (56%)
421
235 (56%; 95%CI 51.3-60.7) 
118* (28%; 95% Cl 23.8-32.3) 
109 (46%; 95% Cl 39 .8-52.2)
* P =  0.01 compared with village residents, P =  0.04 compared with farm residents. * P =  0.009 compared with village residents, P  =  0.03 compared with farm 
residents.
*Nine sera were negative to cell-surface proteins in ELISA but positive in CagA ELISA.
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healthy schoolchildren living in the urban and rural 
areas of the same geographical region. It was found that 
children living in rural areas (in villages and farms) 
were more often infected with H. pylori and with 
cytotoxic strains. In a study by Mitchell et al. [35], a 
significantly higher prevalence of H. pylori was found 
in a city in southern China compared with that in rural 
areas. However, this difference was found in children 
aged 0-5  years. In the study by Elitsur and Neace [32], 
the prevalence of CagA-positive H. pylori strains in 
asymptomatic children of West Virginia was 64%, and 
the location of the community (urban/rural) did not 
influence significantly the distribution of CagA-positive 
strains. Thus, literature data do not substantiate the 
tendency observed in the present study.
The fact that children living in rural areas had a higher 
seroprevalence of H. pylori and anti-CagA antibodies 
might hypothetically be explained by the use of differ­
ent water sources (i.e. external ones) in farms compared 
with urban households. Klein etal. [36] showed that 
children living in homes with external water sources 
were three times more likely to be infected with H. 
pylori compared to households with internal water 
sources.
Comparison of H. pylori and CagA prevalence in the 
age groups of 9, 12 and 15 years showed only a 
tendency to increase in positivity with age in our study. 
The literature indicates that a major proportion of H. 
pylori infection is acquired in early childhood [9,35-40], 
Based on a three-year follow-up of Estonian children 
from birth, Lindkvist et al. [41] found very high 
seroconversion rates during the children’s first years of 
life: first year 27%, second year 25%, third year 12%. 
The sharpest rise of antibodies to H. pylori in Sweden 
appears between 9 and 10 years of age (20%) [42]. In a 
study by Graham etal. [9], it was shown that the 
prevalence of H. pylori infection was stable during a 
variable period in late childhood but increased in early 
adulthood. According to Sipponen etal. [43,44], H. 
pylori gastritis is acquired in childhood and adolescence 
(age less than 20) in more than 50% of cases. In the 
present study, half of the schoolchildren in the first 
decade of life were infected with H. pylori and half of 
these possessed cytotoxin-producing strains.
Taking into account the results of our previous study 
[14] on H. pylori and CagA prevalence in a random 
sample of adults from a region of southern Estonia, it is 
evident that children are less infected with cytotoxic 
strains compared with total prevalence in the random 
sample of adults (46% versus 71%; P =  0.000008). 
However, our previous study [14] showed that 59% of 
young people aged 15-19 years were infected with H. 
pylori, 69% of them being CagA-positive, which is not 
significantly higher compared with the values for 15-
year-old schoolchildren in the present study (P =  0.9 
for H. pylori status; P =  0.22 for CagA status).
According to the data of our previous studies, the first 
significant increase in H. pylori positivity in adults was 
shown to occur at the age of 20-29 years (88% in a 
Karksi-Nuia population and 83% in a Kuressaare popu­
lation study) [13,45], CagA positivity among H. pylori 
positive persons was also the highest (82%) in this age 
group [14]. It is possible that young people in Estonia 
achieve a high seroprevalence of H. pylori, including 
infection with cytotoxic strains, during the third decade 
of life. However, this fact needs to be confirmed during 
a prospective study of H. pylori incidence in the group 
of the studied schoolchildren. The cohort effect also 
should be taken into account [44], In an extensive sero- 
epidemiological study of H. pylori infection in various 
populations, Megraud etal. [46] showed that in France 
only 3.5% of children were infected in the first decade 
of life. In the second decade, H. pylori prevalence 
increased to 16.3%, and to 24.8% in the third decade, 
which is however a markedly lower percentage com­
pared with our results.
Conclusion
This study showed that 56% of schoolchildren in south­
ern Estonia had H. pylori infection and 46% of these 
were anti-CagA-positive. Neither H. pylori nor CagA 
positivity was significantly different in girls and boys, or 
in children aged 9, 12 or 15 years. The H. pylori 
prevalence rate and CagA positivity were significantly 
higher in children living in villages and farms compared 
with those living in towns. Children with anti-CagA 
antibodies should be given further attention with 
respect to the development of atrophic gastritis, peptic 
ulcer or gastric cancer later in life.
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A B S T R A C T ____________________________________
Background. Previous morphological and serological 
studies of gastric Helicobacter pylori (H. pylori) coloni­
zation among Estonian children with abdominal com­
plaints, as well as among populations of schoolchildren, 
have shown a high prevalence of H. pylori (49-60%). 
Based on published data concerning the high specificity 
and sensitivity of immunohistochemical detection of H. 
pylori, we examined the prevalence of H. pylori in gas­
tric biopsy specimens of Estonian children by different 
localization and morphological type of gastritis com­
paring Giemsa staining with immunohistochemistry. 
Material and Methods. Formalin-fixed biopsies (107 an­
tral, 108 corpus mucosa) of 112 children (41 boys, 71 
girls, age range 1-16 years, median age 12 years) with 
abdominal complaints were stained with hematoxylin 
Sc eosin and Giemsa stains, as well as examined using 
the peroxidase antiperoxidase (PAP) method with poly­
clonal antibodies to H. pylori.
The prevalence of H elicobacter pylori (H. p y ­lori) infection in Estonian children is high. 
Over 50% of children are affected based on either 
histological [1] or serological [2] methods.
Several studies have reported on immunohis­
tochemical methods using polyclonal or m ono­
clonal antibodies to H. pylori for identification of 
this agent in biopsy specimens and documented 
their high specificity and sensitivity [3-9]. Immu­
nohistochemistry allows the detection of even sin­
gle bacteria and to identify the coccoid form of H. 
pylori [5,9]. However, Negrini et al. [10-12] dem­
onstrated that some of the monoclonal antibodies 
against H. pylori cross-react with epithelial cells of 
the human and murine gastric mucosa; this and
Reprint requests to: Tamara Vorobjova, University of 
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Results. Gastritis of any degree and localization was 
found in 84/112 (75%) children. Using Giemsa staining 
H. pylori were detected in 83/112 (74%) of all children, 
and by use of the PAP method in 55/112 (49%) 
(p = .001). Concordance of the results of immunohis­
tochemical and Giemsa methods in antrum biopsies 
was 70%, in corpus biopsies 73%. In 12 out of 108 
(11%) corpus mucosa specimens a positive staining 
with anti-H. pylori IgG was localized in the cytoplasma 
of corpus mucosal cells in the neck part of the glands. 
Conclusions. The prevalence of H. pylori was higher 
when employing the Giemsa stain in comparison with 
immunohistochemistry. Antibody reactivity of cells in 
the neck part of the corpus glands may either be due to 
cross-reactivity of anti-H. pylori IgG with epithelial cell 
epitopes, or to internalization of H. pylori by these 
cells, suggesting a pathogenic role of neck cells in an 
anti-H. pylori immune response.
other groups therefore suggested a possible role of 
H. pylori to induce autoantibodies involved in the 
progression of chronic gastritis [12-16],
The aim o f the present study was to assess the 
prevalence o f H. pylori in gastric biopsies o f chil­
dren as a function of gastritis type and of gastric 
anatomical site. In addition, we compared the effi­
cacy of H . pylori detection based on Giemsa stain­
ing with that o f immunohistochemistry. Thirdly, 
we examined the reactivity o f polyclonal antibod­
ies to H . pylori in the cytoplasm of antral and cor­
pus epithelial cells.
Subjects, Materials and Methods 
One hundred twelve children (41 boys and 71 
girls; age range 1 -16  years, median age 12 years) 
with abdominal complaints defined according to 
Apley’s criteria [17] and endoscoped in Tartu 
Children’s Hospital, were studied.
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Two biopsy specimens each from antral and 
corpus mucosa were taken. In 4 children only bi­
opsy specimens from antrum and in 5 children 
only specimens from corpus mucosa were exam­
ined due to inadequate size of specimens. Formalin- 
fixed, paraffin-embedded biopsy specimens (107 
from the antral and 108 from the corpus mucosa) 
were stained with hematoxylin and eosin for as­
sessing type and grade of gastritis. Parallel sec­
tions were either stained with Giemsa or processed 
for immunohistochemistry (see below).
Gastric mucosa was graded as normal or as 
showing superficial or atrophic gastritis [18]. The 
severity of H. pylori colonization in Giemsa-stained 
sections was graded as follows: 0 (absence of bacte­
ria); 1 (< 2 0  per field); 2 (20-60  per field); 3 (> 6 0  
per field) [18]. Four to six fields were examined 
per specimen (X40 objective, X10 eyepiece) by 
one investigator (H.-I. M.). The section was re­
garded as H. pylori positive by detection of H. p y ­
lori colonization of grade 1 or more.
Immunohistochemical Detection of H. pylori 
Formalin-fixed, paraffin-embedded biopsy speci­
mens were studied using the peroxidase-antiper- 
oxidase (PAP) method. After deparaffinization, 
tissue sections 5 |xm thick were pretreated with
0.1% trypsin (Spofa, Praha, Czech Republic) dur­
ing 15 min at 37°C and with hydrogen peroxide in 
methanol (30 min at 20°C) to prevent nonspecific 
reactions. As primary antibodies rabbit anti-H. 
pylori polyclonal antibodies (anti-H. pylori IgG; 
DAKO, Glostrup, Denmark) were used (dilution: 
1:50; incubation overnight at 4°C). Sections from 
the same biopsy specimens incubated without pri­
mary antibody served as negative controls. As sec­
ondary antibody swine-anti rabbit IgG (DAKO) was 
used (dilution: 1:100; incubation 1 hour at 20°C), 
followed by incubation with peroxidase antiper­
oxidase rabbit complex (DAKO; dilution: 1:500; 
incubation 1 hour at 20°C). Binding of specific an­
tibodies was visualized using 3,3- diaminobenzi- 
dine tetrahydrochloride (DAB; Sigma, St. Louis, 
M O, USA). Sections were counterstained with he­
matoxylin and examined by one investigator (T.V.) 
without knowing the results of gastritis grading 
and the results of H. pylori positivity, based on 
Giemsa preparations. The entire surface of all sec­
tions present on the slide was examined. The 
staining was considered positive if brown-stained 
organisms of typical shape were seen on the lumi­
nal surface o f corpus or antrum glands. Addition­
ally, we assessed immunostaining of antral or cor­
pus epithelial cells with anti-H. pylori IgG.
Statistical analyses were performed using the %2 
test. The study was approved by the Committee of 
Ethics at the University of Tartu, Estonia.
Results
Gastritis of any degree and localization was found 
in 84/112 (75%) children with abdominal com­
plaints. Both antrum and corpus mucosa were 
available in 103 children. The most frequent topo­
graphical and morphological type o f gastritis was 
superficial gastritis localized simultaneously in an­
trum and corpus mucosa (47/103 or 45.6%  cases 
studied). Superficial gastritis restricted to antrum 
was seen in 30/103 (29%) cases, and superficial 
gastritis restricted to corpus in 3/103 (3%) cases. 
The prevalence of different states of gastric mucosa 
and of H. pylori positivity as detected using the two 
different methods are presented in Table 1.
H. pylori was detected by Giemsa staining in 83/ 
112 (74%) of children. Immunohistochemical as­
sessment of H. pylori using anti-H. pylori IgG re­
sulted in a significantly lower H. pylori yield (55/ 
112 or 49%; p  =  .001). Children with superficial 
gastritis, localized simultaneously in antrum and cor­
pus, were H. pylori-positive in 41/47 (87%) cases 
according Giemsa staining and in 31/47 (66%)
Table I H. pylori positivity found by Giemsa and 
immunohistochemical staining in children with 
topographically and morphologically different types of 
gastritis in antrum or/and in corpus mucosa
Topography 
of mucosa
Morphological 
type of mucosal 
change
No. of 
persons 
studied
H. pylori 
positivity 
using 
Giemsa 
staining
H. pylori 
positivity 
using 
anti- 
H  pylori 
IgG
Antrum normal
Corpus normal 21 S/21 2/21
Antrum superficial gastritis
Corpus normal 30 30/30* 19/30**
Antrum normal
Corpus superficial gastritis 3 2/3 1/3
Antrum superficial gastritis
Corpus superficial gastritis 47 41/47* 3l/47«
Antrum atrophic gastritis
Corpus normal 2 1/2 0/2
Antrum normal
Corpus — 3 1/3 1/3
Antrum superficial gastritis
Corpus — 1 I/I 0/1
Antrum —
Corpus normal 4 1/4 0/4
Antrum —
Corpus superficial gastritis 1 I/I I/I
Total 112 83/112 55/112
(74%)* (49%)«
*>**)> = .008;' > »f> = .01; * > = .001
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Table 2 Comparison of detection of H. pylori using Giemsa staining and anti-H. pylori polyclonal antibodies in antrum and 
corpus biopsy specimens in different morphological types of gastric mucosa
Topography 
of mucosa
No. of biopsy 
specimens studied Staining
Morphological type of gastric mucosa
Total H. pylori+ 
in biopsy 
specimens
Normal mucosa 
H. pylori+
Superficial gastritis 
H. pylori+
Atrophic gastritis 
H. pylori+
Antrum 107 Giemsa 8/27 (30%) 68/78 (87%)* Ml 77/107 (72%)»
107 anti-H. pylori IgG 4/27(15%) 46/78 (59%)** 0/2 50/107 (47%)»
Corpus 108 Giemsa 16/57 (28%) 37/51 (73%)t 0/0 53/108 (49%)*
108 anti-H. pylori IgG 13/57 (23%) 24/51 (47%)tt 0/0 37/108 (34%)»
*  >  ** p  =  .0007; * >  =  .008; ‘  >  «/> =  .001; < >  »f> =  -02
cases using anti-H. pylori IgG (p = .01). Children 
with superficial gastritis restricted to the antrum 
were all H. pylori-positive, based on Giemsa stain­
ing, whereas immunohistochemically only 19/30 
(63%) were H. pylori-positive (p =  .008).
Comparison of positive staining for H. pylori us­
ing the Giemsa method and anti-H. pylori IgG in 
antrum and corpus biopsy specimens in different 
morphological types of gastric mucosal change is 
presented in Table 2. In antrum and in corpus biop­
sies detection of H. pylori by use of Giemsa staining 
sections was superior to immunohistochemistry 
(77/107 or 72% vs. 50/107 or 47% in antrum; 53/ 
108 or 49% vs. 37/108 or 34% in corpus speci­
mens; p — .001 and p  -  .02, respectively). H. p y ­
lori were found more often in antrum (77/107; 
72%) than in corpus (53/108; 49%) biopsies 
(p = .005) using Giemsa staining. Immunohis­
tochemical evaluation resulted in a tendency for a 
higher prevalence of H . pylori in antrum than in 
corpus (50/107; 47% vs. 37/108; 34%; p  =  .06).
When comparing the results of H. pylori evalu­
ation using the two staining methods separately 
on antrum and on corpus biopsies of each patient, 
the concordance of H. pylori positivity in antrum 
mucosa was 45% , of H. pylori negativity 25% , 
whereas in corpus the concordance of H. pylori 
positivity was 34% , of H. pylori negativity 39%. 
(Table 3).
Among the 30 Giemsa-positive, immunostain- 
negative antrum samples, the bacteria grade as based 
on Giemsa-stained sections was as follows: grade 1 in
16 cases, grade 2 in 7 cases, and grade 3 in 7 cases. 
Among corpus biopsies, 19 cases were Giemsa- 
positive and immunostain-negative, and the respec­
tive bacteria grades as based on Giemsa-stained sec­
tions were grade 1 in 15 cases, grade 2 in 1 case, 
grade 3 in 3 cases. Thus, in antrum 16/30 (53%) and 
in corpus 15/19 (79%) of discrepant cases belong to 
the low Giemsa grade. Among antrum biopsies, 2 
were Giemsa-negative, immunostain-positive.
In 12 out of 108 (11%) corpus mucosa speci­
mens a positive staining with anti-H. pylori IgG 
was localized in the cytoplasma of corpus mucosal 
cells in the neck part of the glands. This staining 
was diffuse and affected mainly apical part of the 
cells. N o  H. pylori bacilli have been identified in 
cytoplasma of mucus neck cells. All negative con­
trols sections (incubated without primary antibod­
ies) were negative for such a staining (Figs. 1 and 
2). In 8 out of these 12 cases corpus mucosa was 
normal, whereas in 4 out of 12 cases superficial 
gastritis was found, and in 2 out of these 12 cases 
H. pylori were detected in Giemsa-stained sections.
Discussion
In the present retrospective study we compared 
the detection yield of H . pylori in antrum and cor­
pus mucosal biopsies of 112 children using two  
methods, Giemsa staining and immunohistochemis­
try. It turned out that H. pylori were more frequently 
found in Giemsa preparations than by immunohis­
tochemistry employing a polyclonal antibody di­
rected against H. pylori. The concordance of these 
two methods in detection of H. pylori in antrum 
biopsies was 70% , and in corpus biopsy sections 
concordance was 73%.
Table 3 Concordance in detection of H. pylori (HP) using 
Giemsa staining and anti-H. pylori IgG as compared separately 
in antrum and corpus biopsy specimens in the same person
Biopsy specimens Concordance
No. of cases in 
concordance
Antrum biopsy specimen 
Total
Corpus biopsy specimen 
Total
in H. pylori positivity
in H. pylori negativity
concordance
in H. pylori positivity
in H. pylori negativity
concordance
48/107 (45%) 
27/107 (25%) 
75/107 (70%) 
37/108 (34%) 
42/108 (39%) 
79/108 (73%)
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Figure I A positive staining with anti-H. pylori polyclonal 
DAKO antibodies localized in the cytoplasma of corpus mu­
cosa cells in the neck part of the glands, affected mainly apical 
part of the cells. (PAP method, X20 objective, XIO eye­
piece).
The observation that the most frequent mor­
phological and topographical type of gastritis in 
Estonian children with abdominal complaints is 
superficial gastritis simultaneously affecting an­
trum and corpus, supports the findings of a previ­
ous investigation [1], This type of gastritis was as­
sociated with H. pylori-positivity in our and the 
study of M aaroos [1] in 87% and 84% , respec­
tively, however, based on Giemsa-stained sections.
Overall H. pylori-positivity in children with ab­
dominal complaints detected morphologically us­
ing the Giemsa method was 74% and using anti- 
H. pylori IgG 49% , which is higher than in most 
developed countries [19-24]. Our study of sero­
prevalence of H. pylori in an Estonian population 
of schoolchildren [2] showed that children aged 9,
12 and 15 years were also frequently infected with 
H. pylori (in 49-60% ).
The fact that in our study H. pylori was identi­
fied in 30% of cases with normal antrum and in 
28%  of cases with normal corpus using Giemsa 
staining hypothetically may be explained by the 
nonstable adherence capability of bacteria in these 
children, knowing that the adherence to mucosa is 
an important virulence factor in development of 
gastritis [25,26]. Recent study of children and 
adults with chronic gastritis by Blom et al. [27] 
showed that there exist different patterns of H. 
pylori adherence to gastric mucosa cells. Addition­
ally, this situation could be explained by the fact 
that these children have been recently infected and 
their mucosa is still normal, but they can be pre­
disposed to develop gastritis later in life. The 
grade of colonization in these cases in our study 
was predominantly low. The grade of colonization  
of normal antrum mucosa was as follows: grade 1 
in 5 cases, grade 2 in 2 cases, and grade 3 in 1 case 
of 8 normal biopsies with identified organisms. In 
normal corpus mucosa grade 1 was found in 9, 
grade 2 in 5 (Fig. 3) and grade 3 in 2 cases o f 16. 
It is known that the degree of gastric mucosal in­
flammation and severity o f epithelial damage is 
positively correlated to the degree o f colonization  
of the mucosa by H. pylori [28,29].
The evidence o f normal-looking mucosa with 
identified organisms may be also due to the pres­
ence of H. pylori strains that cause less inflamma­
tory response, e.g., strains not expressing the 
CagA and VacA proteins. There are literature data 
that the mucosal responses to different strains is 
variable and that strains expressing the CagA and 
VacA proteins are more pathogenic [30,31]. How-
* /
..Vjr
Jcf
...
•
" I ; ' ; !
. • %  &
•,
- k  '
vCr^ -S , - *  .
Figure 2 Negative staining of the corpus mucosa section in- Figure 3 Normal corpus mucosa with presence of H. pylori, 
cubated w ithout anti-H. pylori polyclonal antibodies (PAP stained with anti-H pylori 
method, X20 objective, X 10 eyepiece).
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ever, the data concerning CagA status in studied 
children were not available.
The fact that using polyclonal antibodies and 
the PAP method for the assessment of H. pylori re­
sulted in an H. pylori yield inferior to that of 
Giemsa staining is not in line with data of other 
authors, who showed that immunohistochemistry 
is the most sensitive and specific staining method 
for the evaluation of H. pylori in biopsies as com­
pared with conventional staining [5,9,32,33]. One 
possible reason for this disagreement includes the 
hypothesis that H . pylori strains colonizing the gas­
tric mucosa of the children analyzed might contain 
different antigenic components than strains o f H. 
pylori against which the polyclonal antibodies of 
this study have been raised. Andersen eta l. [5] 
pointed out this possibility based on some dis­
agreement between recognition of H. pylori in he- 
matoxylin-eosin— and peroxidase-stained sections. 
A second reason why some of Giemsa-positive 
cases were immunostain-negative could be the fact 
that most of the Giemsa-positive cases belong to 
the low  grade of H. pylori density. In some of 
these cases we cannot exclude the possibility that 
the immunohistochemical stain may be negative 
due to the different level of the section which was 
stained [33]. Giemsa staining detects both, intact 
and damaged or non-vital H. pylori, whereas im­
munohistochemical reactivity may depend on the 
presence of fully intact organisms harboring a still 
complete set of respective antigens.
An additional aspect of differential epitope re­
activity of the antibody used in the present study 
is evident by the staining of subsets of gastric epi­
thelial cells. Staining o f corpus gland neck cells by 
anti-H. pylori antibodies were found in 11% of 
biopsies, suggesting cross-reactivity of anti-H. p y­
lori antibodies with gastric epithelial epitopes, as 
previously proposed by Negrini et al. [11-13], The 
reaction may be related to autoimmune mecha­
nisms playing a pathogenic role of H. pylori in the 
progression of chronic gastritis [12,13]. This hy­
pothesis is in part supported by our previous study 
that long term H. pylori infection may be a predic­
tor for the development of gastric autoimmunity 
[14]. It is, however, notable that in 8 out of 12 
cases with intracytoplasmic staining of corpus mu­
cosal cells, corpus mucosa was otherwise normal,
i.e., without gastritis. This observation does not 
preclude that these children with a still normal 
mucosa may be predisposed to develop autoim­
mune gastritis later in life. In this light, the finding 
of neck cell reactivity in a young age group is of 
particular significance. An alternative mechanism
involved in staining of gastric gland neck cells by 
anti-H. pylori antibodies may be related to an epi­
thelial invasion by H. pylori [7]. In fact, internal­
ization of H. pylori by cells has been observed and 
discussed with respect to an inflammatory re­
sponse [7,33-36]. The finding that H. pylori can­
not be detected within cells by Giemsa staining 
may indicate intracellular bacterial breakdown. 
We regard it as promising to test whether gastric 
neck cells capable of internalizing H. pylori may 
express features of antigen-presenting cells opera­
tional in an immune response, as has been pro­
posed for other epithelial cells. In case that immu- 
noreactivity detected in mucus neck cells should in 
fact be due to the presence of H. py/on-related an­
tigenic material instead of a so-far not further 
specified cross-reactivity, accumulation of H. p y­
lori product in these cells would be a possible ex­
planation. We are not aware that these cells are 
capable for the intake of bacterial components, 
but endocytosis o f antigen, but not o f particulate 
matter, may be one pathogenic mechanism, even 
though neck cell reactivity was also observed in H. 
pylori-negative cases and normal samples.
In conclusion, superficial gastritis, simultaneously 
affecting antrum and corpus, was the most fre­
quent alteration (42%) in a subset o f children 
with abdominal complaints. They were H. pylori 
positive in antrum and/or corpus in 87% cases ac­
cording Giemsa-staining and in 66%  using anti-H. 
pylori IgG.
Prevalence of H. pylori among Estonian chil­
dren with abdominal complaints using Giemsa 
staining was higher (74%) in comparison with im­
munohistochemistry employing anti-H. pylori poly­
clonal antibodies (49%).
The concordance of H. pylori yields using these 
two staining methods by comparing histological sec­
tions from the same persons was 70% for antrum 
mucosa, and 73% for corpus mucosa sections.
The staining of epithelial cells in the neck part 
of corpus glands by use o f anti-H. pylori IgG indi­
cates a possible cross-reactivity of anti-H. pylori 
IgG with epithelial cell epitopes or the internaliza­
tion o f H. pylori by these cells.
Part of the data were presented in abstract form at the First 
Open Meeting of the European Study Group on Immunol­
ogy in Helicobacter Infection “Pathogenesis and host re­
sponse in Helicobacter pylori infections 1994,” Elsinore, 
Denmark, June 21-24, 1994. This work was supported by 
the Estonian Science Foundation grant No. 3045. The au­
thors thank Juta Oha and Ija Talja for technical assistance 
in cutting paraffin sections and Giemsa staining.
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Maaroos H-I, Vorobjova T, Sipponen P, Tammur R, Uibo R, Wadström T, Keevalik R, Villako K. An 18- 
year follow-up study of chronic gastritis and Helicobacter pylori: association of CagA positivity with 
development of atrophy and activity of gastritis. Scand J Gastroenterol 1999;34:864-869.
Background: We wanted to evaluate the coursc of chronic gastritis and its association with Helicobacter 
pylori and CagA seropositivity in an adult sample from Saaremaa (Estonia) during an 18-year follow-up. 
M ethods: Seventy persons (31 men, 39 women; median age, 57.5 years) from a primary sample of 304 
subjects endoscoped in 1979 were reinvestigated by endoscopy and biopsy in 1997. The state of the gastric 
mucosa and the presence of H. pylori in histologic sections from the antrum and corpus were assessed both 
in 1979 and 1997 in 66 subjects in accordance with the Sydney system, and H. pylori status in all 70 
subjects was determined with the enzyme-linked immunosorbent assay (ELlSA). Anti-CagA IgGs were 
determined with the ELISA, using the recombinant fragment of CagA. Results. During an 18-year follow- 
up 11% of the subjects developed atrophy in the antrum, whereas 35% developed it in the corpus. 
Development of atrophy in the corpus and the appearance of intestinal metaplasia in the antrum were 
associated with increased activity of gastritis both in the initial and last follow-up biopsies. Anti-CagA 
positivity was found in 71% of H. />y/«n-seropositive persons (94% of subjects). There was a significant 
association between CagA positivity and the activity of gastritis, the presence of atrophy or damage to 
surface epithelial cells in the antrum and in corpus mucosal biopsy specimens at the last follow-up 
endoscopy. Conclusion: The CagA-positive strains of H. pylori enhance the development of atrophic 
gastritis compared with CagA-negative strains.
Key words: Activity of gastritis; atrophy; CagA; follow-up of gastritis; Helicobacter pylori
Tamara Vorobjova, Dept, o f Immunology, University o f Tartu, Veski 34, EE 51014 Tartu, Estonia (fax: 
+372 7-421165)
Long-term  follow -up studies have shown that gastritis is a dynam ic process. The m ain tendency is progression o f  gastritis w ith tim e from  a non-atrophic to an 
atrophic form , although there are data indicating som e 
regression o f gastritis (1 -6 ). There is am ple evidence that 
infection w ith H elicobacter pylori, and especially  with the 
strains expressing the 128-kDa cytotoxin-associated (CagA) 
protein, constitutes a factor associated with enhanced gastric 
inflam m atory response and increased risk o f developm ent of 
atrophic gastritis (7 -1 0 ), peptic ulcer (11-15), and even 
gastric cancer (16-22).
The aim  o f our study was to evaluate the course o f  gastritis 
during 18 years and its association w ith H. pylori  and CagA 
seropositivity  in an adult sam ple from  Saarem aa, Estonia. 
This study is an extension o f our earlier studies (1, 2 ,4 , 5) and 
is based  on the hypothesis that the local im m une response to
the CagA  protein o f  H. py lo ri  is associated  w ith increased 
recruitm ent o f  inflam m atory cells in the gastric m ucosa and 
w ith epithelial dam age (7, 8 , 13, 2 3 -2 8 ) and on the possib ility  
that CagA is highly im m unogenic and  stim ulates a strong 
hum oral response (1 1 ,1 2 ,2 9 -3 1 ) .  W e have tested the 
hypothesis that the CagA  strain is associated with a trophic 
gastritis and progression o f atrophic gastritis as a direct result.
Subjects and Methods
Subjects
Seventy persons (31 m en, 39 w om en; m edian age, 57.5 
years) o f  an adult sam ple o f  304 from  S aarem aa Island, m ost 
o f  whom  had previously been investigated w ith endoscopy 
and biopsy in 1979, 1985, and 1991, w ere reinvestigated  by 
m eans o f  endoscopy and b iopsy in 1997. O f the initial 304
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Table I. Grading of activity of gastritis, inflammation, atrophy, intestinal metaplasia, epithelial damage, and Helicobacter pylori in the antrum 
and corpus mucosa in samples from 1997
Grade
Activity of 
gastritis, n
Inflammation,
n Atrophy, n
Intestinal 
metaplasia, n
Epithelial 
damage, n H. pylori, n
In antrum
0 16/66 7/66 51/66 53/66 20/66 9/66
1, mild 45 10 13 10 44 17
2, moderate 5 38 2 3 2 9
3, severe 0 11 0 0 0 31
Total (1-3) 50/66 59/66 15166* 13/66 46/66f 57/66
In corpus
0 24/66 5/66 34/66 56/66 32/66 6/66
I, mild 29 10 17 9 29 19
2, moderate 13 28 10 1 5 10
3, severe 0 23 5 0 0 31
Total (1-3) 42/66 61/66 32/66** 10/66 34/66ft 60/66
Statistically significant difference (on the basis of the chi-square test): ** >  * P = 0.003, t  >  t t  P = 0-03.
subjects, 227 were randomly selected and 77 wished to be 
investigated (2).
During the 18-year follow-up 39 of the original 304 
subjects had died by 1997 (gastric carcinoma, 2; coronary 
heart disease and heart failure, 17; malignancies other than 
gastric causes or leukaemia, 11; cerebral insult, 6; and other 
causes, 3). The other subjects (n = 195) were lost to follow-up 
because of high age, severe illness, change of residence, and 
failure of communication or refusal. Gastroduodenal endos­
copy was performed at the beginning of the study and 
subsequently at 6,12, and 18 years. The results of a 6- and 12- 
year follow-up study of the course of gastritis are described 
elsewhere (4, 5). The results of the last follow-up examina­
tions are analysed in the present study, and the course of 
gastritis is evaluated as the difference between the first and 
last follow-up examinations over 18 years.
The seventy persons who were investigated in 1997 were 
endoscoped, and technically acceptable data (biopsies) were 
obtained for 66 subjects.
At the last examination five subjects had duodenal ulcer or 
duodenal ulcer scar, four had antral polyps, and five had 
antral/prepyloric erosions. Three mucosal specimens were 
taken from the antrum and six from the corpus. Formalin- 
fixed, paraffin-embedded biopsy specimens were stained with 
haematoxylin and eosin and modified Giemsa. The state of the 
gastric mucosa and the presence of H. pylori in histologic 
sections were assessed in accordance with the Sydney system 
(32) and scored from 0 (no changes) through 1 (mild) and 2 
(moderate) to 3 (severe changes).
Serum samples were collected from all 70 subjects and 
were stored at —20°C until assayed.
Methods
H. pylori status was determined on the basis of a serologic 
evaluation of IgG antibodies to H. pylori (strain CCUG 
17874), using the enzyme-linked immunosorbent assay 
(ELISA), as reported previously (33). In brief, 0.5 (ig of 
acid glycine (pH 2.2)-extracted cell surface proteins per well
were used for the coating of microtitre plates (Nunc, 
Roskilde, Denmark). The studied sera were diluted to 
1:800; the second antibody was alkaline phosphatase-labelled 
anti-human IgG (Dako, Glostrup, Denmark), which was 
diluted to 1:500. The results were expressed as corrected 
mean absorbance values as a percentage of the reference 
standard (human gammaglobulin, Pharmacia & Upjohn, 
Stockholm, Sweden). The cut-off value for seropositivity 
was set at a relative antibody activity (RAA) of 25. Interassay 
variation was 13%, and intra-assay variation 5%.
Anti-CagA IgG were detected with the ELISA using a 
recombinant fragment of the CagA antigen His-17/12 of the 
H. pylori strain CCUG 17874, kindly donated to us by Dr. A. 
Covacci (Chiron, Biocine, Siena, Italy), using the method 
described by Xiang et al. (34), with modifications. In our 
study the recombinant CagA antigen was diluted in 0.1 M 
carbonate buffer, pH 9.6, to a final concentration of 1.25 ng/ 
ml. Maxisorp Immunoplates (Nunc) were coated with 100 jj.1/ 
well in duplicate, incubated for 16 h at 4°C, and washed three 
times with phosphate-buffered saline (PBS) (pH 7.4) contain­
ing 0.05% Tween 20. The wells were saturated with 200 \l\I 
well of 1% bovine serum albumin (BSA) in PBS-Tween at 
37°C for 2h. After the plates had been washed three times, 
100 (j.1 of each serum sample, diluted to 1:300 in 1% BSA- 
PBS, was added in triplicate (two wells with the antigen and 
one without the antigen) and incubated at 37°C for 2 h. The 
plates were then washed three times, and 100 (il/well of 
alkaline phosphatase-conjugated anti-human IgG (Dako), 
diluted to 1:1000 in 1% BSA-PBS, was added, and the plates 
were incubated at 37°C for 1.5 h. After three washes, 100 |iL/ 
well of a substrate solution containing p-nitrophenyl phos­
phate (Sigma Chemical Co, St. Louis, Mo., USA) in 
diethanolamine-MgCl2 buffer was added to each well and 
incubated at 37°C for 30 min. Each plate contained a positive 
and a negative control serum. Absorption was measured at 
405 nm. The absorption value derived from the mean value of 
absorption in two wells with the antigen minus the absorption 
value for the well without antigen was taken as the absorbance
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Table II. 18-year follow-up of gastritis and CagA status
Gastritis 1979->1997
Antrum Corpus
n %
No. of CagA+ 
in 1997 n %
No. of CagA+ 
in 1997
No development 42* 66 24 25** 39 13*
Development of AG 7 t 11 6 22t t 35 20M
No change 5 8 5 4 6 3
Progression of AG 2 3 2 4 6 3
Decrease of AG 1 1 1 2 3 2
Disappearance of AG 7 11 6 7 11 3
Total 64 100 44 64 100 44
AG = atrophic gastritis of any degree.
Statistically significant difference (on the basis of the chi-square test): * > * * />  = 0.002; f t  >  t  P = 0.001; I t  >  $ P = 0.009.
value of the studied sera. Instead of the cut-off at 0.250 optical 
density (OD), used by Xiang et al. (34), the cut-off point in 
this study was set at an absorbance value of0.300 (A 405 nm), 
on the basis of the calculation of the ELISA results, derived 
from the mean absorbance value of 25 H. py lo ri  histologically 
and serologically negative subjects plus two standard devia­
tions, using square-root transformation (35). Interassay 
variation was 8% and intra-assay variation was 3%.
Sta tistica l analysis
Differences in H. pylori status and in prevalence of 
antibodies to CagA between the groups were checked by 
means of the chi-square test. Differences in the mean values 
of OD as the expression of anti-CagA IgG level were 
calculated with the Student t test. Odds ratios (OR) with 
95% confidence intervals (Cl) were estimated by using 
Mantel-Haenzel statistics with Exact software. Differences 
were considered statistically significant when 95% Cl did not 
include the value 1.0. Association of the grade of activity of 
gastritis, inflammation, atrophy, intestinal metaplasia, and 
surface epithelial cell damage with CagA positivity was also 
evaluated by using multiple logistic linear regression analysis 
with the SAS package; a P  value <0.05 was considered 
statistically significant.
The Committee of Ethics at the University of Tartu 
approved this study.
Results
H isto logic  observation
Histologic data and H. p y lori  status for the 1977 samples 
are presented in Table I.
The course of atrophy in the antrum and corpus mucosa 
during 18 years is presented in Table II. Between two 
observations, in 1979 and 1997, 7 of 64 (11%) subjects 
developed atrophy in the antrum, whereas 22 of 64 (35%) 
developed atrophy in the corpus (P = 0.001).
Analysis of the association between the development of 
atrophy in the antrum and corpus mucosa and the grade of 
activity of the antrum and corpus gastritis at the first and the
last follow-up investigations is presented in Table III. The 
results indicated that the development of atrophy in the corpus 
but not in the antrum was significantly associated with a high 
activity of gastritis both in the initial and in the last periods of 
observation (P  = 0.0003).
Serologic data
The prevalence of IgG antibodies in 1997 was 94% (66 of 
70). Of H. py lo ri-positive persons 71% (47 of 66) were CagA- 
positive.
The OR for the association of the grade of activity of 
gastritis, inflammation, atrophy, intestinal metaplasia, or 
epithelial cell damage with CagA positivity for 1997 are 
presented in Table IV. Logistic linear regression showed that 
anti-CagA positivity was significantly associated with the 
activity of gastritis in the antrum and corpus (P = 0.04, 
P  = 0.0001, respectively). In the corpus mucosa the gastritis 
activity was also associated with the level of CagA antibodies 
(P = 0.002). No association was found between CagA 
positivity and severity of chronic inflammation in the antrum 
or corpus (P = 0.14, P  = 0.18, respectively). On the other 
hand, CagA positivity was significantly associated with the 
presence of atrophy in the antrum and corpus (P  = 0.04, 
P  = 0.002, respectively). In the corpus mucosa the association 
between the presence of atrophy and the level of anti-CagA 
antibodies was also significant (P = 0.0007). CagA positivity 
was associated with the presence of intestinal metaplasia (IM) 
in the antrum but not in the corpus. Multiple regression 
analysis showed the strongest association between CagA 
positivity and the presence of atrophy of the antrum mucosa 
(P = 0.04) and between CagA positivity and activity of 
gastritis in the corpus mucosa (P  = 0.01).
The mean OD values of anti-CagA IgG for different grades 
of activity of corpus gastritis showed a significantly higher 
mean OD value of antibodies to CagA in persons with mild 
(OD = 0.893 ±0.495) or moderate (OD = 1.028 ±  0.563) 
grade of activity than in those without polymorphonuclear 
cell infiltration (OD = 0.331 ±  0.366; t  -  4.59, P  = 0.0002 and 
f = 4.55, P -  0.0006, respectively). However, there was no 
significant difference between the mean OD values of anti-
Scand J Gastroenterol 1999 (9)
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Table III. Association between development of atrophic gastritis in the antrum and corpus mucosa and grade of activity o f gastritis in 1979 and 
1997
Dynamics of grade 
of atrophy 
1979—>1997
Activity of gastritis in 1979 Activity of gastritis in 1997
Cases with 
grade 1-3
Cases with 
grade 0 Total
OR
(95% Cl)
P value for 
trend*
Cases with 
grade 1-3
Cases with 
grade 0 Total
OR
(95% Cl)
P  value for 
trend*
Antrum
No development 19 22 41 1 29 13 42 1
of AG
Development or 5 4 9 1.4 0.89 7 2 9 1.6 0.90
progression of (0.36-5.69) (0.32-7.52)
AG
Corpus
No development 4 21 25 1 9 16 25 1
of AG
Development or 17 7 24 12.7 0.0003 23 3 26 13.6 0.0003
progression of (3.35-48.5) (3.4-54.7)
AG
AG = atrophic gastritis; OR = odds ratio; Cl = confidence interval. 
* P  value for trends evaluated with the chi-square test.
C agA  IgG  correspond ing  to different grades o f  activity  o f  
gastritis in the  an trum  m ucosa: for g rade 0 ,0 .5 6 9  ±  0.622; for 
grade 1, 0 .729 ±  0.519; by  g rade 2, 1.061 ±  0.468; P  =  0 .32, 
P  =  0 .12, P  =  0 .17 , respectively).
C ourse o f  gastr itis  during  fo llo w -u p  a n d  CagA sta tus
T here w as ah association  betw een  C agA  positiv ity  in 1997 
and p rogression  o f  a trophy in the antrum  and corpus m ucosa 
during  fo llow -up from  1979 to 1997. A m ong  persons who had 
no  a trophy in the an trum  m ucosa in 1979 and in 1997, 24  o f  
42  (57% ) w ere C agA -positive , w hereas am ong those in w hom  
atrophy appeared  during  fo llow -up 8 o f  9  (89% ) w ere  CagA - 
positive . A m ong persons w ho did no t develop  atrophy in 
co rpus m ucosa, during  fo llow -up 13 o f  25 (52% )  w ere C agA - 
positive . O n the o ther hand, am ong persons w ho developed 
atrophy o r in w hom  atrophy progressed  23 o f  26 (88 %) w ere 
C agA -positive  (P  =  0 .01; O R  =  7.07 (1 .80-27 .7 )).
T here  w ere significantly  m ore C agA -positive  subjects 
am ong those in w hom  activ ity  o f  corpus gastritis increased
during  fo llow -up (13 o f  17) than  am ong those in w hom  no 
activ ity  w as detected  e ither at the  beginn ing  o r at the  end  o f 
the study period  (7 o f  21; P  = 0 .02; O R  =  6 .50  (1 .6 3 -2 5 .9 1 ).
Discussion
T h e present s tudy is a prospective 18-year endoscop ic  fo llow - 
up show ing that chronic  H. p y lo r i  gastritis progresses 
gradually  but slow ly  into a trophic gastritis and  th a t this 
p rogression  particu larly  appears to  be rela ted  to  the  p resence 
o f  C agA -positive  strains. T he  specific finding o f  the  p resen t 
p opulation  study is that the  C agA  stra in  w as associated  w ith  
progression  o f both  atrophic  gastritis in  the  co rpus and 
atrophic gastritis in the  antrum .
P rogression  o f  gastritis to atrophic  gastritis  has b een  know n 
fo r a long  tim e (1 -6 ). W hy atrophic gastritis develops in som e 
b ut not in all affected  ind iv iduals is unknow n. In fection  w ith
H. py lori, especia lly  in the p resence o f  C agA , and the 
cy to toxicity  o f  the bacterium , constitu te  one p ossib le  m eans
Table IV. Odds ratios (OR) for association between CagA positivity and grade of activity of gastritis, inflammation, atrophy, intestinal 
metaplasia, and epithelial damage in the antrum and corpus in follow-up biopsy specimens (1997)
Antrum Corpus
Grading n CagA+ C agA - OR (95% Cl) n CagA+ C agA - OR (95% Cl)
No activity of gastritis (0) 16 7 9 1 24 8 16 1
Activity (1-3) 50 38 12 4.1 (1.3-12.7) 42 37 5 14.8 (4.5-50.3)
No inflammation (0) 7 3 4 1 5 2 3 1
Inflammation (1-3) 59 42 17 3.3 (0.7-14.6) 61 43 18 3.6 (0.7-19.5)
No atrophy (0) 51 31 20 1 34 17 17 1
7.0 (2.1-23.1)Atrophy (1-3) 15 14 1 9.0(1.4-57.9) 32 28 4
No intest, metapl. (0) 53 33 20 1 56 37 19 1
Intest, metapl. (1-3) 13 12 1 7.3 (1.1-46.9) 10 8 2 2.1 (0.4-9.4)
No epith. damage (0) 20 9 11 1 32 17 15 1
4.1 (1.4-12.2)Epith. damage (1-3) 46 36 10 4.4(1.4-13.1) 34 28 6
Cl = confidence interval.
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o f affecting the state o f  gastric m ucosa and the dynam ics o f 
gastritis (8 -1 1 ). T h e  present study supports this possibility  
and showed an association betw een CagA  positivity  and the 
activity o f  gastritis, the p resence o f  atrophy, and epithelial cell 
dam age in both  the antrum  and the corpus m ucosa. O ur data 
are in accordance w ith the studies indicating that CagA- 
positive H. py lo ri  status causes m ore aggressive gastritis than 
the C agA -negative status. This finding suggests that CagA - 
positive gastritis tends to  progress to atrophic gastritis m ore 
frequently  than  C agA -negative  gastritis ( 7 -1 0 ,1 3 ,2 5 -2 8 , 
3 6 -3 8 ).
According to our study the developm ent o f  atrophy in the 
corpus m ucosa was significantly associated w ith the activity 
o f  corpus gastritis. Furtherm ore, association betw een the 
activity o f  gastritis and CagA  positivity  w as particularly  
m arked in the  corpus. CagA  protein is highly im m unogenic 
(1 2 ,2 9 -3 1 )  and m ay stim ulate a strong hum oral response. 
Indirect determ ination o f  the degree o f polym orphonuclear 
cell infiltration in the stom ach corresponding to the levels of 
system ic IgG  antibodies to this cytotoxic protein has been 
proposed by F igura  (25). T here is evidence that CagA - 
positive strains have a h igher pathogenic potential than CagA - 
negative strains. T hey increase m ucosal cy tokine expression 
and polym orphonuclear cell infiltration and induce an 
im m une response leading  to m ucosal dam age (7, 13, 39 ,4 0 , 
41). In  o u r study the  m ean O D  values o f anti-CagA  IgG 
(w hich reflect the level o f  antibodies in sera) was associated 
w ith  a h igher grade o f activity  o f  gastritis and atrophy, 
especially  in the corpus m ucosa.
T here  is evidence that patients infected by cytotoxic strains 
and/or patien ts w ith anti-C agA  antibodies are m ore likely to 
have active gastritis and to develop peptic ulcer or gastric 
cancer (1 1 -2 2 ,2 6 ). Both  d irect bacterial cytotoxicity  and 
inflam m atory cell aggression against gastric epithelium  may 
predispose the patien t to peptic u lcer disease (39). The 
association betw een CagA , peptic ulcer, and gastric cancer is 
m ost logical i f  it is assum ed that CagA is related to 
aggressiveness o f  gastritis. O ccurrence o f CagA  infection 
results in m ore active gastritis, which is m ore likely to end up 
as atrophic gastritis. Such a sequence o f  events is supported 
by the results o f  this study.
O ur 18-year fo llow -up study o f  gastritis show ed a 
difference in the course  o f  atrophy betw een the antrum  and 
corpus m ucosa and established its relation to the activity o f 
gastritis. In the study population 11% o f the subjects 
developed atrophy in the antrum , w hereas 35%  developed it 
in the corpus. A nalysis o f  the course  o f  gastritis and CagA 
status in these patien ts show ed that CagA  positivity  was m ore 
closely associated  w ith the developm ent o f  atrophy in the 
corpus than in the antrum .
A  som ew hat surprising finding was that the relationship 
betw een C agA  and atrophic antral gastritis w as not so strong 
as the relationship betw een CagA and atrophic corpus 
gastritis. This fac t seem s illogical but is obviously based on 
the natural course o f  gastritis in the present study population:
in som e patients healing o f  antral gastritis is accom panied  by 
a rapid exacerbation o f  atrophic gastritis in the corpus (4, 6). 
Such healing o f  antral gastritis m ay take p lace in the p resence 
o f  a CagA -positive strain and confound the analysis o f  events 
in the antrum . In o ther w ords, a significant progress o f 
atrophic gastritis in the corpus, as is the case  in the presence o f  
CagA strains, is associated w ith opposite events in the antrum . 
If  analysis were to be restricted to patients w ith a trophic antral 
gastritis only, the presence o f  CagA  strains w ould show  an 
association w ith atrophic antral gastritis too. H ow ever, the 
present m aterial did not enable  such an analysis. S till, even in 
our series, a significant association w as observed betw een 
CagA  and IM  in the antral m ucosa.
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A bstract In 30% of H. py/on-infected patients a cer­
tain type of antigastric autoantibodies, reacting against 
canalicular structures within human parietal cells, is de­
tectable, Furthermore, it has been shown that these au­
toantibodies are correlated with atrophy of the mucosa 
in the corpus. The aim of this study was to analyse the 
prevalence of these anticanalicular autoantibodies 
(ACAB) and their significance for development o f gas­
tric mucosa atrophy in a 12-year follow-up period. Gas­
tric biopsy specimens from 62 persons in Saaremaa Is­
land, Estonia, were collected in 1997 and assessed inde­
pendently by two pathologists in accordance with the 
updated Sydney system. The sera of these persons were 
immunohistochemically screened for ACAB and for 
classic parietal cell antibodies (PCA). In addition, for 
37 of the 62 persons, gastric biopsies and sera collected 
12 years earlier (1985) were investigated in an analo­
gous manner. ACAB increased significantly, from 8 out 
of 37 in 1985 to 17 out of 37 in 1997 (P=0.004; 
McNemar test). In 1997 a significant correlation existed 
between the presence of ACAB and corpus mucosa at­
rophy (19 out o f 30 versus 10 out of 32 without atro­
phy; />=0.01; odds ratio (OR)=3.8, 95% CI 1.4-10.6). 
However, no correlation was found between ACAB and 
development of atrophy in the period from 1985 to 
1997. All 37 persons were PCA negative in 1985, 
whereas in 1997, 2 turned out to be PCA positive.
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ACAB increased significantly with duration of H. pylo ri 
gastritis. The correlation between ACAB and presence 
of gastric corpus atrophy was confirmed. However, it is 
possible that ACAB are the consequence o f and not a 
causative factor in gastric mucosa atrophy, insofar as 
the association of ACAB with progression o f corpus 
atrophy was not significant.
Key words Anticanalicular autoantibodies • Corpus 
atrophy • Follow-up of gastritis • H elicobacter  p y lo r i ■ 
Parietal cell antibodies
Introduction
H. p y lo ri gastritis leads to the development of gastric 
mucosa atrophy [11, 17, 18, 24, 26]. Furthermore, recent 
studies have shown that a considerable proportion o f H. 
p y lo ri-infected patients develop autoimmune reactions 
against gastric epithelial cells [4, 14, 15, 23], In particu­
lar, anticanalicular autoantibodies (ACAB) reacting 
against canalicular structures within human parietal cells 
can be demonstrated in 30% of infected patients. Gastric 
H+,K+-adenosine triphosphatase (H+,K+-ATPase) repre­
sents a major autoantigen of these autoantibodies. This 
particular type of antigastric autoimmunity is associated 
with atrophic corpus gastritis [2, 4, 5, 15].
It has been speculated that molecular mimicry be­
tween H. p y lo ri and the host plays some part in the for­
mation of ACAB in H. p y lo r i gastritis [1, 14, 15, 23]. 
However, more recent data have provided evidence that 
pathogenic pathways other than molecular mimicry may 
also be responsible for this type o f antigastric autoimmu­
nity [2, 6].
The aim o f the present study was to analyse the prev­
alence of ACAB and their significance for development 
of gastric corpus mucosa atrophy in a 12-year follow-up 
in an adult population from Saaremaa Island in Estonia. 
The study is an extension o f earlier long-term follow-up 
research into chronic gastritis [12, 25-27] and parietal 
cell antibodies (PCA) in different Estonian populations
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Fig. 1 Atrophic gastritis of 
moderate degree in the corpus. 
There is a remarkable loss of 
oxyntic glands and intestinal 
metaplasia (arrow) is present. 
Chronic inflammation is mild 
or moderate, and inactive. HE, 
original m agnification xlOO
accordance with the updated Sydney system [3] and scored from 0 
(no changes) through 1 (mild) and 2 (moderate) to 3 (severe 
changes) (Fig. 1).
Anticanalicular autoantibodies
ACAB reacting against canalicular structures within human pari­
etal cells were detected using an immunohistochemical method 
described earlier [4]. Briefly, heterologous formalin-fixed and par­
affin-embedded gastric corpus mucosa with no pathological altera­
tions and not expressing blood groups A and B were incubated 
overnight at 20°C with sera diluted 1:100 in RPMI 1640 medium 
(Biochrom, Berlin, Germany). As the secondary antibody, alkaline 
phosphatase-conjugated rabbit anti-human IgG (DAKO, Hamburg, 
Germany), diluted 1:10 in RPMI 1640 medium was used (incuba­
tion at 20°C for 90 min). After washing, positive reaction was in­
duced with fast red. Sections were counterstained with haematox- 
ylin, mounted with Aquatex and examined by light microscopy, 
without knowledge o f the respective patient data or histological al­
terations. One positive control serum was included in each immu­
nohistochemical staining session, and negative controls were per­
formed by omitting the human serum. Intensive red imm unohisto­
chemical staining, visible at the canaliculi o f parietal cells in the 
corpus mucosa, was taken as a positive reaction (Fig. 2).
Parietal cell antibodies
Classic IgG-type PCA were examined in all sera by an indirect 
imm unofluorescence method, as described previously [21].
H. pylori status
H. pylori status was determined on the basis o f a serological eval­
uation of IgG antibodies to H. pylori (strain CCUG 17874), using 
the enzyme-linked immunosorbent assay (ELISA) method, as re­
[21-23] with a high prevalence o f H. pylo ri infection 
[28].
Materials and methods
This study was approved by the Committee o f Ethics o f the Uni­
versity of Tartu. All persons gave their informed consent prior to 
their inclusion in the study.
Subjects
Seventy persons (mean age 57.8±11.4; 31 men, 39 women) who 
had been part of an adult random sample o f 304 persons from 
Saaremaa Island, most of whom had previously been investigated 
by endoscopy and gastric biopsy in 1979, 1985 and 1991 [25-27], 
were re-investigated in 1997. In 1997, gastric biopsy specimens 
from the antrum and corpus mucosa and also serum samples were 
obtained from 66 o f  these 70 persons (mean age 5 7 .7 ± ll.3 ; 
30 men, 36 women). Inclusion criteria for 62 (mean age 57.6±11.4,
30 men, 32 women) out o f  66 persons for assessment of ACAB 
were: seropositivity for H. pylori in ELISA, presence o f H. pylori 
in antrum and/or corpus biopsy specimens assessed by two pathol­
ogists.
Additionally, antrum and corpus biopsies and serum samples for 
37 out of the 62 persons (mean age 43.7+10.6, 21 men, 16 women) 
were available from 1985, i.e. from a time 12 years earlier. Serum 
samples from both points of time were stored at -20°C  and were 
then screened for ACAB and classic PCA.
Formalin-fixed, paraffin-embedded gastric biopsy specimens 
from the antrum (3 specimens) and corpus mucosa (6 specimens) 
were stained with haematoxylin and eosin and with a modified 
Giemsa stain. H. pylori colonisation, grade and activity o f gastri­
tis, and presence of gastric mucosa atrophy were assessed inde­
pendently by two pathologists (P.S. and G.F.) in blinded fashion in
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Fig. 2 In situ binding pattern 
o f anticanalicular autoantibod­
ies reacting against canalicular 
membranes within human pari­
etal cells o f the gastric corpus 
mucosa. Original m agnification 
x400
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ported previously [28], Briefly, 0.5 pg of acid glycine (pH 2.2)- 
extracted cell surface proteins per well were used for coating mi- 
crotitre plates (NUNC, Roskilde, Denmark). The studied sera were 
diluted to 1:800; the secondary antibody was alkaline phospha- 
tase-labelled anti-human IgG (DAKO, Glostrup, Denmark), which 
was diluted 1:500. The results were expressed by corrected mean 
absorbance values as percentages o f the reference standard (hu­
man gamm a globulin, Pharmacia and Upjohn, Stockholm, Swe­
den). The cut-off value for seropositivity was set at a relative anti­
body activity (RAA) o f 25.
Statistics
Statistical differences between the ACAB-positive and ACAB-nega- 
tive groups were evaluated by X2-and the McNemar tests using Stat- 
graphics and SPSS statistical software. Odds ratios (OR) with 95% 
confidence intervals (Cl) were estimated using the Mantel-Haenzel 
statistics with the Exact software. Differences were considered statis­
tically significant if 95% C l did not include the value 1.0. Differences 
in the mean values of age were calculated by the Mann-Whitney test 
(Statgraphics software). The K-value for measuring agreement be­
tween histological assessments was calculated using SPSS statistical 
software. P-values <0.05 were considered significant.
Results
H. p y lo ri status
In the sample of 1997, positive H. p y lo ri serology in 
ELISA was evaluated in 63 out o f the 66 (95%) sera 
studied. Morphologically, H. p y lo ri was confirmed in 62 
of them. Three persons were serologically and morpho­
logically negative for H. p y lo ri, while 1 was serological­
ly positive but morphologically negative.
The sensitivity o f ELISA was 100%, specificity 75%, 
positive predictive value (PPV) 98%, and negative pre­
dictive value (NPV) 100%. Interassay variation was 13% 
and intra-assay variation was 5%.
In all 37 subjects who passed the follow-up study, H. 
p y lo ri infection was confirmed histologically from the 
presence o f bacteria in biopsy specimens from the an­
trum and/or corpus as well as from positive H. p y lo ri se­
rology in ELISA at both time points.
Gastric mucosa alterations
The grading o f chronic inflammation, activity o f gastri­
tis, atrophy, intestinal metaplasia and H. p y lo r i colonisat­
ion in the antrum and corpus mucosa samples in the fol­
low-up group are presented in Table 1.
The grading o f antrum and corpus mucosa atrophy, as 
evaluated independently by two pathologists, is dis­
played in Table 2. Interobserver agreement regarding at­
rophy in follow-up samples was as follows: Kappa values 
for samples of 1985: 0.770 (agreement 94.5%) for an­
trum biopsies and 0.548 (agreement 89.2%) for corpus 
biopsies; kappa values for samples o f 1997: 0.247 
(agreement 67%) for antrum biopsies and 0.455 (agree­
ment 73%) for corpus biopsies. Kappa values for 62 
samples o f 1997 were 0.376 (agreement 72.5%) for an­
trum biopsies and 0.416 (agreement 71%) for corpus bi­
opsies.
Prevalence of ACAB
Prevalence of ACAB in the follow-up group (samples of 
1985 and 1997) and in 62 persons investigated in 1997 
are presented in Tables 1 and 3.
ACAB were immunohistochemically detectable in 29 
of the 62 (47%) subjects investigated in 1997. In the fol- 
low-up group, made up o f 37 infected persons, ACAB 
were detected in 8 o f the 37 (22%) in 1985 and in 17 of
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Table 1 Grading of chronic inflammation, activity of gastritis, atrophy, intestinal metaplasia. Helicobacter pylori and anticanicular au­
toantibody (ACAB) positivity in antrum and corpus mucosa samples in the follow-up group (n=37) in 1985 and 1997
Grade Chronic inflammation Activity of gastritis Atrophy Intestinal metaplasia H elicobacter pylori
1985 1997 1985 1997 1985 1997 1985 1997 1985 1997 
ACAB+//1 ACAB+//1 ACAB+/;; ACAB+//1 ACAB+//I ACAB+//! ACAB+/;i ACAB+//I ACAB+//I ACAB +ln
In antrum
0 0/0 0/0 0/1 0/1 5/33 9/23 6/32 12/30 1/4 0/2
1, mild 0/1 0/1 i/2 6/11 2/2 5/11 2/5 5/7 3/14 6/12
2, moderate m i 13/29 6/26 11/25 1/2 3/3 0/0 0/0 3/12 1/3
3, severe 2/9 4/7 1/8 0/0 0/0 0/0 0/0 0/0 1/7 10/20
Total 8/37 17/37 8/37 17/37 8/37 17/37 8/37 17/37 8/37 17/37
In corpus
0 0/0 0/0 1/4 0/0 7/34 10/23 6/33 14/33 1/4 0/2
1, mild 3/11 3/7 3/12 8/19 0/0 5/11 2/4 3/4 4/13 8/12
2, moderate 4/24 11/25 4/20 9/18 1/3 2/3 0/0 0/0 2/15 2/6
3, severe 1/2 3/5 0/1 0/0 0/0 0/0 0/0 0/0 1/5 7/17
Total 8/37 17/37 8/37 17/37 8/37* 17/37** 8/37 17/37 8/37 17/37
Statistically significant difference: **>*/>=0.004 (on the basis of McNemar test)
Table 2 Grading of antrum and 
corpus mucosa atrophy in the 
samples of 1985 and 1997 as 
evaluated independently by two 
pathologists
Grade Follow-up group Samples of 1997 (n=62)
1985 (n=37) 1997 (n=37) Pathologist I Pathologist II
Pathologist I Pathologist II Pathologist I Pathologist II
In antrum
1, mild 3 2 7 11 14 14
2, moderate 3 2 1 3 2 6
3, severe 0 0 0 0 0 0
Total (1-3) 6 4 8 14 16 20
In corpus
1, mild 4 0 10 11 17 19
2, moderate 2 3 5 3 9 6
3, severe 1 0 3 0 4 1
Total 7 3 18 14 30 26
them (46%) in 1997. All 8 patients who were positive for 
ACAB in 1985 remained positive for these autoantibod­
ies, whereas 9 of the 29 patients who were negative in 
1985 developed ACAB during the follow-up period. The 
increase in ACAB during this period was statistically 
significant (P=0.004; McNemar test). These results are 
presented in Fig. 3.
At the study point in 1985, the mean age (41.7+10.3) 
of the ACAB-negative persons who were also negative 
in 1997 did not differ significantly from the mean age 
(46.1+10.6) o f those who were ACAB positive in 1985 
or had become ACAB positive in 1997 (P =0.18).
Prevalence of PCA
Among the 62 serum samples examined in 1997, 3 were 
positive for classic PCA. All these 3 persons were also 
positive for ACAB in 1997. In the follow-up sample, all 
37 patients were negative for classic PCA in 1985, while
□ 1985
□ 1997
Fig. 3 Significant increase in anticanalicular autoantibodies in a 
12-year follow-up o f untreated H. pylori gastritis
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2 of the 37 had bccomc PCA positive in 1997. The latter 
were also ACAB positive in 1985 and 1997. All PCA- 
positive persons revealed highly intensive staining for 
ACAB throughout the cytoplasm.
Among the persons who possessed PCA in 1997, 1 
had grade 2, and another had grade 3 corpus atrophy, 
while the third showed grade 2 chronic inflammation in 
the corpus but no atrophy. In the follow-up group, o f the 
2 persons who developed PCA in 1997, 1 developed 
grade 2 corpus atrophy, but the other did not. The latter 
person had grade 2 chronic inflammation in the corpus at 
both time points.
Course o f gastritis and ACAB
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In samples for 62 persons examined in 1997 a significant 
association was found between ACAB and corpus muco­
sa atrophy (grades 1-3) by both pathologists. According 
to pathologist I, of 30 persons with corpus mucosa atro­
phy (grades 1-3), 19 (63%) had ACAB, while autoanti­
bodies were found in only 10 of the 32 (31%) subjects 
without atrophy (/*=().() 1; OR=3.8; 95% Cl 1.4-10.6). 
According to the diagnosis of atrophy established by pa­
thologist II, 16 o f 26 (62%) subjects with corpus atrophy 
grade 1-3 had ACAB, whereas only 13 of 36 (36%) per­
sons without corpus atrophy had these autoantibodies 
(/>=0.04; OR=2.8; 95% Cl 1.02-7.8).
In Table 4 the relationship between ACAB and devel­
opment of corpus atrophy o f different grades is shown 
separately for 37 persons who were followed up for 12 
years. In summary, according to pathologist I (the values 
given by pathologist II are presented in brackets) 2 (1) of 
8 patients with ACAB had some grade of atrophy in 
1985, while 5 (2) o f 29 infected patients without ACAB 
also had corpus atrophy already in 1985 (P=1.0). In 
1997, 10 (7) out of 17 ACAB-positive subjects had atro­
phy (grade I, 4; grade 2, 4; grade 3, 2; according to pa­
thologist I; grade 1, 5; grade 2, 2; according to patholo­
gist II), while 8 (7) out o f 20 ACAB-negative patients 
showed similar mucosal alterations (atrophy grade 1, 6; 
grade 2, 2 according to pathologist I; atrophy grade 1, 6 
grade 2, 1; according to pathologist IT; P=0.25). Thus, al­
though the prevalence o f atrophy determined by either 
pathologist was higher in the subset of infected persons 
with ACAB than in the subset without these autoanti­
bodies, no statistically significant association between 
ACAB and corpus mucosa atrophy could be established 
either at the beginning of the study or at the end of the 
follow-up period.
Furthermore, out of 9 persons who developed ACAB 
during the follow-up period, 4 (3) subjects also devel­
oped corpus mucosa atrophy (grade 1, 2; grade 2, 1; 
grade 3, 1 according to pathologist I; grade 1, 2; grade 2, 
1 according to pathologist II). On the other hand, out of 
the 14 (11) persons who developed atrophy (grade 1 , 9; 
grade 2, 1; grade 3, 1 according to pathologist I; grade 1, 
9; grade 2, 2 according to pathologist II) in the follow-up 
period, 6 (6) had no autoantibodies either at the begin-
4 2
Table 4 Grading of corpus 
atrophy in persons with and 
without ACAB in 1985 and 
1997 («=37). Atrophy was 
graded from 0 (no atrophy) 
through 1 (mild) and 2 (moder­
ate) to 3 (severe)
Pat.
no.
ACAB 
in 1985
ACAB 
in 1997
Pathologist 1 Pathologist 11
Corpus atrophy 
1985
Corpus atrophy 
1997
Corpus atrophy 
1985
Corpus atrophy 
1997
1 _ _ 0 1 0 0
2 - - 0 1 0 1
3 - - 2 0 2 1
4 - - 0 0 0 0
5 - - 0 2 0 2
6 - - 0 0 0 0
7 - - 0 0 0 0
8 - - 0 0 0 0
9 - - 0 0 0 1
10 - - 0 0 0 0
11 - - 0 0 0 0
12 - - 1 2 0 1
13 - - 0 0 0 0
14 - - 0 1 0 0
15 - - 0 1 0 0
16 - - 1 0 0 1
17 - - 0 1 0 0
18 - - 0 0 0 0
19 - - 1 1 0 1
20 - - 0 0 0 0
21 - + 0 1 0 1
22 - + 0 3 0 2
23 - + 0 0 0 0
24 - + 0 1 0 0
25 - + 0 2 0 1
26 - + 0 0 0 0
27 - + 3 2 2 2
28 - + 0 0 0 0
29 - + 0 0 0 0
30 + + 0 2 0 1
31 + + 0 0 0 0
32 + + 0 1 0 0
33 + + 2 3 2 1
34 + + 0 1 0 0
35 + + 0 2 0 1
36 + + 1 0 0 0
37 + + 0 0 0 0
ning or at the end of the study (P=l .0). Again, at follow- 
up no statistically significant correlation was found be­
tween evolution o f ACAB and development o f gastric at­
rophy, or vice versa.
Intestinal metaplasia and ACAB
The grading of intestinal metaplasia and its association 
with ACAB are presented in Tables 1 and 3. In the fol­
low-up group, persons with corpus intestinal metaplasia 
grade 1 were ACAB positive in 2 out of 4 cases in 1985 
and in 3 out o f 4 in 1997 (P>0.05); persons with antrum 
intestinal metaplasia grade 1 were ACAB+ in 2 out o f 5 
cases in 1985 and in 5 out of 7 cases in 1997 (P>0.05). 
In the larger sample o f 1997 (»=62) a significant associa­
tion was noted between presence of intestinal metaplasia 
in the corpus (grades 1-2) and ACAB (8 ACAB positive 
out o f 8 cases with intestinal metaplasia grade 1-2 ver­
sus 21 ACAB positive out o f 54 cases without intestinal 
metaplasia; P=0.004). This association was not signifi­
cant in the antrum mucosa: 8 ACAB positive out of 12 
cases with intestinal metaplasia versus 21 out o f 50 cases 
without intestinal metaplasia (P=0.22).
Isolated antrum atrophy and ACAB
With reference to the association between atrophic an­
trum gastritis and ACAB, cases with isolated atrophic 
antrum gastritis are o f special interest. In the samples 
of 1997 (n=62), according to the data o f pathologist I 
there were 4 cases o f isolated antrum atrophy, while 2 
o f them were ACAB positive. According to the data of 
pathologist II, 4 out o f 9 cases o f isolated antrum atro­
phy were ACAB positive. In the follow-up group, ac­
cording to the data o f pathologist I, 2 persons devel­
oped isolated antrum atrophy (1 ACAB positive); ac­
cording to the data o f pathologist II, 4 persons devel­
oped isolated antrum atrophy (2 o f them ACAB posi­
tive).
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Chronic inflammation, activity o f gastritis,
H. p y lo ri colonisation and ACAB
ACAB positivity at different grades of chronic inflam­
mation and activity of gastritis and at different grades of 
H. pylo ri colonisation are presented in Tables 1 and 3. 
The tendency to an increase in the prevalence of ACAB 
in 1997 compared with 1985 was seen in a group o f per­
sons with grade 2 chronic inflammation in corpus muco­
sa (11/25 versus 4/24; P=0.14, McNemar test). During 
the follow-up period ACAB formed in 9 o f the 37 per­
sons studied. Among these 9 persons the grade of chron­
ic inflammation in the corpus mucosa progressed in 5 
cases, retained the same in 3 cases and decreased in 1 
case. The grade o f chronic inflammation in the antrum 
mucosa progressed in 2 cases, remained the same in 6 
cases and decreased in I case.
In the corpus mucosa, periglandular lympocytic infil­
trates were found in the samples of 1985 in 5 of the 37 
cases, while all these 5 cases were ACAB negative both 
in 1985 and in 1997. In the 1997 sample periglandular 
lymphocytic infiltrates were found in 9 cases (7 o f them 
newly diagnosed) and ACAB were present in 4 out of 9 
cases. All persons with the finding of periglandular lym­
phocytic infiltrates were PCA negative.
Concerning changes in the activity of corpus gastritis 
in persons who developed ACAB, the grade of activity 
progressed in only 1 case, remained the same in 6 cases 
and decreased in 2 cases. In the antrum mucosa no pro­
gression of activity was observed, activity remaining the 
same grade in 4 cases and decreasing in 5 cases.
Thus, there was no significant association between 
grade of activity of gastritis and the presence or absence 
of ACAB at any time of observation. A tendency to an 
increase in the prevalence o f ACAB during 12 years’ 
follow-up was observed among persons with moderate 
grades of chronic inflammation.
In the sample o f 1997 the number of persons with H. 
p y lo ri colonisation grade 3 had increased significantly; 
in antrum specimens from 7 o f 37 in 1985 to 20 of the 37 
in 1997 (PsO.OOS); in corpus specimens from 5 of the 37 
in 1985 to 17 in 1997 (/MX005). However, development 
of ACAB in these persons was not statistically signifi­
cant (P=0.11 for antrum specimens with H. p y lo ri co­
lonisation grade 3; P = 0A 2  for corpus mucosa specimens 
with H. p y lo ri colonisation grade 3) and only 1 person in 
whom the grade o f H. p y lo ri colonisation progressed to 
severe developed a severe grade of atrophy in the corpus.
Discussion
The present study represents the first prospective investiga­
tion of anticanalicular autoantibodies (ACAB) and their 
significance for development of atrophic gastritis in a long­
term follow-up of an infected random adult cohort with 
noneradicated H. pylori. In a previous study by Uibo et al. 
[22] the correlation between classic anti-PCA and develop­
ment and progression of chronic gastritis was studied in
a similar group followed up for 6 years. Furthermore, a 
32-year follow-up study o f chronic H. pylo ri gastritis has 
provided evidence that progression of corpus gastritis 
might be associated with the occurrence of PCA [24],
The most important finding of the present study was 
that the prevalence o f ACAB increased significantly dur­
ing the follow-up period of 12 years. One might suppose 
that ACAB are formed in the course o f time and their ap­
pearance may be related to the duration of H. p y lo ri in­
fection. However, as the exact time o f onset o f H. p y lo ri 
infection is unknown in the persons enrolled in this 
study, the duration of infection cannot be established ei­
ther. It should be pointed out that the mean age o f per­
sons who were positive for ACAB at the beginning of 
the study, or became positive for ACAB during the next 
12 years, did not differ significantly from the mean age 
of those who remained negative for ACAB during the 
whole period. This is in agreement with earlier data pub­
lished by Faller et al. [5], indicating that the age profile 
of H. /ry/on-infected patients with antigastric autoanti­
bodies was not significantly different from the age pro­
file o f patients without these autoantibodies. As most H. 
pylo ri infections occur in childhood [19] and can persist 
throughout life, the age o f an infected adult person and 
duration of H. pylo ri infection can be regarded as rough­
ly equivalent. The evidence o f the role o f the person’s 
age or duration of H. p y lo ri gastritis in formation of 
ACAB is based on studies o f infected children, in which 
a lower prevalence o f ACAB was reported [7, 9], Fur­
thermore, a significant age-dependent increase in PCA 
positivity was shown in H. p y lo r i- infected persons but 
not in H. p y lo ri-negative persons, which suggests that 
long-lasting H. p y lo ri gastritis might represent an impor­
tant factor for formation of PCA [23], Other studies in 
which the formation of classic PCA was followed up 
over time have given similar results [8, 22].
The association of ACAB with H. p y lo r i  gastritis, 
particularly with atrophic gastritis, in the corpus mucosa 
has been established in several previous studies [2, 4, 5, 
15, 20] and was confirmed again in a group of 62 per­
sons in this investigation. The histological diagnosis of 
atrophy is difficult, and significant interobserver varia­
tion in the determination and grading o f atrophy has 
been reported only recently [161. The two pathologists 
who participated in this study attained interobserver 
agreement comparable to that seen in the last study. The 
fact that both investigators found a significant correla­
tion between corpus atrophy and ACAB confirms the ex­
istence of a link between antigastric autoimmunity and 
gastric atrophy in H. p y lo ri gastritis.
Progression of superficial gastritis to atrophic gastritis 
has been shown in several previous follow-up studies 
[10, 11, 24-27]. In the present study we attempted to 
find an answer to the question o f why gastritis remains 
confined to superficial mucosal layers in some patients 
while gastric atrophy develops in others. Since ACAB 
are correlated with atrophic corpus gastritis, and an auto- 
immunological reaction can lead to loss o f parietal cells 
and to evolution o f gastric atrophy, then ACAB can
serve as relevant markers Tor defining patients who are at 
higher risk for development o f gastric atrophy [5]. How­
ever, in this follow-up study we could not establish a sig­
nificant association between presence o f ACAB and de­
velopment of atrophy over the 12 study years. The lack 
of any such correlation is obviously due to the low num­
ber of enrolled persons, since such a correlation was ob­
served when the number of patients with the same epide­
miological background was increased from 37 to 62 at 
the end of the study. Also, the study period might have 
been too short. Uibo et al. (1989) reported that in a 
6-year follow-up period, changes in the gastric mucosa 
in autoimmune gastritis and in autoantibody-negative 
gastritis revealed no significant differences [22], The an­
trum and corpus mucosa of 2 persons who developed 
PCA did not reveal any alterations over 6 years. In con­
trast, in a much longer, 32-year, follow-up study, the ap­
pearance of PCA occurred in parallel with progression of 
corpus atrophy, disappearance of H. p y lo ri and improve­
ment of the antral mucosa [24],
Although our study could not establish a significant 
correlation between ACAB and development of atrophic 
alterations in the corpus mucosa, we found a tendency to 
an increase in the prevalence of ACAB over the 12 study 
years in persons with moderate chronic lympocytic infil­
tration in the corpus mucosa and in the case of intestinal 
metaplasia in the corpus. The importance of lymphocytic 
infiltration in the corpus mucosa, especially in associa­
tion with intestinal metaplasia, as an increased risk for 
development of gastric carcinoma, was stressed in a 
study conducted by Meining et al. [13].
As in previous investigations, all PCA-positive per­
sons in our study were also positive for ACAB [5], On 
the other hand, only 3 of all 29 ACAB-positive persons 
were positive for PCA. This can be explained by differ­
ent binding sites of ACAB and classic PCA within pari­
etal cells [2], Interestingly, 3 persons who had classic 
PCA in 1997 showed very intensive staining for ACAB 
throughout the cytoplasm. Two of them had moderate or 
severe corpus atrophy. In the follow-up group only 2 per­
sons turned out to be positive for PCA in 1997. Howev­
er, although both had already revealed intensive staining 
for ACAB in 1985 and 1997, I developed corpus atro­
phy but the other did not. It could be hypothesised that 
ACAB precede classic PCA and that epitope switching 
takes place in the process of H. /jy/on-associated anti­
gastric autoimmunity. This hypothesis could also explain 
why not all ACAB-positive persons were PCA positive 
in our study and in previous research [2, 5].
Our study confirmed previous reports o f a significant 
correlation between ACAB and gastric mucosa atrophy 
[5, 6, 20]. However, from the data presented in this study 
we cannot clearly define whether ACAB are the cause or 
the consequence of gastric atrophy. There are some pa­
tients who are ACAB positive but (still) do not have at­
rophy. In these patients antigastric autoimmunity pre­
cedes atrophy. On the other hand, there are also patients 
who have atrophy but who are negative for ACAB. We 
can surmise that in this subgroup of persons ACAB
might be developed during further progression of atro­
phy and appear when gastric cells are sufficiently de­
graded and autoantigens are presented to immunocompe­
tent cells. It is evident that further research into antigas­
tric autoimmunity is needed to get a better insight in the 
pathogenesis of chronic atrophic gastritis.
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antrum and corpus mucosa in chronic Helicobacter pylori gastritis. An 18-year follow-up study. Scand J 
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Background: The association o f apoptosis was analysed in three different compartments (foveolar cells—  
FC, proliferating zone—PZ and glandular part—GP) of antrum and corpus mucosa specimens with 
development of atrophy and the extent of apoptosis as depending on grade of chronic inflammation, 
activity of gastritis and Helicobacter pylori colonization at two time points of an 18-year follow-up in an 
adult population from Saaremaa, Estonia, with a high prevalence of H. pylori infection were compared. 
M ethods: A total of'68 persons (3 1 men, 37 women; median age, 39 years in 1979) from a primary sample 
of 304 subjects, endoscoped in 1979 and reinvestigated by endoscopy and biopsy in 1997, were included in 
the study. The state of the gastric mucosa and the presence of H. pylori in the antrum and corpus mucosa 
were assessed in accordance with the Sydney system. The dynamics of apoptotic index (AI) between two 
time points in 1979 and 1997 was evaluated in antrum biopsies of 49 persons and in corpus biopsies of 64 
persons. Apoptosis was measured using terminal deoxyuridine nucleotide nick end labelling (TUNEL) 
histochemistry. Results: The antrum as well as the corpus of 2/68 persons were H. pylori negative at both 
time points. Atrophy developed in 9/68 persons in the antrum and in 23/68 in the corpus. In PZ and GP of 
the corpus mucosa as well as in GP of the antrum mucosa, Al decreased significantly during 18 years 
compared with initial values (P <  0.05), which was not associated with development of atrophy. In all 
compartments of the antrum and corpus mucosa, studied at the initial and end points of observation, AI did 
not reveal a difference in persons with and without development of atrophy (P >  0.05). In the samples of 
1979 the highest independent effect on the value of Al in the FC compartment for the antrum was exerted 
by grade of activity of gastritis (/> = 0.01) and in GPby degree of chronic inflammation (/> = 0.03), while in 
the samples of 1997 the highest effect was exerted by grade of H. pylori colonization (P = 0.02 and 0.03 in 
FC and GP, respectively). For the corpus mucosa AI was most strongly affected also by grade of activity of 
gastritis in FC compartment (P = 0.02) and by degree of chronic inflammation in PZ (P = 0.04), but not by 
grade of H. pylori colonization. Conclusion: AI was not associated with development of atrophy, but was 
largely dependent on grade of activity of gastritis and degree of chronic inflammation; in the antrum 
mucosa AI depended also on grade of H. pylori colonization.
Key words: Activity of gastritis; antrum and corpus mucosa; apoptosis; atrophy; follow-up of gastritis; 
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~T~ fe l i c o b a c te r  pylori gastritis leads to developm ent of
§ ...■# gastric m ucosa atrophy (1 -5 ). There is also
JL evidence that H. p y lo ri  is associated with changes 
o f  epithelial cell tu rnover (6 -9 ) and increased apoptosis 
(program m ed cell death) in the gastric ep ithelium  (10-16), 
which can lead to developm ent o f atrophy o f the gastric 
m ucosa (17). A  recent study by  M oss et al. (18) on gastric 
cellu lar turnover and developm ent o f atrophy after 31 years of 
follow -up show ed that patients who developed atrophy later 
had had initially m ildly increased gastric epithelial cell 
proliferation and apoptosis, how ever, the ratio  o f  apoptosis 
to proliferation was not a determ inant o f risk for developm ent 
o f  atrophy several decades later.
T he aim  o f  the present study was to analyse the association 
o f apoptosis in the foveolar cells (FC), proliferating zone (PZ) 
and glandular part (GP) o f  antrum  and corpus m ucosa 
specim ens w ith developm ent o f  atrophy, as well as to  com ­
pare apoptosis at d ifferent grades o f  chronic inflam m ation, 
activity o f  gastritis and H. p y lori  colonization at tw o tim e 
points o f  an 18-year follow -up in an adult population from  
Saarem aa, Estonia, w ith a  high prevalence o f  H. p y lori  
infection.
This study is an extension o f  o u r earlier long-term  follow- 
up research into chronic gastritis in an Estonian adult sam ple 
from  Saarem aa (1, 19-23). In the present study w e tested the 
hypothesis that increased apoptosis m ay be responsib le for
©  2001 Taylor & Francis
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progression o f atrophy and is associated with higher degree of 
chronic inflam m ation, activity o f  gastritis and H, pylori  
colonization in the antrum  and corpus m ucosa.
Subjects and Methods
Subjects
O f the initial 304 subjects from  an adult sam ple from 
Saarem aa Island in Estonia, who had been investigated by 
endoscopy and gastric biopsy in 1979, 1985 and 1991, 70 
persons w ere reinvestigated in 1997. S ixty-eight persons (31 
men, 37 wom en; m edian age, 39 in 1979), whose antrum  and 
corpus biopsy specim ens were available for both tim e points, 
1979 and 1997, were included in the study.
During the 18-year follow -up o f  the initial 304 subjects, 39 
had died by 1997, the rem aining 195 subjects were lost to 
follow -up because o f  high age, severe illness, change o f 
residence, failure o f com m unication o r refusal. The studied 
persons had not received any H. p y lori  eradication therapy.
The course o f  gastritis was evaluated as the difference 
betw een the first (1979) and the last (1997) follow -up 
exam ination over 18 years.
A poptotic index (A l) was evaluated in the sam ples o f  1979 
for 52 antrum  and 64  corpus biopsy specim ens and in the 
sam ples o f  1997 for 58 antrum  and 66 corpus biopsy speci­
m ens. The dynam ics o f  Al betw een the two tim e points, 1979 
and 1997, was evaluated in the antrum  biopsies o f  49 persons 
and in the corpus biopsies o f  64 persons. The histological 
exam ination and evaluation o f  apoptosis were perform ed 
sim ultaneously in the tissue sam ples o f  1979 and 1997.
M ethods
Form alin-fixed, paraffin-em bedded gastric biopsy speci­
m ens from  the antrum  (three specim ens) and corpus m ucosa 
(six specim ens) were stained w ith haem atoxylin  and eosin, 
and with a modified G iem sa stain. The state o f  the gastric 
m ucosa and the presence o f  H. pylori in histological sections 
were assessed in accordance with the updated Sydney system  
(24) and scored from  0 (no changes) through 1 (m ild) and 2 
(moderate) to 3 (severe changes).
TU NEL histochem istry
Apoptosis was evaluated with the use o f  the TU N EL 
(terminal desoxynucleotidyl-transferase m ediated dU T P - 
b iotin nick end labelling) histochem istry m ethod (25). A fter 
deparaffinization and rehydration, the sections were digested 
with proteinase K (Sigm a, St Louis, M O) for 30 min at 20 °C 
(20 pg/m l in TR IS-H C 1). A fter w ashing w ith PBS (pH 7.4) a 
TU N EL  reaction was perform ed using the In Situ Death 
D etection F luorescein K it (B oehringer M annheim , Germ any). 
The principle o f  the test: DNA strand breaks generated during 
apoptosis w ere identified by  labelling with fluorescein dUTP 
(digoxigenin-11-deoxyuridine triphosphate) using term inal 
deoxynucleotidyl transferase (TdT). By an enzym atic reac­
tion (incubation for 40  min at 37 °C) with TdT, fluorescein
labelled dU TP was specifically transferred to the 3 '-O H  ends 
o f DNA. A fter w ashing with PBS (pH 7.4) and treatm ent with 
BSA (bovine serum  album in, 1 m g/m l in PBS) for 10 m in, the 
sections were subsequently  incubated with m onoclonal 
m ouse antifiuorescein antibodies (D A K O , G lostrup, D en­
mark, diluted 1:10, incubation for 30 m in at 20 °C). A fter 
washing the sections were incubated with rabbit anti m ouse 
biotinylated m onoclonal antibodies (D A K O , G lostrup, D en­
mark, diluted 1:50, for 30 min at 20 °C), followed by incu­
bation with the Strept AB Com plex, labelled w ith alkaline 
phosphatase (D A K O , G lostrup, Denmark.) and fast red as a 
substrate. Counterstaining was done with haem atoxylin. 
Apoptotic cells with incorporated dU T P show ed a d istinct 
bright red signal in the nucleus (Fig. 1). F or negative controls 
T dT  was om itted. The corpus gastric m ucosa w ith lym pho- 
follicules, containing apoptotic lym phocytes, was used as 
positive control.
M orphom etry. The rate o f  apoptotic cells in the antrum  and 
corpus m ucosa was quantified by counting three tim es 200 
cells o f  the FC com partm ent, 200 cells in the PZ  (neck part) 
(only for w ell-oriented glands) and 200 cells o f  the G P o f the 
section, using a light m icroscope w ith  m agnification x 4 0 0 . 
The m ean value o f  positively labelled nuclei p er 200 cells, 
calculated in three d ifferent section areas separately for FC, 
PZ and GP. were expressed as A l. Intra-assay variation for A l 
was 11 %. Counting was done by one observer (T. V.) w ho was 
not aware o f  m orphological data or y ear o f  sam pling (done in 
m ixed m anner).
Sta tistica l analysis
Data were presented as m eans w ith standard deviation. The 
W ilcoxon signed rank test served for evaluation o f  the 
differences betw een Al o f  the sam e persons in sam ples o f 
1979 and 1997, and the M ann-W hitney  unpaired, nonpara- 
m etric test served for analysis o f  A l fo r tw o groups according 
to d ifferent grades o f  atrophy, chronic infiltration, activity o f 
gastritis and H. pylori colonization. D ifferences in the num ber 
o f  persons w ith a different grade o f  H. p y lo ri  colonization at 
two tim e points o f  observation w ere checked by m eans o f  the 
chi-square test. The effect o f  d ifferent variables on  the 
expected values o f A l and on  the  difference betw een the 
m ean values o f  A l for different com partm ents o f  antrum  
and corpus m ucosa sections in the sam ples o f  1979 and 1997 
was evaluated by m ultifactorial d ispersion analysis by the 
SA S/LAB with the SAS package. Values o f  P  <  0.05 were 
considered significant.
The Ethics C om m ittee o f  the U niversity  o f  Tartu approved 
this study. All persons gave their inform ed consent p rio r to 
inclusion in the study.
Results
Gastric m ucosa alterations a nd  H. pylori status
Grading o f chronic inflam m ation, activity o f gastritis, 
atrophy, intestinal m etaplasia and H. pylori  colonization in
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Fig. 1. Apoptotic cells in the foveolar cells compartment of the antrum mucosa (TUNEL histochemistry; 
original magnification x400).
the antrum  and corpus m ucosa sam ples from  68 persons 
studied in 1979 and 1997 are presented in Table I. Both the 
antrum  and corpus m ucosa specim ens o f 9/68 persons in 1979 
and 6/68 persons in 1997 w ere H. p y lori  negative. Both parts 
o f the gastric m ucosa rem ained H. pylori negative in only two
persons at the initial and end points o f  observation. In 1997 
the num ber o f  cases with a severe grade o f  H. p y lori co loniza­
tion w as significantly  higher than in 1979 (32/68 versus 16/68 
for antrum  m ucosa specim ens, P = 0 .004; 31/68 versus 13/68 
for corpus m ucosa specim ens, P = 0 .009).
Table I. Grading of activity of gastritis, chronic inflammation, atrophy, intestinal metaplasia and H. pylori in the antrum and corpus mucosa in 
the samples of 1979 and 1997
1979 1997
Grade
Activity of 
gastritis
Chronic
inflamm. Atrophy
Intestinal
metaplasia H. pylori
Activity of 
gastritis
Chronic
inflamm. Atrophy
Intestinal
metaplasia //. pylori
Antrum
0 31 24 53 58 15 16 7 51 55 9
1 (mild) 20 14 13 9 15 47 10 15 10 18
2 (moderate) 14 27 2 1 22 5 40 2 3 9
3 (severe) 3 3 0 0 16 0 11 0 0 32
Total 68 68 68 68 68 68 68 68 68 68
Corpus
0 33 28 51 63 16 25 5 36 58 6
1 (mild) 20 17 10 5 16 29 11 17 9 21
2 (moderate) 12 15 5 0 23 14 29 10 1 10
3 (severe) 3 8 2 0 13 0 23 5 0 31
Total 68 68 68 68 68 68 68 68 68 68
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Table II. Course of mucosal alterations in antrum and corpus during 
18-year follow-up
Mucosal alterations 1979-1997 Antrum Corpus
No development of atrophy 44 28
Development of atrophy 9 23
Progression of atrophy 2 4
Disappearance of atrophy 8 7
No changes 5 6
Total 68 68
Course o f  gastritis a nd  dynam ics o f  A l  
The course of atrophy in the antrum and corpus mucosa 
during 18 years of observation is presented in Table II. During 
the follow-up period, development of any grade of atrophy in 
the antrum mucosa was established in 9/68 persons and in the 
corpus in 23/68 persons.
The dynamics of Al in three compartments of the studied
sections in samples from persons without and with develop­
ment of atrophy in the antrum mucosa are presented in Fig. 2; 
the dynamics of Al in the corpus is shown in Fig. 3.
D ynam ics o f  A l  in F C  
The value of Al for FC of the antrum as well as of the 
corpus mucosa at two time points of observation showed no 
significant changes either in the persons without atrophy 
(P = 0.74 for the antrum and P  = 0.62 for the corpus) or in the 
persons who developed atrophy (P = 0.10 for the antrum and 
P  = 0.18 for the corpus).
D ynam ics o f  A l  in P Z  a nd  G P
Al for PZ and GP in the corpus mucosa specimens of 1997 
decreased significantly compared with the specimens of 1979 
irrespective of the dynamics of atrophic alterations, i.e. in 
persons who developed atrophy (P = 0.005 for PZ and P =
in proliferating zone of antrum in persons 
without development of atrophy
p=0.37
in proliferating zone of antrum in persons 
with development of atrophy
p=1.0
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Õ 30  
2  20 
8- 10
19 79  1997
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Fig. 2. Dynamics of apoptotic index for the antrum mucosa in persons without 1) and with development 2) of atrophy during 18 years of 
observation.
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in foveolar cells of corpus in persons 
without development of atrophy
in foveolar cells of corpus in persons 
with development of atrophy
p=0.18
in proliferating zone of corpus in persons 
without development of atrophy
1979 1997
in proliferating zone of corpus in persons 
with development of atrophy
p=0.005
in glandular part of corpus in persons 
without development of atrophy
p=0.00007
in glandular part of corpus in persons 
with development of atrophy
p=0.00008
Fig. 3. Dynamics of apoptotic index for the corpus mucosa in persons without 3) and with development 4) of atrophy during 18 years of 
observation.
0.00008 for G P) as well as in persons w ithout developm ent o f 
atrophy (P  =  0 .02 and P -  0 .00007 for PZ and GP. respec­
tively). In the antrum  m ucosa there occurred a significant 
decrease in A l fo r G P from  the initial to the end point o f 
observation in persons w ithout developm ent o f  atrophy (P = 
0.0000005) and an obvious decrease o f  A l also in persons 
with developm ent o f  atrophy (P = 0.05).
No significant d ifference was observed betw een the mean 
values o f  Al for FC, PZ and GP o f the antrum  in groups with 
and w ithout developm ent o f atrophy either in the initial year 
o f observation (P  =  0 .98, 1.0 and 0.63 for FC, PZ and GP, 
respectively) o r  at the end point (P = 0.21, 0.69 and 0.36 in 
FC, PZ and GP, respectively). A nalogously, in FC, PZ and GP 
o f the corpus, the m ean values o f  Al did not differ signi­
ficantly in groups w ith and w ithout developm ent o f  atrophy 
(P  = 0 .33, 0.82 and 0.71 for 1979 and /J =  0 .30, 0.52 and 0.94 
for 1997).
According to m ultifactorial dispersion analysis (Table III), 
in 1979 the strongest independent cffect on A l in the antrum  
m ucosa was exerted by grade o f  activity  o f  gastritis (in FC;
=  ().() I) and degree o f chronic inflam m ation (in GP; P = 
0.03) and in 1997, by grade o f  H. py lo ri  co lonization (in FC 
and GP; P = 0.02 and 0.03); in the corpus m ucosa, the 
strongest independent effect on A l in 1979 w as exerted by 
activity o f  gastritis (in FC; P  = 0 .02) and chronic inflam m a­
tion (in PZ; P = 0.04). In the sam ples o f 1997 fo r corpus 
m ucosa no analysed factor exerted a sta tistically  significant 
effect on A l, only chronic inflam m ation tended to affect Al 
for PZ (P  = 0.09).
In 1979, a significantly h igher m ean A l value for FC in 
the antrum  was found in the case o f  h igher activity  o f  
gastritis (sum  o f grades 1-3) com pared with grade 0  activity  
(10.5 ± 6 .9  versus 6.3 ±  5.8; P  = 0.01). In the corpus 
m ucosa h igher A l for FC was observed in the case o f
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Table III. Results of multifactorial dispersion analysis of the effect of different variables on the expected values of AI in different 
compartments of antrum and corpus mucosa sections in the samples of 1979 and 1997
1979 1997
Foveolar cells Prolifer. zone Glandular part Foveolar cells Prolifer. zone Glandular part
Factors affecting AI F  statistic P value F  statistic P value /■’statistic /'v a lu e  /■" statistic P value F  statistic P value /■" statistic P  value
Age 2.80 0.09 0.69 0.42
Antrum
0.006 0.93 1.22 0.27 4.83 0.06 0.24 0.61
Activity of gastritis 4.70 0.01 0.91 0.43 1.06 0.37 0.73 0.48 3.3 0.11 0.52 0.59
Chronic inflamm. 1.50 0.23 0.90 0.43 3.15 0.03 0.05 0.98 1.5 0.28 1.50 0.22
Atrophy 0.18 0.67 0.01 0.89 3.60 0.06 0.27 0.60 0.33 0.58 0.79 0.37
Intest, metaplasia 1.10 0.28 0.20 0.69 3.20 0.07 0.12 0.73 0.25 0.60 0.11 0.74
H. pylori 1.80 0.15 0.69 0.57 1.16 0.33 3.37 0.02 2.4 0.15 3.05 0.03
Age 0.01 0.90 0.03 0.84
Corpus
0.16 0.68 1.40 0.24 0.35 0.55 0.04 0.83
Activity of gastritis 1.54 0.22* 0.009 0.99 0.16 0.85 1.33 0.27 0.48 0.62 0.17 0.83
Chronic inflamm. 1.06 0.37 2.16 0.1 I t 1.27 0.29 0.96 0.41 2.35 0.09 0.94 0.42
Atrophy 0.15 0.85 0.79 0.46 0.47 0.62 0.25 0.85 0.28 0.83 0.30 0.82
Intest, metaplasia 0.10 0.74 1.38 0.24 0.004 0.94 0.23 0.63 1.11 0.30 1.20 0.27
H. pylori 0.49 0.68 0.80 0.50 0.62 0.60 0.75 0.52 0.15 0.92 0.30 0.82
AI = apoptotic index.
* After gradual exclusion of the other factors, the effect of activity of gastritis appeared to be significant (P = 0.02). 
t  The effect of chronic inflammation appeared to be significant (P = 0.04).
m oderate activity o f  gastritis (9.2 ±  4.7 versus 6.4 ±  6.4 by 
grade 0; P  = 0.02).
Concerning the grade o f  chronic inflam m ation, in 1979 
m ild grade o f  chronic inflam m ation had a significant positive 
effect on AI for G P o f  the antrum  m ucosa and for PZ o f  the 
corpus m ucosa, then in 1997 a significantly low er AI was note 
in the case o f  severe grade o f  chronic inflam m ation in the 
corpus com pared with grade 0  (1.1 ± 2 .0  versus 2.9 ± 0 .8 ;  
P = 0.01).
Significant association o f  AI with grade o f H. pylori  
colonization was found only in antrum  m ucosa: in sam ples o f 
1979 in FC in the case o f  m oderate H. pylori colonization 
com pared w ith m ild colonization (10.2 ± 6 .9  versus 4.4 ±  
3.7; P  =  0.01) and in FC in the sam ples o f  1997 in the case o f 
severe (10.4 ± 6 .7 )  versus mild colonization (3.6 ± 3 .9 ;  
P  = ().00 l), as well as for G P in the ease o f  severe (1.9 ±  
2.4) versus m ild colonization (0.3 ± 0 .4 ;  P = 0.0006).
A nalysis o f Al at different grades o f  atrophy and intestinal 
m etaplasia in the sam ples o f  1979 and 1997 revealed no 
significant association betw een the m ean values o f AI and 
grade o f  atrophy or p resence o f intestinal m etaplasia either in 
the antrum  or in the corpus (P > 0.05).
M ultifactorial dispersion analysis o f  the effect o f the 18- 
year dynam ics o f  g rade o f  the Sydney param eters (activity o f 
gastritis, chronic inflam m ation, atrophy, intestinal m etaplasia 
and H. pylori  colonization) on the difference betw een the 
m ean values o f  AI in 1979 and 1997 show ed that only grade 
o f H. pylori  colonization had a significant effect on the 
difference betw een AI values for FC in the antrum . At higher 
scores o f  H. pylori colonization in 1997 the difference 
betw een m ean AI values for FC in the antrum  was signi­
ficantly h igher (F  statistic = 3.21; P  = ().03).
M ild and m oderate grades o f  activity  o f antrum  gastritis in 
1979 tended to affect the d ifference in mean AI values for FC
in the antrum  betw een the two tim e points (F  = 2.16; P  =
0.12) and severe grade o f  chronic inflam m ation in 1997 ap­
peared to affect the d ifference in m ean AI values for G P  in the 
corpus m ucosa betw een 1979 and 1997 ( F =  1.99; P  = 0.05).
Discussion
T he present work represents the first prospective investigation 
o f apoptosis in three d ifferent com partm ents o f  both antrum  
and corpus m ucosa specim ens, taken from  a random  adult 
cohort in the initial and end years o f an 18-year follow -up o f 
chronic H. pylori gastritis according to d ifferent grades o f  
atrophy, chronic inflam m ation, activity o f gastritis and H. 
pylori  colonization. A lthough the results o f  a 31-year follow- 
up study o f  gastric cellu lar turnover and developm ent o f 
atrophy were recently published by M oss et al. (18), these 
authors exam ined apoptosis at one (initial) tim e point and 
only in corpus biopsies.
The specific finding o f  the present study was that com pared 
with initial values AI for PZ and G P o f  the corpus m ucosa as 
well as for G P o f  the antrum  m ucosa decreased significantly 
during 18 years o f  follow -up, irrespective o f the dynam ics o f 
atrophic alterations (in persons w ithout developm ent o f  
atrophy and in persons w ith developm ent o f  atrophy), but 
not for the FC com partm ent.
There is ev idence that cell turnover in the gastric m ucosa is 
related to a delicate balance betw een cell proliferation and 
apoptosis. M ore intensive cell proliferation m ay induce 
increase in apoptosis, i.e. program m ed cell death, in order 
to m aintain tissue hom eostasis (1 1 ,2 6 , 27). It can be supposed 
that cell turnover is m ore intensive in younger persons. 
Evidence also exists that som e cell types m ay lose their ability 
to undergo apoptosis with increasing age (28). The subjects o f  
our study were 18 years younger in 1979 than in 1997.
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Therefore, one explanation o f  the significantly h igher Al for 
PZ and GP o f antrum  and corpus m ucosa specim ens sampled 
in 1979, com pared with those sam pled in 1997, could have 
been the h igher capacity o f  cells in PZ and GP for pro­
liferation in the initial period o f  observation when persons 
w ere younger. Consequently , to keep  cell turnover in balance, 
apoptosis m ust be m ore intensive. One can suppose that cell 
tu rnover in the FC  com partm ent, w hich is continuously m ore 
exposed to several dam aging factors, has to m aintain inten­
sive cell tu rnover also in old age. From  a m ethodological point 
o f view , com parison o f  paraffin-em bedded biopsy specim ens, 
obtained w ith an 18-year interval, should not affect the 
results, because according to the data o f  Bardales et al. (29) 
the use o f  form alin-fixed and paraffin-em bedded archival 
m aterial as old as 25 years yielded a staining pattern by the 
T U N EL m ethod sim ilar to that o f  freshly prepared tissues.
The fact that for all studied com partm ents o f the antrum  as 
well as o f  the co ipus m ucosa in the initial year o f observation, 
A l was not significantly different in the group without atrophy 
and in the g roup w ho developed a trophy 18 years later, refutes 
our hypothesis that increased apoptosis m ight induce pro­
gression o f  atrophic gastritis. An analogous result was dem on­
strated in a follow -up study by M oss et al. (18), in which the 
ratio  o f apoptosis to proliferation was not a determ inant o f 
risk fo r developm ent o f  atrophy 31 years later.
It seem s that developm ent o f  atrophy cannot be explained 
m erely by violation o f  the balance betw een apoptosis and 
proliferation. An im portant scenario o f  developm ent of 
autoim m une gastritis has been proposed by Judd et al. (30), 
nam ely that norm al developm ental pathw ays o f the gastric 
m ucosa are disrupted in autoim m une gastritis, resulting in an 
amplification o f  im m ature cell types. Differentiation o f these 
im m ature cells appears to be blocked, which contributes to 
depletion o f  end-stage cells.
C oncerning the association o f  apoptosis with gastritis the 
results o f several studies are quite different. Thus the findings 
o f  a study o f Stein inger e t al. (17) suggest that gastric atrophy 
m ight be the result o f  apoptosis in the gastric epithelium . 
A lso, according to the opinion o f  Genta (31), increased 
apoptosis in the gastric m ucosa can lead to developm ent o f  
a trophy. How ever, M oss et al. (11) found that apoptotic cell 
num ber does not correlate with the degree o f histological 
gastritis and that a com pensatory decrease in apoptotic 
activity takes place during progression o f atrophic gastritis 
and intestinal m etaplasia. A recent study o f Scotiniotis et al. 
(14) show ed that in H. pylori antral gastritis apoptosis was 
significantly reduced within foci o f intestinal m etaplasia due 
to increased cell proliferation, which could contribute to H. 
pylori associated gastric carcinogenesis. N either the study by 
M oss et al. ( 11) nor the study by Anti et al. (7) established the 
correlation o f A l w ith acute or chronic inflam m ation, whereas 
Jang & Kim  (32) found an association betw een increased 
apoptosis in antra! epithelial cells with the degree o f acute 
inflam m ation and density  o f H. pylori colonization.
An im portant finding o f  our study was that the grade o f
activity o f gastritis had the strongest effect on A l for FC, 
especially in the antrum  m ucosa, and the degree o f  chronic 
inflam m ation had the strongest effect on A l for G P  in the 
antrum  and for PZ in the corpus m ucosa. A ccording to our 
results, the grade o f  H. pylori  co lonization  affects A l for FC 
and GP only in the antrum  m ucosa. T he fact that increase in
H. pylori colonization in the antrum  during 18 years o f  
observation had a significant effect on the difference in Al 
betw een two tim e points o f observation only fo r FC o f  the 
antrum  m ucosa was also notew orthy.
M ost authors have found a significant association betw een 
apoptosis and the presence o f H. p y lori  in the gastric m ucosa 
(11-15 , 3 3 -35), suggesting a d irect effect (10, 11, 33, 35) o f
H. pylori on m ucosal cell apoptosis, o r on further m odulation 
o f  gastric epithelial cell apoptosis by im m une m ediators 
produced by neutrophils in response to H. py lo ri  (36).
The finding o f  K onturek et al. (13) suggests that H. pylori  
induces apoptosis in the gastric epithelium  due to upregula- 
tion o f proapoptotic Bax protein, while B ax overexpression  is 
stronger in the antrum  than in the corpus. The authors also 
found that activity o f gastritis was h igher in the antrum  than in 
the corpus. T hese results are in accordance w ith o u r results 
concerning the association o f  Al in the FC com partm ent with 
grade o f  H. pylori co lonization and activity  o f  gastritis, w hich 
was m ore pronounced in the antrum  than in the corpus 
mucosa.
A  significant finding o f our study was that the association 
o f  apoptosis with grade o f  H. pylori co lonization  was 
expressed d ifferently  in the antrum  and corpus m ucosa, and 
that the effect o f  grade o f activity  o f  gastritis and chronic 
inflam m ation on A l was m ore expressed in the antrum  than in 
the corpus, w hich may support the ev idence o f  a d ifferent 
environm ent in the antrum  than in the corpus (37).
In conclusion, A l is related to intensity o f  gastritis in 
general but does not appear to be associated w ith atrophy or to 
predict atrophy. In the antrum , A l was also highly dependent 
on grade o f  H. pylori  colonization.
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Abstract
Helicobacter pylori is a cause of chronic gastritis and leads to development of atrophy in some cases. There is evidence that the heat shock 
protein 60 (HSP60) o f 11 pylori is involved in induction o f chronic inflammation. Seroprevalence o f IgG antibodies to H. pylori HSP60 in an 
adult cohort from Saaremaa, Estonia (68 persons, median age 57 years), with a high prevalence o f antibodies to cell surface proteins o f  H. 
pylori (92%) and a well characterized dynamics o f  chronic gastritis in an 18-year follow-up study, was tested using purified H. pylori HSP60 
at a concentration o f 1 (ig m l" ' with ELISA. The state of the gastric mucosa and the presence o f H. pylori in histological sections in the 
samples o f  1979 and 1997 were assessed in accordance with the Sydney system. Seropositivity for H. pylori HSP60 was 65%. Immunological 
response to H. pylori HSP60 is associated with the m orphological presence of H. pylori in the antrum  and corpus (P  = 0.01) and is strongly 
correlated with the grade o f  chronic inflammation, particularly in the antrum  mucosa (/- = 0.34; / > = 0.003; O R  = 5.97 (95% Cl 1.21-29.3)), 
but is not associated with development of atrophy during 18 years of follow-up, or with the activity o f gastritis. This finding supports the 
evidence that immunological response to H. pylori HSP6Ü may play a role in triggering o f the inflam m atory process in the gastric 
mucosa. © 2001 Federation o f European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
Keywords: Helicobacter pylori h ea t shock  p ro te in  60; IgG  an tib o d y  tite r; C h ron ic  in flam m ation ; A n tru m ; C o rp u s  m ucosa;
L ong-term  fo llow -up  o f  ch ro n ic  gastritis
1. Introduction
Helicobacter pylori is a cause of chronic gastritis leading 
to development of gastric mucosa atrophy [1-4]. In 1992, 
Dunn et al. [5] identified a homologue of the chaperonin 
60 family of heat shock proteins (HSP) in H. pylori and 
showed that this protein is immunogenic in individuals 
infected with H. pylori. Among other HSPs, H. pylori 
produces mainly two HSPs: a GroES analogue, class 
HSP A (HSP13), and a GroEL analogue, class HSP B 
(HSP60) [5-7], Several reports have shown that H. pylori
* C o rresp o n d in g  au th o r. T e l.: +372 (7) 374 230;
F ax : +372 (7) 374 232; E -m ail: ta m a ra ,vorobjova@ kH inikum .ee
HSP60 plays a role in induction of chronic mucosal in­
flammation, suggesting also the triggering role of HSP60 
in mucosal inflammation o f an autoimmune type, which 
results in gastric atrophy [8-16]. Furthermore, considering 
the fact that HSP represents a dominant antigen in micro­
bial infections, a role of pathogen-derived HSP, including 
HSPs of H. pylori, has been suggested in protective im­
munity and vaccination [17-19].
The aim of the present study was to evaluate the sero­
prevalence of IgG antibodies to H. pylori HSP60 in an 
adult cohort from Saaremaa, Estonia, with a high preva­
lence of antibodies to glycine-extracted cell surface pro­
teins of H. pylori and a well characterized dynamics of 
chronic gastritis in an 18-year follow-up study [20-25], 
Another aim was to investigate the association between
0928-8244/01 /$ 2 0 .00 ®  2001 F ed era tio n  o f  E u ropean  M icrobio logical Societies. Published  by Elsevier Science B.V. A ll righ ts reserved. 
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the serological response to H. pylori HSP60 and the grade 
of H. pylori colonization, chronic inflammation, atrophy 
and activity of gastritis. Also, we analyzed whether the 
immunological response to H. pylori HSP60 was associ­
ated with the progression of chronic inflammation and 
atrophy during 18 years of follow-up.
2. Subjects and methods
2.1. Subjects
Of the initial 304 subjects of an adult sample from Saar­
emaa Island in Estonia, who had been investigated by 
endoscopy and gastric biopsy in 1979, 1985, and 1991, 
70 persons were reinvestigated in 1997. The results of these 
investigations have been published previously [20-24], 
Sixty-eight persons (31 men, 37 women, median age 57 
in 1997) in whom the state of the gastric antrum and 
corpus mucosa was evaluated at the initial (1979) and 
end (1997) points of observation and from whom serum 
samples were collected in 1997, were included in the study.
During the 18-year follow-up of the 304 subjects, 39 had 
died by 1997, and of the remaining subjects 195 were lost 
to follow-up because of severe illness, change of residence, 
failure of communication or refusal. The studied persons 
had not received any FI. pylori eradication therapy.
2.2. Histopathological examination
In 68 persons formalin-fixed, paraffin-embedded gastric 
biopsy specimens from the antrum (three specimens) and 
corpus mucosa (six specimens), taken in 1979 and 1997, 
were stained with hematoxylin and eosin, and with a 
modified Giemsa stain. The state of the gastric mucosa 
and the presence of H. pylori in histological sections 
were assessed in accordance with the updated Sydney sys­
tem [26] and scored from 0 (no changes) through 1 (mild) 
and 2 (moderate) to 3 (severe changes). The course of 
gastritis was evaluated as the difference between the first 
(1979) and the last (1997) follow-up examination over 18 
years [24].
2.3. Serological evaluation o f  IgG antibodies to 
glycine-extracted cell surface proteins o f  H. pylori
Seropositivity to H. pylori cell surface proteins (strain 
CCUG 17874) was evaluated using an enzyme-linked im­
munosorbent assay (ELISA) method as reported previ­
ously [24,25,27], In brief, 0.5 fig of acid glycine-extracted 
cell surface proteins per well were used for coating micro­
titer plates (Nunc, Roskilde, Denmark). The studied sera 
were diluted to 1:800 and as the second antibody an alka­
line phosphatase-labelled anti-human IgG (Dako, Glos­
trup, Denmark) diluted 1:500 was used. The results are 
expressed as corrected mean absorbance value as a per­
centage of the value for a reference standard (human 
y-globulin, Pharmacia and Upjohn, Stockholm, Sweden) 
as relative antibody activity (RAA) [28]; the cut-off value 
for seropositivity was set at 25 RAA units [27], The sensi­
tivity of the test was 98% and the specificity 75%.
2.4. Serological evaluation o f  IgG antibodies to H. pylori 
HSP60
For determination of antibodies for H. pylori HSP60, 
LabSyst (Labsystems, Finland) 96-well plates were coated 
with HSP60 at a concentration of 1 (ig ml-1 (0.1 jxg per 
well) for 16 h at 4°C. The used HSP60 was purified from 
supernatant of sonicated H. pylori cells by gel filtration on 
Superose 12® and by ion exchange chromatography on 
MonoQ® at pH 6.7. The purity of antigen was checked 
by immunoblot using serum of H. pylori-infected patients 
and found to be approximately 97% homogeneous. After
1.5 h of blocking with 2% bovine scrum albumin in phos- 
phate-buffered saline (PBS), plates were washed four times 
with PBS-0.05% Tween 20 (Sigma, St. Louis, MO, USA). 
Serum samples were diluted to 1:800 in PBS-0.02% Tween 
and incubated for 1.5 h at 37°C. Alkaline phosphatase- 
conjugated rabbit anti-human IgG (Dako, Glostrup, Den­
mark) was used as the secondary antibody (dilution 1:500, 
incubation for 1 h at 37°C). Bound antibodies were visu­
alized by addition of a substrate solution containing 1 mg 
ml-1 /7-nitrophenylphosphatase (Sigma, St. Louis, MO, 
USA) in diethanolamine buffer, pH 9.8. The optical den­
sity was read at 405 and 492 nm after 50 min of incuba­
tion.
The results are expressed as corrected mean absorbance 
values as a percentage of the value for a reference stan­
dard (human y-globulin, Pharmacia and Upjohn, Stock­
holm, Sweden) as relative antibody activity (RAA). The 
cut-off value for seropositivity to H. pylori HSP60 
(RAA = 24) was based on results obtained by testing 28 
sera, previously known to be negative for antibodies 
against the H. pylori glycine-extracted cell surface protein 
(mean absorbance value of 28 II. pylori-negative persons 
plus 2 S.D.). The sensitivity of the test was 69% and the 
specificity 83%.
2.5. Statistical analysis
Data are presented as positive or negative test results 
for antibodies against H. pylori glycine-extracted cell sur­
face proteins and H. pylori HSP60 and as the mean values 
of RAA to H. pylori HSP60. Differences in the number of 
positive cases between the groups were tested using the y}  
test. Differences in the mean values of RAA as the expres­
sion of the anti-H. pylori HSP60 IgG level were calculated 
with Student’s Mest. Odds ratios (OR) with 95% confi­
dence intervals (Cl) were estimated using Mantel-Haenzel 
statistics with Exact software. Differences were considered 
statistically significant when the 95%> Cl did not include
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the value 1.0. Correlation between the values of RAA of 
H. pylori HSP60 antibodies and the grade of H. pylori 
colonization, chronic inflammation, atrophy, and ac­
tivity of gastritis, as well as their interrelationships were 
evaluated using Spearman’s rank correlation test and mul­
tiple regression analysis (Statistika, Statsoft 99). P values 
<  0.05 were considered significant.
The Committee of Ethics of the University of Tartu 
approved this study.
3. Results
3 .I. Seropositivity to H. pylori HSP60 in the serum 
samples o f  1997 and its correlation with gastritis 
parameters
Forty-four out of 68 (65%) tested sera were positive for 
H. pylori HSP60 antibodies compared to 63 out of 68 
(92%) positive sera in ELISA using //. pylori glycine-ex­
tracted cell surface proteins as the antigen. Seventy percent 
(44 out of 63) of sera positive for glycine-extracted cell 
surface proteins of H. pylori possessed IgG antibodies to 
H. pylori HSP60.
Grading of H. pylori colonization, activity of gastritis,
chronic inflammation, and atrophy, as well as ORs for the 
association between positivity to II. pylori HSP60 and 
gastritis parameters and the mean values of RAA to 
//. pylori HSP60 in the antrum and corpus mucosa are 
presented in Table 1. A significant difference was found 
in seroprevalence with respect to H. pylori HSP60 between 
persons with histological presence and persons with histo­
logical absence of H. pylori in the gastric mucosa (41/59 
versus 3/9 in antrum, P -  0.03; 43/62 versus 1/6 in corpus, 
P = 0.01). Among six persons whose antrum as well as 
corpus were morphologically H. pylori-negative, only one 
was seropositive for H. pylori HSP60, while two had 
antibodies to the H. pylori glycine-extracted cell surface 
antigen. The RAA value of anti-//, pylori HSP60 IgG in 
persons without histologically observable H. pylori coloni­
zation in antrum or in corpus mucosa was significantly 
lower than in persons with morphologically diagnosed 
H. pylori (P = 0.01 for the antrum and P = 0.01 for the 
corpus mucosa). However, the grade of histological 
H. pylori colonization did not correlate significantly with 
seropositivity for H. pylori HSP60 (r = 0 .12, P  =  Q.29 for 
the antrum and r -Q .Q l, P  =  0.52 for the corpus).
The correlation between anti-H. pylori HSP60 IgG anti­
bodies and grade of chronic inflammation was significant 
(r = 0.34, P = 0.003 for the antrum and r = 0.26, / > = 0.04
T ab le  1
G rad e  o f  activ ity  o f  g astritis , chronic  in flam m ation , a trophy , H. pylori co lonization , and  O R s fo r assoc ia tion  betw een an tibod ies  fo r H. pylori H SP60 
and  all these p aram eters  fo r the  an tru m  an d  co rpus m ucosa
G rad in g A n tru m C orpus
n IgG  to  H SP60 
presen t
O R
(95'/» C l)
RA A
(m ean ±  S.D .)
n Ig G  to  H SP60 
presen t
O R
(95%  C l)
R A A
(m ean ±  S .D .)
A ctiv ity  o f  gastritis
0 16 8 1 35.3 ± 3 4 .6 25 15 1 35.8 +  28.5
1 Al 31 1.93 (0.63-5.89) 42.7 ± 29.8 29 20 1.48 (0 .49-4.40) 46.9 ± 31 .1
2 5 4 4.0 (0.48-32.90) 52.2 + 24.7 14 9 1.20 (0.32-4.30) 41.4 ± 2 9 .7
3 0 0 - - 0 0 - -
1-3 52 35 2.05 (0.68-6.18) 43.6 + 29.2 43 29 1.38 (0.5-3 .740) 4 5 .1 + 3 0 .4
C hron ic  in flam m ation
0 7 2 1 13.4 ± 16.8* 5 1 1 12.8 ±  19.3*
1 10 6 3.75 (0.55-25.30) 44.6 ± 34 .7** 11 6 4.8 (0 .53-43 .20) 38.4 ± 2 9 .9
2 40 28 5.83 (1.13-29.90) 44.7 ±  30.0 29 20 8.8 (1 .1-69 .0) 42.5 ± 2 8 .5
3 11 9 11.2 (1.41-89.50) 61.3 ±31 .4*** 23 17 11.3 (1.37-93 .40) 48.5 ± 3 1 .0 ”
1-3 61 43 5.97 (1.21-29.30) 47.7 ±31 .2**** 63 43 8.6 (1 .18-61 .50) 4 3 .9 ± 2 9 .5 m
A trophy
0 51 33 1 42.5 ± 3 1 .2 36 22 1 41.2 ± 3 0 .6
1 15 10 1.09 (0.33-3.50) 45.0 ± 30.2 17 11 0.33 (0.08-1 .33) 38.0 ± 2 6 .0
2 2 1 0.54 (0.05-5.59) 24.0 ± 8 .4 10 8 2.54 (0 .53-12.10) 48.0 ± 3 2 .4
3 0 0 - - 5 3 0.95 (0.16-5 .40) 45.6 ± 3 8 .4
1-3 16 11 1 (0.32-3.39) 42.5 ± 29.2 32 22 1.4 (0 .51-3.720) 42.3 ± 2 9 .4
H. pylori
0 9 3 1 20.8 ± 24.2" 6 1 1 14.3 ±  17.7*
1 18 13 5.2 (1.02-26.40) 48.7 ± 33 .7** 21 16 16 (1 .92-133 .0) 50.6 ±  3 3 .0 "
2 9 7 7.0 (1 .0-48.60) 47.5 ±  26.3 10 8 20 (1 .82-218 .0) 38.9 +  21.9
3 32 21 3.82 (0.87-16.60) 42.0 ± 28.4""* 31 19 7.9 (1 .07-58.20) 41.9 ±  29.3—
1-3 59 41 4.55 (1.1-18.50) 44.8 ± 29.5s '" '" 62 43 11.3 (1.62-78 .90) 44.3 ±  29.5’““"
Significant difference: * < * * / ’ = 0.02; * < * * * /*  =  0.003: * <  ****p  = 0 .003; w<" * /> =  0.03; »<*#»/> =  0.01; #<#### p  — Q Q | . T <11 p  - 0.02; , < n t /> =  0.01;
•<- />  =  0.01; *<* " P = 0.02; •<" " / >  =  0.01.
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Grade of chronic inflammation in the antrum
Fig. 1. C orre la tion  betw een an ti-/A  pylori H SP60 R A A  a n d  grade o f 
ch ron ic  inflam m ation  in the  an tru m  m ucosa accord ing  to  the sam ples o f 
1997. r  =  0.34, P  =  0.003.
for the corpus mucosa) (Figs. 1 and 2). The OR for the 
association of seropositivity for H. pylori HSP60 and 
chronic inflammation was particularly high in the case of 
a severe grade of chronic inflammation both for the an­
trum (OR =11.2 (95% CT 1.41-89.5)) and for the corpus 
mucosa (OR =11.3 (95% Cl 1.37-93.4)). Persons with a 
severe grade of chronic inflammation expressed simultane­
ously in both parts of the stomach displayed significantly 
higher values of RAA of anti-//, pylori HSP60 
(73.8.±20.8) compared with those with absence of chronic 
inflammation (15.5 ± 21.2, / ’ = 0.004) (Table 2).
No significant correlation was found of seropositivity to 
H. pylori HSP60 with grade of atrophy (r = 0.013, P -Q .9 \  
for the antrum and r = 0.04; P -  0.70 for the corpus), or 
with activity of gastritis (r = 0.20, P = 0.08 for the antrum; 
r = 0.12, P =  0.29 for the corpus).
In multiple regression analysis, H. pylori HSP60 was 
significantly associated with the grade of chronic inflam­
mation (for the antrum: /?= 0.635, P - 0.003; for the cor­
pus: /J= 0.474, / > = 0.01). The grade of chronic inflamma­
tion in the antrum was the highest independent predictor 
of seropositivity to H. pylori HSP60 (^ = 0.628, /> = 0.01). 
Moreover, a correlation between grade of chronic inflam­
mation and grade of H. pylori was found for the antrum 
(r = 0.45, P -  0.00008) but not for the corpus mucosa 
(r = 0.19, P = 0.11).
Fig. 2. C orre la tion  betw een an ti-H. pylori H SP60 R A A  a n d  grade  o f  
ch ron ic  in flam m ation  in the  co rp u s m ucosa acco rd ing  to  the  sam ples o f  
1997. /• =  0.26, P  =  0.04.
3.2. Progression o f  chronic inflammation and seropositivity 
to H. pylori HSP60
The progression of chronic inflammation in grade in the 
antrum and corpus mucosa, positivity, and the mean val­
ues of RAA to H. pylori HSP60 in the serum samples of 
1997 are presented in Table 3. Persons whose grade of 
chronic inflammation in the antrum increased from grade 
0 in 1979 to grade 3 in 1997 showed significantly higher 
values of RAA to H. pylori HSP60 (65.7 ±21.2) compared 
with those who had no inflammation (17.4 ± 18.8, 
P  = 0.008) or with those in whom inflammation regressed.
The corpus mucosa of persons whose chronic inflamma­
tion increased from mild to severe displayed significantly 
higher mean values o f RAA to H. pylori HSP60 
(72.5 ±34.8) compared with persons in whom chronic in­
flammation remained mild during the follow-up period 
(P = 0.04). Also, persons with severe chronic inflammation 
in the corpus at both time points showed a more pro­
nounced response to H. pylori HSP60 (62.7 ±30.6) than 
those who had moderate chronic inflammation in 1979 
and 1997 (29.0 ±16.5, P  =  0.02).
3.3. Dynamics o f  atrophy and seropositivity to H. pylori 
HSP60
Additionally, we compared seropositivity for H. pylori 
HSP60 in persons who developed atrophy in the antrum 
during 18 years of observation (four out of five cases;
Seropositiv ity  for H. pylori H SP60 a t different g rades o f  ch ron ic  in flam m ation  expressed sim ultaneously  in the  a n tru m  an d  c o rp u s  m ucosa  accord ingly  
to  the  sam ples o f  1997
G ra d e  o f  ch ron ic  inflam m ation  
A n tru m  C o rp u s
n IgG  to  H SP60 presen t O R  (95% C l) R A A  (m e a n ± S .D .)
0 0 4 1 1 15.5 + 21.2*
1 1 3 2 6.0 (0.34-103.80) 48.3 ± 3 7 .5
2 2 19 14 8.4 (0 .94-74.80) 42.1 ± 2 5 .2
3 3 5 5 15 (0.95-236.0) 73.8 +  20.9**
* * > * p  =  0.004.
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Tabic 3
Dynam ics o f  grad? o f  chronic in flam m ation  in the antrum  and corpus mucosa and seropositivity to H. p y lo r i  H SP60
D ynam ics o f  
chronic 
inflam m ation  
(grades 0 -3 )
A n trum Corpus
1979 1997 n Ig G  to H SP60  
present 1997
O R  (95%  C l) R A A
(m c a n ±  S .D .)
n Ig G  to H SP60  
present 1997
O R  (95'/» C l) R A A
(mean 1  S .D .)
0 0 5 2 1 1 7 ,4 ±  18.8* 4 I 1 1 5 .5 1 2 1 .2
0 1 2 1 3.2 (0 .50-20 .60) 40.5 +  41.7 5 4 12.0 (0 .7 4 -19 2 .30 ) 5 1 .0 1 3 3 .5
0 2 13 8 2.4(0 .35 -16.40) 42.7 ± 3 5 .0 9 6 6.0 (0 .5 7 -62 .6 0 ) 4 9 .3 1 3 4 .7
0 3 4 4 6.0 (0 .49-72 .90) 65.7 +  21 .2»* 10 5 3.0 (0 .3 1 -28 .7 0 ) 33.1 1 3 0 .0
1 1 4 4 6.0 (0 .49-72 .90) 56.0 +  29.6 5 1 0.75 (0 .0 5 -10 .5 0 ) 2 4 .6 1 2 5 .8 ’
1 2 7 5 3.7 (0 .41-33 .70) 4 4 .0 ± 2 6 .8 7 6 18.0 (1 .15 -28 0 .80 ) 46.7 +  27.9
1 3 2 1 1.5 (0 .09-24 .00) 4 7 .5 1 5 1 .6 4 3 9.0 (0 .54 -14 8 .10 ) 7 2 .5 1 3 4 .8 * *
2 2 17 12 3.6 (0 .54-23 .80) 38.1 + 2 0 .2 9 5 3.8 (0 .3 7 -37 .3 0 ) 2 9 .0 1 1 6 .5 “
2 3 5 4 6.0 (0 .49-72 .90) 6 2 .2 1 3 4 .9 5 5 15.0 (0 .9 5 -23 6 .50 ) 4 8 .8 1 1 7 .0
3 3 0 0 - - 4 4 12.0 (0 .74 -19 2 .30 ) 6 2 .7 1 30.6#*
1 0 1 0 0 2.0 1 0 0 2.0
2 0 t 0 0 5.0 0 0 - -
3 0 0 0 0 0 - -
2 1 4 1 0.5 (0 .0 4 -6 .00 ) 35.2 +  43.0 1 1 0 45 .0
3 2 3 2 3.0 (0 .22-40 .30) 3 8 .6 1 3 4 .5 4 3 9.0 (0 .5 4 -14 8 .10 ) 50.5 +  35.8
To ta l 68 44 68 44
* *  >  T  =  0.008; t t> i7 ’  =  0.04; m > P  =  0.02.
RAA = 49 ±21.4) and in persons who did not develop it 
(24 out of 37 cases; RAA = 41.2±29.5, P = 0.57, OR = 
2.16 (95% Cl 0.29-15.9)). Among persons who developed 
atrophy in the corpus mucosa, 17 out of 23 cases displayed 
seropositivity for H. pylori HSP60 (RAA = 44.7 ±27.5), 
while among persons who did not develop atrophy, sero­
positivity was detected in 16 out of 27 cases (RAA = 
40.0 ±32.2, P =  0.58).
4. Discussion
In the present study the seroprevalence of IgG antibod­
ies to H. pylori HSP60 was evaluated in a random adult 
cohort with knowledge of the dynamics of chronic gastritis 
during an 18-year follow-up and with a high prevalence of 
antibodies to the glycine-extracted cell surface proteins of
H. pylori [20-26],
The specific finding of the study was that immunological 
response to H. pylori HSP60 was restricted to morpholog­
ical presence of H. pylori and was strongly correlated with 
grade of chronic inflammation, particularly in the antrum 
mucosa.
Our results concerning seropositivity to H. pylori HSP60 
among H. pylori-infected persons are in accordance with 
the data of Macchia et al. [6], who found that 50% of H. 
pylori-infected patients with gastroduodenal diseases dis­
played an immune response for H. pylori HSP60. These 
authors noted that the presence of H. pylori HSP60 pos­
itivity varied greatly among different individuals. Suer- 
baum et al. [7] demonstrated too that 76.3% of H. pylo- 
r/-infected patients were positive for MBP-HspB
recombinant proteins. Why only some of the infected per­
sons develop an immunological response to HSP60 is not 
known. Kansau and Labigne [29] explained this by host- 
specific factors.
In our study we established a significant difference in 
seroprevalence for H. pylori HSP60 between persons in 
whom H. pylori was morphologically present in the gastric 
mucosa and those in whom it was absent. A noteworthy 
finding of our study is that the immunological response to 
H. pylori HSP60 is strongly correlated with grade of 
chronic inflammation, particularly in the antrum mucosa, 
supporting the view that H. pylori HSP60 is able to evoke 
an inflammation response in the gastric mucosa [5,8,9—
11,13-16], A good correlation between serological re­
sponse to H. pylori Hp54K (an analogue of HSP60) and 
mucosal inflammation (both acute and chronic) was found 
in a study of Perez-Perez et al. [10], In our study, however, 
we could not establish a correlation between serological 
response to H. pylori HSP60 and grade of activity of gas­
tritis in the antrum or in the corpus mucosa. Nor did we 
detect any association with atrophy or with dynamics of 
atrophic alterations during 18 years of follow-up, whereas 
in a study of Barton et al. [12], IgA antibodies to myco­
bacterial and human HSP60 (sharing 75% sequence ho­
mology with H. pylori HSP60) were associated with the 
presence of gastric atrophy.
The particular association of a serological response to 
H. pylori HSP60 with chronic gastric inflammation can be 
explained by the fact that H. pylori HSP60 induces inter­
leukin-8 (IL-8) secretion from human gastric cells [16]. IL- 
8 is known to be an inflammatory cytokine [30].
The important finding of our study was that the pres­
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ence of antibodies to H. pylori HSP60 was also associated 
with an increase in chronic inflammation during 18 years 
of follow-up. Persons who developed a higher grade of 
inflammation during 18 years also had a higher level of 
IgG antibodies to H. pylori HSP60 at the end point of 
observation. Regrettably, since serum samples from 1979 
were not available any more, it was not possible to follow 
the presence of antibodies to H. pylori HSP60 during this 
period. Nevertheless, the follow-up data support the view 
that H. pylori HSP60 plays an important role in triggering 
gastric mucosal inflammation [10,14].
In conclusion, the immunological response to H. pylori 
HSP60 was associated with the histological presence of 
H. pylori in the antrum and corpus mucosa and was 
strongly correlated with grade of chronic inflammation, 
particularly for the antrum mucosa, as well as with pro­
gression of chronic inflammation, but not with develop­
ment of atrophy during 18 years of follow-up or with 
activity of gastritis.
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Abstract
The aim of the study was to assess the effect of H. pylori on epithelial cell 
proliferation and on the expression of the apoptosis protector oncoprotein bcl-2 
at different grades of chronic inflammation and atrophy in the antrum and 
corpus mucosa. Furthermore, the effect of H. pylori and of the severity of 
chronic gastritis on the density of gastrin (G) and somatostatin (S) cells as well 
as on the number of P~ H+, K+ ATP-ase immunoreactive cells was tested. The 
antrum and corpus biopsies of 59 patients (34 men, median age 47) endoscoped 
at the Gastrointestinal Unit of University Hospital, Bern, were analysed for 
H. pylori density, presence of chronic inflammation and atrophy. Immuno­
staining for PCNA (APAAP method), Ki-67, bcl-2, G-, and D-cells, as well as 
for P- H+, K+ ATP-ase (Avidin-Biotin method) was performed on formalin 
fixed, paraffin embedded biopsy specimens. Gastric mucosal glands in the 
antrum and corpus were divided into the foveolar cell (FC) compartment, the 
proliferating zone (PZ) and the glandular part (GP). There was a significant 
correlation between the labelling index of PCNA and Ki-67, and severity of 
chronic inflammation and atrophy in the corpus (p=0.03; p=0.01) but not in the 
antrum mucosa. Bcl-2 positive epithelial cells were found in PZ of atrophic 
antrum and PZ and GP of non-atrophic and normal corpus glands. In the corpus 
mucosa, the density of bcl-2 positive interstitial lymphocytes in PZ and GP was 
significantly higher in atrophic than in non-atrophic mucosa (p=0.01; p=0.002), 
while in the antrum bcl-2 positivity of interstitial lymphocytes was more 
associated with H. pylori score (p=0.08). The densities of G and D cells in the 
PZ of antral glands and of P- H+, K+ ATP-ase positive parietal cells in the
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corpus mucosa showed significant negative correlations with severity of 
atrophic alterations (p=0.009; p=0.0004; p=0.0009), but not with H. pylori 
density (p=0.87). We conclude, that severity of gastritis and presence of H. 
pylori affect gastric epithelial cell proliferation and the expression of bcl-2 
protein in gastric epithelial cells and interstitial lymphocytes differently in the 
antrum and corpus mucosa.
Key words: Helicobacter pylori, chronic gastritis, antrum and corpus mucosa, 
PCNA, Ki-67, bcl-2, gastrin and somatostatin cells, p - H+, K+ ATP-ase.
Introduction
Helicobacter pylori (H. pylori) is associated with enhanced gastric inflam­
matory response, atrophy and increased risk for development of peptic ulcer and 
gastric cancer [10, 16, 36, 41, 43]. There is also evidence that H. pylori is 
associated with changes in epithelial cell turnover, including the influence on 
programmed cell death or apoptosis [1, 5, 9, 19, 20, 25, 28, 33, 50]. Up- 
regulation of apoptosis protectors may supply cells with a survival advantage 
and hence play a role in carcinogenic pathway [26], The expression of the 
apoptosis protector, bcl-2 protein, is enhanced in the case of gastric carcinoma 
as well as in the proliferative zone of gastric glands in presence of chronic 
atrophic gastritis with intestinal metaplasia [26, 38, 40, 47].
Several earlier studies have shown that H. pylori can affect gastrin (G) cells 
as well as somatostatin (D) cell density, in particular with selective reduction 
and suppression of D-cells, which results in reduced inhibition of G-cell 
secretion by somatostatin [17, 21, 22, 32, 34, 35, 37, 39, 48]. In contrast, the 
influence of H. pylori on the density of parietal cells, expressing the p subunit 
of H+, K+ ATP-ase, is not so widely described. However, recent studies have 
demonstrated association between H. pylori and development of autoimmune 
reactions against canalicular structures within human parietal cells [14, 51]. 
Gastric H+, K+ ATP-ase represents a major autoantigen in the canaliculi of 
parietal cells and the association of anticanalicular autoantibodies with gastric 
corpus atrophy was confirmed [8, 14, 23, 51]. The significance of homology 
between the P subunit of H+, K+ ATP-ase of parietal cells and H. pylori urease 
was also shown [49]. These relationships suggest a role of H. pylori in 
development of gastric corpus autoimmunity [14, 49].
The aim of the present study was to assess the effect of H. pylori on epithe­
lial cell proliferation and on the expression of the apoptosis protector onco­
protein bcl-2 as a function of gastric site (antrum versus corpus), grade of 
chronic inflammation and atrophy. Furthermore, using the same biopsy speci­
mens, we aimed to assess the effect of H. pylori and the severity of gastritis on 
the density of G and D cells and p H+, K+ ATP-ase immunoreactive cells.
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In this study we tested the hypothesis that H  pylori enhances epithelial cell 
proliferation and affects the expression of the bcl-2 protein as well as the 
density of specific glandular cells in the antrum and corpus at advanced grades 
of chronic inflammation and in case of antrum and corpus mucosal atrophy.
Subjects and Material
A total of 59 patients (34 men, median age 47), endoscoped at the Gastro­
intestinal Unit of University Hospital, Bern, during 1993 (retrospective study -  
39 persons) and in January-February 1994 (prospective study -20 persons) were 
studied. The group of patients included 20 persons with peptic ulcer (gastric 
ulcer -  4 cases; duodenal ulcer -  16 cases); 18 with erosion in the antrum or/and 
corpus mucosa and duodenitis; 5 with hiatus hernia; one with reflux 
oesophagitis; one with gastric corpus adenocarcinoma; one with a tumor of the 
liver and pancreas; one with colon carcinoma; and one with liver cirrhosis. In 
11 patients no pathological gastroduodenoscopic findings were established.
In 40 patients, minimum two biopsies were sampled both from the antrum and 
corpus, in 16 patients only from the antrum, and in 3 patients only from the 
corpus. The 56 antrum and 43 corpus biopsies were fixed in 4% formalin and 
embedded in paraffin.
Methods
Histopathologic evaluation
The state of the gastric mucosa and the presence of H. pylori was examined in 
haematoxylin and eosin-stained sections and graded as normal — no loss of 
glands and no chronic inflammation (score 0), non-atrophic gastritis: chronic 
inflammation present without atrophy and scored as 0.5 (mild), 1.0 (moderate) 
and 1.5 (severe) and atrophic gastritis in three stages: mild, moderate, severe 
loss of mucosal glands, varying grade and extent of inflammation (score 
numbers correspondingly 2, 3, 4). The severity of H  pylori colonization was 
evaluated as follows: absence of bacteria (grade 0), mild (grade 1), moderate 
(grade 2) or severe (grade 3) colonization, according to evaluation of gastritis, 
described by Kekki et al. [24] and used in the study of Maaroos et al. [32]. 
These grades correspond to the Sydney classification system [13 ].
Immunohistochemistry
Gastric epithelial cell proliferation was assessed by employing both the 
Proliferating Cell Nuclear Antigen (PCNA) and Ki-67 (MIB 1) labelling. Since 
PCNA is increasingly expressed through the Gj phase, reaching its maximum in 
the early S phase and persisting in the G2 phase [31], while the Ki-67 antigen is 
expressed in all phases except G0 and early G] [15], we used both antibodies.
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PCNA immunostaining was performed using the alkaline phosphatase anti- 
alkaline phosphatase (APAAP) procedure. After deparaffinisation and pre­
treatment with 20% acetic acid (15 sec, 4°C) and 3% BSA (Merck) in TRIS- 
NaCl buffer (20 min., 20°C), tissue sections were incubated overnight (4°C) 
with a primary mouse monoclonal antibody against PCNA (PCNA PC 10, 
DAKO, Glostrup, Denmark, dilution 1:50). Rabbit anti-mouse immunoglobulin 
(DAKO, Glostrup, Denmark, dilution 1:30) was used as the secondary antibody 
(incubation 30 min, at 20°C). The APAAP mouse monoclonal antibody 
complex (DAKO, Glostrup, Denmark, dilution 1:50) was then applied for 60 
min. To enhance the intensity of final staining, these two steps were repeated. 
New fuchsine (Merck)- naphthol AS-Bi phosphate (Sigma, St. Louis, USA), in 
TRIS-HC1 buffer, pH 8.7, containing 2.1 mg/ml levamisole (Sigma, St. Louis, 
USA) was used as the alkaline phosphatase substrate for 20 min. at room 
temperature. The reaction was stopped by rinsing the sections in cold water. 
The sections were counterstained with haematoxylin (Merck) and mounted with 
Aquatex (Merck).
Immunostaining for Ki-67, bcl-2 oncoprotein, as well as for gastrin, somato­
statin, and (3-H+, K+ ATPase immunoreactive cells was performed using 
avidin-biotin procedure. After deparaffinisation and rehydration, the sections 
were treated in the microwave oven in 10 mM citrate buffer, pH 6.0 at 190 W 
for 5 min. and twice at 140 W for 5 min. before staining for Ki-67, bcl-2 and 
gastrin cells. Further, the plastic jar was allowed to cool for 15 min. at room 
temperature and was then washed for 10 min. in TRIS-NaCl buffer, pH 7.5.
As primary antibodies, monoclonal anti Ki-67 (MIB-1, Dianova, Hamburg, 
dilution 1:50), the anti-human bcl-2 oncoprotein (clone 124, DAKO, Glostrup, 
Denmark, dilution 1:50), the anti- (3 subunit of H+, K+ ATP-ase (AB 2611 
kindly donated by Dr. J.G. Forte, Berkeley, USA; dilution 1:200), and 
polyclonal anti-gastrin (DAKO, Glostrup, Denmark; dilution 1:300) and anti­
somatostatin (DAKO, Clostrup, Denmark; dilution 1:1000) were used. Anti- (3- 
H+, K+ ATPase and anti-somatostatin antibodies were applied on tissue 
sections without microwave pre-treatment of the last. All primary antibodies 
were diluted in the TRIS-NaCl buffer with 0.1% casein and 0.1% NaN3 (pH 
7.5). The preparations were incubated with primary antibodies for 60 min. at 
20°C. Subsequently, the sections were incubated with rabbit anti-mouse 
biotinylated immunoglobulins (DAKO, Glostrup, Denmark) for monoclonal 
primary antibodies, or with swine anti-rabbit immunoglobulins biotinylated 
immunoglobulins (DAKO, Glostrup, Denmark) for polyclonal primary antibo­
dies at dilution 1:200 for 45 min. The Avidin-Biotin Complex (DAKO, 
Glostrup, Denmark) was applied for 45 min. at room temperature. Alkaline 
phosphatase reaction was developed for 30 min. in the New Fuchsine substrate 
solution. The specimens were then washed in tap water, counterstained with 
haematoxylin and mounted with Aquatex (Merck). Negative controls were 
performed by replacing the primary antibodies by the TRIS-NaCl buffer.
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Evaluation o f immunostained sections
The sections were examined using an objective x40 and an eyepiece xlO. Antral 
and corpus mucosa glands were divided into the foveolar cells compartment 
(FC), the proliferating zone (PZ; neck-isthmus) and the glandular part (GP). In 
each of them five fields were examined.
Only bright red stained nuclei were considered positive either for PCNA or 
for Ki-67. PCNA and Ki-67 labelling index (LI) were defined as the proportion 
of bright red stained nuclei in relation to 100 nuclei counted per field. Bcl-2 
positive staining for interstitial lymphocytes was scored as 0-5. Bcl-2 staining 
of epithelial cells in the antrum and corpus mucosa was considered positive (red 
staining of cytoplasm) or negative.
The densities of G, D and p- H+, K+ ATP-ase positive cells were expressed 
as the mean values of cells counted in five fields of each gland part. The slides 
were analysed by one investigator (T.V.) who was not aware of the data of 
histological alterations. The intraobserver variability was 12.6±7.0 %.
Statistics
Values of LI were indicated as mean ± SD. Statistical analysis was done with 
Student’s t-test, %2, Spearman rank correlation analysis (Statgraphics software) 
as well as with the use of multiple regression analysis (Statistika, StatSoft 99). 
P-values <0.05 were considered significant.
The Ethics Committee of University Bern, Switzerland has approved the 
study protocol.
Results
The state of the antrum and corpus mucosa and the presence of H  pylori in the 
studied biopsy specimens are presented in Table 1. There was a significant 
positive correlation between density of H. pylori and severity of gastritis in the 
antrum (r=0.37, p=0.006) but not in the corpus mucosa (r=0.13, p=0.37).
Gastric epithelial cell proliferation in association with severity o f gastritis and
H. pylori colonization
Mean PCNA and Ki-67 LI in different parts of antral and corpus glands, and 
their relation to gastritis and H  pylori status are presented in Table 2. Overall 
mean PCNA LI was significantly higher in the antrum than in the corpus 
mucosa (p=0.02 for PZ; p=0.01 for GP). PCNA LI in FC and GP of corpus 
glands by presence of atrophic alterations was significantly higher as compared 
to non-atrophic and normal mucosa (p=0.007 and p=0.03 respectively). Also the 
correlation analysis showed a significant correlation of PCNA LI in corpus 
glands with severity of chronic inflammation and atrophy (r=0.34; p=0.03 for 
FC and r=0.46; p=0.001 for GP). However, there was no correlation of PCNA
5
LI and severity of gastritis in antrum (p=0.40, p=0.81; p=0.29 for FC, PZ and 
GP respectively). PCNA LI and Ki-67 LI in FC, PZ and GP of the corpus 
mucosa did not correlate with the H. pylori colonization (p=0.47, p=0.53; 
p=0.09 for PCNA LI and p=0.99; p=0.51; p=0,14 for Ki-67). GP of antral 
glands, however, revealed a tendency for a negative correlation between mean 
PCNA LI and H. pylori density score (r=-0.23; p=0.09). Mean values of PCNA 
and Ki-67 LI in the antrum and corpus were significantly correlated (p=0.01 to
0.004 depending on the gland part). A significant positive correlation was found 
between Ki-67 LI and severity of chronic inflammation and atrophy in FC and 
GP of corpus mucosa (r=0.32; p=0.04; r=0.46; p=0.01), but not with H. pylori 
density score (p=0.12; p=0.70; p=0.51 in FC, PZ and GP).
Multiple regression analysis showed that proliferation activity in the corpus 
mucosa depended significantly on the severity of chronic inflammation and 
atrophy but not on the H. pylori density (for PCNA LI in FC (3=0.51; p=0.0007; 
in GP (3= 0.46; p=0.002; for Ki-67 LI in FC (3=0.33; p=0.03; for GP (3=0.36; 
p=0.01). In the antrum mucosa proliferation activity showed a tendency for 
negative association with antrum gastritis only for Ki-67 in PZ ((3= -0.23; 
p=0.09).
Immunoreactivity o f gastric epithelial cells and interstitial lymphocytes 
for bcl-2 protein
Bcl-2 positive staining was found in epithelial cells, i.e. parietal cells in the 
corpus and neck cells in the antral mucosa (in 16 cases: 8 in the antrum and 8 in 
corpus mucosa; (Table 3). In the antrum positive staining for bcl-2 positive 
epithelial cells was observed predominantly in the atrophic PZ of the mucosa 
(4/8 cases), whereas in the corpus bcl-2-positive staining of epithelial cells 
occurred in the normal and non-atrophic GP of the glands (3/8 and 2/8 cases 
respectively), in 2 out 8 cases in non-atrophic PZ and only in one case in 
atrophic PZ of corpus mucosa.
The density of bcl-2 positive interstitial lymphocytes in the corpus mucosa 
was positively correlated with the severity of chronic inflammation and atrophy 
in PZ and GP (r=0.37, p=0.01; r=0.29, p=0.04). The mean value of bcl-2 
positive staining score of interstitial lymphocytes (Table 3) was significantly 
higher in atrophic corpus gastritis than in non-atrophic gastritis (in FC, PZ and 
GP, p=0.01, p=0.02 and p=0.002 respectively). The overall mean bcl-2 positive 
staining score of interstitial lymphocytes for PZ of the antrum mucosa was 
significantly higher compared with the respective score for PZ of the corpus 
mucosa (p=0.02).
Multiple regression analysis showed that the bcl-2 positive staining of 
interstitial lymphocytes in the corpus mucosa depended significantly on the 
severity of gastritis but not on the H. pylori density score (for FC P=0.45; 
p=0.002; for PZ (3=0.47; p=0.001; for GP (3=0.58; p=0.00003). In the antral
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mucosa, positive staining of interstitial lymphocytes for bcl-2 was more 
associated with H. pylori score (in PZ p=0.24; p=0.08).
G, D and (3- H+, K+ ATP-ase -positive cell densities and association with 
gastritis and H  pylori scores.
The densities of G and D cells in PZ of antral glands revealed a significant 
negative correlation with the severity of atrophic alterations score (r— 0.34, 
p=0.009, r=-0.52, p=0.0004, respectively). Mean G and D cell density (Table 4) 
was significantly lower in non-atrophic and in atrophic gastritis compared with 
the normal mucosa (p=0.04; p=0.02 for G cells and p=0.02 and p=0.0005 for D 
cells). Mean G cell number in the H. pylori positive atrophic mucosa tended to 
be lower (16.2±14.7) compared with the H. pylori negative atrophic mucosa 
(26.2±25.2, p=0.22), and D cell density in the antrum tended to have a negative 
correlation with H. pylori score in the antrum (r— 0.24, p=0.06, respectively).
The density of (3-H+, K+ ATP-ase positive parietal cells in the atrophic 
corpus mucosa was significantly lower compared with the normal mucosa 
(p=0.0004) and non-atrophic gastritis (p=0.0001). There were no significant 
differences between the mean densities of p-H+, K+ ATP-ase positive parietal 
cells in the H. pylori positive and H. pylori negative mucosa (p=0.29). Also, 
multiple regression analysis showed that the density of (3- H+, K+ ATP-ase 
positive cells was significantly dependent on grade of atrophy in corpus 
(P=-0.65; p=0.000007) but not on H. pylori score ((3=0.053; p=0.66).
The comparison of the antrum and corpus with regard to proliferation 
activity, expression of bcl-2 and density of specific cells in association with 
severity of gastritis and H. pylori colonization is summarized in Table 5.
Discussion
In the present study, gastric epithelial cell proliferation, the expression of the 
apoptosis protector, bcl-2 protein, as well as the density of specific cells in the 
antrum and corpus mucosa and their dependence on severity of gastritis and H. 
pylori colonization were studied with conventional morphologic and immuno- 
histochemic techniques in gastric biopsies from 59 patients who had an upper 
gastrointestinal endoscopy. The most important finding of our study was that 
the severity of gastritis and the presence of H. pylori have an influence on 
gastric epithelial cell proliferation and expression of the bcl-2 protein in gastric 
epithelial cells and in interstitial lymphocytes differently in the antrum and 
corpus mucosa. A significant positive correlation between proliferation activity 
and grade of chronic infiltration and atrophy was found in the corpus (atrophic 
mucosa exhibiting higher PCNA and Ki-67 LFs), while in the antrum mucosa 
proliferation indices tended to correlate negatively with grade of gastritis 
(atrophic mucosa in the antrum showed lower Ki-67 LI). These findings are in
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accordance with the data of Bechi et al. [3], which suggest differences in the 
proliferative activity of epithelial cells between the mucosa of gastric antrum 
and corpus, but in contrast to the data of other authors, which show enhance­
ment of LI with increasing degrees of gastritis both in the antrum and in corpus 
mucosa [18, 27].
Proliferation rates of corpus glandular epithelia were not related to H. pylori 
status in our study. In the antrum glands, Ki-67 LI tended to be inversely related 
to higher H. pylori score as well as to gastritis score. The study of Chow et al. 
[7] showed too that H. pylori do not increase antrum cell proliferation. Reduced 
proliferative activity of antrum gland cells with increasing grade of atrophic 
gastritis is not an unexpected finding, because it represent gastritis harbouring a 
significant proportion of involutes glands in probable proliferative quiescence, 
since severe cell loss does not permit normal cell maturation and differentiation 
[3]. The contrasting findings in the gastric corpus, namely an increased proli­
ferative activity, especially in FC and GP, suggest that the corpus gland cell 
populations maintain active cell turnover despite reduction in cellular mass as 
established through grading criteria. Extension of the proliferative compartment 
with consequent displacement of proliferating cells to the epithelial surface has 
indeed been reported in advanced gastritis [12, 18]. Moreover, corpus gastritis 
may be in an earlier phase of inflammatory evolution compared with antrum 
gastritis, retaining still its proliferative repertoire: there is evidence that lesions 
in the antrum can be considered older than lesions in the corpus [27]. Indeed, in 
our group of patients, cases with atrophic antrum alterations prevailed over 
atrophic corpus alterations.
In the present study it was our aim to test whether cell protection from 
apoptosis is related to gastritis and H. pylori colonization. Immunoreactivity for 
the apoptosis protector, bcl-2 protein, was detected in a subset of gastric 
epithelial cells, mainly in the glandular neck region. The noteworthy finding of 
our study was that both glandular proliferation and bcl-2 protein reactivity were 
differentially expressed already in the normal (i.e. without chronic inflammation 
or atrophy of the glands) corpus and antrum mucosa. In normal corpus glands, 
the balance between cell proliferation and programmed cell death was 
manifested as lower PCNA and Ki-67 Li’s and higher bcl-2 protein staining of 
epithelial cells in GP compared with the atrophic mucosa. However, compared 
with atrophic glands, in the normal antrum mucosa the balance between cell 
proliferation and apoptosis was attained in a different way: there was a tendency 
for elevated cell proliferation and reduced bcl-2 protein staining of epithelial 
cells. In our study overall mean PCNA LI too was significantly higher in the 
antrum than in the corpus. This finding may support the evidence for the 
presence of a different environment in the antrum and corpus mucosa [45], as 
well as dissimilarities in antrum and corpus regarding the interaction of the 
bacterium and host [42].
For the atrophic corpus mucosa, we established higher proliferation index, 
compared with the respective index for normal corpus glands, and simultaneous
increase in bcl-2 positivity of interstitial lymphocytes. While upregulation of the 
bcl-2 as apoptosis protector factor suggests reduced apoptosis, its association 
with prolonged higher proliferation activity can be regarded as a factor 
contributing to development of MALT lymphoma and carcinogenesis [2, 26]. A 
positive correlation of positive staining for bcl-2 in interstitial lymphocytes of 
the corpus with grade of gastritis may also indicated that these lymphocytes are 
protected from programmed cell death and may hence be responsible for 
increase in chronic inflammation.
The lower Ki-67 proliferation index for the atrophic antral mucosa was 
associated with more frequent bcl-2 protein staining of epithelial cells in the 
neck part of glands (PZ) than in the normal mucosa, which indicates possible 
protection from cell loss and thus may reflect an important mechanism for 
retaining the renewal potential of antrum glands [26].
Concerning specific gastric cells, the present investigation shows that antral 
G and D cell densities decrease significantly already in the stage of non- 
atrophic gastritis and reach a minimum in atrophic gastritis. This finding 
confirms previous data demonstrating a decrease in G cells, particularly in 
atrophic gastritis [11, 30, 44, 52]. We detected only a few G and D cells in the 
corpus, predominantly in atrophic areas, probably in the transition area between 
the antrum and the corpus. In our study the presence of H. pylori tended to be 
associated with decrease in G and D cell density in the antrum, however, this 
decrease was significantly affected by advanced grade of atrophic gastritis. Our 
results are consistent with observation of Wyatt et al. [52] who also found 
significantly fewer gastrin cells in H. pylori positive patients whereby this 
decrease was positively correlated to the degree of antral atrophic gastritis. The 
lower density of D-cells in H. pylori positive antrum mucosa found in our study 
is in agreement with the evidence that H. pylori induces reduction of 
somatostatin cells [32, 34, 35, 48].
Concerning the third type of specific gastric cells, p~ H+, K+ ATP-ase — 
reactive parietal cells, we found that their density was rather dependent on the 
grade of atrophic gastritis. Atrophy in the corpus mucosa may represent a more 
powerful factor for inducing decrease in specific cells, and advanced stages of 
mucosal atrophy exhibit depletion of specific cells irrespective of H. pylori 
status.
In conclusion, the severity of gastritis and H. pylori colonization influence 
gastric epithelial cell proliferation and the expression of bcl-2 differently in the 
antrum and corpus mucosa. In the corpus mucosa, proliferation activity and the 
expression of bcl-2 in interstitial lymphocytes was significantly higher in 
atrophic than in non-atrophic gastritis, but did not dependent on H. pylori 
density. In contrast the antral mucosa proliferative activity showed a tendency 
toward a negative association with severity of gastritis, and the expression of 
bcl-2 positive interstitial lymphocytes was more associated with H. pylori 
density. Homeostasis of antral G and D cells as well as loss of |3- H+, K+ ATP-
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ase — reactive cells in the corpus was shown to be a rather a function of degree 
of atrophic alterations than of H. pylori.
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Table 1. State of antral and corpus mucosa and grade o f H. pylori colonization in the studied patients.
State of gastric mucosa ANTRUM CORPUS
H. pylori grade H. pylori grade
n Absence Mild Moderate Severe n Absence Mild Moderate Severe
Normal (grade 0)
(no chronic inflammation, 4 4 0 0 0 11 10 1 0 0
no atrophy)
Non-atrophic gastritis
(grade of chronic 
inflammation): 
mild (0.5) 9 9 0 0 0 15 8 2 4 1
moderate (1.0) 11 6 3 1 1 6 3 0 0 nJ
severe (1.5) 8 1 3 3 1 5 2 0 3 0
Atrophic gastritis
(grade of atrophy): 
mild (2.0) 15 7 4 3 1 0 0 0 0 0
moderate (3.0) 2 0 0 0 2 2 2 0 0 0
severe (4.0) 7 4 1 2 0 4 4 0 0 0
Total 56 31 11 9 5 43 29 3 7 4
Table 2. PCNA and Ki-67 LI in different parts of antral and corpus glands and their relation to gastritis and H. pylori status.
State of gastric ANTRUM CORPUS
mucosa PCNA LI Ki-67 LI PCNA L I Ki-67 LI
FC PZ GP FC PZ GP __ FC PZ riDVJ1 FC PZ GP
Normal 0.8+0.4 8.5±7.3 1.5±1.2 0.310.3 7.3±7.8 0.9±0.7 2.212.0* 9.2+8.8 0.9+0.8n 0.6+0.7 4.414.8 0.110.34-
(grade 0) 
Non-atrophic 
gastritis (chr. 2.6+2.3 12.818.7## 2.6±3.9 1.3+1.4 8.3±7.4 0.6±1.3 3.212.3** 7.5+5.9# 0.9+1.3n 1.2+1.0 5.314.1 0.711.0
inflammation 
grades 0.5-1.5) 
Atrophic 
gastritis (atrophy 3.0±3.1 + 11.5+5.5 3.1+3.3 1.5+2.0 5.1+4.3 0.5±0.7 10.0+10.9* 12.6+6.6 3.2+1.7oa 1.80±1.7 7.016.2 0.911.24-4-
grades 2-4) 
H. pylori + 2.2+1.8 11.6±7.5 2.6±4.2 1.5±2.0 5.7±4.6 0.4+0.7 2.9±2.3 9.7±8.6 1.2+1.7 1.5+1.2 4.913.3 0.611.1
H. pylori - 3.0+3.1 12.3±7.5 2.9±2.8 1.1+1.3 7.8±7.4 0.711.2 4.5±6.0 8.1±6.0 1.4+1.4 0.9+1.0 5.515.1 0.510.8
Totally 2.712.6 12.017.4* ★ 2.7±3.5 1.311.6 6.9±6.3 0.6±1.0 3.9+5.1 8.716.9* 1.3+1.5 1.111.1 5.714.9 0.510.8
Significant difference: in corpus: •  > * p= 0.03 (as compared to normal); • > ** p= 0.007 (as compared to non-atrophic gastritis); 
aa > a p= 0.001 (as compared to normal and non-atrophic gastritis); > 4- p=0.04 (as compared to normal). 
Significant difference: between antrum and corpus: ## > # p= 0.01; •  > +  p= 0.009; ★★ > ★ p= 0.02;
Table 3. Number of cases with bcl-2 positive staining o f epithelial cells (EC) and mean score of bcl-2 stained interstitial lymphocytes (IL) 
in different parts of antral and corpus glands and their relation to gastritis and H. pylori status.
State of gastric ANTRUM CORPUS
mucosa Foveolar cells Proliferating
zone
Glandular part Foveolar cells Proliferating zone Glandular part
EC IL EC IL EC IL EC IL EC IL EC IL
Normal 0/4 0.0±0.0 0/4 1.0±0.7 1/4 0.2±0.5 0/11 0.09±0.3 0/11 0.2±0.6 3/11 0.0±0.0
Non-atropic gastritis 0/27 1.3+1.3 1/28 2.3±1.2 1/28 2.3+1.3 0/24 0.9+0.9Q 2/25 1.6±1.1* 2/25 0.9±1.0#
(chr. inflammation 
grades 0.5-1.5) 
Atrophic gastritis 0/23 1.3±1.4 4/23 2.3±1.2 1/23 1.7+1.3 0/6 2.1±1.6an 1/6 2.8±1.5*» 0/6 3.2+1.7##
(atrophy grades 2-4) 
H. pylori + 0/23 1.411.4 2/24 2.7±0.8* . 0/24 2.1±1.3 0/12 0.9±1.0 0/13 1.8±1.2 1/13 0.6±1.0
H. pylori - 0/31 1.4+1.1 3/31 1.9+1.3** 3/31 00 1+ u> 0/29 1.3±1.1 3/29 1.6±1.3 4/29 1.5+1.4
Total 0/54 1.3+1.2 5/55 2.3±1.24 3/55 1.9±1.3 0/41 1.1+1.1 3/42 1.7±1.24> 5/42 1.2±1.3
Significant difference: in antrum: * > ** p=0.02 (as compared to H. pylori -); in corpus: aa > a p= 0.01; • •  > • p=0.01 (as compared to 
non-atrophic gastritis); ## > # p=0.002 (as compared to non-atrophic gastritis);
Significant difference between antrum and corpus: ♦ > ♦ ♦ p=0.02.
Table 4. Number o f specific cells and grade of gastritis in H. pylori positive and H. pylori negative antrum and corpus mucosa (mean±SD).
Specific cells and state of 
gastric mucosa
ANTRUM CORPUS
Gastrin cells FAT/pnlpr paIIc± U V VU1U1 VV11J T^ r*o1ifarotinrr 7Atia a i u iiiv i uiiiig zjviiv nionHTilpr noH- vj iuiiuuiui pui i PrvA/^ r\1 ar /-*a11o a vy v w iu i wviij T^ rrvlif^ ratincr '7r\n&1 X U111V1 UHllfi ZjV/IIW Glandular part
Normal 0 54.2±46.5* 5.5±6.5 0 0.2±0.6 0
Non-atrophic gastritis 0.3±0.3 26.5+20.4** 2.9±3.3 0 0.7±2.1 0.9±2.4
Atrophic gastritis 0.4±0.6 21.6±20.8*** 2.8±4.2 0 2.1±3.2 2.6±5.1
H. pylori + 0.2±0.3 20.6±20.0 2.4+2.4 0 0.1±0.1 0.1±0.2
H. pylori - 0.4+0.5 30.9±25.9 3.6±4.7 0 1.5±3.0 1.2+3.1
Somatostatin cells
Normal 0.1+0.1 14.1±10.5a 0.7±0.4 0 1.3±1.8 0.9±2.2
Non-atrophic gastritis 0.1±0.2 7.2+4.4na 1.1+1.5 0.1±0.1 0.6±1.2 0.6±0.9
Atrophic gastric 0.2±0.7 4.1±3.1ööd 0.8±0.9 0.1±0.1 1.9±2.5 0.9±1.6
H. pylori + 0.1±0.2 5.1±4.3 1.0±0.9 0 0.5+1.1 0.7±1.1
H. pylori — 0.2±0.6 7.4+5.7 0.8±1.4 0.1±0.1 1.2±1.7 0.8+1.5
(3-H+, K+ ATP positive 
cells
Normal nd nd nd 0.2±0.4 100.6+26.7* 35.1+23.0
Non-atrophic gastritis nd nd nd 0 84.7+27.8»» 39.6+18.3
Atrophic gastritis nd nd nd 0 22.8±23.7*** 2.0±4.0
H. pylori + nd nd nd 0 89.7+30.5 40.2±13.2
H. pylori - nd nd nd 0 76.8±37.1 31.8+24.5
Significant difference in antrum: * > ** p=0.04 (as compared to non-atrophic gastritis); * > *** p=0.02 (as compared to atrophic gastritis); 
a > aa p=0.02 (as compared to non-atrophic gastritis); a > aaa p= 0.0005 (as compared to atrophic gastritis); in corpus: • > • •  p= 0.0001 
(as compared to non-atrophic gastritis); • > • • •  p= 0.0004 (as compared to atrophic gastritis).
Table 5. Comparison o f the antrum and corpus in relation to proliferation activity, expression o f bcl-2 and density of specific cells ii 
association with gastritis and H. pylori colonization.
ANTRUM CORPUS
Gastritis and H. pylori Correlation with H. pylori score (p=0.006)
Atrophic gastritis More cases of atrophic gastritis in comparison with
corpus (11/31; 35%); p=0.02
Proliferation activity:
PCNA LI Overall mean PCNA LI higher than in corpus
(p=0.02)
No correlation with gastritis score
Tendency to negative correlation with H. pylori score
(r=-0.23;p=0.09)
Ki-67 LI No correlation with gastritis score
No correlation with H. pylori score 
Bcl-2 positive interstitial No correlation with gastritis score, 
lymphocytes Tendency to positive correlation with H. pylori score
(r=0.29; p=0.08)
Overall mean bcl-2 positive staining score higher than 
in corpus (p=0.02)
Bcl-2 positive epithelial 4/8 cases of positive staining localized in atrophic 
cells proliferating zone
G and D cell density Negative correlation with gastritis score
(r= -0.36; p= 0.009)
Tendency to negative correlation with H. pylori score 
(r= -0.24; p= 0. 06)
|3- H+, K+, ATP-ase 
positive cells
No correlation with H. pylori score (p=0.37)
Less cases of atrophic gastritis in comparison with 
antrum (6/43; 14%)
Overall mean PCNA LI lower than in antrum
Correlation with gastritis score (r= 0.46; p=0.001) 
No correlation with H. pylori score
Correlation with gastritis score (r= 0.46; p=0.01) 
No correlation with H. pylori score 
Correlation with gastritis score (r=0.37; p=0.01) 
No correlation with H. pylori score
Overall mean bcl-2 positive staining score lower 
as in antrum
3/8 cases o f positive staining localized in normal 
foveolar cell compartment (no chronic 
inflammation, no atrophy)
Negative correlation with gastritis score 
(i= -0.53; p= 0.0009)
No correlation with H. pylori score
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